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 Zusammenfassung 
 
 
Die weitgehenden Entwicklungen im Bereich der homogerner Katalyse zeigt die wichtige Rolle 
von Goldkatalysatoren als carbophile Lewis-Säure. Auf Grund des starken relativistischen Effekts 
besitzt Gold diese Koordinationseigenschaften. Sowohl Gold(I) als auch Gold(III) können 
ungesättigte funktionelle Gruppen aktivieren, was Zugang zu einer weiten Palette an 
Transformationen gibt. Abgesehen von dessen Eigenschaft als Lewis-Säure, kann Gold auch für 
Ringerweiterungen eingesetzt werden. 
Eine ausgereifte Strategie für den Zugang hoher Struktordiversität ist die Anwendung von 
Propargylcarboxylaten in katalytischen Prozessen, bei denen die Carbonylgruppe als Nukleophil 
ein metall-aktiviertes Alkin angreift. Auf Grund des modularen Aufbaus, können verschiedene 
zusätzliche  funktionelle Gruppe einfach eingefügt werden. Dies kann auch bei intramolekulare 
Reaktionen eingesetzt werden um hochgradig funktionalisierte Verbindungen zu erhalten. 
Diese Doktorarbeit beschreibt neue methodologisch ausgearbeitete übergangsmetalle-katalysierte 
Verfahren wie Cycloisomerisierungen von  δ+ stabilisierend funktionalisierten 
Cyclopropylringsystemen, was neue Zugänge für die Synthese strukturell komplexen Molekülen 
gibt. 
Im ersten Teil dieser Arbeit wird die Weiterentwicklung  Gold katalysierten Cyclopropylring 
Erweiterung durch Alkene und Alkine beschrieben. Eine höchst effiziente Methode für die 
Synthese von (Z)-5-Alkylidene-cyclopent-1-enyl Acetaten, Cyclohexanonen und 
Cyclopentylketonen, beinhaltend einer neuen intramolekularen Acyl Migration zu nukleophielen 
Au(I)-C(sp2) Bindungen,  konnten unter milden Bedingungen entwickelt werden. Um die Natur 
der involvierten Zwischenprodukte zu verstehen, wurden mechanistische Studien durchgeführt. 
Zusammenfassend kann gesagt werden, dass die Umlagerungen kationischer Natur sind. Auf 
Grund des hohen Grades der Transformation der Stereoselektivität kann gesagt werden, dass 
goldstabilisierte nicht-klassische Carbokationen mit einer gewissen strukturellen Stabilität, 
involviert sind. 
Im zweiten Teil, zwei hoch diastereoselektive Au-katalysierte 3-Schritt Kaskade Prozesse  für die 
Synthese von hochgradig substituierten Fünferringe und Siebenerringe ausgehend von Propargyl 
Acetaten und Alkenen oder 1,4-Dienen wurden entwickelt. Die Reaktion bevorzugt die Bildung 
des trans-2,3-disubstituierte Cyclopentylacetats durch einen carbokationischen 
Übergangszustands, während durch die Gold katalysierte Cope Umlagerung das cis-2,3-
disubstituierte Cyclopentylacetat gebildet wird. Die konzertierte Natur des letzten Prozesses 
erlaubt eine alternative formelle enantioselektive Synthese von Frondosin A und B. 
 Im letzten Teil dieser Arbeit wird die Anwendung von Gold als Lewis-Säure für die Aktivierung 
von Cyclopropylalkinen gegenüber verschiedener Nukleophielen beschrieben. Hochsubstituierte 
Tetrahydrocarbazole wurden nach einer Sequenz erhalten, welche einen Gold katalysierten 
nukleophielen Angriff des heteroaromatischen Nukleophils in der Gegenwart stabilisierten 
Cycloprpylring enthaltenden Alkinen. Eine tiefgehende mechanistische Studie wurde 
durchgeführt, um diese Transformation besser zu verstehen und  hauptsächlich die 
Regioselektivität dieses Prozesses zu erklären. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Summary 
 
 
The largest developed area in homogeneous catalysis comprises the use of gold as a carbophilic 
Lewis acid due to the strong relativistic effects governing its coordination behavior. Both gold(I) 
and gold(III) complexes are able to activate unsaturated moieties, triggering a broad palette of 
transformations. However, beyond its Lewis acidity, gold has also proved to be extremely 
powerful in triggering ring-expansion processes to introduce structural complexity into organic 
molecules. 
A mature strategy to access a large structural diversity is the use of propargylic carboxylates in 
catalytic processes, where the carbonyl group acts as a nucleophile onto the metal-activated 
alkyne complex. Due to their easy and modular preparation, various additional functional groups 
can be readily incorporated to decorate the core structure and, importantly, be rendered to 
participate in reactions in an intramolecular manner, therefore offering highly functionalized 
products and increasingly diverse reaction manifolds. 
The work described in this thesis is dedicated to the development of new methodologies catalyzed 
by late transition metals involving cycloisomerizations of cyclopropyl rings bearing groups δ+ 
stabilizing that have opened new venues for the synthesis of structurally complex molecules. 
In the first part of this thesis we report our investigation into the cyclopropyl ring expansion 
driven by Au-activation of alkynes and allenes. A highly efficient method for the synthesis of  
(Z)-5-alkylidene-cyclopent-1-enyl acetates, cyclohexenones and cylopentenyl ketones has been 
developed under mild conditions, featuring a novel intramolecular acyl migration to nucleophilic 
Au(I)-C(sp2) bonds.  Mechanistic studies have been performed in order to get a better 
understanding of the nature of the intermediates involved in these transformations. Although the 
rearrangements are cationic in nature, the high degree of stereochemical information transfer in 
these reactions suggests that gold-stabilized nonclassical carbocations with a certain 
configurational stability are involved. 
In the second part, two highly diastereoselective Au-catalyzed 3-step cascade processes for the 
synthesis of highly substituted 5- and 7-membered rings from propargyl acetates and alkenes or 
1,4-dienes, were investigated. The reaction favors trans-2,3-disubstituted cyclopentenylacetates 
through a tightly bound carbocationic transition state whereas the gold-catalyzed Cope 
rearrangement delivers cis-2,3-disubstituted cycloheptenylacetates. The concerted nature of the 
last process has allowed an alternative formal enantioselective synthesis of frondosins A and B. 
In the last part of this thesis, we investigated on the use of gold as a Lewis acid for the activation 
of cyclopropylalkynes towards a variety of nucleophiles. Highly substituted tetrahydrocarbazols 
are obtained in a sequence that involves the gold-catalyzed nucleophilic attack of heteroaromatic 
nucleophiles in the presence of stabilized cyclopropyl rings bearing alkyne moieties. An in-depth 
 mechanistic study to better understand these transformations is also performed, particulary those 
aspects related to the regioselectivity of the process. 
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CHAPTER 1 
Introduction 
1.1. Introduction 
 1.1.1 An historical perspective  
 From the very early days, gold has fascinated mankind. The symbol of gold (Au) is 
coming from the Latin “aurum” and its discovery is not associated to any chemist. Alchemist 
were convinced metals were present in nature just as precursors of gold, as gold was consider to 
be the most perfect metal and nature always strives for perfection. Gold is a dense, soft, shiny, 
malleable and ductile metal. Pure gold has a bright yellow color and luster traditionally 
considered attractive, which it maintains without oxidizing in air or water. For a long time, gold 
was considered to possess only low catalytic activity1 and therefore only its stoichiometric 
coordination and organometallic chemistry was investigated intensively. However, in the last two 
decades, the use of gold as catalyst in homogeneous and heterogeneous systems has grown 
exponentially.2 
 Nowadays, the most successful area in gold homogeneous catalysis falls into the ability of 
gold to coordinate and activate unsaturated moieties such as alkenes, alkynes, allenes or even 
arenes due to the strong relativistic effects governing its coordination chemistry.3 
  1.1.2 Basic concepts of carbophilic activation: alkynophilicity and π-acidity  
 The Dewar-Chatt-Duncanson (DCD) model is a qualitative model in organometallic 
chemistry that explains the type of chemical bonding between an alkene or alkyne and a metal (π-
complex) in certain organometallic compounds.4 The bond between the metal and the ligand is 
consider as a donor-acceptor interaction between the two closed-shell fragments assuming that a σ 
bond is formed by overlapping of the π system of the ligand (alkene or alkyne) with an empty 
metal orbital of suitable symmetry.5 Two contributions in plane as well as two contributions out 
of plane are found in d10-gold complexes (Scheme 1). 
Scheme 1. Qualitative DCD diagram for a metal-alkyne bond 
 
 The in-plane interactions represent the major contributions of this bonding situation: σ-
symmetric M←L donation arises from the overlapping between the π orbital of the ligand with an 
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empty orbital (dz2) of the metal. π-Symmetric M→L back-donation occurs by donation of electron 
density from the filled dxz orbital of the metal into an anti-bonding π* orbital of the ligand. 
 On the other hand, the orthogonal, out-of-plane π orbitals can engage in M←L π 
donation, while mixing of an occupied d orbital of the metal and the empty π* orbital of the ligand 
can result in an additional component of M→L back-donation. The DCD model predicts a partial 
rehybridization and an elongation of the double or triple bond as a consequence of the net shift of 
elelctron density from the bonding π orbital into the antibonding π* orbital. Indeed, withdrawal of 
electron density from any metal that binds to an unsaturated C-C bond makes it more electrophilic 
and thereby can be defined as a π acid.  
 Minor changes in the C-C bond length between the coordinated and the free ligand are 
observed. In addition, the C atoms present a near linear or near trigonal coordination geometries 
for alkyne and alkene respectively, with low degrees of rehybridation. Due to the overall 
depletion of electron density, the alkyne or alkene ligand is susceptible to nucleophilic attack to 
form alkenyl- or alkyl metal complexes respectively. However, the mechanism of nucleophilic 
attack to a coordinated olefin or alkyne has been the subject of much controversy. The 
alkynophilicity of the gold catalyst reflects the preference of the incoming nucleophile for attack 
at the coordinated triple bond. 
 Computational studies have showed that for various model complex-ligand systems the 
transition state for nucleophilic addition reactions are not near the equilibrium η2 structure. It is 
now accepted that the non symmetric contribution of each of the carbons of the π moiety is 
enhanced upon η2 → η1 deformation (slippage), facilitating charge transfer from the nucleophile 
to the π ligand and finally to the metal center (Scheme 2).6 
Scheme 2. Schematic representation of slippage 
 
1.2. Non-Classical Carbocations: From Controversy to Convention 
 1.2.1 Classical carbocations 
 A cornerstone of the classical theory of structural chemistry since the time of Kekulè in 
the XIX century is that carbon can bind at most four other atoms (tetra-coordination). A 
carbocation (carbonium ion) is an ion with a positively-charged carbon atom. The charged carbon 
atom in a carbocation has only six electrons (“sextet”) in its outer valence shell instead of the 
eight valence electrons (“octet”). Therefore carbocations are reactive forms that are seeking to 
fulfill the octet of valence electrons to gain a neutral charge. Carbocations present a sp2 
hybridization with a trigonal planar geometry (Scheme 3). 
Scheme 3. Representation of a carbocation 
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 Carbocations are intermediates in several kinds of reactions,7 and are classified as 
primary, secondary and tertiary depending on the number of carbon atoms bonded to the ionized 
carbon. The stability order can be explained by inductive effect, which is the transmission of 
charge through a chain of atoms by electrostatic induction, and by hyperconjugation, which is the 
interaction of the electrons in a sigma bond (usually C-H or C-C) with an adjacent empty non-
bonding or antibonding orbital. In the polar or inductive effect, nonconjugated substituents exert 
an influence on stability through bonds (inductive effect) or through space (field effect). Tertiary 
carbocations presents a greater polar effect that leads to great stability (Scheme 4). 
  According to the hyperconjugation model, is seems that the primary ion has only two 
hyperconjugative forms while tertiary has six. Furthermore, the greater number of resonance 
forms, the greater the resonance stability. 
Scheme 4. Order of stability of alkylcarbocations 
 
There are several structural types of delocalization which have been summarized in Table 1.8 
Table 1. Types of carbocation delocalization 
Entry Valence structures Shorthand Name 
1 ππ Simple conjugation 
2 σπ Hyperconjugation 
3 πσ Homoconjugation 
4 σσ Homohyperconjugation 
5 σπ/ππ Hyperconjugation/conjugation 
6 σπ/ σπ Double hyperconjugation 
 
 In the allyl cation, the simplest and most fundamental type of delocalization is found 
(Table 1, entry 1). This mode is based on the fact that both donor and acceptor orbitals are π-type, 
and the use of simple conjugation indicates that there are no intervening saturated atoms between 
donor and acceptor. When the donor is a σ bond, the phenomenon is called hyperconjugation 
(Table 1, entry 2). The effects of hyperconjugation are greater with better sigma donors such as 
Si-C rather than C-H or C-C bonds.9 The presence of a saturated atom between the donor and 
acceptor orbitals leads the homoconjugation (Table 1, entry 3). The orbital overlap is a mix of σ 
and π contributions due to the non-parallel relationship between each other.10 When a saturated 
center intervenes between a σ donor and the carbocationic acceptor, the phenomenon is called 
homohyperconjugation (Table 1, entry 4). This mode of delocalization is considered to be 
primarily direct and through space. In the hyperconjugation/conjugation mode of delocalization 
(Table 1, entry 5), the positive charge moves into the σ system through hyperconjugation and then 
into the π system through simple conjugation. The last entry in Table 1 ilustrates the concept of 
double hyperconjugation as two stages of hyperconjugation to bring the effect of the donor 
element to the empty π orbital.11 
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 1.2.2 Non-classical carbocations 
 Non-classical cations in organic chemistry are a special type of carbonium ions displaying 
delocalization of sigma bonds in 3-center-2-electron bonds of bridged systems. Around 1950, 
Winstein and Trifan found a short-lived carbocation that contained a penta-coordinated carbon 
atom. They observed that the solvolysis reaction in acetic acid of optically active exo-2-norbornyl 
brosylate 1 gave racemic mixtures of the two exo acetates 2 (Scheme 5).12 
Scheme 5. Solvolysis of exo- and endo-2-nobornyl brosylates 
 
 Furthermore, the exo-2-norbornyl brosylate 1 solvolyzed around 350 times faster that its 
endo isomer 3. These results were interpreted by means of the nonclassical intermediate 4, which 
was involved in the departure of the leaving group. Due to the non favorable position for backside 
attack, solvolysis of the endo isomer 3 takes place at normal rate compared to the exo isomer 1. 
Therefore the much faster rate for the solvolysis of 1 must be caused by anchimeric assistance of 
the neighboring σ bond. 
 The stereochemical outcome of the reaction was explained by the intermediacy of 5. In 
this intermediate, positions 1 and 2 are equivalent and would be equally attacked by the 
nucleophile only from the exo direction (Scheme 6). 
Scheme 6. Wistein’s postulate 
 
 Winstein postulate that a classical ion 4 is formed after the release of the leaving group in 
1 and then converted into the more stable carbocation 5. 
 This pioneering and controversial discovery initiated a vigorous academic dispute. The 
concepts of σ participation and the nonclassical ion 5 were challenged by H. C. Brown.13 He 
concluded that the norbornyl cation was a tri-coordinated cation (carbenium ion) that rapidly 
rearranged into an identical tri-coordinated ion in which the positive charge had moved to another 
carbon atom in a rapid equilibrium (Scheme 7).14 
Scheme 7. Brown’s hypothesis 
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 Despite great efforts by many leading physical organic chemists, the problem remained 
unsolved until Olah’s method of preparing long-lived carbocations was applied.15 This method 
consisted in the preparation of stable carbocations using a new type of extremely acid compounds 
(superacids) as solvent at low temperatures. Olah and coworkers represented the nonclassical 
structure as a corner-protonated nortricyclane 6, whose symmetry is better seen in 7 (Scheme 8). 
Scheme 8. Olah’s representation of nonclassical cation 
 
 In these structures, almost all the positive electron density resides on C-1 and C-2 and few 
on the bridging carbon C-6. Other evidence for the nonclassical nature of 2-norbornyl cation 
comes from the experiment that show that the 2-norbornyl cation is more stable (6-10 Kcal/mol) 
than would be expected without the bridging.16 Infrared spectra experiments of the 2-norbornyl 
cation in gas phase also point towards a nonclassical structure.17 Ab initio calculations have 
showed that the nonclassical structure corresponds to an energy minimum.18 
 
 1.2.3 Other important non-classical carbocations 
 The participation of a C=C double bond as a neighboring group represents another class 
of nonclassical carbocation. In this context, the most striking evidence that the C=C double bond 
acts as a neighboring group is the fact that the acetolysis of 8 is 1011 times faster than that of 9 and 
proceeds via retention of the configuration.19 The rate of acetolysis of 8 involves the formation of 
a nonclassical intermediate 10, with the strong evidence that the C=C group assists the departure 
of the OTs group. In this system, the double bond is geometrically fixed in a favorable position 
for backside attack on the carbon bearing the leaving group (Scheme 9).  
Scheme 9. C=C bond as neighboring group 
 
 1H-NMR studies of norbornadienyl model system 11 proved the nonequivalence of the 
protons bonded to the alkenylic carbons 2,3 and 5,6 in the norbornenyl cation 12. Thus, an 
evidence for the existence of this nonclassical carbocation 12 is that there is interaction between 
the charged carbon atom and one double bond (Scheme 10).20 
Scheme 10. Norbornenyl cation model 
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 Apart from the 2-norbornyl case, the cyclopropylmethyl system represents another 
important class of this special type of carbocations. Cyclopropylcarbinyl benzenesulfonates 13 
solvolyze with high rates and the products include unrearranged cyclopropylmethyl as well as 
cyclobutyl and homoallylic compounds. In these systems, the participation of the σ bonds of the 
ring enhances the rate of solvolysis of simple primary cyclopropylmethyl substrates. In the 
symmetrically stabilized cation 14 formed in the reaction, both the 2,3 and 2,4 σ bonds help the 
stabilization of the generated positive charge (Scheme 11).21 
Scheme 11. Cyclopropylmethyl cation system 
 
 Phenonium ion is another important figure in the context of nonclassical carbocations. 
There is a great deal of evidence that aromatic rings in the β position of a leaving group can act as 
neighboring groups.22 Solvolysis rates of L-threo-3-phenyl-2-butyl tosylate 15 in acetic acid have 
been extensively studied. 23 The aryl group behaves as neighboring group pushing out the leaving 
group to give the bridged ion 16 (phenonium ion). The stereochemical outcome of this reaction is 
an evidence of the formation of these type of intermediates (Scheme 12). The solvolysis reaction 
of 15 afforded 96% of the threo isomer and only about 4% of the erythro. Moreover, both the (+) 
and (-) threo isomers were produced in approximately equal amounts. When the reaction is 
conducted in formic acid, even less erythro isomer was obtained. This result leads to the 
conclusion that configuration is retained because phenyl group acts as neighboring group. 
Scheme 12. Solvolysis of L-threo-3-phenyl-2-butyl tosylate 15 
 
 
1.3. Rearrangement of Propargyl Carboxylates 
 1.3.1 General considerations 
 Homogeneous gold catalysis is currently undergoing an impressive renaissance centered 
on alkyne activation and subsequent functionalization.24 A growing area of research concerns the 
use of propargylic carboxylates in catalytic processes. The nature of such substrates is 
complementary to the pull-push reactivity of metal-activated alkynes. Upon coordination to the 
alkyne, gold can effiently activate propargyl carboxylates  (I) towards two competitive processes 
that seem to be mechanistically related: 1,2-acyloxy migration and/or [3,3]-sigmatropic 
rearrangement (Scheme 13).25 
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Scheme 13. 1,2-acyloxy migration vs. [3,3]-sigmatropic rearrangement 
 
 Notably, the propensity of these easily accessible compounds to undergo a migration of 
the carbonyloxy group leads to the formation of a gold vinyl carbenoid species III via 1,2-
migration of the acetyl moiety in which both the ester and the π system have migrated from their 
original positions whereas allenyl acetates V are formed via [3,3]-sigmatropic rearrangement. 
Allenyl acetates V can be formed in a single process or stepwise by a second acetate migration 
from the corresponding carbene intermediate III.26 In presence of the gold catalysts, allenyl 
species V can be further activated opening a broad palette of chemical transformations. 
Substitution patterns on the propargyl moiety play an essential role in dictating the reaction 
pathway. It is widely accepted that terminal or electron-poor alkynes react via 1,2-acyloxy 
migration,27 whereas internal alkynes prefer the 1,3-migration pathway.28 
 
 1.3.2 1,2-Acyloxy migration 
 In 1976, Günter Ohloff reported the first example of a rearrangement of propargyl 
acetates mediated by stoichiometric amounts of Zn-salts.29 Ten years later, Valentin 
Rautenstrauch, reported a related Pd-catalyzed cyclization of 1-ethynyl-2-propenyl acetates 17 to 
give cyclopentanones 19 postulating the formation of a Pd-carbene intermediate 18 (Scheme 
14).30  
Scheme 14. Rautenstrauch cyclization 
 
 Twenty years later, Toste and coworkers revisited this chemistry using enantiomerically 
pure propargyl acetates and gold(I) complexes.31 These authors observed that the stereochemical 
information in the propargyl position of the starting material 20 was transferred into the final 
Chapter 1 
 
10 
 
product 22. The high degree of enantioselectivity observed in these rearrangements suggests that a 
mechanism involving C-C bond formation prior to scission of the stereogenic C-O bond is 
operating (Scheme 15). DFT calculations suggest that this reaction would be classified as the 
intramolecular attack of an enol acetate (with some additional charge donation from the gold 
complex) to an allyl cation, involving the imprint of the chiral information of the original 
stereocenter in the helical conformation of a pentadienyl cation 21.32 
Scheme 15. Toste’s synthesis of substituted cyclopentenones 22 
 
 Indirect proof for the intermediacy of a carbene intermediate III was provided by its 
interception in presence of different reagents as shown in the following sections.  
 1.3.2.1 1,2-Acyloxy migration and olefin cyclopropanation 
 One of the first transformations providing evidence of the implication of gold carbenes in 
the gold-catalyzed rearrangement of propargyl acetates is shown in Scheme 16. The gold-carbene 
reacts with monosubstituted olefins to afford vinylcyclopropanes such as 24 and 26.33 The 
intermediacy of a planar intermediate formed in the reaction is supported by the use of 
enantiomerically enriched propargyl carboxylates 23. As expected, a lack of configuration 
transfer affords racemic products 24. However, good levels of asymmetric inductions can be 
reached when using chiral cationic gold complexes with racemic propargyl pivaloates 25 in the 
synthesis of cyclopropyl pivaloate 26 (Scheme 16).34 Moreover, similar reactivity was observed in 
reactions of vinyl esters and vinyl sulfonamides with terminal propargyl esters for the synthesis of 
highly substituted cyclopropane derivates.35 
Scheme 16. Olefin cyclopropanation 
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 Replacing the olefin with cyclopentadiene rings 27 resulted in the formation of mixtures 
of vinylcyclopropanes 28 and cycloheptadienyl acetates 29 (Scheme 17).36 A mechanism that 
involves a gold-catalyzed 1,2-acyloxy migration followed by an intermolecular [4+3] 
cycloaddition is proposed. Vinylcyclopropanes 28 can be converted into the corresponding 
cycloheptadienyl acetates 29 through a Cope rearrangement by heating the solution in toluene for 
12 hours. The use of furan as a diene counterpart affords the formation of the corresponding 7-
membered ring 30 and the triene aldehydes 31. The same reactivity has been demonstrated in the 
presence of ruthenium catalysts.37 
Scheme 17. Cyclopentadiene and furan cyclopropanation of propargyl esters 
 
 Independently, Fürstner38 and Fehr39 demonstrated earlier on the synthetic potential of 
propargyl acetate rearrangements in the stereocontrolled synthesis of (-)-cubebol and related 
products via 1,2-acetoxy migration followed by intramolecular cyclopropanation (Scheme 18). 
Two possible mechanistic pathways were proposed to justify the experimental results: either the 
olefin reacts before the acetoxy migration via vinyl gold species 32, or alternatively the 
nucleophilic attack of the olefin takes place prior the migration of the ester moiety leading 
cyclopropyl carbenes type 33. Thus, either 32 or 33 could justify the observed stereochemical 
configuration transfer in the above-mentioned process. 
Scheme 18. (-)-Cubebol synthesis 
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 1.3.2.2 1,2-Acyloxymigration and annulations 
 A rapidly developing area involves the use of gold intermediates generated from 1,2-
rearrangement of propargyl esters with a huge palette of dipolarophiles in a intermolecular fasion. 
In these reactions, the gold intermediate showed analogous reactivity to that reported for 
electrophilic metal-stabilized vinylcarbenoids.40 
 Based on this concept, the group of Toste has developed a gold(III)-catalyzed tandem 
process that involves 1,2-acyloxy migration/intermolecular [4+3] annulation for the 
straightforward synthesis of azepines 36.41 The authors envisioned, in analogy to related reactions 
of rhodium-stabilized vinylcarbenoids, that the generation of zwitterionic intermediates 35 could 
be accomplished by the reaction of gold-carbene 34 with a nucleophilic diene, such as an α,β-
unsaturated imine. A proposed mechanism that accounts for the observed diastereoselective is 
proposed. Gold-promoted isomerization of the propargyl ester leads to gold-carbenoid 
intermediate 34. Subsequent nucleophilic addition of the imine nitrogen generates the allylgold 
intermediate 35 that undergoes intramolecular nucleophilic addition onto the pendant iminium 
electrophile (Scheme 19). 
Scheme 19. Gold-catalyzed synthesis of azepines 36 
 
 Polysubstituted benzenes can be selectively obtained under catalysis control via [2+2+2] 
cyclotrimerization of alkynes42 or through metal-catalyzed [4+2] cycloaddition of enynes and 
activated alkynes.43 Additionally, readily available enynes 38 and propargyl esters 37 can be 
selectively transformed into styrenes 40 and fluorenes 41 through a gold-catalyzed intermolecular 
annulation processes by choice of the appropriate reaction conditions (Scheme 20).44 
Scheme 20. Gold-catalyzed synthesis of styrenes 40 and fluorenes 41 
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 The mechanistic rationale proposed by the authors involves first, a highly 
diastereoselective cyclopropanation between the propargyl ester 37 and enyne 38 for the 
formation of the cis-1-vinyl-2-alkynylcyclopropanes 39. Subsequent coordination of the gold 
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catalyst onto the gold-activated alkyne in 39 triggers the cyclopropyl ring opening affording 
styrenes 40 and fluorenes 41 in good yields. The outcome of this transformation was controlled 
simply through the choice of the catalyst counteranion. 
 The first example of a formal [3+3] cycloaddition reaction between a gold carbenoid 
derived from propargyl esters 42 and azomethine imine 43 was reported in 2009 for the synthesis 
of diazabicycles 44 (Scheme 21).45 The cis selectivity observed for these transformations can be 
explained by steric interactions between the methyl groups of the propargyl ester and the β-
substituent in the ring closing transition state 45. This process highlights the differences in the 
reactivity of alkenyl Fischer carbenes and the alkenyl gold-carbenoids generated in situ from the 
rearrangement of propargyl esters. The reaction of alkenyl Fischer carbenes with 1,3-dipoles 
typically proceeds via concerted [3+2] cycloaddition whereas alkenyl gold-carbenoids undergo 
the above mentioned [3+3] cycloaddition. 
Scheme 21. Gold-catalyzed [3+3] cycloaddition between propargyl esters 42 and azomethine 
imines 43 
 
 Propargyl esters-containing diynes have been employed in a number of rearrangement 
reactions,46 including the formation of cyclopropanes by an intramolecular cycloisomerization.27c 
In contrast, intermolecular cyclopropanations were not observed even in the presence of excess of 
olefin.27a Cationic phosphinegold(I) complexes catalyzed a tandem cyclopropanation/ 
hydroarylation process with propargyl ester-containing diynes 46 and styrenes for the synthesis of 
substituted benzonorcaradienes 47 (Scheme 22).47 
Scheme 22. Gold-catalyzed tandem cyclopropanation/hydroarylation 
 
 A mechanistic hypothesis is proposed for this transformation involving sequential 
rearrangements that proceed via gold(I)-promoted alkyne activation (Scheme 23). 1,2-Acyloxy 
rearrangement followed by 1,3-metallotropic rearrangement delivers the formation of 
intermediate 48. Cyclopropanation of styrene occurs selectively through carbenoid 48, affording 
intermediate 49 and regeneration of the catalyst. Subsequent gold-coordination to the alkyne in 49 
induces the nucleophilic attack by the arene onto the gold-activated alkyne complex leading to the 
formation of intermediate 50, which furnishes bezonorcaradiene 47 via proton transfer. 
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Scheme 23. Mechanistic proposal for the gold-catalyzed tandem cyclopropanation/hydroarylation 
 
 1.3.2.3 1,2-Acyloxymigration and attack by nucleophiles 
 To further examine the nature of the gold-carbenoid intermediates, one should explore 
their reactivity with reagents previously described to be reactive toward metal carbenes. In this 
context, an atom-economical functionalization of carbon nucleophiles under catalytic conditions 
using propargyl carboxylates has been reported by Echavarren.48 Propargyl carboxylates react 
with 1,3-dicarbonyl compounds and electron-rich arenes as nucleophiles in the presence of gold(I) 
catalysts to give enol carboxylates via α,β-unsaturated gold(I) carbenes formed by 1,2-acyl 
migration (Scheme 24). Although the factors that control the regioselectivity of the nucleophilic 
addition are still not totally understood, the authors observed that substrates bearing phenyl or 
gem-dimethyl groups at the propargyl position led to 1,2-addition products through α,β-
unsaturated gold(I) carbenes 53, whereas secondary propargyl acetates bearing a methyl group at 
the propargyl position or propargyl acetates with no substituents gave adducts 52 as a result of a  
1,3-acyl migration via intermediates 51. 
Scheme 24. Gold-catalyzed nucleophilic attack of 1,3-dicarbonyl and arenes onto gold-activated 
propargyl acetates 
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 The transition-metal-catalyzed decomposition of diazo compounds is a well established 
strategy to access metal carbenoids. The Doyle-Kirmse reaction is a powerful tool to generate 
new C-C and C-S bonds using diazo compounds with Rh(II) and Cu(I) catalysts (Scheme 25).49 In 
this process, an allylsulfide 56 reacts with the metal carbenoid 55 derived from ethyl diazoacetate 
54 to give a sulfur ylide intermediate 57 that is capable to undergo a [2,3]-sigmatropic 
rearrangement to deliver 58. However, in this context, the group of Davies50 reported a method 
that demonstrates that gold carbenoids derived from propargylic carboxylates can show a 
complementary mode of reactivity to carbenoids derived from the above mentioned α-diazo 
carbonyl compounds. 
Scheme 25.Comparation between Doyle-Kirmse reaction and Davies method. 
 
 Davies proposed the generation of a ylide 61, which can be explained via gold-catalyzed 
1,2-acyl rearrangement followed by the nucleophilic attack of the allyl sulfide 60 onto the gold 
carbene 59. The subsequent evolution of 61 into the final products proceeds through one of two 
pathways: a 1,2-shift or a [2,3]-sigmatropic rearrangement of the allyl fragment. An absence of 
chirality transfer was demonstrated in the reaction of enantioenriched starting materials, thus 
suggesting the intermediacy of achiral species 59. 
 Toste and coworkers have been able to intercept the putative carbene intermediates 
generated after pivaloate migration in propargyl pivaloates by oxidation with diphenyl sulfoxide 
to give the aldehydes 65. The gold carbenoid 64 that could be generated through gold(I)-induced 
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1,2-acyl rearrangement, can be trapped in the presence of an external oxidant, which undergoes 
intermolecular oxygen atom transfer to afford the aldehydes 65 with good selectivity in favor of 
the Z-olefin isomer (Scheme 26). 
Scheme 26. Gold-catalyzed synthesis of aldehydes 65 with diphenyl sulfoxide 
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 1.3.3 1,3-Acyloxy Migration 
 As it was shown in Scheme 12, when internal alkynes are used, a 1,3-migration of the 
ester moiety is generally observed. However, DFT calculations developed by Cavallo26 suggests 
that a net 3,3-rearrangement may be the result of two competitive 1,2-acyloxy migrations. Whilst 
the 1,2-acyl migration results in a variety of useful transformations, the corresponding 1,3-
migration of propargyl carboxylates also provide valuable opportunities in a preparative context. 
The lack of chemoselectivity observed for cationic gold catalysts generates significant limitations 
for this transformation: (a) the gold-catalyzed 3,3-sigmatropic rearrangement was not considered 
as a practical approach for allene synthesis due to the good reactivity of the gold-activated 
allenes; (b) the rapid equilibrium between alkyne and allene under the reaction conditions caused 
poor stereoselectivity due to the rapid racemization of the propargyl stereocenter.  
 In absence of nucleophiles, the in situ generated allenyl acetate reacts with the gold 
catalyst affording vinyl-gold intermediates type VI (Scheme 13). Different types of reactivity can 
be observed for this intermediate depending on the substrate used in the transformation. Zhang 
and coworkers developed a highly efficient method for the synthesis of α-ylidene-β-diketones 68 
via gold(III)-catalyzed [3,3]-sigmatropic rearrangement of propargyl esters 66 (Scheme 27).51 
They observed that, after [3,3]-sigmatropic rearrangement, intermediate 67 underwent to an 
intramolecular 1,2-acyl migration to the nucleophilic AuIII-C(sp2) bond, affording α-ylidene-β-
diketones 68 in excellent yields and moderate Z/E selectivities. 
Scheme 27. Synthesis of α-ylidene-β-diketones 
 
 Another example that involves the reactivation of an allenyl acetate to give a vinyl gold 
intermediate is shown in Scheme 28.52 The allenyl acetate 70 is formed by 1,3-migration of the 
acetoxy moiety in 69. Reactivation of 70 by the gold catalyst triggers the nucleophilic attack of 
the aromatic ring affording the indene 71 in excellent yield. 
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Scheme 28. Gold-catalyzed synthesis of indenes 71 
 
 Cyclobutanes are useful building blocks in organic synthesis.53 A powerful tool to access 
these structures is a tandem gold-catalyzed [3,3]-acyloxy rearrangement followed by [2+2] 
cycloaddition as reported by Zhang.54 Highly functionalized 2,3-indoline-fused cyclobutanes 76 
were obtained through a 1,3-migration of the acyloxy moiety in 72 delivering the allenic ester 
intermediate 73 (Scheme 29). Further activation of the allene moiety in 73 resulted in the 
formation of the thermodynamically more favored E-oxonium cation 74. The formation of the 
cyclobutane product 76 can be explained through a [2+2] cycloaddition reaction via 1,4-
zwitterionic intermediate 75. 
Scheme 29. Gold-catalyzed synthesis of 2,3-indoline-fused cyclobutanes 76 
 
 
 Recently, the group of Chan reported the use of propargyl benzoates 77 for the synthesis 
of highly substituted azabicyclo[4.2.0]oct-5-enes 78 (Scheme 30).55 After the well-known [3,3]-
sigmatropic rearrangement of the propargyl benzoate moiety in 77, allene 79 is formed. Due to 
steric interactions, the gold catalyst selectively coordinates to the alkene triggering a stepwise 
[2+2] cycloaddition that involves the anti addition of the allenic group onto the gold-activated 
alkene affording intermediate 80. Finally, the corresponding azabicyclo[4.2.0]oct-5-ene 78 is 
formed by the nucleophilic attack of the Au-C(sp3) bond onto the carbonyl group in 80.  
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Scheme 30. Gold-catalyzed synthesis of azabicyclo[4.2.0]oct-5-enes 78 
 
 The group of Toste and Oh reported simultaneously the synthesis of aromatic ketones 83 
from alkyne-propargyl acetates 81. 56 A gold- or silver-catalyzed [3,3]-sigmatropic rearrangement 
followed by a Myers-Saito type cyclization57 of the allenoate intermediate 82 is proposed by the 
authors for the synthesis of the naphthyl ketones 83 in a highly efficient manner. (Scheme 31). 
Scheme 31. Intramolecular gold-catalyzed cyclization of alkyne-propargyl acetates 76 
 
 Structural features at the acetylenic position in the starting materials are also crucial for 
the outcome of the reaction of internal propargyl acetates in the presence of gold. When enynes 
are used as substrates, a Nazarov-type cyclization was observed, leading cyclopentanones 84 and 
cyclopentadienylic esters 85 (Scheme 32).58 In contrast to conventional Nazarov reactions where 
the control of the cyclopentenone double bond is not easy, the regioselectivity of these 
transformations is a remarkable feature. Computational studies have revealed that the reaction of 
enynyl acetates was found to be faster in wet CH2Cl2 compared to the reaction under exhaustive 
dry conditions.59 
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Scheme 32. Gold-catalyzed Nazarov cyclizations 
 
 On the other hand, when a vinyl group is bound to the acetylenic position of the propargyl 
acetate substrate, bicycle[3.1.0]hexenes 89 were obtained in the presence of gold catalysts 
(Scheme 33).60 After the initial gold-catalyzed 3,3-rearrangement of the acetate moiety, gold-
reactivation of the distal double bond in the carboxyallene intermediate 86 leads to the 
nucleophilic attack of the vinyl group affording vinyl-gold species 87. The cyclopropyl ring can 
be formed by back-donation of electron density from the gold catalyst onto the double bond. A 
final 1,2-hydride shift regenerates the gold catalyst and produces bicycle[3.1.0]hexanes 89 in 
excellent yields. 
Scheme 33. Gold-catalyzed synthesis of bicycle[3.1.0]hexane 89 
 
 Further modifications of the substitution pattern of the alkyne allowed the synthesis of 
conjugated dienes 90 by gold-catalyzed protodesilylation of intermediate V (Scheme 13),61 
formation of dihydrofurans 91 from propargyl alcohols62 and highly substituted tetrahydropyrans 
92 by cycloetherification of ω-hydroxy propargyl esters63 (Scheme 34). 
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Scheme 34. Synthesis of conjugated dienes 90, dihydrofurans 91 and tetrahydropyrans 92 
 
 In the last years, gold-catalyzed homogeneous reactions involving gold(I)/gold(III) redox 
catalytic cycles represents a growing area in the context of organic synthesis. Zhang and 
coworkers64 have developed a gold-catalyzed oxidative homocoupling reaction of propargyl 
acetates using external oxidants. The process involves a gold(I)-catalyzed [3,3]-sigmatropic 
rearrangement of the propargyl acetate to deliver the intermediate 93, which is oxidized in 
presence of Selectfluor to form gold(III) intermediate 94. Transmetallation with a molecule of 95 
delivers the gold(III)-intermediate 96 affording the homo-coupling products 97 by reductive 
elimination and regeneration of the catalyst (Scheme 35). 
Scheme 35. Gold(I)/gold(III) redox process for the synthesis of homocoupling products 90 
 
 Our research group65 expanded the scope of this chemistry. We found that, instead of the 
phosphine based-gold catalyst used in Zhang’s approach, the use of a bulky N-heterocyclic ligand 
such as 1,3-bis(2,6-diiso-propylphenyl)-imidazol-2-ylide, afforded selectively the fluorinated 
products 98 (Scheme 36). 
Scheme 36. Nevado’s modification for the synthesis of fluorinated enones 98 
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 1.3.4 Exceptions to the 1,2- vs. 1,3-acyloxy migration pathways 
 The interconnection between the two mechanistic pathways shown in Scheme 13 for the 
gold-catalyzed rearrangement of propargyl acetates is an issue that has been computationally 
studied.26 The reaction outcome can be influenced by sterics and electronics factors in the 
substituents of the starting materials.  
 The group of Zhang66 has reported the use of propargylic pivalates with electronically 
unbiased internal alkynes for the selective synthesis of (1Z,3E)-2-pivaloxy-1,3-dienes 99. The 
exceptional nature of this transformation stems from the fact that despite using internal propargyl 
acetates, which preferably undergo [3,3]-sigmatropic rearrangement, the reaction products can be 
explained by a gold carbene intermediate 100 (Scheme 37). In this process, bulky migrating 
groups as well as bulky catalysts are the key for the reaction success. In our research group,67 we 
have developed a new gold-catalyzed tandem 1,2/1,2-bisacetoxy rearrangement of 1,4-bis-
propargyl acetates 101, which provides access to 2,3-bisacetoxy-1,3-dienes 103 and 104 (Scheme 
37). Although that 1,4-diacetoxy-alkynes should react via 1,3-acyl migration, the formation of 
these products can be explained via gold-carbene 102, which is formed by a first 1,2-
rearrangement of the acetate in 101.  Based on experimental and computational studies we 
demonstrated that the stereochemistry of the double bond, after the first acetoxy migration, in the 
final product is controlled by the ligand of the catalyst. The second migration of the ester moiety 
always seems to be selective to the Z isomer. Propargyl esters with lower stabilization in the 
propargyl position showed a reaction selectivity influenced by the order of the migrating groups. 
Scheme 37. 1,2- vs. 1,3-acyloxy migration. Exceptions 
 
 
1.4. Synthetic applications of gold-catalyzed ring expansions 
 New methodologies catalyzed by late transition metals involving cycloisomerizations of 
strained rings such as cyclopropanes and cyclobutanes can open new venues for the synthesis of 
structurally more complex molecules.68 The gold-catalyzed ring expansion of strained rings is 
already considered a mature synthetic tool in organic synthesis.69 
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 1.4.1 Ring expansions involving oxygenated rings 
 The gold-catalyzed ring expansion of cyclopropanols and cyclobutanols 105 is a versatile 
strategy for the synthesis of building blocks such as cyclobutanones and cyclopentanones 
(Scheme 38). Toste and coworkers70 reported the synthesis of alkylidenecyclobutanone 106 and 2-
metylene-3-neopentylcyclopentanone 107 through a process rationalized as a result of the π-
activation of the triple bond in by the metal in alkynyl cyclopropanols followed by migration of 
the C-C bond and final 1,4-proton shift.71 The outcome of the reaction changed dramatically using 
internal alkynyl cyclobutanols such as 108, as reported by Chung and coworkers for the synthesis 
of α,β-unsaturated ketones 109.72 In the latter case the formation of cumulene 110 was proposed. 
Nucleophilic attack of a molecule of water onto the external gold-activated double bond of the 
cumulene gives the corresponding allenyl alcohol 111, which tautomerized to deliver the α,β-
unsaturated ketones 109. 
Scheme 38. Gold-catalyzed ring expansions of cyclopropanols and cyclobutanols 
 
 Pyrrolidines 113 can be efficiently synthesized from cyclopropylmethanols 112 in a 
tandem amination/ring expansion process (Scheme 39).73 The reaction proceeds by the following 
sequence: activation of the cyclopropylmethanol 112 by the gold catalyst triggers the departure of 
the hydroxyl function followed by cyclopropyl ring opening. The new carbocation is trapped in 
the presence of the sulfonamide. Subsequent intramolecular hydroamination of the double bond 
affords the pyrrolidine product 113 in excellent yield. 
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Scheme 39. Synthesis of pyrrolidine 113 
 
 Oxiranes can be efficiently activated by an oxophilic Lewis acid such as gold (Scheme 
40). A good example is the gold-catalyzed ring opening of the aryl alkyl epoxide 114 for the 
synthesis of 3-chromanol 115.74 The authors proposed two types of mechanism that can explain 
the formation of the products through an aromatic auration step followed by the nucleophilic 
attack of the arylgold(III) onto the epoxides or a concerted mechanism where gold(III) purely 
activates the epoxide group triggering an electrophilic aromatic substitution reaction. Alkynyl 
epoxides 116 can be transformed into furans 117 via intramolecular nucleophilic addition of the 
oxirane oxygen atom onto the π-metal-alkyne complex.75 The reaction seems to proceed through 
metal activation of the triple bond followed by cyclization. In a related method, the group of Shi 
has used epoxy alkynes 118, which can be selectively transformed into ketals 121. The reaction 
seems to commence with the epoxide ring opening in the presence of the nucleophile to give 
intermediate 119 followed by metal activation of the alkyne and intramolecular attack of the 
alcohol to give 120. Reactivation of the olefin by the gold catalyst and subsequent incorporation 
of a second molecule of nucleophile (water or alcohol) affords ketals 121 in good yields. 
Acyloxylated alkynyl oxiranes 122 can be selectively transformed into divinyl ketones 125. The 
authors proposed a reaction sequence that involves the coordination of the gold catalyst on both 
the alkynyl and oxirane moieties, rearrangement of the ester to deliver the allenic alcoholate 123, 
which cyclizes to form the oxetane intermediate 124. Cycloreversion in oxetane 124 furnishes the 
acyloxydivynyl ketones 125 in good yields.  
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Scheme 40. Gold-catalyzed cycloisomerization of oxiranes 
 
 
 1.4.2 Ring expansions involving saturated alkyl rings 
 Metal-catalyzed ring expansions of cyclopropyl alkynes are a versatile method to access a 
wide range of building blocks.76 Upon gold activation of the triple bond, a wide palette of 
transformations can be addressed either in an inter- or intramolecular fashion (Scheme 41). The 
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group of Yu77 developed a synthesis of cyclobutanamines 127 in a process that involves a 
cyclopropyl ring expansion to form the cyclobutyl cation 126 followed by trapping of 126 with an 
external tosylamino nucleophile. Schmalz and coworkers78 reported a gold-catalyzed cascade 
reaction of alkynyl cyclopropyl ketones 128 for the synthesis of cycloheptenylfurans 130. In this 
process, the cyclopropyl ring triggers the nucleophilic attack of the carbonyl moiety onto the 
gold-activated alkyne to give the carbocationic intermediate 129, which is trapped in the presence 
of external nucleophiles to afford furans 130. Toste79 and Davies80 reported alternative routes for 
the synthesis of substituted pyrrols 132 and 134 using azides 131 and aziridines 133 moieties as 
starting materials respectively. 
Scheme 41. Gold-catalyzed cycloisomerization of cyclopropyl alkynes 
 
  
 1.4.3 Ring expansions involving enynes 
 The combination of 1,6-enyne substrates and gold-catalyzed heteroatom-assisted 1,2-H-
shift offers a synthetic tool towards the construction of molecular complexity (Scheme 42). 
Echavarren and coworkers81 have successfully combined this reaction mode in a 
cycloisomerization process that involves a gold-catalyzed Prins cyclization of enynes 135 to 
afford trans- and cis-octahydrocyclobuta[a]pentalene skeletons 136 and 137. The reaction seems 
to proceed in a concerted fashion via cyclopropyl carbene 138, which undergoes ring expansion to 
afford the alkenyl-gold intermediate 139. Nucleophilic attack of the vinyl-gold moiety onto the 
oxonium cation gives the tricyclic pentalene skeletons 136 and 137. A remarkable synthetic 
application of this methodology has been reported by Toste and coworkers82 applying the gold-
catalyzed ring expansion of cyclopropanols with enynic substrates 140 for the synthesis of the 
angular triquinane ventricosene 141.  
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Scheme 42. Gold-catalyzed cycloisomerization of enynes 135 and cyclopropanols 140 
 
 
 1.4.4 Ring expansions involving annulations reactions 
 The combination of gold-catalyzed ring expansions and annulation reactions is a powerful 
tool employed by organic chemists to construct molecular complexity. Dipoles have been usually 
described as transient, difficult to harness species towards cycloaddition reactions and can 
undergo many side reactions. Zhang envisioned that dipoles can be stabilized in its negative 
terminus by the presence of a gold catalyst triggering [n+m] annulations processes (Scheme 43). 
The cationic end of the dipole reacts with a dipolarophile in a bimolecular process to generate 
cycloadducts.83 
Scheme 43. Gold-catalyzed annulations processes  
 
 In this context, the gold-catalyzed ring expansion in cyclopropyl ketones can be used to 
generate 1,4-dipoles (Scheme 44). 1-(1-Alkynyl)cyclopropyl ketones 142, in the presence of 
indoles 145, afforded tetracyclic furans 146 in excellent yields. The mechanism for this 
transformation involves a [4+2] annulation reaction of the furan intermediate 144 that could be 
formed via oxocarbenium 143. Furthermore, compounds 147 also reacted as dipolarophiles with 
the 1,4-furan dipole 144 in the presence of catalytic amounts of AuCl3 for the synthesis of furans 
148.84 In contrast, when alkoxy vinyl ethers 149 are employed,85 the cyclization takes place prior 
to the formation of the furan intermediate 144. In this case the bicyclic[3.2.0]heptane skeleton 151 
is obtained in excellent yields upon 1,3-dipolar cycloaddition of the alkoxy vinyl ether 149 and 
the 1,4-dipole 143 followed by 1,2-alkyl migration and cyclopropyl ring expansion. The reaction 
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of 150 with a protic acid in water activates the enone system triggering the nucleophilic attack of 
water to give 151.  
Scheme 44. Gold-catalyzed synthesis of furans 146 and 148. 
 
1.5 Conclusions and Objectives 
 One of the most successful area in homogeneous catalysis falls into the ability of gold to 
coordinate unsaturated moieties. This mode of coordination can be explained as a donor-acceptor 
interaction between the metal and the ligand. According to the Dewar-Chatt-Duncanson model, a 
net shift of electron density is withdrawn from the unsaturated moiety to the metal doing the 
unsaturated C-C bond more electrophilic and thereby can be defined as π acid. 
 π-Bonds activated by gold can undergo a huge palette of transformations. The utility of 
gold complexes for the activation of alkynes towards the rearrangement of propargyl carboxylates 
has grown exponentially during the last years. Upon 1,2- or 1,3-acyl migration of the ester moiety 
onto the gold-activated alkyne, the formation of a vinyl-gold carbene or gold-activated allene 
open new venues for the construction of molecular complexity. The gold-catalyzed ring 
expansion of strained rings is considered as a powerful synthetic tool in organic chemistry. 
 The main objective of this thesis is the development of new methodologies involving a 
gold-catalyzed ring expansion of stabilized cyclopropyl rings for the synthesis of small complex 
molecules. 
 The chapter 2 and 3 of this PhD thesis will describe experimental studies into cyclopropyl 
ring opening expansions driven by gold-activation of alkynes and allenes for the synthesis of 
cyclopent-1-enyl acetates, cyclohexenones and cyclopentenyl ketones. In addition, 
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enantiomerically enriched cyclohexenones and cyclopentenyl ketones can be prepared by the 
gold-catalyzed cyclization of optically active propargyl acetates. Although the rearrangements are 
cationic in nature, the high degree of stereochemical information transfer in these reactions 
suggests that gold-stabilized nonclassical carbocations with a certain configurational stability are 
involved. 
 In the second part of this thesis (Chapter 4), a highly diastereoselective gold-catalyzed 
three-step cascade reaction for the synthesis of highly substituted five- and seven-membered rings 
from propargyl acetates and alkenes or 1,4-dienes will be described. The Cope rearrangement of 
propargyl acetates and 1,4-dienes represents an attractive alternative to previously reported Rh-
catalyzed methodology for the synthesis of cis-2,3-disubstituted cyclopentenylacetates. In 
addition, the concerted nature of the process has allowed an alternative formal enantioselective 
total synthesis of both Frondosins A and B. 
 The last chapter of this PhD thesis (Chapter 5) will describe the role of both gold catalysts 
and acid for the activation of 1-cyclopropyl alkynes toward heteroaromatic nucleophiles. An 
efficient method to synthesize highly substituted tetrahydrocarbazoles via formation of a 1,5-
dipole will be reported therein. 
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CHAPTER 2 
Gold-Catalyzed Cycloisomerization of 1-Cyclopropyl Alkynyl Acetates: 
A Versatile Approach to 5-, 6- and 7-Membered Carbocycles 
Y. Zou; D. Garayalde; Q. Wang*; C. Nevado* and A. Goeke* 
(Angew. Chem. Int. Ed. 2008, 47, 10110-10113) 
 2.1 Introduction  
 During the last decade, late transition metal catalyzed cycloisomerizations have emerged 
as a powerful tool to access unprecedented structural and mechanistical diversity.0F1 In this context, 
a rapidly developing area involves the use of propargylic esters, preferably acetates, where the 
carbonyl unit acts as a nucleophile onto the metal-activated alkyne complex I (Scheme 1). Two 
distinctive mechanistic scenarios arise from this intermediate.1F2 If terminal alkynes are used, 1,2 
migration of the acetate affords vinyl metal species II which can result in the formation of a 
“carbenoid” III. 2F3 In contrast, internal alkynes undergo [3,3]-sigmatropic rearrangement forming 
allenyl acetates V which can be further activated in the presence of the metal catalyst to give VI, 
triggering also an extensive palette of transformations.3F4,4F5 
Scheme 1. 1,2- vs. 1,3-acetate migration 
 
 Intermediates of type III were proposed by Rautenstrauch in the Pd-catalyzed 
cycloisomerization/in situ hydrolysis of vinyl-propargyl acetates VII to 2-cyclopentenones VIII 
(Scheme 2). 5F6 One example of a conversion of cyclopropyl derivative IX to cyclopentadienyl 
acetate X was also reported. Recently, Toste et al. widely expanded the scope of this 
cyclopentenone synthesis by application of cationic Au(I) catalysts.6F7 An interesting chirality 
transfer from an optically active propargyl pivaloate XI to the cyclopentenone XIV was 
postulated to proceed via cyclic oxonium ion XII, similar to mechanisms proposed for such 
conservation of stereochemical information in other cases.8,9 In a subsequent calculation, the 
helical intermediate XIII was found to retain the stereochemical information of the starting 
material.10 
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Scheme 2. Pd- and Au-catalyzed cyclopentannulation 
 
 In order to access Rautenstrauch rearrangement products of larger ring sizes we decided 
to construct a homologous system 1a (Scheme 3). The reaction in the presence of catalytic 
amounts of AuCl3 aimed to probe the behavior of the canonical carbenoid 2 which could 
subsequentially arise from the Au-promoted 1,2-acetate migration.3 However, to look at 
intermediate 2 with regard to the recently discussed nonclassical carbocationic nature of 
carbenoid-like intermediates of gold-catalyzed enyne cyclizations1b,1g could be more illuminative, 
as resonance structures 3-6 visualize  the possibilities to undergo consecutive cyclizations more 
clearly: while intermediate 2 could lead to 7-membered ring products by Cope 
(divinylcyclopropane) rearrangement, the allylcations 5 and/or 6 may cyclize to 6- or 8-membered 
ring systems, respectively. We were pleased to find that compound 1a exclusively led to 
cyclohexadienyl acetate 7a. Herein, we report our investigation on this novel gold-catalyzed 
homo-Rautenstrauch rearrangement and hope it will help to further unravel the mechanistic blur 
of gold catalysis. 
Scheme 3. Au-catalyzed homo-Rautenstrauch rearrangement 
 
 
  2.2 Results and discussion  
 To further broaden the insight into this initial result several optimization reactions were 
carried out. The primary product 7a is a sensitive dienol acetate and it was generally converted to 
2-hexenone 8a by an in situ methanolysis during 30 min. In light of the previous success of 
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cationic gold(I) complexes for alkyne activation, compound 1a was treated with a variety of such 
catalysts (Table 1). Using 1 mol% pregenerated cationic complex Ph3PAuSbF6 in CH2Cl2 
produced acetate 7a within 2 min and 85% isolated yield after hydrolysis (entry 2). Even at 0.1 
mol% of catalyst loading, the reaction was fast and no significant decrease in yield was observed 
(entry 3). Interestingly, decomposition of substrate 1a was observed when changing the 
counterion from SbF6- to TfO- (entry 4). Control experiments employing either 5 mol% Ph3PAuCl 
or 5 mol% AgSbF6 as the sole catalyst did not lead to any product 7a (Table 1, entries 5 and 6). 
Notably, under the original reaction condition reported by Rautenstrauch,6 decomposition of 1a 
was observed (entry 7). 
Table 1. Catalyst optimization. 
OAc
OAc
Catalyst
CH2Cl2
K2CO3
MeOH
30 min O
1a 7a 8a  
Entry Catalyst (mol%) t (min) Yield (%)P[a] 
1 AuClR3R (2%) 360 75 
2 PhR3RPAuSbFR6R (1%) 2 85 
3 PhR3RPAuSbFR6R 
(0.1%) 
30 80 
4 PhR3RPAuOTf(5%) 5 0P[b]
5 PhR3RPAuCl (5%) 360 0P[c]
6 AgSbFR6R (5%) 5 0P[b] 
7 PdClR2R(MeCN)R2 360 0P[b] 
 [a] Yield of isolated product 8a after column 
chromatography. [b] Decomposition occurred. [c] 
Starting material was recovered. 
 With good working conditions in hand, the scope of the gold(I)-catalyzed 
cycloisomerization of 1-cyclopropyl-propargyl esters 1 was examined (Table 2). The reactions 
were all carried out on gram scale under very mild conditions. In none of the cases 
cyclopentenones were detected. Alkyl (Table 2, entries 1-4) and aryl (entry 5) substitutions at the 
double bonds were tolerated and products 8 were obtained in good to excellent yields. As 
expected, sterically hindered substrate 1i resulted in a slower reaction, but full conversion was 
achieved after 6 h, giving bicyclic compound 8i in an excellent isolated yield of 90% (entry 8). 
The cyclopropyl ring cleavage can be also stabilized by a para-methoxyphenyl substituent (1j) 
affording 7j in good yield (entry 9). 
Table 2. Scope of the Au(I)-catalyzed 2-cyclohexenone synthesis.[a] 
 
Entry Substrate Product t (min) P[b] Yield (%)P[c] 
1 1b RP1P=RP2P=Et, RP3P=H 8b 5 78 
2 1c RP1P=H, RP2P=n-Pr, RP3P=H 8c 10 62 
3 1d RP1P=CHR3R, RP2P=Et, RP3 P=H 8d 10 82 
4 1e RP1P=H, RP2P=Et, RP3P=CHR3 8e 10 96 
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5 1f RP1P=H, R P2P=Ph, RP3P=CHR3 8f 10 88P11 
6 
OAc
 
1g 
O  
8g 
10 56 
7 
OAc
 
1h O  8h 
10 71 
8 
OAc
 
1i 
O  
8i 
360 90 
9 
OAc
MeO  
1j 
MeO
OAc
7j 
60 
 
 
70P[d] 
 
 
[a] Conditions: (1) Substrate (10 mmol, 1 M in CH2Cl2), Ph3PAuSbF6 (1mol% 
in CH2Cl2), RT. (2) K2CO3 (20 mmol), MeOH (10 mL), RT, 30 min. [b] 
Reaction time for the first step with 100% conversion determined by GC-MS. 
[c] Isolated yield after 2 steps. [d] Isolated yield after the first step. 
 We could also extent this process to homopropargyl acetates, which have been reported to 
undergo acetate migration to the internal alkyne position, although serious limitations were 
observed when restricted conformations were not achieved.12 To our delight, cyclization of 
substrate 9 occured smoothly affording cycloheptenone 10 in 72% yield (Schme 4). 
Scheme 4. Homopropargyl acetate cycloisomerization 
 
 Apparently, the stabilization of positive charge in intermediates 3 and 5 (Scheme 3) is 
essential for a smooth conversion of 1 to cyclization products 7: even under harsh conditions, 
secondary acetate 11 did not cyclize but ring-opened to trienone 12 after hydrolysis, albeit in low 
yield (Scheme 5). Likewise, the simple cyclopropyl derivative 13 did not cyclize but rearranged to 
allene 14. 
Scheme 5. Side reactions of the cycloisomerization 
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 As shown in Scheme 1, substitution at the terminal position of the acetylene unit may 
initiate a 6-endo-dig-like 1,3-migration of the carboxylate group.2,4 We envisioned that substrates 
such as 15a would generate, by treatment with Ph3PAuSbF6, cyclopropylalkyl carbenium ion 16a 
which is mesomeric to intermediate 17a (Table 3). Cyclization of these species at the allyl 
cationic positions may occur, but only trienyl acetate 18a was obtained in almost quantitative 
yield as a mixture of cis/trans isomers. Methanolysis with concomitant isomerization led to 19a 
as a single isomer. Further investigation (Table 3) revealed that the cyclization also tolerates a 
variety of differently substituted substrates. 
Table 3. Scope of the Au (I) catalyzed 1-cyclopentenylketone synthesis.[a] 
 
Entry Substrate Product t (min) P[b] Yield (%)P[c] 
1 
15b
 
19b 
5 88 
 
2 
15c 
 
19c 
 
2 
 
87 
3 
15d 
 
18d 
10 90P[d] 
[a] Conditions: (1) Substrate (10 mmol, 1 M in 
CH2Cl2), Ph3PAuSbF6 (1mol% in CH2Cl2), RT. (2) 
K2CO3 (20 mmol), MeOH (10 mL), RT, 16 h. [b] 
Reaction time of first step with 100% conversion 
determined by GC-MS. [c] Isolated yield after 
column chromatography. [d] Yield of isolated product 
18d after column chromatography. 
 The interesting question of a possible chirality transfer in these systems was addressed 
using optically active substrates 1k and 15e, both easily available from optically pure (1S,3S)-(−)-
trans-chrysanthemum acid (99% ee) (Scheme 6).13 Cycloisomerization of 1k (dr = 6:4, 99% de) 
under standard conditions (Ph3PAuSbF6, CH2Cl2, rt) cleanly afforded (R)-8k after methanolysis, 
however, with only 27% ee. Lowering the temperature to -20 °C only increased the reaction time 
to 24 h without significantly improving the ee value (31% ee). Performing the reaction in various 
solvents did not improve these results either. Surprisingly, using AuCl3 as catalyst retained the 
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enantioselectivity most effectively, leading to (R)-8k with 87% ee. On the other hand, 
Ph3PAuSbF6-promoted cycloisomerization of compound 15e delivered acetylcyclopentenone (R)-
19e with good chirality transfer (89% ee) (Scheme 6). The absolute configurations of (R)-8k and 
(R)-19e were determined by comparing the vibrations of a measured ROA (Raman Optical 
Activity) spectra with those of the theoretical spectra, calculated at the B97-1/pc-2 level with the 
Gaussian program. ROA calculations at the TDHF/DPS level were carried out with the Dalton 
program.14 
Scheme 6. Chirality transfer of compounds 1k and 15e to 6- and 5-membered ring products 
 
In our view, these results disfavor intermediates analogous to XII or XIII (Scheme 2) since 
the stereochemical information of the position 2’ in substrate 1k (Scheme 6) does not overrule 
that inherent at C1 and C3.15 In contrast, as the reaction depends on stabilization of positive 
charge in particular at positions 3 and 2’ in 1k (see Scheme 4 and ref. 12), but only to an extent 
that prevents formation of the achiral cation 5 (Scheme 3), we propose a more concerted 
mechanism, where carbene 2k can be also redefined as nonclassical carbonium ion1,16complex 3k 
or, under participation of the vinyl-gold unit species 5k,17 as the enantioselectivity preserving 
intermediate (Scheme 7). Depending on the electronic stabilization and geometry, these species 
display a certain configurational stability by which stereochemical information is retained 
throughout the reaction. 
Scheme 7. Proposed non-classical intermediates for the chirality transfer to product 8k.  
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 2.3 Conclusion  
 In conclusion, we have found a new Au-catalyzed homo-Rautenstrauch rearrangement of 
1-cyclopropylpropargylic esters to cyclohexenones 8 and cyclopentenyl ketones 19 under mild 
conditions. In addition, enantiomerically enriched cyclohexenones and cyclopentenyl ketones can 
be prepared by the gold-catalyzed cyclization of optically active propargyl acetates. Although the 
rearrangements are cationic in nature, the high degree of chirality transfer in these reactions 
suggests that gold-stabilized nonclassical carbocations with a certain configurational stability are 
involved. Further studies to elucidate the homologization strategy by gold-promoted 
cycloisomerizations of cyclopropane derivatives to novel products are underway. 
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1. General information 
 1H and 13C NMR spectra were recorded with AW 300 and AV2 400 MHz Bruker 
spectrometer instruments in CDCl3. Chemical shifts in CDCl3 and CD2Cl2 are reported in δ (ppm) 
relative to tetramethylsilane (TMS), chloroform and dichloromethane as internal reference unless 
otherwise stated. In the 13CNMR spectra, the nature of the carbons (C, CH, CH2, or CH3) was 
determined by recording the DEPT 90 and DEPT-135 experiments, and is given in parentheses. 
The following abbreviations are used: s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, dd = double doublet, bs = broad singlet, sept = septet. Solvents for extraction and 
chromatography were technical grade and used without further purification. Flash 
chromatography was performed using Tsingdao Haiyang Chemical silica gel (200 ± 300 mesh) 
and silica gel Merck grade (60 Å). Unless otherwise noted, a mixture of hexane:MTBE (50:1) was 
used as eluent. IR spectra were recorded with a Bruker Tensor 27 and a Jasco FT/IR-4100. High 
resolution MS were obtained with a Finnigan MAT 95 (San Jose, CA; USA) double-focusing 
magnetic sector mass spectrometer (geometry BE) and GC/MS spectral data were obtained from 
an Agilent 6890 N and MSD 5975 using a column HP-5 MS, 30 m, 0.25 mm, 0.25 μm. The 
enantiomeric excess (ee) of 8k and 19e were determined by GC in comparison to the 
corresponding racemic samples using MN HYDRODEX-beta-6TBDM column (25 m x 0.25 mm, 
program 80-150 °C, 2 °C /min, Helium carrier pressure 13.2 psi, FID detection (250°C) . 
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2. General experimental procedure for the preparation of 2-(2-vinylcyclopropyl)but-3-
yn-2-yl acetates (compounds 1a-j): 
 
 
 
1)   Sodium hydroxide (0.4g, 0.01 mol) was added to a solution of an α,β-unsaturated 
aldehydes 20 (0.5 mol) in acetone (200 mL). The reaction mixture was refluxed for 2 
hours and then cooled to room temperature. After neutralization with 1 N HCl 
solution, the mixture was concentrated and partitioned with MTBE and water. The 
organic layer was washed with brine (200 mL), dried (MgSO4) and evaporated in 
vacuo. The residue was purified by distillation to give crude hexa-3,5-dien-2-ones 
which were pure enough for further transformations (yield 30-60%). 
2)   To a suspension of trimethyl sulfoxonium iodide (20 mmol) in DMSO (30 mL) with 
vigorous stirring was added sodium hydride (20 mmol, 60% in mineral oil) in 3 
portions under argon atmosphere. After 30 min, the reaction mixture was cooled to 0  
oC and crude hexa-3,5-dien-2-one (20 mmol) prepared above was added dropwise. The 
mixture was stirred at RT for 16 h, cooled to 0 oC, quenched with water (150 mL) and 
extracted 3 times with MTBE (100 mL). The combined organic layers were washed 
with brine (200 mL), dried (MgSO4) and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (eluent:hexane/MTBE = 50/1) to 
give the corresponding 1-(2-vinyl-cyclopropyl)-ethanone 22. 
3)  Acetylene gas was bubbled through a solution of KOtBu (20 mmol) in THF (100 mL) 
until saturation was reached. Then, ketone 22 (10 mmol) was added dropwise to the 
viscous suspension. The mixture was stirred for 2 hours until completion of the 
reaction. Water (150 mL) was added and the mixture was extracted 3 times with 
MTBE (100 mL). The combined organic layers were washed with brine (200 mL), 
dried (MgSO4) and concentrated in vacuo to give the crude propargylic alcohol of 
larger than 95% purity (GC). This material was directly used in the next step. 
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4)  Acetic anhydride (4.8 mL, 50 mmol) was added to a solution of the propargylic alcohol 
(10 mmol), Et3N (14 mL, 100 mmol) and DMAP (0.12g, 1.0 mmol) in anhydrous 
CH2Cl2 (50 mL) at 0 oC. The reaction was stirred at room temperature for 24 h, was 
concentrated and partitioned between MTBE and water. The organic layer was washed 
with sat. NaHCO3 (100 mL) and brine (100 mL), dried (MgSO4) and concentrated in 
vacuo. The residue was distilled bulb to bulb to give the desired acetate 1a-i. 
 
rac-trans-1-(-2-(2-Methylprop-1-enyl)cyclopropyl)ethanone (22a) 
Yield 80%, colorless liquid. The analytical results are in accordance to the reference 
data.1 
 
rac-trans-1-(-2-(2-Ethylbut-1-enyl)cyclopropyl)ethanone (22b) 
Yield 50%, colorless liquid. 1H NMR (300 MHz, CDCl3): δ = 4.55 (d, J = 9.2 Hz, 
1H), 2.26 (s, 3H, COCH3), 2.13 (q, J = 7.5 Hz, 2H, CH2(CH3)a), 2.12-2.06 (m, 1H), 2.03 (q, J = 
7.5 Hz, 2H, CH2(CH3)b), 1.96-1.87 (m, 1H), 1.53-1.42 (m, 1H), 0.99 (t, J = 7.5 Hz, 3H, 
CH2(CH3)a), 0.95 (t, J = 7.5 Hz, 3H, CH2(CH3)b), 0.96-0.91 (m, 1H) ppm. 13C NMR (75 MHz, 
CDCl3): δ = 207.4 (s), 145.4 (s), 122.9 (d), 30.7 (d), 30.6 (q), 29.0 (t), 24.8 (d), 23.9 (t), 18.6 (t), 
13.1 (q), 12.5 (q) ppm. GC/MS (EI): 166 (M+, 30), 151 (2), 137 (10), 123 (59), 108 (6), 95 (33), 
81 (100), 67 (41), 55 (23), 43 (59). IR (neat, ν/cm-1): 2966, 2935, 1697, 1462, 1433, 1400, 1379, 
1173, 967, 855. HRMS (EI): m/z: calcd. for C11H18O 166.1358; found: 166.1346. 
rac-trans-1-(2-((E)-Pent-1-enyl)cyclopropyl)ethanone (22c) 
Yield 38%, colorless liquid. 1H NMR (300 MHz, CDCl3): δ = 5.65-5.52 (m, 1H), 
5.02 (dd, J = 15.3, 8.3 Hz, 1H), 2.25 (s, 3H, COCH3), 2.18-1.86 (m, 4H), 1.60-1.30 (m, 3H), 1.04-
0.95 (m, 1H), 0.93 (t, J = 7.3 Hz, 3H, CH2CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 207.1 (s), 
131.3 (d), 129.9 (d), 34.4 (t), 30.5 (q), 30.4 (d), 27.9 (d), 22.4 (t), 19.8 (t), 13.6 (q) ppm. GC/MS 
(EI): 152 (M+, 13), 137 (3), 123 (20), 109 (47), 95 (23), 79 (25), 67 (97), 55 (15), 43 (100). IR 
(neat, ν/cm-1): 3003, 2960, 2929, 1699, 1450, 1437, 1397, 1357, 1173, 962, 592. HRMS (EI): 
m/z: calcd. for C10H16O 152.1201; found: 152.1197. 
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rac-1-(2-(2-Methylbut-1-enyl)cyclopropyl)ethanone (22d) 
Yield 55%, colorless liquid. Mixture of isomers: 1H NMR (300 MHz, CDCl3): δ = 
4.60 (d, J = 8.2 Hz, 1H), 2.26 (s, 3H, COCH3), 2.18-2.04 (m, 2H), 1.98 (q, J = 7.4 Hz, 1H), 1.89 
(m, 1H), 1.71, 1.67 (2s, 3H, CH3), 1.50-1.45 (m, 1H), 1.06-0.94 (t, J = 7.4 Hz, 3H, CH2CH3), 
0.94-0.86 (m, 1H) ppm. 13C NMR (75 MHz, CDCl3): δ = 207.3, 207.2 (s), 139.7, 139.3 (s), 124.5, 
123.3 (d), 32.0, 31.5 (t), 30.6, 24.7 (d), 30.5, 30.4 (q), 25.3, 18.5 (t), 24.7, 24.6 (d), 16.5 (q), 12.6, 
12.4 (q) ppm. GC/MS (EI): 152 (M+, 28), 137 (3), 123 (6), 109 (88), 95 (29), 81 (35), 67 (89), 55 
(29), 43 (100). IR (neat, ν/cm-1): 2966, 2934, 1697, 1434, 1397, 1360, 1174, 963, 915. HRMS 
(EI): m/z: calcd. for C10H16O 152.1201; found: 152.1197. 
 
rac-trans-1-(2-((E)-Pent-2-en-2-yl)cyclopropyl)ethanone (22e)2 
Yield 50%, colorless liquid. 1H NMR (300 MHz, CDCl3): δ = 5.25 (t, J = 7.1 Hz, 
1H), 2.25 (s, 3H, COCH3), 2.07-1.92 (m, 4H), 1.51 (s, 3H), 1.35-1.28 (m, 1H), 1.16-1.09 (m, 1H), 
0.95 (t, J = 7.5 Hz, 3H, CH2CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 207.5 (s), 131.8 (s), 
127.7 (d), 33.0 (d), 30.4 (q), 28.7 (d), 21.0 (t), 15.7 (t), 14.0 (q), 13.9 (q) ppm. GC/MS (EI): 152 
(M+, 2), 137 (8), 123 (11), 109 (100), 93 (15), 81 (26), 67 (52), 55 (19), 43 (77). IR (neat, ν/cm-
1): 2963, 2933, 1698, 1439, 1399, 1356, 1319, 1173, 965, 592. 
 
rac-trans-1-(2-((E)-1-Phenylprop-1-en-2-yl)cyclopropyl)ethanone (22f) 
O
22f Yield 85%, yellow liquid. 1H NMR (300 MHz, CDCl3): δ = 7.40-7.18 (m, 5H, 
Ar-H), 6.38 (s, 1H), 2.30 (s, 3H, COCH3), 2.23-2.09 (m, 2H), 1.76 (s, 3H, CH3), 1.50-1.40 (m, 
1H), 1.31-1.25 (m, 1H) ppm. 13C NMR (75 MHz, CDCl3): δ = 207.2 (s), 137.7 (s), 136.0 (s), 
128.8 (d), 128.1 (d), 126.3 (d), 125.9 (d), 33.7 (d), 30.6 (q), 28.9 (d), 16.1 (d), 15.6 (q) ppm. 
GC/MS (EI): 200 (M+, 9), 185 (5), 167 (4), 157 (100), 142 (45), 129 (57), 115 (31), 91 (19), 77 
(8), 43 (17). IR (neat, ν/cm-1): 3022, 1697, 1492, 1397, 1355, 1179, 700. HRMS (EI): m/z: calcd. 
for C14H16O 200.1201; found: 200.1207. 
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1-(2-(4-(Prop-1-en-2-yl)cyclohex-1-enyl)cyclopropyl)ethanone (22g) 
Yield 62%, yellow liquid. 1H NMR (300 MHz, CDCl3): δ = 5.55-5.50 (m, 
1H), 4.72 (s, 1H), 4.70 (s, 1H), 2.25 (s, 3H, COCH3), 2.18-2.02 (m, 2H), 2.00-1.78 (m, 6H), 1.73 
(s, 3H, CH3), 1.52-1.37 (m, 1H), 1.36-1.22 (m, 1H), 1.20-1.06 (m, 1H) ppm. 13C NMR (75 MHz, 
CDCl3): δ = 207.5 (s), 149.6 (s), 135.0 (s), 121.9, 121.7 (d), 108.6 (t), 41.0 (d), 31.3 (d), 30.6 (t), 
30.4 (q), 28.4 (d), 27.5 (t), 27.0 (t), 20.7 (q), 15.9, 15.3 (t) ppm. GC/MS (EI): 204 (M+, 6), 189 
(5), 161 (75), 146 (19), 131 (18), 119 (37), 105 (45), 91 (87), 77 (47), 67 (23), 53 (19), 43 (100). 
IR (neat, ν/cm-1): 2920, 1698, 1437, 1399, 1355, 1177, 888. HRMS (EI): m/z: calcd. for C14H20O 
204.1514; found: 204.1511. 
 
rac-1-(2-(2,6-Dimethylhepta-1,5-dienyl)cyclopropyl)ethanone (22h) 
Yield 46%, yellow liquid. 1H NMR (300 MHz, CDCl3): δ = 5.08 (t, J = 6.9 
Hz, 1H), 4.63 (d, J = 9.1 Hz, 1H), 2.25 (s, 3H, COCH3), 2.18-1.86 (m, 5H), 1.73 (s, 3H, CH3), 
1.69 (s, 3H, CH3), 1.60 (s, 3H, CH3), 1.50-1.40 (m, 1H), 1.25-0.90 (m, 2H) ppm. 13C NMR (75 
MHz, CDCl3): δ = 207.4, 207.2 (s), 137.8, 137.6 (s), 131.8, 131.6 (s), 125.6, 124.7 (d), 124.0, 
123.9 (d), 39.4, 32.5 (t), 30.6 (d), 26.5, 26.4 (t), 25.6 (q), 25.0 (d), 23.2 (q), 18.5, 18.4 (t), 17.6 (q), 
16.7 (q) ppm. GC/MS (EI): 206 (M+, 8), 191 (2), 163 (12), 148 (30), 137 (22), 121 (8), 107 (14), 
95 (58), 79 (25), 69 (100), 53 (10), 43 (91). IR (neat, ν/cm-1): 2967, 2920, 1698, 1435, 1398, 
1360, 1173, 1107, 967. HRMS (EI): m/z: calcd. for C14H22O 206.1671; found: 206.1672. 
 
rac-1-(2-(2,6,6-Trimethylcyclohex-1-enyl)cyclopropyl)ethanone (22i)3 
Yield 8%, colorless liquid. Data obtained match the reference data.4 1H NMR (300 
MHz, CDCl3): δ = 2.29 (s, 3H, COCH3), 2.20-1.84 (m, 4H), 1.66 (s, 3H, CH3), 1.64-1.32 (m, 5H), 
1.20-1.16 (m, 1H), 1.12 (s, 3H, CH3), 1.02 (s, 3H, CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 
208.4 (s), 134.6 (s), 131.8 (s), 41.1 (t), 35.2 (s), 33.4 (t), 30.5 (q), 30.3 (d), 39.1 (q), 29.0 (q), 26.5 
(d), 20.8 (q), 19.1 (t), 19.0 (t) ppm. GC/MS (EI): 206 (M+, 20), 191 (29), 173 (6), 163 (27), 147 
(25), 135 (37), 121 (40), 107 (86), 91 (63), 79 (37), 69 (45), 55 (29), 43 (100). IR (neat, ν/cm-1): 
2930, 2867, 1698, 1458, 1359, 1254, 1173, 976. 
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rac-trans-1-(2-(p-Methoxyphenyl)cyclopropyl)ethanone (22j) 
Yield 80%, colorless liquid. 1H NMR (400 MHz, CDCl3): δ = 7.04-7.01 (m, 
2H), 6.84-6.81 (m, 2H), 3.78 (s, 3H, OCH3), 2.51-2.46 (m, 1H), 2.29 (s, 3H, COCH3), 2.16-2.12 
(m, 1H), 1.65-1.61 (m, 1H), 1.35-1.30 (m, 1H) ppm. 13C NMR (100 MHz, CDCl3): δ = 206.8, 
158.3, 132.2, 127.2, 113.9, 55.3, 32.7, 30.7, 28.5, 18.8 ppm. MS (EI): 190.1 (M+, 31), 148 (11), 
147 (100), 132 (10), 131 (7), 117 (7), 116 (6), 115 (15), 103 (8), 91 (18), 43 (14). IR (neat, ν/cm-
1): 1693, 1612, 1514, 1394, 1245, 1179, 1166, 1034, 828, 818 537. HRMS (EI): m/z: calcd. for 
C12H14O2 190.0980; found: 190.0992. 
 
rac-2-(2-(2-Methylprop-1-enyl)cyclopropyl)but-3-yn-2-yl acetate (1a) 
Purified by distillation under reduced pressure to give a colourless liquid. Yield 
80%. B.p. 110-113 °C/0.07 mbar. 2 Isomers in a ratio of 6:4. 1H NMR (300 MHz, CDCl3): δ = 
4.66-4.59 (m, 1H), 2.52, 2.51 (s, 1H), 2.04, 2.03 (s, 3H), 1.76, 1.75 (s, 3H), 1.74 (s, 3H), 1.68 (s, 
3H), 1.32-1.10 (m, 2H), 0.98-0.89 (m, 1H), 0.62-0.49 (m, 1H) ppm. 13C NMR (75 MHz, CDCl3): 
δ = 169.3, 169.2 (s), 132.0, 131.8 (s), 126.3, 126.1 (d), 81.2 (s), 76.8, 76.7 (s), 73.9, 73.8 (d), 28.5 
(d), 27.2, 27.0 (q), 25.5, 25.4 (q), 21.9 (q), 18.2 (q), 15.9, 15.4 (d), 12.0, 10.9 (t) ppm. GC/MS 
(EI): 206 (M+, 1), 164 (7), 146 (28), 131 (100), 115 (36), 105 (33), 82 (94), 67 (34), 53 (20), 43 
(77). IR (neat, ν/cm-1): 2980, 2927, 1747, 1446, 1369, 1241, 1074. HRMS (EI): m/z: calcd. for 
C13H18O2 206.1307; found: 206.1285. 
 
rac-2-(2-(2-Ethylbut-1-enyl)cyclopropyl)but-3-yn-2-yl acetate (1b) 
Purified by distillation under reduced pressure to give a colourless liquid. Yield 
78%. B.p. 125-130 °C/0.04 mbar. 2 isomers in a ratio of 6:4. 1H-NMR (300 MHz, CDCl3): δ = 
4.55-4.53 (m, 1H), 2.51 (s, 1H), 2.25-1.62 (m, 4H), 2.03, 2.01 (s, 3H), 1.75 (s, 3H), 1.33-1.26 (m, 
1H), 1.18-1.11 (m, 1H), 1.05-0.93 (m, 1H), 1.01 (t, J = 7.5 Hz, 3H), 0.96 (t, J = 7.5 Hz, 3H), 0.61-
0.51 (m, 1H) ppm. 13C-NMR (75 MHz, CDCl3): δ = 169.3 (s), 143.4, 143.2 (s), 124.3, 124.2 (d), 
81.3 (s), 76.9 (s), 73.9 (d), 28.9 (t), 28.6 (d), 27.1, 26.9 (q), 23.7 (t), 22.0, 21.9 (q), 15.5, 15.1 (d), 
13.3, 13.2 (q), 12.6 (q), 12.2, 11.3 (t) ppm. GC/MS (EI): 234 (M+, 1), 192 (2), 174 (45), 159 (35), 
145 (100), 129 (47), 113 (71), 91 (70), 77 (52), 53 (26), 43 (67). IR (neat, ν/cm-1): 2965, 2936, 
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2875, 1748, 1462, 1368, 1240, 1136. HRMS (EI): m/z: calcd. for C15H22O2 234.1620; found: 
234.1609. 
 
rac-(E)-2-(2-(pent-1-enyl)cyclopropyl)but-3-yn-2-yl acetate (1c) 
1c
OAc
Purified by distillation under reduced pressure to give a colourless liquid. 
Yield 70%. B. p. 110-115 °C/0.08 mbar. 1H-NMR (300 MHz, CDCl3): δ = 5.50 (ddd, J = 6.8, 6.8, 
15.3 Hz, 1H), 5.05 (dd, J = 8.1, 15.3 Hz, 1H), 2.49 (s, 1H), 2.03 (s, 3H), 1.94 (dt, J = 6.8, 6.8 Hz, 
2H), 1.75 (s, 3H), 1.58-1.49 (m, 1H), 1.39-1.29 (m, 3H), 1.10 (ddd, J = 5.3, 5.3, 8.5 Hz, 1H), 0.87 
(t, J = 7.3 Hz, 3H), 0.63 (ddd, J = 5.3, 5.3, 8.5 Hz, 1H) ppm. 13C-NMR (75 MHz, CDCl3): δ = 
169.2 (s), 131.3 (d), 129.5 (d), 81.1 (s), 76.8 (s), 73.9 (d), 34.5 (t), 28.3 (d), 27.1 (q), 22.6 (t), 21.9 
(q), 18.7 (d), 13.6 (q), 11.5 (t) ppm. IR (neat, ν/cm-1): 2960, 2932, 1748, 1457, 1240, 1171, 1075, 
1014. HRMS (EI): m/z: calcd. for C14H20O2 220.1463; found: 220.1448. 
 
rac-2-(2-(2-Methylbut-1-enyl)cyclopropyl)but-3-yn-2-yl acetate (1d). 
Purified by distillation under reduced pressure to give a colourless liquid. Yield 
85%. B. p. 120-125 °C/0.08 mbar. 4 Isomers in a ratio of 4:2:2:1. 1H-NMR (300 MHz, CDCl3): δ 
= 4.64-4.57 (m, 1H), 2.52-2.51 (m, 1H), 2.26-1.61 (m, 9H), 2.04 (s, 3H), 1.35-1.25 (m, 1H), 1.91-
1.11 (m, 1H), 1.06 -0.95 (m, 3H), 0.62-0.51 (m, 1H) ppm. 13C-NMR (75 MHz, CDCl3): δ = 169.2 
(s), 137.7, 137.6, 137.4 (s), 125.9, 125.8, 124.7, 124.5 (d), 81.3 (s), 76.0, 76.8, 76.7 (s), 73.9, 73.8 
(d), 32.0, 25.3 (t), 28.6, 28.5 (d), 27.2, 27.1, 27.0 (q), 22.0 (q), 22.6, 16.4 (q), 15.8, 15.5, 15.4, 
15.1 (d), 12.8, 12.7, 12.5 (q), 12.2, 12.1, 11.1 (t) ppm.GC/MS (EI): 220 (M+, 1), 178 (2), 160 
(17), 145 (45), 131 (38), 115 (25), 99 (61), 81 (70), 67 (20), 53 (24), 43 (100). IR (neat, ν/cm- 1): 
2966, 2936, 1748, 1457, 1369, 1240, 1176, 1014. HRMS (EI): m/z: calcd. for C14H20O2 220.1463; 
found: 220.1446. 
 
rac-(E)-2-(2-(pent-2-en-2-yl)cyclopropyl)but-3-yn-2-yl acetate (1e) 
Purified by distillation under reduced pressure to give a colourless liquid. Yield 
82%. B. p. 120-122 °C/0.08 mbar. 2 Isomers in a ratio of 6:4. 1H-NMR (300 MHz, CDCl3): δ = 
5.21-5.14 (m, 1H), 2.51 (s, 1H), 2.04 (s, 3H), 2.04-1.94 (m, 2H), 1.77, 1.75 (2s, 3H), 1.58-1.58 
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(m, 4H), 1.39-1.32 (m, 1H), 1.04-0.93 (m, 1H), 0.93 (t, J = 7.5 Hz, 3H), 0.83-0.72 (m, 1H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 169.2 (s), 133.3, 133.0 (s), 126.1, 125.8 (d), 81.4 (s), 77.0, 76.8 
(s), 73.9 (d), 27.2, 26.9 (d), 27.1, 26.8 (q), 24.2, 23.8 (d), 22.0 (q), 21.1, 21.0 (t), 15.1, 14.8 (q), 
14.2 (q), 9.3, 8.3 (t) ppm. GC/MS (EI): 220 (M+, 1), 178 (4), 160 (36), 145 (82), 131 (62), 115 
(33), 99 (69), 91 (61), 81 (67), 67 (15), 53 (22), 43 (100). IR (neat, ν/cm-1): 2963, 2935, 2873, 
1748, 1455, 1369, 1241, 1170, 1076, 1014. HRMS (EI): m/z: calcd. for C14H20O2 220.1463; 
found: 220.1470. 
 
rac-(E)-2-(2’-(1-(Phenylprop-1-en-2-yl)cyclopropyl)but-3-yn-2yl acetate (1f) 
Purified by distillation under reduced pressure to give a colourless liquid. 
Yield 75%. B. p. 165- 175°C/0.08 mbar. 2 Isomers in a ratio of 1:1. 1H-NMR (300 MHz, CDCl3): 
δ = 7.33-7.15 (m, 5H), 6.33-6.31 (m, 1H), 2.55, 2.54 (s, 1H), 2.06 (s, 3H), 1.97-1.50 (m, 8H), 
1.82-0.91 (m, 2H) ppm. 13C-NMR (75 MHz, CDCl3): δ = 169.2 (s), 138.2, 138.1, 137.7, 137.5 
(2s), 128.8 (2d), 128.1 (2d), 126.0 (d), 124.5, 124.3 (d), 81.3 (s), 76.8, 76.6 (s), 74.3, 74.2 (d), 
27.7, 27.5 (d), 27.3, 27.0 (q), 25.4, 24.9 (d), 22.0 (q), 16.7, 16.5 (q), 10.1, 9.1 (t) ppm. GC/MS 
(EI): 268 (M+, 1), 226 (2), 208 (20), 193 (34), 178 (41), 165 (15), 147 (44), 129 (100), 115 (30), 
91 (23), 77 (13), 65 (6), 43 (35). IR (neat, ν/cm-1): 3286, 3021, 2938, 1746, 1442, 1368, 1240, 
1076. HRMS (EI): m/z: calcd. for C18H20O2 268.1463; found: 268.1472. 
 
2-(2’-(4”-(Prop-1-en-2-yl)cyclohex-1”-enyl)cyclopropyl)but-3-yn-2-yl acetate (1g) 
Purified by distillation under reduced pressure to give a colourless liquid. 
Yield 65 %. B. p. 175-180 °C/0.10 mbar. 2 Main isomers in a ratio of 6:4. 1H-NMR (300 MHz, 
CDCl3): δ = 5.52-5.39 (m, 1H), 4.72-4.68 (m, 2H), 2.51 (s, 1H), 2.12-1.59 (m, 13H), 2.04 (s, 3H), 
1.53- 1.31 (m, 2H), 1.04-0.67 (m, 2H) ppm. 13C-NMR (75 MHz, CDCl3): δ = 169.3 (s), 150.0, 
149.9 (s), 136.4, 136.1 (s), 120.2, 119.9 (d), 108.5 (t), 81.4, 81.3 (s), 76.8 (s), 73.9 (d), 41.2 (d), 
30.6 (t), 27.7 (2t), 27.1 (q), 26.8, 26.6 (d), 22.6, 22.1 (d), 22.0 (q), 20.8 (q), 9.6, 8.6 (t) ppm. 
GC/MS (EI): 272 (M+, 1), 230 (2), 212 (22), 197 (19), 183 (6), 169 (44), 151 (72), 143 (35), 129 
(96), 115 (44), 105 (57), 91 (92), 79 (56), 65 (19), 53 (25), 43 (100). IR (neat, ν/cm- 1): 2921, 
1748, 1437, 1369, 1240, 1075, 1014, 889. HRMS (EI): m/z: calcd. for C18H24O2 272.1776; found: 
272.1782. 
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rac-2-(2’-(2,6-Dimethylhepta-1,5-dienyl)cyclopropyl)bu-3-yn-2-yl acetate (1h) 
Purified by distillation under reduced pressure to give a colourless liquid. 
Yield 55%. B. p. 155-160 °C/0.10 mbar. 2 Main isomers in a ratio of 6:4. 1H-NMR (300 MHz, 
CDCl3): δ = 5.22-5.06 (m, 1H), 4.65-4.62 (m, 1H), 2.52, 2.51 (s, 1H), 2.16-1.60 (m, 16H), 2.04 (s, 
3H), 1.33-1.27 (m, 1H), 1.19-1.13 (m, 1H), 0.98-0.92, 0.62-0.51 (m, 2H) ppm. 13C-NMR (75 
MHz, CDCl3): δ = 169.3 (s), 135.6, 135.4 (s), 131.4, 131.3 (s), 126.1, 125.9 (d), 124.2, 124.1 (d), 
81.3, 81.2 (s), 76.9, 76.7 (s), 73.9, 73.8 (d), 39.4 (t), 28.6 (d), 27.2 (q), 26.6 (t), 25.6 (q), 22.0 (q), 
17.7 (q), 16.5 (q), 15.87, 15.38 (d), 12.16, 11.1 (t) ppm. GC/MS (EI): 274 (M+, 1), 214 (10), 195 
(4), 171 (10), 153 (9), 145 (32), 135 (32), 115 (22), 105 (38), 91 (35), 69 (100), 53 (18), 41 (57). 
IR (neat, ν/cm-1): 2968, 2918, 1748, 1447, 1368, 1240, 1075, 1014. HRMS (EI): m/z: calcd. for 
C18H26O2 274.1933; found: 274.1913. 
 
rac-2-(2’-(-2,6,6-Trimethylcyclohex-1-enyl)cyclopropyl)but-3-yn-2-yl acetate (1i) 
Purified by distillation under reduced pressure to give a colourless liquid. Yield 
65%. B. p. 155-160 °C/0.04 mbar. 1H-NMR (300 MHz, CDCl3): δ = 2.55 (s, 1H), 2.04 (s, 3H), 
1.95-1.89 (m, 2H), 1.80 (s, 3H), 1.71 (s, 3H), 1.69-1.51 (m, 4H), 1.41-1.34 (m, 2H), 1.12 (s, 3H), 
1.11 (s, 3H), 0.95 (ddd, J = 4.6, 4.9, 9.0 Hz, 1H), 0,71 (ddd, J = 4.7, 6.3, 9.0 Hz, 1H) ppm. 13C-
NMR (75 MHz, CDCl3): δ = 169.3 (s), 135.3 (s), 130.4 (s), 82.3 (s), 77.1 (s), 73.8 (d), 41.7 (t), 
35.5 (s), 33.8 (t), 29.1 (q), 28.7 (q), 26.9 (d), 26.0 (q), 22.0 (q), 21.0 (q), 19.2 (t), 17.7 (d), 11.4 (t) 
ppm. GC/MS (EI): 274 (M+, 1), 214 (25), 199 (54), 171 (17), 153 (69), 143 (100), 135 (98), 122 
(44), 107 (98), 91 (98), 77 (71), 69 (25), 55 (29), 43 (79). IR (neat, ν/cm-1): 2929, 1746, 1459, 
1368, 1241, 1073, 734. HRMS (EI): m/z: calcd. for C18H26O2 274.1933; found: 274.1930. 
 
rac-2-(2-(p-Methoxy)cyclopropyl)but-3-yn-2-yl acetate (1j) 
A solution of trimethylsilyl acetylene (0.4 mL, 2.7 mmol) in THF (4 mL) 
was cooled to -78ºC and BuLi (1.6 M in hexanes, 1.6 mL, 2.6 mmol) was added dropwise. After 
1h, a solution of 22j (0.5 g, 2.6 mmol) in THF (2 mL) was added and the reaction was warmed up 
to room temperature overnight. The reaction was then diluted with MeOH (3 mL) and K2CO3 (1.0 
g, 6.5 mmol) was added. The mixture was stirred at room temperature for 3 h, filtered over a path 
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of celite and rotavaped under reduced pressure. The residue was diluted with brine and extracted 
with dichloromethane, dried over Na2SO4 and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (Hexane/EtOAc = 100:1 to 20:1) to give propargylic alcohol 
as a colorless oil (0.35 g, 60% over 2 steps) which was subjected to the general procedure III.4) 
for acetylation affording 1j as a colorless oil (0.18 g, 42%) as a mixture of isomers 3:1. 1H NMR 
(400 MHz, CD2Cl2): δ = 7.06-7.03 (m, 2H, major and minor), 6.82- 6.78 (m, 2H, major and 
minor), 3.76 (s, 3H, OCH3, major and minor), 2.58 (s, 1H, major), 2.59 (s, 1H, minor), 2.32-2.21 
(m, 1H, major and minor), 2.01 (s, 3H, COCH3, minor), 1.99 (s, 3H, COCH3, major), 1.78 (s, 3H, 
CH3, minor), 1.76 (s, 3H, CH3, major), 1.59-1.54 (m, 1H, minor), 1.54-1.49 (m, 1H, major), 1.35-
1.30 (m, 1H, minor), 1.17-1.08 (m, 1H, major and minor), 0.97-0.90 (m, 1H, major) ppm. 13C 
NMR (100 MHz, CDCl3, major and minor): δ = 168.9 (2 x C), 158.0, 157.9, 133.9, 133.8, 127.3, 
127.2, 113.7, 113.6, 81.3, 81.1, 76.4, 76.1, 73.9, 73.8, 55.2 (2 x C), 30.4, 30.2, 26.9, 26.8, 21.6 (2 
x C), 20.4, 19.5, 12.6, 11.4 ppm. ESIMS (M+ + Na): 281.1. IR (neat, ν/cm-1): 2982, 1514, 1462, 
1244, 1177, 1034, 825. HRMS (EI): m/z: calcd. for C16H18O3Na 281.1154; found: 281.1157. 
 
rac-2-(2-(2-Methylprop-1-enyl)cyclopropyl)pent-4-yn-2-yl acetate (13) 
A mixture of aluminum (93 mg, 3.45 mmol) and HgCl2 (2.5 mg, 0.02 mmol) in THF 
(1.5 mL) was vigorously stirred for 1 h at room temperature. A solution of propargyl bromide (0.4 
mL, 3.45 mmol) in THF (2.5 mL) was added dropwise over 1 hour. After stirring for 1 h at 25ºC, 
the mixture was cannulated to a solution of 22a (0.19 g, 1.15 mmol) in THF (4 mL) at -78ºC. 
After 5 minutes, the reaction was quenched with a saturated solution of NH4Cl, extracted with 
Et2O, and dried over MgSO4. The crude was used as such for the next acetylation step according 
to general procedure III.4) affording compound 13 as a colorless oil (0.14 g, 53%). Mixture of 
isomers: 1.5:1. 1H NMR (400 MHz, CDCl3): δ = 4.61-4.58 (m, 1H, major and minor), 3.11-2.74 
(m, 2H, major and minor), 2.35 (s, 1H, major), 2.34 (s, 1H, minor), 1.99 (s, 3H, COCH3, major), 
1.98 (s, 3H, COCH3, minor), 1.72-1.64 (m, 6H, major and minor), 1.58-1.49 (m, 1H, major and 
minor), 1.38 (s, 3H, CH3, major), 1.37 (s, 3H, CH3, minor), 0.98-0.93 (m, 1H, major and minor), 
0.84-0.87 (m, 1H, major), 0.59-0.53 (m, 1H, minor), 0.52-0.45 (m, 1H, major and minor) ppm. 
13C NMR (100 MHz, CDCl3): δ = 170.71, 170.69, 131.81, 131.70, 127.47, 127.37, 81.82, 81.79, 
80.70, 80.68, 70.90, 70.89, 29.86, 29.77, 28.56, 28.54, 26.01, 26.00, 22.69 (2 x C), 22.25, 22.16, 
18.68, 18.66, 15.47, 15.10, 11.26, 11.06 ppm. MS (EI): 220 (M+), 160 (8), 145 (36), 130 (11), 
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127 (16), 105 (22), 91 (26), 85 (48), 82 (90), 43 (100). IR (neat, ν/cm-1): 3298, 2971, 2365, 1733, 
1367, 1241, 1078, 623. HRMS (EI): m/z: calcd. for C14H20O2 220.1463; found: 220.1464. 
 
rac-4-Cyclopropyl-2-(2-(2-methylprop-1-enyl)cyclopropyl)but-3-yn-2-yl acetate (15a) 
According to steps 3) and 4) of general procedure for preparation of compounds 22. 
The only difference is using cyclopropylacetylene instead of acetylene. Purified by distillation 
under reduced pressure to give a colourless liquid. Yield 40%. B. p. 125-130 °C/0.10 mbar. 2 
Isomers in a ratio of 6:4. 1H-NMR (300 MHz, CDCl3): δ = 4.63 (d, J = 8.5 Hz, 1H), 2.01, 2.00 (s, 
3H), 1.75-1.67 (m, 9H), 1.60-1.50, 1.10-1.04 (m, 1H), 1.31-1.20 (m, 2H), 0.88-0.63 (m, 5H), 
0.55-0.45 (m, 1H) ppm. 13C-NMR (75 MHz, CDCl3): δ = 169.9 (s), 132.3, 132.1 (s), 127.1, 127.0 
(d), 90.3, 90.2 (s), 78.6, 78.5 (s), 73.2 (s), 29.3 (q), 28.2, 28.0 (d), 26.1 (q), 22.8 (q), 18.8 (q), 
16.5, 16.3 (d), 12.6, 11.7 (t), 9.0 (2t), 0.0 (d) ppm. GC/MS (EI): 246 (M+, 1), 204 (2), 186 (25), 
171 (43), 156 (25), 143 (90), 128 (100), 115 (54), 105 (28), 91 (67), 77 (49), 65 (25), 53 (20), 43 
(56). IR (neat, ν/cm-1): 3008, 2977, 2923, 1745, 1445, 1367, 1242, 1071. HRMS (EI): m/z: calcd. 
for C16H22O2 246.1620; found: 246.1620. 
 
 
General experimental procedure for the preparation of Compounds 15b-d. 
 
 
 
1) 1-Propynylmagnesium bromide (24 mL, 0.5 M in THF, 12 mmol) was was added dropwise to 
the corresponding cyclopropylmethyl ketones 22 (10 mmol) in THF (20 mL) at 0 oC. The reaction 
mixture was stirred at RT for 2 hours until completion of the reaction. Sat. NH4Cl (100 mL) was 
added and the mixture was extracted 3 times with MTBE (100 mL). The combined organic layers 
were washed with brine (200 mL), dried (MgSO4) and concentrated in vacuo to give the crude 
propargylic alcohol of larger than 95% purity (GC). This material was directly used in the next 
step. 
2) Acetic anhydride (4.8 mL, 50 mmol) was added to a solution of the propargylic alcohol (10 
mmol), Et3N (14 mL, 100 mmol) and DMAP (0.12g, 1.0 mmol) in anhydrous CH2Cl2 (50 mL) at 
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0 oC. The reaction was stirred at room temperature for 24 h, was concentrated and partitioned 
between MTBE and water. The organic layer was washed with sat. NaHCO3 (100 mL) and brine 
(100 mL), dried (MgSO4) and concentrated in vacuo. The residue was distilled bulb to bulb to 
give the desired acetate 15b-d. 
 
rac-1-Methyl-1-[2-(1-methyl-2-phenyl-vinyl)-cyclopropyl]-but-2-ynyl acetate (15b) 
Purified by distillation under reduced pressure to give a colourless liquid. Yield 
45%. B. p. 185-195 °C/0.07 mbar. 2 Isomers in a ratio of 3:2 1H-NMR (300 MHz, CDCl3): δ = 
7.38-7.15 (m, 5H; Ar-H), 6.32, 6.30 (2s, 1H), 2.03 (s, 3H), 1.86 (s, 3H), 1.83, 1.80 (2s, 3H), 1.78, 
1.77 (2s, 3H), 1.74-1.62 (m, 1H), 1.59-1.50 (m, 1H), 1.15-0.87 (m, 2H) ppm. 13C-NMR (75 MHz, 
CDCl3): δ = 169.4 (s), 138.3, 138.2 (s), 138.1, 137.8 (s), 128.8 (2d), 128.0 (2d), 125.9 (d), 124.3, 
124.1 (d), 82.2, 82.1 (s), 78.1, 77.8 (s), 76.8, 76.7 (s), 28.0, 27.8 (d), 27.6, 27.3 (q), 25.4, 25.0 (d), 
22.2 (q), 16.7, 16.5 (q), 10.0, 9.2 (t), 3.6 (q) ppm. GC/MS (EI): 282 (M+, 1), 240 (4), 222 (44), 
207 (44), 192 (58), 178 (22), 165 (25), 147 (63), 129 (100), 115 (46), 105 (15), 91 (53), 77 (26), 
65 (17), 55 (13), 43 (57). IR (neat, ν/cm-1): 2982, 2919, 1742, 1494, 1442, 1368, 1239, 1073, 699. 
HRMS (EI): m/z: calcd. for C19H22O2 282.1620; found: 282.1619. 
 
2-(2’-(4”-(Prop-1-en-2-yl)cyclohex-1”-enyl)cyclopropyl)pent-3-yn-2-yl acetate (15c) 
Purified by distillation under reduced pressure to give a colourless liquid. Yield 
45%. B. p. 165-177 °C/0.06 mbar. 2 Isomers in a ratio of 6:4. 1H-NMR (300 MHz, CDCl3): δ = 
5.51-5.38 (m, 1H), 4.73-4.68 (m, 2H), 2.12-1.61 (m, 7H), 2.02 (s, 3H), 1.83 (s, 3H), 1.73 (s, 3H), 
1.72 (s, 3H), 1.53-1.32 (m, 2H), 1.01-0.65 (m, 2H) ppm. Major isomer: 13C-NMR (75 MHz, 
CDCl3): δ = 169.3 (s), 150.0, 149.9 (s), 136.6, 136.4 (s), 119.9, 119.6 (d), 108.4 (t), 81.9, 81.8 (s), 
78.1, 78.0 (s), 76.8 (s), 41.2 (d), 30.6 (t), 27.9 (t), 27.8 (t), 27.4 (q), 27.2, 26.9 (d), 22.5, 22.2 (d), 
22.1 (q), 20.7 (q), 9.6, 8.7 (t), 3.5 (q) ppm. GC/MS (EI): 286 (M+, 1), 244 (2), 226 (44), 211 (29), 
197 (7), 183 (44), 169 (19), 151 (54), 143 (100), 128 (84), 115 (44), 105 (45), 91 (88), 77 (51), 67 
(25), 53 (20), 43 (68). IR (neat, ν/cm-1): 2920, 1741, 1437, 1369, 1239, 1073, 889. HRMS (EI): 
m/z: calcd. for C19H26O2 286.1933; found: 286.1932. 
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7-Methyl-2-((1R,2S)-2-(2-methylprop-1-enyl)cyclopropyl)oct-6-en-3-yn-2-yl acetate (15d) 
2 Isomers in a ratio of 1:4. 1H-NMR (300 MHz, CDCl3): δ = 5.25-5.12 (m, 1H), 
4.67-4.60 (m, 1H), 2.95 (d, J=6.0 Hz, 2H), 2.01, 2.00 (s, 3H), 1.85-1.81 (m, 1H), 1.75-1.67 (m, 
12H), 1.35-0.85 (m, 5H), 0.55-0.45 (m, 1H) ppm. 13C-NMR (75 MHz, CDCl3): δ = 169.4, 169.3 
(s), 133.8, 133.7 (s), 131.6, 131.4 (s), 126.6, 126.4 (d), 118.8, 118.7 (d), 85.2, 85.1 (s), 79.3, 79.1 
(s), 78.1 (s), 29.4 (q), 28.7 (d), 27.6, 27.3 (q), 25.5, 25.4 (q), 25.3 (q), 22.2 (q), 18.1 (q), 17.8 (t), 
15.9, 15.8 (d), 11.9, 11.2 (t) ppm. IR (neat, ν/cm-1): 2974, 2921, 1736, 1448, 1375, 1242, 1018. 
HRMS (EI): m/z: calcd. for C18H26O2 274.1933; found: 274.1933. 
 
Preparation of 1k, (1S,3S)-1k, 15e and (1S,3S)-15e: 
 
 
Oxalyl dichloride (12.7 g, 0.10 mol) was added dropwise to a solution of rac-trans-
Chrysanthemic acid 24 or (1S,3S)-Chrysanthemic acid5 (1S,3S)-24 (16.8 g, 0.10 mol, 99%ee) in 
dichloromethane (100 mL) containing 1mL of DMF at 0 oC. The reaction mixture was stirred at 0 
oC for 2 hours. Following that, a mixture of N-methoxymethanamine (12.2 g, 0.20 mol) and 
triethylamine (20.2 g, 0.20 mol) in dichloromethane (50 mL) was added dropwise. The mixture 
was stirred at RT for 2 hours. The solid was filtered off, the filtrate was concentrated and 
dissolved in MTBE (100 mL), washed once with water and then dried .  
Distillation yielded 13.7 g (65%) of amide 25 as a colorless liquid. B. p. 125-130 °C/0.07 mbar 1H 
NMR (300 MHz, CDCl3): δ = 4.93 (d, J = 7.7 Hz, 1H), 3.69 (s, 3H), 3.21 (s, 3H), 2.15 (dd, J = 
5.3, 7.7 Hz, 1H), 1.84 (d, J = 5.3 Hz, 1H), 1.71 (s, 6H), 1.19 (s, 3H), 1.17 (s, 3H) ppm. 13C NMR 
(75 MHz, CDCl3): δ = 172.4 (s), 134.9 (s), 121.6 (d), 61.4 (q), 33.1 (d), 32.7 (q), 30.3 (d), 27.8 
(s), 25.5 (q), 22.3 (q), 20.4 (q), 18.5 (q) ppm. GC/MS (EI): 211 (M+, 10), 196 (6), 180 (3), 151 
(31), 123 (100), 109 (12), 91 (16), 81 (71), 67 (16), 55 (14), 41 (22). IR (neat, ν/cm-1): 2935, 
1656, 1441, 1379, 1179, 1113. HRMS (EI): m/z: calcd. for C12H21NO2 211.1572; found: 
211.1565. (1S,3S)-25 [α]22 = -0.2 (c = 1.04, CHCl3). 
 
rac-trans-1-(-2,2-Dimethyl-3-(2-methylprop-1-enyl)cyclopropyl)ethanone (26).6 To a solution 
of 25 (10.5 g, 0.050 mol) in THF (50 mL) at 0 oC was added methyl magnesium bromide (2.0 M 
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in THF, 30 mL, 0.060 mol) dropwise. The reaction mixture was stirred at 0 oC for 2 hours. The 
reaction mixture was quenched by addition of 1 N HCl and extracted with MTBE (150 mL). The 
organic layer was washed with brine and dried (MgSO4). The crude product was purified by 
distillation to give 26 (4.1 g, yield 50%) as a colorless liquid. The analytical results were in 
accordance with the reference data. 1H NMR (300 MHz, CDCl3): δ = 4.91 (d, J = 7.9 Hz, 1H, 
(CH3)2C=CH-), 2.22 (s, 3H, COCH3), 2.23-2.17 (m, 1H), 1.73 (d, J = 5.4 Hz, 1H), 1.71 (s, 3H, 
(CH3)2C=C), 1.68 (s, 3H, (CH3)2C=C), 1.30 (s, 3H, CH3), 1.18 (s, 3H, CH3) ppm. 13C NMR (75 
MHz, CDCl3): δ = 206.0 (s), 135.2 (s), 121.3 (d), 43.7 (d), 34.2 (d), 32.3 (q), 32.2 (q), 25.5 (q), 
22.4 (q), 19.6 (q), 18.4 (q) ppm. GC/MS (EI): 166 (M+, 2), 151 (3), 123 (100), 108 (4), 95 (12), 
81 (65), 67 (14), 55 (10), 43 (36). IR (neat, ν/cm-1): 2925, 1695, 1415, 1377, 1360, 1194, 1172, 
1113, 952, 848. 
 
(1S,3S)-trans-1-(-2,2-Dimethyl-3-(2-methylprop-1-enyl)cyclopropyl)ethanone ((1S,3S)-26). 
This compound was prepared from (1S,3S)-25 in an analogous way. 99% ee. [α]22 = -55.7 (c = 
0.96, CHCl3). The enantiomeric excess of 26 was determined by GC with a chiral MN 
HYDRODEX-beta-6TBDM column. 
 
GC chromatogram of rac-(26) 
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GC chromatogram of (1S,3S)-(26) 
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rac-2-(2,2-Dimethyl-3-(2-methylprop-1-enyl)cyclopropyl)but-3-yn-2-yl acetate (1k) 
From compound rac-26 according to steps 3) and 4) of the procedure for preparation 
of compounds 23. Purified by distillation under reduced pressure to give a colourless liquid. Yield 
45%. B. p. 130-136 °C/0.08 mbar. 2 Isomers in a ratio of 3:1. 1H-NMR (300 MHz, CDCl3): δ = 
4.92-4.87 (m, 1H), 2.61 (s, 1H), 2.02 (s, 3H), 1.82-1.76 (m, 1H), 1.74 (s, 3H), 1.72 (2s, 6H), 1.30 
(s, 3H), 1.03 (s, 3H), 0.91 (d, J = 5.8 Hz, 1H) ppm. Major isomer: 13CNMR (75 MHz, CDCl3): δ = 
169.3, 168.7 (s), 133.9 (s), 123.0 (d), 83.5 (s), 75.6 (s), 74.7, 74.6 (d), 41.9, 41.6 (d), 29.7, 29.3 
(d), 27.9 (q), 27.8 (q), 25.5 (q), 23.8 (s), 22.7 (q), 21.9 (q), 20.5, 18.4 (q) ppm. GC/MS (EI): 234 
(M+, 1), 192 (2), 174 (12), 159 (100), 144 (25), 129 (39), 117 (29), 105 (51), 91 (61), 65 (20), 53 
(21), 43 (99). IR (neat, ν/cm-1): 2971, 1736, 1438, 1368, 1248, 1129. HRMS (EI): m/z: calcd. for 
C15H22O2 234.1620; found: 234.1626. 
 
(1S,3S)-2-(2,2-Dimethyl-3-(2-methylprop-1-enyl)cyclopropyl)but-3-yn-2-yl acetate ((1S,3S)-
1k). This compound was prepared from (1S,3S)-26 in an analogous way. 99% ee. D.r = 6:4. [α]22 
= -36.5 (c = 0.84, CHCl3). 
 
rac-2-(2,2-Dimethyl-3-(2-methylprop-1-enyl)cyclopropyl)prop-2-ynyl acetate (9) 
To a solution of amide 25 (4.22 g, 0.02 mol) in diethyl ether (30 mL) was added 
LiAlH4 (0.760 g, 0.02 mol) in 4 portions under argon atmosphere at -45 oC . The reaction mixture 
was stirred at -45 oC for 30 min and quenched with 1 N HCl. The organic phase was separated 
and washed with brine, then dried (MgSO4). The crude product was purified by distillation to give 
2.13 g (yield 70%) of aldehyde 27 as a colorless liquid. The analytical results were in accordance 
to the reference data.7 Preparation of 9 was performed according to steps 3) and 4) of the general 
procedure for preparation of compounds 22. Purified by distillation under reduced pressure 
yielded 9 (80%) as a colourless liquid. B. p. 110-111 °C/0.09 mbar. 2 Isomers in a ratio of 1:1. 
1H-NMR (300 MHz, CDCl3): δ = 5.14, 5.00 (2dd, J = 2.1, 10.0 Hz, 1H), 4.91, 4.85 (2 bd, J = 7.5 
Hz, 1H), 251, 2.45 (2d, J = 2.1Hz, 1H), 2.10, 2.09 (2s, 3H), 1.72-1.66 (m, 6H), 1.39-0.96 (m, 8H) 
ppm. 13C-NMR (75 MHz, CDCl3): δ = 170.0, 169.7 (s), 134.6, 134.2 (s), 122.1, 121.9 (d), 81.5, 
81.4 (s), 73.3, 72.6 (d), 65.1, 64.9 (d), 36.4, 36.3 (d), 29.8, 28.4 (d), 25.6 (q), 23.2, 22.6 (s), 22.3, 
22.2, 21.8, 21.3, 21.1, 21.0 (3q), 18.4, 18.1 (q) ppm. GC/MS (EI): 220 (M+, 1), 178 (2), 160 (13), 
Chapter 2 
 
 
 
63 
 
145 (85), 123 (75), 106 (38), 91 (80), 81 (82), 67 (21), 53 (21), 43 (100). IR (neat, ν/cm-1): 2925, 
1743, 1451, 1371, 1234, 1126, 1017. HRMS (EI): m/z: calcd. for C14H20O2 220.1463; found: 
220.1467. 
 
(1S,3S)-2-(2,2-Dimethyl-3-(2-methylprop-1-enyl)cyclopropyl)pent-3-yn-2-yl acetate (15e) 
According to steps 1) and 2) of general procedure for preparation of compounds 15b-
d. Purified by distillation under reduced pressure to give a colourless liquid. Yield 35%. B. p. 
125-132 °C/0.07 mbar. 2 Isomers in a ratio of 4:1. 1H-NMR (300 MHz, CDCl3): δ = 4.93-4.90 (m, 
1H), 2.02 (s, 3H), 1.87 (s, 3H), 1.85 (s, 3H), 1.85-1.65 (m, 1H), 1.71 (s, 6H), 1.32 (s, 3H), 1.17 (d, 
J = 5.3 Hz, 1H), 1.01 (s, 3H), ppm. Major isomer: 13C-NMR (75 MHz, CDCl3): δ = 169.5 (s), 
133.5 (s), 123.3 (d), 83.6 (s), 79.2 (s), 78.8 (s), 41.9 (d), 30.0 (d), 29.6 (q), 25.5 (q), 24.0 (s), 23.4 
(q), 22.2 (q), 20.9 (q), 18.4 (q), 3.52 (q) ppm. GC/MS (EI): 248 (M+, 1), 206 (2), 188 (10),173 
(100), 158 (25), 143 (32), 131 (28), 119 (35), 105 (32), 91 (36), 77 (20), 67 (12), 53 (11), 43 (39). 
IR (neat, ν/cm-1): 2921, 1737, 1448, 1367, 1244, 1144, 1014. HRMS (EI): m/z: calcd. for 
C16H24O2 248.1776; found: 248.1779. 
 
(1S,3S)-2-(2,2-Dimethyl-3-(2-methylprop-1-enyl)cyclopropyl)pent-3-yn-2-yl acetate ((1S,3S)-
15e). This instable compound was prepared from (1S,3S)-26 in an analogous way and 
cycloisomerized immediately. The analytical data are identical with those of rac-15e. 
 
 
 General procedure A for the 2-cyclohexenone synthesis: 
 
2-Methyl-5-(2-methylprop-1-enyl)cyclohex-2-enone (8a) 
Methylene chloride (10 mL) was added to a mixture of gold complex [AuCl(PPh3)] 
(49.4 mg, 0.10 mmol) and AgSbF6 (34.3 mg, 0.10 mmol), and the reaction mixture was stirred for 
10 min under argon atmosphere. The resulting solution was filtered through a pad of celite. A 
solution of 1a (2.06 g, 10 mmol) in CH2Cl2 (10 mL) was added, and the mixture was stirred for 2 
min. Methanol (10 mL) and K2CO3 (2.76 g, 20 mmol) were added. The resulting mixture was 
stirred for 30 min and concentrated. The residue was neutralized with 1N HCl and extracted 3 
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times with MTBE (30 mL). The combined organic layers were washed with brine (20 mL), dried 
(MgSO4) and evaporated in vacuo. The residue was purified by column chromatography on silica 
gel, eluent: hexane:MTBE (10:1) to yield 8a (1.39 g, 85%) as colorless liquid. 1H NMR (300 
MHz, CDCl3): δ = 6.78-6.68 (m, 1H, CH=C(CH3)C=O), 5.05 (d, J = 8.4 Hz, 1H, CH=C(CH3)2), 
3.05-2.86 (m, 1H, 5-H), 2.48-2.14 (m, 4H), 1.78 (s, 3H, CH3), 1.69 (s, 3H, CH3), 1.62 (s, 3H, 
CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 199.8 (s), 144.8 (d), 135.5 (s), 132.7 (s), 127.1 (d), 
44.7 (t), 35.1 (d), 32.8 (t), 25.7 (q), 17.8 (q), 15.8 (q) ppm. GC/MS (EI): 164 (M+, 34), 149 (5), 
121 (5), 107 (6), 93 (5), 82 (100), 67 (11), 54 (16). IR (neat, ν/cm-1): 2965, 2876, 1676, 1455, 
1432, 1244, 1138, 1101. HRMS (EI): m/z: calcd. for C11H16O 164.1201: Found: 164.1192. 
 
3-(2-Ethylbut-1-enyl)-6-methylcyclohexa-1,5-dienyl acetate (7a) 
In another example, the reaction mixture was concentrated prior methanolysis and 
the crude product was purified by distillation under reduced pressure to give compound 7a as a 
colorless liquid. Yield 80%. B. p.: 115-122 °C/0.09 mbar. 1H-NMR (300 MHz, CDCl3): δ = 5.63-
5.59 (m, 1H), 5.25-5.15 (m, 2H), 3.41-3.29 (m, 1H), 2.30-1.95 (m, 5H), 1.68 (s, 3H), 1.65 (s, 3H), 
1.61 (s, 3H) ppm. 13CNMR (75 MHz, CDCl3): δ = 169.5 (s), 146.7 (s), 131.9 (s), 129.0 (s), 126.4 
(d), 124.0 (d), 116.8 (d), 32.8 (d), 29.5 (t), 25.6 (q), 20.6 (q), 17.8 (q), 16.6 (q) ppm. GC/MS (EI): 
206 (M+, 12), 164 (100), 149 (48), 131 (12), 121 (71), 109 (49), 96 (46), 79 (16), 69 (15), 55 (11), 
43 (26). IR (neat, ν/cm-1): 2967, 1757, 1460, 1370, 1214. HRMS (EI): m/z: calcd. for C13H18O2 
206.1307: Found: 206.1311. 
 
5-(2-Ethyl-but-1-enyl)-2-methyl-cyclohex-2-enone (8b) 
Using general procedure A, a mixture of 1b (2.34 g, 10 mmol) and gold complex 
Au(PPh3)SbF6 (0.10 mmol) were reacted and methanolyzed to give 8b as a colorless liquid (1.50 
g, 78 % yield). 1H NMR (300 MHz, CDCl3): δ = 6.75-6.68 (m, 1H, 3-H), 4.99 (d, J = 9.2 Hz, 1H), 
3.06-2.93 (m, 1H, 5-H), 2.47-2.41 (m, 1H), 2.39-2.30 (m, 1H), 2.27-2.10 (m, 2H), 2.03 (q, J = 7.5 
Hz, 2H, CH2CH3), 2.01 (q, J = 7.5 Hz, 2H, CH2CH3), 1.78 (s, 3H, 2-CH3), 0.98 (t, J = 7.5 Hz, 
3H, CH2(CH3)a), 0.96 (t, J = 7.5 Hz, 3H, CH2(CH3)b) ppm. 13C NMR (75 MHz, CDCl3): δ = 
199.7 (s), 144.7 (d), 144.1 (s), 135.5 (s), 125.2 (d), 45.1 (t), 34.7 (d), 33.2 (t), 28.9 (t), 23.4 (t), 
15.7 (q), 13.7 (q), 12.7 (q) ppm. GC/MS (EI): 192 (M+, 21), 163 (11), 121 (15), 110 (53), 95 (22), 
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82 (100), 67 (5), 54 (17), 41 (18). IR (neat, ν/cm-1): 2965, 2934, 2876, 1676, 1460, 1366, 1243, 
1103. HRMS (EI): m/z: calcd. for C13H20O 192.1514; found: 192.1523. 
 
2-Methyl-5-((E)-pent-1-enyl)cyclohex-2-enone (8c) 
 Using general procedure A, a mixture of 1c (2.20 g, 10 mmol) and gold complex 
Au(PPh3)SbF6 (0.10 mmol) were reacted and methanolyzed to give 8c as a colorless liquid (1.10 
g, 62 % yield). 1H NMR (300 MHz, CDCl3): δ = 6.80-6.65 (m, 1H, 3-H), 5.52-5.35 (m, 2H), 2.84-
2.65 (m, 1H, 5-H), 2.55-2.51 (m, 1H), 2.47-2.35 (m, 1H), 2.30-2.10 (m, 2H), 2.04-1.93 (m, 2H), 
1.77 (s, 3H, 2-CH3), 1.43-1.31 (m, 2H), 0.88 (t, J = 7.4 Hz, 3H, CH2CH3) ppm. 13C NMR (75 
MHz, CDCl3): δ = 199.5 (s), 144.3 (d), 135.6 (s), 132.4 (d), 130.3 (d), 44.4 (t), 38.5 (d), 34.5 (t), 
32.7 (t), 22.4 (t), 15.7 (q), 13.5 (q) ppm. GC/MS (EI): 178 (M+, 2), 149 (1), 134 (14), 122 (7), 107 
(8), 93 (8), 82 (100), 67 (5), 54 (22), 39 (12). IR (neat, ν/cm-1): 2958, 2925, 2873, 1677, 1452, 
1434, 1366, 1243, 969. HRMS (EI): m/z: calcd. for C12H18O 178.1358; found: 178.1363. 
 
2-Methyl-5-(2-methyl-but-1-enyl)-cyclohex-2-enone (8d) 
Using general procedure A, a mixture of 1d (2.20 g, 10 mmol) and gold complex 
Au(PPh3)SbF6 (0.10 mmol) were reacted and methanolyzed to give 8d as a colorless liquid (1.46 
g, 82 % yield). Mixture of isomers: 1H NMR (300 MHz, CDCl3): δ = 6.77-6.68 (m, 1H, 3-H), 
5.07-4.98 (m, 1H), 3.05-2.88 (m, 1H, 5-H), 2.49-2.40 (m, 1H), 2.39-2.27 (m, 1H), 2.26-2.06 (m, 
2H), 2.03-1.94 (m, 2H), 1.78 (br s, 3H, 2-CH3), 1.68, 1.62 (s, 3H, CH3), 1.00-0.94 (m, 3H, 
CH2CH3) ppm. Major isomer: 13C NMR (75 MHz, CDCl3): δ =199.8 (s), 144.7 (d), 138.2 (s), 
135.5 (s), 125.5 (d), 44.7 (t), 34.9 (d), 32.8 (t), 32.2 (t), 16.0 (q), 15.7 (q), 12.6 (q) ppm. GC/MS 
(EI): 178 (M+, 21), 163 (1), 149 (5), 122 (6), 107 (8), 96 (25), 82 (100), 67 (5), 54 (17), 41 (13). 
IR (neat, ν/cm-1): 2965, 2923, 1676, 1451, 1364, 1101, 902. HRMS (EI): m/z: calcd. for C12H18O 
178.1358; found: 178.1366. 
 
2-Methyl-5-(1-methyl-but-1-enyl)-cyclohex-2-enone (8e) 
Using genral procedure A, a mixture of 1e (2.20 g, 10 mmol) and gold complex 
Au(PPh3)SbF6 (0.10 mmol) were reacted and methanolyzed to give 8e as a colorless liquid (1.71 
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g, 96 % yield). 1H NMR (300 MHz, CDCl3): δ = 6.84-6.72 (m, 1H, 3-H), 5.20 (t, J = 6.9 Hz, 1H), 
2.70-2.59 (m, 1H, 5-H), 2.50 (dd, J = 3.5, 15.9 Hz, 1H), 2.39-2.25 (m, 3H), 2.06-1.97 (m, 2H), 
1.78 (s, 3H, 2-CH3), 1.61 (s, 3H, CH3), 0.95 (t, J = 7.5 Hz, 3H, CH2CH3) ppm. 13C NMR (75 
MHz, CDCl3): δ = 200.1 (s), 144.9 (d), 135.5 (s), 135.2 (s), 126.9 (d), 44.2 (d), 43.3 (t), 31.4 (t), 
21.0 (t), 15.6 (q), 14.1 (q), 13.8 (q) ppm. GC/MS (EI): 178 (M+, 17), 163 (2), 149 (8), 134 (11), 
121 (11), 107 (12), 82 (100), 54 (18), 41 (12). IR (neat, ν/cm-1): 2962, 1677, 1451, 1366, 1244, 
1099. HRMS (EI): m/z: calcd. for C12H18O 178.1358; found: 178.1358. 
 
2-Methyl-5-(1-methyl-2-phenyl-vinyl)-cyclohex-2-enone (8f) 
Using general procedure A, a mixture of 1f (2.68 g, 10 mmol) and gold 
complex Au(PPh3)SbF6 (0.10 mmol) were reacted and methanolyzed to give 8f as a colorless oil 
(1.99 g, 88 % yield). 1H NMR (300 MHz, CDCl3): δ = 7.35-7.18 (m, 5H, Ar-H), 6.87-6.77 (m, 
1H), 6.34 (s, 1H), 2.92-2.78 (m, 1H), 2.68-2.60 (m, 1H), 2.53-2.40 (m, 3H), 1.86 (s, 3H, CH3), 
1.81 (s, 3H, CH3) ppm. 13C NMR (75 MHz, CDCl3): δ =199.6 (s), 144.6 (d), 139.6 (s), 137.8 (s), 
135.4 (s), 128.9 (d), 128.1 (d), 126.3 (d), 125.3 (d), 45.0 (d), 43.2 (t), 31.3 (t), 15.7 (2q) ppm. 
GC/MS (EI): 226 (M+, 29), 182 (10), 169 (7), 156 (4), 144 (39), 129 (100), 115 (16), 91 (20), 77 
(7), 65 (5), 54 (8), 39 (9). IR (neat, ν/cm-1): 3023, 2921, 1674, 1493, 1448, 1366, 1107. HRMS 
(EI): m/z: calcd. for C16H18O 226.1358; found: 226.1359. 
 
4'-Isopropenyl-4-methyl-bicyclohexyl-4,1'-dien-3-one (8g) 
Using general procedure A, a mixture of 1g (2.72 g, 10 mmol), gold complex 
Au(PPh3)SbF6 (0.10 mmol) were reacted and methanolyzed to give 8g as a colorless oil (1.29 g, 
56 % yield). 1H NMR (300 MHz, CDCl3): δ = 6.77-6.72 (m 1H), 5.55-5.45 (m, 1H), 4.71 (s, 2H), 
2.70-2.45 (m, 2H), 2.44-2.22 (m, 3H), 2.21-1.85 (m, 6H), 1.78 (s, 3H, CH3), 1.74 (s, 3H, CH3), 
1.55-1.38 (m, 1H) ppm. 13C NMR (75 MHz, CDCl3): δ = 200.0 (s), 149.7 (s), 144.8 (d), 138.6 (s), 
135.3 (s), 120.9 (d), 108.6 (t), 43.4 (t), 42.5 (d), 41.0 (d), 31.4 (t), 30.6 (t), 27.7 (t), 26.8 (t), 20.7 
(q), 15.7 (q) ppm. GC/MS (EI): 230 (M+, 18), 215 (3), 202 (4), 187 (29), 173 (6), 159 (10), 145 
(25), 134 (26), 119 (20), 105 (57), 93 (45), 82 (100), 68 (27), 54 (24), 41 (24). IR (neat, ν/cm-1): 
2922, 1675, 1435, 1367, 1099, 889. HRMS (EI): m/z: calcd. for C16H22O 230.1671; found: 
230.1672. 
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5-(2,6-Dimethyl-hepta-1,5-dienyl)-2-methyl-cyclohex-2-enone (8h) 
Using general procedure A, a mixture of 1h (2.74 g, 10 mmol) and gold complex 
Au(PPh3)SbF6 (0.10 mmol) were reacted and methanolyzed to give 8h as a colorless oil (1.65 g, 
71 % yield). 1H NMR (300 MHz, CDCl3): δ = 6.75-6.68 (m, 1H), 5.10-5.03 (m, 2H), 3.04-2.88 
(m, 1H), 2.45 (dd, J = 4.1, 16.2 Hz, 1H), 2.38-2.28 (m, 1H), 2.26-1.92 (m, 6H), 1.79 (s, 3H, CH3), 
1.68 (s, 3H, CH3), 1.62 (s, 3H, CH3), 1.60 (s, 3H, CH3) ppm. 13C NMR (75 MHz, CDCl3): δ 
=199.7 (s), 144.7 (d), 136.2 (s), 135.5 (s), 131.5 (s), 127.0 (d), 123.9 (d), 44.7 (t), 39.5 (t), 34.9 
(d), 32.8 (t), 26.5 (t), 25.6 (q), 17.7 (q), 16.1 (q), 15.7 (q) ppm. GC/MS (EI): 232 (M+, 17), 164 
(18), 149 (19), 135 (4), 121 (25), 109 (29), 93 (17), 82 (28), 69 (100), 55 (14), 41 (44). IR (neat, 
ν/cm-1): 2922, 1677, 1450, 1364, 1246. HRMS (EI): m/z: calcd. for C16H24O 232.1827; found: 
232.1830. 
 
4,2',6',6'-Tetramethyl-bicyclohexyl-4,1'-dien-3-one (8i) 
Using general procedure A, a mixture of 1i (2.74 g, 10 mmol) and gold complex 
Au(PPh3)SbF6 (0.10 mmol) were reacted and methanolyzed to give 8i as a colorless oil (2.09 g, 90 
% yield). 1H NMR (300 MHz, CDCl3): δ = 6.78-6.72 (m, 1H, 3-H), 2.94-2.83 (m, 2H), 2.82-2.68 
(m, 1H), 2.43-2.36 (m, 1H), 2.32-2.18 (m, 1H), 1.92 (t, J = 6.1 Hz, 2H), 1.79 (s, 3H, CH3), 1.72 
(s, 3H, CH3), 1.58-1.48 (m, 2H), 1.45-1.35 (m, 2H), 0.99 (s, 3H, CH3), 0.98 (s, 3H, CH3) ppm. 13C 
NMR (75 MHz, CDCl3): δ = 200.8 (s), 145.8 (d), 138.1 (s), 134.8 (s), 129.5 (s), 42.9 (t), 39.9 (t), 
36.0 (s), 35.7 (d), 34.4 (t), 31.6 (t), 27.9 (q), 27.8 (q), 21.9 (q), 19.3 (t), 15.9 (q) ppm. GC/MS 
(EI): 232 (M+, 36), 217 (14), 175 (15), 161 (10), 150 (24), 135 (100), 123 (76), 109 (40), 91 (31), 
79 (31), 55 (21), 41 (33). IR (neat, ν/cm-1): 2927, 2866, 1675, 1454, 1363, 1244, 1092. HRMS 
(EI): m/z: calcd. for C16H24O 232.1827; found: 232.1827. 
 
3-(p-Methoxyphenyl)-6-methylcyclohexa-1,5-dienyl acetate (7j) 
Using general procedure A, a mixture of 1j (0.10 g, 0.4 mmol) and gold 
complex Au(PPh3)SbF6 (0.004 mmol) were reacted. In this example, the reaction mixture was 
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concentrated prior to methanolysis and the crude product was purified by column chromatography 
on silica gel, eluent: hexane:EtOAc (100:1) to yield 7j (70 mg, 70%) as colorless oil. 1H NMR 
(400 MHz, CDCl3): δ = 7.24-7.22 (m, 2H), 6.85-6.29 (m, 2H), 5.57 (d, J = 1.5 Hz, 1H), 5.43 (d, J 
= 4.2 Hz, 1H), 3.78 (s, 3H, OCH3), 3.70 (dc, J = 4.3, 9.2 Hz, 1H), 2.58-2.50 (m, 1H), 2.37-2.28 
(m, 1H), 2.19 (s, 3H, COCH3), 1.70 (d, 3H, J = 1.8 Hz, CH3) ppm. 13C NMR (100 MHz, CDCl3): 
δ = 169.9, 158.4, 147.7, 136.3, 129.3, 128.5, 123.7, 116.6, 113.9, 55.4, 39.1, 32.6, 20.9, 16.8 ppm. 
MS (EI): 258.1 (M+, 9), 256 (29), 216 (62), 214 (87), 199 (31), 198 (13), 137 (32), 121 (100), 108 
(19), 57 (11), 43 (17). IR (neat, ν/cm-1): 2953, 2917, 2849, 2836, 2355, 2343, 2337, 2327, 1758, 
1609, 1511, 1367, 1245, 1215, 1123, 1036, 828. HRMS (EI): m/z: calcd. for C16H18O3 258.1256; 
found: 258.1250. 
 
2,4,4-Trimethyl-5-(2-methyl-propenyl)-cyclohex-2-enone (8k) 
O8k Using general procedure A, a mixture of 1k (2.34 g, 10 mmol) and gold complex 
Au(PPh3)SbF6 (0.10 mmol) were reacted and methanolyzed to give 8k as a colorless oil (1.50 g, 
78 % yield). 1H NMR (300 MHz, CDCl3): δ = 6.43 (s, 1H, 3-H) 5.03 (d, J = 9.2 Hz, 1H), 2.77 
(ddd, J = 10.5, 10.5, 9.2 Hz, 1H), 2.41-2.24 (m, 2H), 1.75 (s, 3H), 1.73 (s, 3H), 1.62 (s, 3H), 1.04 
(s, 3H), 1.01 (s, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ = 200.0 (s), 156.1 (d), 133.6 (s), 132.3 
(s), 123.9 (d), 43.0 (d), 40.7 (t), 36.9 (s), 28.2 (q), 26.0 (q), 20.9 (q), 18.2 (q), 15.7 (q) ppm. 
GC/MS (EI): 192 (M+, 16), 177 (1), 135 (2), 110 (100), 95 (43), 82 (16), 67 (40), 53 (5), 41 (14). 
IR (neat, ν/cm-1): 2966, 1677, 1448, 1368, 1269, 1086, 1016. HRMS (EI): m/z: calcd. for 
C13H20O 192.1514; found: 192.1520. 
 
(5R)-2,4,4-Trimethyl-5-(2-methyl-propenyl)-cyclohex-2-enone ((R)-8k). This compound was 
prepared from (1S,3S)-1k in an analogous way. 27% ee. [α]22  = +28.4 (c 0.58, CHCl3).  
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GC chromatogram of rac-8k 
 
 
 
GC chromatogram of (R)-8k (27%ee) which was prepared by Au(I) 
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GC chromatogram of (R)-8k (87%ee) which was prepared by Au(III) 
 
 
The absolute configuration of (R)-8k was determined by comparing the vibrations of a measured 
ROA (Raman Optical Activity) spectra (below) with those of the theoretical spectra, calculated at 
the B97-1/pc-2 level with the Gaussian program (above).[1a,b,d] ROA calculations at the 
TDHF/DPS level was carried out with the Dalton program.[1c] 
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rac-3-Methyl-6-(2-methylprop-1-enyl)cyclohept-2-enone (14) 
Methylene chloride (18 ml) was added to a mixture of dichloro(pyridin-2-
carboxylate)gold complex (17 mg, 0.045 mmol) and homopropargyl acetate 13 ( 0.20 g, 0.91 
mmol) and the reaction mixture was stirred for 15 min. under argon atmosphere. The resulting 
solution was diluted with MeOH (18 ml) and K2CO3 (251 mg, 1.82 mmmol) was added and 
stirred at room temperature for 90 minutes. The resulting solution was quenched with water and 
the aquous layer was extracted with dichloromethane several times. The organic layers were dried 
over Na2SO4 anhydrous. The residue was purified by column chromatography on silica gel, 
eluent: hexane:EtOAc (100:1) to yield 14 (0.140 g, 72%) as colorless liquid. 1H NMR (400 MHz, 
CDCl3): δ = 5.92 (s, 1H), 5.06 (dd, J = 1.1, 9.3 Hz, 1H), 2.84-2.75 (m, 1H), 2.63 (dd, J = 5.0, 14 
Hz, 1H), 2.53-2.45 (m, 2H), 2.33 (ddd, J = 3.0, 8.4, 17 Hz, 1H), 1.95 (s, 3H, CH3), 1.93-1.87 (m, 
1H), 1.66 (s, 3H, CH3), 1.61 (s, 3H, CH3), 1.62-1.54 (m, 1H) ppm. 13C NMR (100 MHz, CDCl3): 
δ = 202.3 (s), 159.5 (s), 131.2 (s), 129.9 (d), 128.0 (d), 49.0 (t), 33.1 (t), 33.0 (t), 32.3 (d), 27.5 
(q), 25.6 (q), 17.8 (q) ppm. MS (EI): 178 (M+, 5), 163 (5), 145 (5), 135 (17), 121 (18), 107 (31), 
95 (32), 93 (100), 80 (64), 82 (50), 67 (44), 41 (39). IR (neat, ν/cm-1): 2967, 2924, 2859, 1655, 
1440, 1375, 1273, 1258, 1100, 1021, 835. HRMS (EI): m/z: calcd. for C12H18O 178.1358; found: 
178.1355. 
 
(3E,6E)-5,5,8-Trimethylnona-3,6,8-trien-2-one (10)[2] 
A mixture of 9 (2.34 g, 10 mmol) and gold complex Au(PPh3)SbF6 (0.10 
mmol) in 1,2-DCE were refluxed for 1 hour and methanolyzed to give 10 as a colorless oil (0.354 
g, 20 % yield). 1H NMR (300 MHz, CDCl3): δ = 6.75 (d, J = 16.2 Hz, 1H, 4-H), 6.11 (d, J = 16.1 
Hz, 1H, 7-H), 6.02 (d, J = 16.2 Hz, 1H, 3-H), 5.60 (d, J = 16.1 Hz, 1H, 6-H), 4.95 (2s, 2H, 9-H), 
2.27 (s, 3H, COCH3), 1.84 (s, 3H, 8-CH3), 1.23 (s, 6H, 5-(CH3)2) ppm. 13C NMR (75 MHz, 
CDCl3): δ = 199.0 (s), 155.3 (d), 141.6 (s), 136.2 (d), 130.7 (d), 127.4 (d), 116.1 (t), 38.9 (s), 27.1 
(q), 26.6 (2q), 20.9 (q), 18.6 (q) ppm. GC/MS (EI): 178 (M+, 7), 163 (19), 145 (8), 135 (35), 121 
(19), 107 (35), 93 (60), 77 (26), 65 (10), 55 (14), 43 (100). IR (neat, ν/cm-1): 2965, 1677, 1621, 
1451, 1359, 1256, 970. 
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General procedure B for 2-cyclopentenylketone synthesis: 
 
Cyclopropyl-[2-methyl-5-(2-methyl-propenyl)-cyclopent-1-enyl]-methanone (19a) 
Methylene chloride (10 mL) was added to a mixture of gold complex [AuCl(PPh3)] 
(49.4 mg, 0.10 mmol) and AgSbF6 (34.3 mg, 0.10 mmol), and the reaction mixture was stirred for 
10 min under argon atmosphere. The resulting solution was filtered through a pad of celite. A 
solution of 15a (2.46 g, 10 mmol) in CH2Cl2 (10 mL) was added and the mixture was stirred for 5 
min. Methanol (10 mL) and K2CO3 (2.76 g, 20 mmol) were added to the reaction mixture. The 
resulting mixture was stirred for 4 hours and concentrated. The residue was neutralized with 1N 
HCl and extracted 3 times with MTBE (30 mL). The combined organic layers were washed with 
brine (20 mL), dried (MgSO4) and evaporated in vacuo. The residue was purified by column 
chromatography on silica gel, eluent: hexane:MTBE (10:1) to yield 19a (1.59 g, 78%) as yellow 
oil. 1H NMR (300 MHz, CDCl3): δ = 5.09 (d, J = 9.8 Hz, 1H), 4.03-3.90 (m, 1H), 2.57-2.28 (m, 
2H), 2.19-2.08 (m, 1H), 2.03 (s, 3H, CH3), 2.01-1.95 (m, 1H), 1.69 (s, 3H, CH3), 1.68 (s, 3H, 
CH3), 1.56-1.44 (m, 1H), 1.11-1.04 (m, 1H), 1.00-0.94 (m, 1H), 0.82-0.76 (m, 2H) ppm. 13C NMR 
(75 MHz, CDCl3): δ = 202.1 (s), 151.4 (s), 140.1 (s), 130.9 (s), 128.4 (d), 45.7 (d), 38.9 (t), 30.5 
(t), 25.7 (q), 20.1 (d), 17.9 (q), 16.6 (q), 11.2 (t), 10.6 (t) ppm. GC/MS (EI): 204 (M+, 39), 189 
(100), 161 (67), 147 (51), 133 (74), 119 (28), 105 (44), 91 (56), 77 (30), 69 (96), 55 (26), 41 (67). 
IR (neat, ν/cm-1): 2915, 1663, 1614, 1444, 1384, 1196, 1172, 1113, 972, 848. HRMS (EI): m/z: 
calcd. for C14H20O 204.1514; found: 204.1516. 
 
In another example, the reaction mixture was concentrated prior methanolysis and the crude 
product was purified by column chromatography on silica gel, eluent: hexane:MTBE (10:1). 
Compound 18a was obtained as a colorless oil (2.45 g, 99% yield). 
 
Cyclopropyl(2-methyl-5-(2-methylprop-1-enyl)cyclopent-2-enylidene)methyl acetate (18a) 
2 Isomers in a ratio of 4:1. 1H-NMR (300 MHz, CDCl3): δ = 5.71, 5.58 (2 bs, 1H), 
5.22, 5.05 (2d, J = 9.5 Hz, 1H), 3.85-3.80, 3.65-3.59 (2m, 1H), 2.83-2.59 (m, 1H), 2.10 (s, 3H), 
2.10-1.62 (m, 5H), 1.66 (s, 3H), 1.63 (s, 3H), 0.74-0.48 (m, 4H) ppm. 13C-NMR (75 MHz, 
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CDCl3), major isomer: δ = 169.3 (s), 140.8 (s), 138.7 (s), 137.1 (s), 135.0 (d), 128.9 (d), 128.6 (s), 
41.0 (d), 38.3 (t), 25.5 (q), 20.3 (q), 17.8 (q), 17.2 (q), 12.1 (d), 7.2 (t), 5.6 (t) ppm. GC/MS (EI): 
246 (M+, 25), 200 (64), 189 (4), 161 (5), 148 (76), 133 (45), 119 (9), 105 (15), 91 (21), 79 (12), 
69 (100), 55 (7), 41 (29). IR (neat, ν/cm-1): 2969, 2925, 1753, 1446, 1369, 1202, 1172, 1044. 
HRMS (EI): m/z: calcd. for C16H22O2 246.1620; found: 246.1625. 
 
1-[2-Methyl-5-(1-methyl-2-phenyl-vinyl)-cyclopent-1-enyl]-ethanone (19b) 
Using general procedure B, a mixture of 15c (2.82 g, 10 mmol) and gold complex 
Au(PPh3)SbF6 (0.10 mmol) were reacted and methanolyzed to give 19c as a yellow oil (1.92 g, 88 
% yield). 1H NMR (300 MHz, CDCl3): δ = 7.33-7.14 (m, 5H, Ar-H), 6.28 (s, 1H), 3.85-3.75 (m, 
1H), 2.64-2.53 (m, 1H), 2.48-2.37 (m, 1H), 2.28-2.21 (m, 1H), 2.20 (s, 3H, CH3), 2.12 (s, 3H, 
CH3), 1.81 (s, 3H, CH3), 1.78-1.69 (m, 1H) ppm. 13C NMR (75 MHz, CDCl3): δ = 199.2 (s), 
155.3 (s), 141.0 (s), 138.2 (s), 137.7 (s), 128.8 (d), 128.1 (d), 126.1 (d), 125.1 (d), 56.7 (d), 39.3 
(t), 29.9 (q), 28.9 (t), 16.7 (q), 15.9 (q) ppm. GC/MS (EI): 240 (M+, 51), 225 (19), 197 (18), 181 
(10), 165 (15), 149 (100), 141 (11), 128 (12), 115 (24), 105 (11), 91 (31), 77 (11), 43 (57). IR 
(neat, ν/cm-1): 2937, 1709, 1493, 1450, 1359, 1206, 751, 701. HRMS (EI): m/z: calcd. for 
C17H20O 240.1514; found: 240.1517. 
 
1-[5-(4-Isopropenyl-cyclohex-1-enyl)-2-methyl-cyclopent-1-enyl]-ethanone (19c) 
Using general procedure B, a mixture of 15c (2.86 g, 10 mmol) and gold complex 
Au(PPh3)SbF6 (0.10 mmol) were reacted and methanolyzed to give 19d as a yellow oil (2.12 g, 87 
% yield). 1H NMR (300 MHz, CDCl3): δ = 5.45-5.38 (m, 1H), 4.71 (s, 1H), 4.69 (s, 1H), 3.62-
3.50 (m, 1H), 2.58-2.43 (m, 1H), 2.33 (ddd, J = 17.8, 9.0, 4.5 Hz, 1H), 2.15 (s, 3H, CH3), 2.20-
2.02 (m, 3H), 2.07 (s, 3H, CH3), 2.01-1.86 (m, 3H), 1.85-1.77 (m, 1H), 1.72 (s, 3H, CH3), 1.62 
(ddd, J = 17.9, 9.0, 4.5 Hz, 1H), 1.50-1.38 (m, 1H) ppm. 13C NMR (75 MHz, CDCl3): δ = 199.5 
(s), 154.5 (s), 149.7 (s), 139.8 (s), 137.6 (s), 120.7 (d), 108.5 (t), 54.2 (d), 41.1 (d), 39.3 (t), 30.6 
(t), 29.8 (q), 29.1 (t), 27.8 (t), 26.8 (t), 20.8 (q), 16.6 (q) ppm. GC/MS (EI): 244 (M+, 59), 229 (8), 
201 (35), 181 (10), 175 (23), 161 (32), 147 (18), 133 (54), 121 (56), 105 (25), 91 (32), 79 (28), 67 
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(9), 53 (12), 43 (100).IR (neat, ν/cm-1): 2933, 1675, 1434, 1357, 889. HRMS (EI): m/z: calcd. for 
C17H24O 244.1827; found: 244.1834. 
 
4-Methyl-1-(2-methyl-5-(2-methylprop-1-enyl)cyclopent-2-enylidene)pent-3-enyl acetate 
(18d) 
2 Isomers in a ratio of 4:1. 1H-NMR (300 MHz, CDCl3): δ = 5.75, 5.56 (2 bs, 1H), 
5.25-4.98 (m, 2H), 3.91-3.82, 3.75-3.60 (2m, 1H), 3.32-2.82 (m, 1H), 2.80-2.43 (m, 1H), 2.10 (s, 
3H), 2.10-1,62 (m, 2H), 1.99 (s, 3H), 1.86 (s, 3H), 1.75-1.55 (m, 9H) ppm. 13C-NMR (75 MHz, 
CDCl3): δ = 169.7, 169.5 (s), 141.0, 139.6 (s), 137.5 (s), 136.3, 136.2 (s), 135.6, 133.8 (d), 133.4, 
133.0 (s), 129.0, 128.9 (d), 129.0, 128.6 (s), 120.6, 119.9 (d), 40.6, 39.5 (d), 38.6, 38.0 (t), 30.4, 
29.7 (t), 25.7, 25.6 (q), 25.5 (q), 20.8, 20.6 (q), 17.9, 17.8 (q), 17.7, 17.6 (q), 17.1, 16.3 (q) ppm. 
GC/MS (EI): 274 (M+, 7), 232 (64), 218 (20), 177 (22), 163 (20), 147 (18), 119 (16), 107 (100), 
91 (21), 79 (17), 69 (25), 55 (7), 41 (20). IR (neat, ν/cm-1): 2970, 2925, 1753, 1446, 1368, 1213, 
1069. HRMS (EI): m/z: calcd. for C18H26O2 274.1933; found: 274.1931. 
 
rac-1-[2,4,4-Trimethyl-5-(2-methyl-propenyl)-cyclopent-1-enyl]-ethanone (19e) 
Using general procedure B, a mixture of 15e (2.48 g, 10 mmol) and gold complex 
Au(PPh3)SbF6 (0.10 mmol) were reacted and methanolyzed to give 19e as a colorless liquid (1.13 
g, 55 % yield). 1H NMR (300 MHz, CDCl3): δ = 4.94 (d, J = 10.7 Hz, 1H), 3.33 (d, J = 10.7 Hz, 
1H), 2.37 (d, J = 17.6 Hz, 1H), 2.15 (d, J = 17.6 Hz, 1H), 2.11 (s, 3H, CH3), 2.04 (s, 3H, CH3), 
1.73 (s, 3H, CH3), 1.71 (s, 3H, CH3), 1.06 (s, 3H, CH3), 0.89 (s, 3H, CH3) ppm. 13C NMR (75 
MHz, CDCl3): δ = 199.5 (s), 152.4 (s), 138.7 (s), 132.6 (s), 125.1 (d), 55.9 (d), 53.8 (t), 41.0 (s), 
29.9 (q), 29.7 (q), 25.8 (q), 24.6 (q), 17.9 (q), 17.0 (q) ppm. GC/MS (EI): 206 (M+, 25), 191 
(100), 173 (75), 161 (27), 149 (27), 135 (42), 121 (34), 107 (33), 91 (42), 77 (23), 55 (15), 43 
(100). IR (neat, ν/cm-1): 2957, 2915, 1677, 1610, 1429, 1355, 1240. HRMS (EI): m/z: calcd. for 
C14H22O 206.1671; found: 206.1665. 
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(5S)-1-[2,4,4-Trimethyl-5-(2-methyl-propenyl)-cyclopent-1-enyl]-ethanone ((5R)-19e). This 
compound was prepared from (1S,3S)-15e in an analogous way. 89% ee. [α]22  = +169.2 (c = 1.15, 
CHCl3). 
 
GC chromatogram of rac-19e 
 
 
GC chromatogram of (R)-19e 
 
 
The absolute configuration of (R)-19e was determined by comparing the vibrations of a measured 
ROA (Raman Optical Activity) spectra (below) with those of the theoretical spectra, calculated at 
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the B97-1/pc-2 level with the Gaussian program (above).[1a,b,d] ROA calculations at the 
TDHF/DPS level was carried out with the Dalton program.[1c] 
 
 
                                                 
1 Wessjohann, L. A.; Fulhorst, M.; Zakharova, S. Pol. J. Chem. 2006, 80, 673-678. 
 
2 Bledsoe, J. O.; Johnson, W. E. (SCMCorp.), US4097531, 1978. 
 
3 Dawson, M.; Marcia, I.; Hobbs, P. D.; Derdzinski, K.; Chan, R. L. S.; Gruber, J.; Chao, W.; Smith, S.; 
Thies, R. W.; Schiff, L. J. J. Med. Chem. 1984, 27, 1516-31. 
 
4 Bohmer, J.; Schobert, R. J Chem. Res. 1998, 7, 1565-1584. 
 
5 Rosini, G.; Ayoub, C.;  Borzatta, V.; Marotta, E.; Mazzanti, A.; Righi, P. Green Chem., 2007, 9, 441–448. 
 
6 Sasaki, T.; Eguchi, S.; Ohno, M. Bull. Chem. Soc. Jp. 1980, 53, 1469-1470; Ohno, M.; Matsuoka, S.; 
Eguchi, S. J. Organic Chem. 1986, 51, 4553-4558.  
 
7 Armesto, D.; Gallego, M. G.; Horspool, W. M.; Agarrabeitia, A. R. Tetrahedron 1995, 51, 9223-9240. 
 
 
 
 
 
 
 
 
 
 77 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
Mechanistic Insights in Gold-Stabilized Nonclassical Carbocations: Gold-
Catalyzed Rearrangement of 3-Cyclopropyl Propargyl Acetates 
 
 
 
78 
 
 
 
 
 
 
 
 
Chapter 3 
 
79 
 
CHAPTER 3 
Mechanistic Insights in Gold-Stabilized Nonclassical Carbocations: 
Gold-Catalyzed Rearrangement of 3-Cyclopropyl Propargyl Acetates 
 D. Garayalde, E. Gómez-Bengoa, X. Huang, A. Goeke and C. Nevado* 
(J. Am. Chem. Soc. 2010, 132, 4720-4730) 
 3.1 Introduction  
 From the seminal discovery of the Zn-mediated rearrangement of propargyl acetates 
reported by Ohloff et al. in 1976, the chemistry of propargyl esters has experienced an exponential 
growth.1 Ten years later, a related Pd-catalyzed cyclization of 1-ethynyl-2-propenyl acetates to 
give 2-cyclopentenones was reported by Rautenstrauch and co-workers.2 Although lacking an in 
depth mechanistic study, the formation of a Pd-carbene intermediate was already postulated. 
Work from Ohe and Uemura with ruthenium,3 and Malacria with platinum4 re-opened the interest 
in this class of transformations at the beginning of this decade. Later, Toste demonstrated that 
intermediate achiral carbenes are an insufficient explanation for the observed chirality transfer in 
a gold promoted version of the Rautenstrauch reaction.5 Now, after 30 years of research mainly 
driven by the irrumption of platinum and gold complexes in modern catalysis, a more clear 
mechanistic picture has been evolved for these transformations (Scheme 1).6  
Scheme 1. 1,2- vs. 1,3-Carboxylate Migration 
 
 Gold in particular has proven to efficiently activate propargyl carboxylates (I) towards 
1,2-acyloxy migration and/or [3,3]-sigmatropic acyloxy rearrangement at room temperature (red 
and blue paths respectively).7 These two competitive processes seem to be mechanistically 
related: 1,2-migration proceeds via metal carbene (III), whereas [3,3]-sigmatropic rearrangement 
proceeds via allenyl acetate (V) in a single process or stepwise by a second acetate migration from 
III (Scheme 1).8 Allenyl acetates V can be further activated in the presence of the metal catalyst 
to give VI, triggering an extensive palette of transformations. It is widely accepted that terminal 
or electron poor alkynes react via 1,2-9,10 whereas internal alkynes prefer the 1,3-migration 
pathway11 and only few exceptions to this general pattern have been described.12  
 We have recently reported a new Au-catalyzed homo-Rautenstrauch rearrangement of 1-
cyclopropyl propargylic esters (1, 2) to give 5-, 6- and also 7-membered ring vinyl acetates under 
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mild conditions (Scheme 2).13 A key factor in the successful development of this transformation is 
the presence of a substituent at the cyclopropyl ring able to stabilize the positive electron density 
developed during the concomitant ring opening process. The almost complete chirality transfer we 
observed in these reactions suggested that gold-stabilized nonclassical carbocations with a certain 
configurational stability (VII, VIII) might be involved, since enantiomerically enriched 
cyclohexadienyl (3) and cyclopentenyl acetates (4) could be obtained when optically active 
starting materials were employed. 
Scheme 2. Au-Catalyzed Homo-Rautenstrauch Rearrangement of 1-Cyclopropyl Propargylic 
Acetates 
 
 To get a further insight in the reactive species involved in these transformations, we 
decided to explore the chemistry of related 3-cyclopropyl propargylic carboxylates 5 (Scheme 3). 
Such settings had already been studied by Zhang and co-workers.14 In the presence of gold 
catalysts, Zhang´s group developed an elegant method to obtain α-ylidene-β-diketones as a result 
of the 1,3-migration of the acyl group onto the alkyne moiety followed by acetate fission. The 
cyclopropyl ring behaved in this case as mere spectator in the reaction (5a to 6a, Scheme 3). 
Based on our previous experience, we decided to explore whether the presence of a group able to 
stabilize a developing positive electron density could induce the cyclopropyl ring opening to give 
cyclopentannulation products 7 instead.  
Scheme 3. Au-Catalyzed Acetate Migration+Fission to α-Ylidene-β-diketones vs. 
Cyclopentannulation 
 
 Herein, we report our in depth investigation on the cyclization of 3-cyclopropyl 
propargylic carboxylates and related species. We also present a DFT computational study on the 
reaction mechanism, which reveals the decisive intermediates determining the stereoselectivity of 
these transformations. This work also sheds light on the role of the substituents at the propargylic 
position in defining the reaction pathway since products of both, 1,2- and 1,3-acyloxy migration 
pathways, have been found in these processes. 
 
Chapter 3 
 
81 
 
 3.2 Results and discussion 
 3.2.1 Reaction Optimization.  
 3-((2-Methylpropenyl)cyclopropyl propargyl)-1-phenylprop-2-ynyl acetate (5b) was used 
as benchmark substrate to find suitable reaction conditions. The results of this optimization are 
summarized in Table 1. In the presence of PtCl2 in toluene as solvent, no reaction was observed at 
room temperature (Table 1, entry 1). Heating to 80 ºC, 5b was completely consumed affording a 
complex mixture of products from which α-ylidene-β-diketone 6b could be isolated albeit in low 
yield (Table 1, entry 2). This result reflects the preference for the acetate fission pathway vs. the 
cyclopropyl ring opening with Pt salts. We then decided to turn our attention towards gold 
catalysts in CH2Cl2 as a solvent. Treatment with gold(I) chloride delivered a complex mixture due 
to partial decomposition of the starting material even at room temperature (Table 1, entry 3). 
Cationic complexes generated by chloride abstraction from [(Ph3P)Au(Cl)] such as 
[(Ph3P)Au(NTf2)] and [(Ph3P)Au(SbF6)] provided, for the first time, cyclopentene acetate 7b as 
the major produt of the reaction (Table 1, entries 4 and 5). Surprisingly, dichloro(pyridine-2-
carboxylato)gold(III), the catalyst of choice in Zhang´s transformations,14 did not produce the 
expected α-ylidene-β-diketone 6b, but only 7b in moderate yield upon heating to 50 ºC (Table 1, 
entry 6). The use of a bulky phosphine ligand as in {[(tBu)2(BPH)]PAu(SbF6)} afforded 7b in 
85% yield as a 2:1 (E:Z) mixture of isomers. (Table 1, entry 7)  Finally, [(IPr)Au(NTf2)] afforded 
the desired alkylidene cyclopentenyl acetate 7b in almost quantitative yield after 5 minutes of 
reaction (Table 1, entry 8). In situ methanolysis of the product produced cyclopentenone 8b in 
75% yield (Table 1, entry 9). Notably, in all the cases studied, 7b was obtained as a variable E:Z 
mixture of isomers.15  
Table 1. Optimizing Reaction Conditions for the Cyclization of 3-Cyclopropyl Propargyl Acetate 
5b 
 
Entry Catalyst (mol %) Conditions Time (h) 
Conversion 
(%)[a] 
Yield (%)[b] 
(ratio 6b:7b) 
1 PtCl2 (5) Toluene, 25 ºC 15 0 - 
2 PtCl2 (5) Toluene, 80 ºC 12 100 <10 (100:0) 
3 AuCl (2) CH2Cl2, 25 ºC 0.5 90 
Complex 
Mixture 
4 [(Ph3P)Au(NTf2)] (3) CH2Cl2, 25 ºC 0.25 100 75 (1:8) 
5 [(Ph3P)Au(SbF6)] (3) CH2Cl2, 25 ºC 0.25 100 85 (1:10) 
6 LAuCl2[c] (5) CH2Cl2, 50 ºC 1 100 65 (1:>99) 
7 
{[(tBu)2(BPH)]P 
Au(SbF6)}[d] (5) 
CH2Cl2, r.t. 0.1 100 85[e] 
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8 [(IPr)Au(NTf2)] (5) CH2Cl2, r.t. 0.1 100 90 (1:>99)[f] 
9 [(IPr)Au(NTf2)]  (5) 
i. CH2Cl2, 25 ºC 
ii.K2CO3 (2equiv.),  
MeOH 
0.1 100 75 (8b)[f] 
[a] Conversion calculated by 1H-NMR. [b] Isolated yield after column chromatography.[c] L = Pyridine-2-
carboxylate.[d] BPH: biphenyl [e] Compound 7b was obtained as a 2: 1 (E:Z) mixture. [f] Compounds 7b and 
8b were obtained as a 15: 1 (E:Z) mixture.  
 3.2.2 General Reactivity.  
 Once the reaction conditions for the selective cyclization of 3-cyclopropyl propargyl 
carboxylate 5b had been established, we decided to explore the scope of this transformation. First, 
we focused on substrates containing secondary acetates, which proved to be unsuccessful in our 
previously developed homo-Rautenstrauch rearrangement reaction.13a These results have been 
summarized in Table 2. To our delight, 2-naphthyl derivative 5c afforded vinyl acetate 7c in 84% 
yield under the optimized reaction conditions (Table 2, entry 1). The presence of alkyl 
substituents at the propargylic position was also examined. Thus, substrates 5d-f were efficiently 
transformed into the corresponding cyclopentenyl acetates (7d-f) (Table 2, entries 2-5). The 
cyclopropyl ring cleavage can be also stabilized by a 1-phenylprop-1-en-2-yl moiety as in 5g 
(Table 2, entries 6, 7) and different migrating groups such as benzoates (5h) were tolerated (Table 
2, entries 8, 9). In some cases, the dichloro(pyridine-2-carboxylato)gold(III) catalyst seemed to 
give better results in terms of yield and/or E:Z selectivity at the exocyclic olefin compared to 
[(IPr)Au(NTf2)] (Table 2, entries 4, 6, 8, 10, 12, 14, 16 vs. 5, 7, 9, 11, 13, 15, 17). Remarkably, 
except for 5j, both catalysts delivered clean and complete conversions and no α-ylidene-β-
diketones (6) were observed. As it was mentioned above, E isomers were always obtained as 
major products of these reactions.15 Attempts to transform Z into thermodynamically favored E 
isomers in the presence of gold catalysts failed.16 The determining step for the E vs. Z exocyclic 
alkene formation seems to be thus, under kinetic control.  
Table 2.  Au-Catalyzed Cyclization of 3-Cyclopropyl-Propargyl-Carboxylates 
Entry Substrate Conditions[a] Product[b] Yield (%)[c,d] 
(E:Z ratio)[e] 
 
1 
 
5c 
 
 
A 
 
 
7c 
 
84 (14:1) 
 
 
2 
 
5d 
 
A 
 
7d 
 
75 (10 : 1) 
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3 
 
5e 
 
A 
 
7e 
 
 
77 (7:1) 
 
4  
5f 
A  
7f 
 
65 (50:1) 
 
5 5f B 7f 96 (17:1) 
 
 
6 
 
 
5g 
 
 
A 
 
 
7g 
 
73 (5:1) 
 
7 5g B 7g 84 (10:1) 
 
8 
 
5h 
A  
7h 
 
51 (14:1) 
 
9 5h B 7h 87 (14:1) 
 
10 
 
5i 
A  
7i 
 
 
80 (3 : 1) 
 
 
11 5i B 7i 82 (3.4:1) 
12 
5j 
A 
7j 
 
 
_ [f] 
13 5j B 7j 75 (100:0) 
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14  
5k 
A  
7k 
84 (5:1) 
15 5k B 7k 94 (100:0) 
16  
5l 
A  
7l 
84 (3:1) 
17 5l B 7l 86 (50:1) 
[a] Reaction Conditions A: [(IPr)Au(NTf2)] (5 mol%), CH2Cl2, 25 ºC, 30 min.; 
B: dichloro(pyridine-2-carboxylato)gold (III) (5 mol%), CH2Cl2, 50 ºC, 30 
min. [b] Only the major product is shown. [c] Isolated yield after column 
chromatography. [d] Determined by 1H-NMR in the reaction mixture. [e] The 
yields after methanolysis of the reaction mixtures to give the corresponding 
ketones can be found in the supporting information. [f] Decomposition was 
observed. 
 3.2.3 Cyclization of Tertiary Acetates.  
 We focused next on the reaction of tertiary propargyl acetates, which have unraveled 
interesting mechanistic features of these transformations. When substrate 9a was treated with 
[(IPr)Au(NTf2)] (5 mol%) in CH2Cl2 at room temperature, the expected product 10a was obtained 
in 58% yield. A careful analysis of the reaction mixture revealed the formation of 1,3-diketone 
11a isolated in 27% yield in its enolic form (Scheme 4). A similar behavior in the presence of 
[(IPr)Au(NTf2)] as catalyst was observed for substrates 9b and 9c affording cyclopentenyl 
acetates 10b-c and diketones 11b-c in 1:2 and 2:1 ratio respectively.  In our view, formation of 
11a-c can be explained by a 1,2-acetoxy migration pathway followed by cyclopropyl ring opening 
and cyclization terminating with the fission of the acetate group. Formation of products from both 
1,2- and 1,3-acyloxy migration pathways from the same substrate under a certain set of conditions 
is rare and deserves further attention. Computational studies on these systems have been 
performed and the results will be discussed in following section.  
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Scheme 4. Reaction of Tertiary Acetates with [(IPr)Au(NTf2)] 
 
 After extensive experimentation, we found that treatment of 9a with [(PhO)3PAu(SbF6)] 
(5 mol%) allowed the clean formation of cyclopentenyl acetate 10a in 81% yield (Table 3, entry 
1). Similarly, 10b-d were efficiently produced under the same reaction conditions (Table 3, 
entries 2-4). The reaction of cyclopentyl and cyclohexyl substituted derivatives 9e-f proceeded 
cleanly at -20 ºC to give products 10e-f in 85% yield (Table 3, entries 5 and 6). Finally, 
compound 9g was cyclized to give 10g as a 4:1 mixture of isomers (Table 3, entry 7).15  
Table 3. Au-Catalyzed Cyclization of 3-Cyclopropyl Propargyl Tertiary Carboxylates 
Entry Substrate Reaction Conditions[a] Product[b] (Yield, %) 
1 9a 
[(PhO)3PAu(SbF6)], 
Tª =  25 ºC, 30 min 
10a (81) 
2 9b 
[(PhO)3PAu(SbF6)] , 
Tª =  25 ºC, 30 min 
 
10b (90) 
3 9c 
[(PhO)3PAu(SbF6)], 
Tª =  25 ºC, 1 h 
 
10c (78) 
4  
9d 
[(PhO)3PAu(SbF6)], 
Tª =  25 ºC, 1 h  
10d (71) 
5  
9e 
[(PhO)3PAu(SbF6)], 
Tª =  - 20 ºC, 1 h  
10e (85) 
6  
9f 
[(PhO)3PAu(SbF6)] , 
Tª =  - 20 ºC, 1 h  
10f (85) 
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7  
9g 
[(PhO)3PAu(SbF6)], 
Tª =  25 ºC, 1 h  
10g (78)[c] 
[a] Reactions run in CH2Cl2  as solvent with 5 mol% catalyst. [b] 
Isolated yield after column chromatography. [c] Obtained as a 4:1 
(E:Z) mixture of isomers.  
 
 To further confirm the 1,2-acetoxy migration pathway operating in the reaction of tertiary 
acetates with [(IPr)Au(NTf2)] as catalyst, the following experiments were designed (Scheme 5). 
Reaction of 9b in the presence of one equivalent of p-anisaldehyde gave a mixture of 10b+11b in 
85% yield together with dihydropyran 12 in 9% yield. The latter can be explained by a [4C+2C] 
cycloaddition reaction between 1,4-dipole 15 (generated in situ along the 1,2-migration path) and 
p-anisaldehyde as dipolarophile.17 On the other hand, when 9c was treated with [(IPr)Au(NTf2)] 
in MeOH as a co-solvent compound 13 was isolated in 28% yield. Formation of both, 12 and 13 is 
a clear indication of a 1,2-acyloxy migration manifold via intermediates 14 and 15 operating in 
competition with the predicted [3,3]-acyloxy rearrangement. 
Scheme 5. Evidence for the 1,2-Acyloxy Migration Pathway in the Reaction of Tertiary Acetates 
with [(IPr)Au(NTf2)] as Catalyst 
 
 The results summarized in Schemes 4 and 5 and Table 3 can be explained in light of the 
distinct nature of the reaction intermediates depending on the ligand bound to the gold center.18 
[(PhO)3PAu(SbF6)] displays a more electrophilic character compared to [(IPr)Au(NTf2)] due to 
the π-acceptor phosphite ligand. The decrease in the gold-to-C π-donation might enhance the 
carbocationic character of the reaction intermediates, thus favoring the cyclopentannulations 
products (10). In contrast, the IPr (1,3-bis(2,6-disiopropylphenyl)imidazol-2-ylidene) ligand is 
strongly σ-donating and only weakly π-acidic, thus increasing the carbene-like reactivity favoring 
intermediate 14 (also preferred by steric reasons) over the allene intermediate and thus triggering 
the formation products such as 11, 12 or 13. 
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 3.2.4 Cyclization of Propargyl Vinyl Ethers.  
 In addition to carboxylic groups (acetates, benzoates, etc…), propargyl vinyl ethers are 
also suitable motifs for rearrangement across the triple bond upon metal activation.19 We expected 
to form two new C-C bonds by coupling the [3,3]-sigmatropic rearrangement to the cyclopropyl 
ring opening reaction. Thus, substrate 16a was treated with [(IPr)Au(NTf2)] (5 mol%) delivering 
the corresponding cyclopent-1-enyl aldehyde 17a  in 71% yield.15  To achieve higher yields, the 
Au-catalyzed cyclization was coupled to an in situ reduction of the aldehyde with NaBH4 as 
previoustly reported by Toste and co-workers (Table 4, entry 2).19b A similar protocol was applied 
for substrates 16b-c which gave the corresponding alcohols 18b-c in excellent yields (Table 4, 
entries 3 and 4). Interestingly, electron-deficient vinyl ethers such as 16d and 16e were cleanly 
transformed into the corresponding (Z)-methyl-2-(2-methylenecyclopentylidene)-3-
oxopropanoates 17d and 17e under the abovementioned reaction conditions (Table 4, entries 5 
and 6).15 It is important to note that no heterocyclization on the allenyl carbonyl intermediate to 
give 3-cyclopropyl substituted furans was observed, as previously reported by Kirsch and co-
workers for similar settings.20 In contrast to the mechanistic dichotomy manifold observed in the 
migration of tertiary acetates with [(IPr)Au(NTf2)], the rearrangement of tertiary vinyl ethers 
under similar reaction conditions delivered only the products derived of a propargyl-Claisen 
rearrangement. Substrates 16f and 16g with a 2-methyl-2-propen-1-yl substituent at the 
cyclopropyl ring delivered upon NaBH4 reduction the expected alcohols 18f and 18g together 
with 18f´ and 18g´ (Table 4, entries 7 and 8).21 The reaction of 16h afforded aldehyde 17h in 
modest yield (Table 4, entry 9), whereas the reductive work-up in MeOH allowed us to isolate 
alcohol 18h in 70% yield and a small amount of 19. The latter is presumably formed by trapping 
the carbocationic intermediate formed during [3,3]-rearrangement in the first step of the reaction 
with MeOH, which is used as solvent in the subsequent step (Table 4, entry 10).19b 
Table 4. Au-Catalyzed Cyclization of 3-Cyclopropyl Propargyl Enol Ethers 
Entry Substrate Conditions[a] Product(s), (Yield, %),[b,c] 
(E:Z ratio)[d] 
1  
16a 
A  
17a (71), (2:1) 
2 16a B  
18a (97), (2:1) 
3  
16b 
B  
18b (88), (3:1) 
4 
 
B 
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16c 18c (88), (1:1) 
5  
16d 
A  
17d (97), (5:1) 
6  
16e 
A  
17e (82), (1:1) 
7  
16f 
B [e]  
18f + 18f´ (90, 17:1 ratio) 
8  
16g 
B [e]  
18g + 18g´ (75, 5:1 ratio) 
9  
16h 
A [e]  
17h (58) 
10 16h B [e]  
18h (70)      19 (10) 
[a] Reaction Conditions A: [(IPr)Au(NTf2)] (5 mol%), CH2Cl2, 25 
ºC, 30 min.; B: i. [(IPr)Au(NTf2)] (5 mol%), CH2Cl2, 25 ºC, 30 
min. ii. NaBH4 (5 equiv.), MeOH. [b] Only the major product is 
shown. [c] Isolated yield after column chromatography. [d] 
Determined by 1H-NMR in the reaction mixture. [e] Reaction time: 
90 min. 
 
 3.2.5 Cyclization of Non-Activated Allenes.  
 The cyclization of propargylic esters and enol ethers presented above presumably proceed 
by the formation of an oxo-allene intermediate (see V in Scheme 1) upon Au-catalyzed [3,3]-
sigmatropic rearrangement. To further confirm this hypothesis, we decided to explore the 
reactivity of “non-activated” cyclopropyl allenes in the presence of gold complexes. We were 
pleased to observe that substrate 20a reacted in the presence of 5 mol% of [(IPr)Au(NTf2)] to 
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afford 2-(ethylylidene)cyclopent-3-enyl 21a in excellent yield following the previously proposed 
sequence: gold activation of the allene-cyclopropyl ring opening-cyclization (Scheme 6). Tri- and 
tetrasubstituted allenes were well tolerated as shown by the reactions of 20b and 20c to give 
cyclopentenes 21b and 21c in 67 and 92% yield, respectively. When a 1-methyleth-2-enyl 
substituent is placed at the terminal position of the allene (20d), the reaction in the presence of 
[(IPr)Au(NTf2)] afforded a complex reaction mixture. In the presence of dichloro(pyridine-2-
carboxylato)gold(III), a clean 6-π-electrocyclization takes place to give bicyclic compound 22 in 
almost quantitative yield as previously reported by other groups.22 
Scheme 6. Cyclization of 3-Cyclopropyl Allenes 
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 3.3 Mechanistic Discussion 
 A simplified vision of the cyclization of 3-cyclopropyl propargylic acetates 5 presumably 
involves an allenyl intermediates IX, which undergoes ring expansion to form a 1,5-dipole X 
where the carbocation is stabilized by aromatic or vinylic groups. From X, a cyclization to form 
alkylidene cyclopentenyl acetates 7 can be proposed (Scheme 7).  
Scheme 7. Simplified Mechanism for the Cyclopentannulation Reaction of 3-Cyclopropyl 
Propargyl Acetates 
 
 To gain a deeper insight into the reaction intermediates defining the stereochemistry of 
the exocyclic double bond, the different behavior of secondary vs. tertiary carboxylates, and a 
potential chirality transfer in this process, we performed DFT calculations on model gold(I)-
complex XI.23 
 3.3.1 Allenyl acetate formation 
  Au(I)-complex of (S)-4-((1R,2S)-2-vinylcyclopropyl)but-3-yn-2-yl acetate XIa reacts 
through TSXIa-XIIa(ΔH≠ = 6.5 kcal/mol) and TSXIIa-XIIIa(ΔH≠ = 2.8 kcal/mol) to give gold 
coordinated allene XIIIa in a reversible and slightly endothermic process (ΔH = 0.4 kcal/mol) 
(Scheme 8).24 XIIIa shows a clear “allene” character, with gold coordinated to the more external 
double bond and the four allenyl substituents disposed perpendicularly resembling the gold-
coordinated minimized structures of simple allenes 20a-d (Scheme 6).  XIIIa is in equilibrium 
with a more cationic-type derivative XIVa through TSXIIa-XIVa(ΔH≠ = 3.4 kcal/mol) 
thermodynamically more stable (ΔH = - 4.0 kcal/mol), where the internal double bond is now 
activated leaving the gold almost exclusively coordinated to the central carbon atom of the 
allene.25 From XIIIa, the formation of an E-configured vinyl gold derivative XIVd can be also 
envisioned although, for the sake of clarity, only XIIIa will be considered here (a complete 
version of Scheme 8 summarizing all possible isomers can be found in the Supporting 
Information).26 The stereochemical information of the acetate at the propargylic position is lost by 
a low barrier transition state TSXIVa-XIVb(ΔH≠ = 3.1 kcal/mol), which converts XIVa into its 
enantiomer XIVb in a slightly exothermic transformation (ΔH = -0.7 kcal/mol). On the other 
hand, XIVb could also arise from XIb in an analogous manner to the one described above. Such 
epimerization event is well precedented experimentally,27 and was recently studied by the groups 
of Malacria25 and Toste.13b, 19  
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Scheme 8. Reaction coordinate diagram for the [3,3]-acetoxy migration of XIa to cationic 
intermediate XIVa-b. Calculations at the B3LYP/6-31G(d) (C, H, O, P), LANL2DZ (Au) level (+ 
ZPE corrected energies are given in kcal/mol). Au = (IPr)Au 
 
 3.3.2 Cyclization step 
 The next step along the reaction coordinate involves the cyclopropyl ring opening and C-
C bond formation to give the cyclopentannulation products. The parallel reactions of the four 
isomers XIVa-d were computed although, for the sake of clarity, only the structures of 
intermediates derived from XIVa are explicitly shown (Scheme 9, left). The relative energies for 
the other isomers (XIVb: epimer at the carbon bearing the acetate, XIVc-d: E vinyl gold isomers, 
respectively) have been summarized in the right part of Scheme 9. Thus, from XIVa two adjacent 
transition states, one higher in energy: TSXIVa(1) (ΔH≠ = 19.9 kcal/mol) and a second one laying 
lower in the reaction profile: TSXIVa(2) (ΔH≠ = 10.9 kcal/mol) were found to deliver cyclopentene 
acetate XVa without an intervening intermediate.28 Interestingly, TSXIVa(1) can be described as a 
gold-stabilized nonclassical carbocation related to those proposed in Scheme 2. 13a,29 On the other 
hand, TSXIVa(2) constitutes a “bifurcation point” in the reaction profile, which can evolve either to 
cyclopentenyl XVa or towards a 6-membered ring XVIa, although formation of XVa is 
thermodynamically much more favorable (HXVa = -36.7 vs. HXVIa = -17.1 kcal/mol). The product 
of a β-hydride elimination in XVIa would yield cyclohexadiene XVIIa, which was never detected 
experimentally.  
 Solvent effects (CH2Cl2) were considered in these calculations (energy values in brackets 
in Scheme 9). As expected, the energy of all TS(1) is lower than in the gas phase since the 
stabilization of the carbocation retards the cyclopropyl ring opening and promotes the formation 
of the cycle. More importantly though, the energies  of all TS(1) are still higher than those of 
TS(2), so that the first step remains the rate-limiting step, thus governing the stereochemistry of 
the exocyclic olefin. 
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Scheme 9. Reaction coordinate diagram for the cyclopentannulation of XIVa. Calculations at the 
B3LYP/6-31G(d) (C, H, O, P), LANL2DZ (Au) level (+ ZPE corrected energies are given in 
kcal/mol. Values in brackets are considering solvent effects (CH2Cl2)). Au = (IPr)Au 
 
 Since the stereochemistry observed in the exocyclic olefin of cyclopentene acetates 7 
seems to be under kinetic control,16 transition states TSXIVa-d(1), higher in energy than TSXIVa-d(2), 
were closely examined. In TSXIVa(1)  and TSXIVc(1), we observe that the configuration at C6 of the 
cyclopropyl ring forces an “endo” reaction, where the Au-C bond is always oriented towards the 
cyclopropyl ring, whereas TSXIVb(1)  and TSXIVd(1), higher in energy, present an “exo” approach, 
where the cyclization takes place from the opposite side of the cyclopropyl ring (Scheme 9). 
TSXIVa-d(1) shows an early carbocation being formed at C6 with the cyclopropyl unit almost intact. 
The δ+ developing in the incipient carbocation interacts with the electron-rich vinyl gold forming 
a pseudo-6-membered ring cycle in a boat conformation (Figure 1).  
  In the two transition states of lower energy, TSXIVa(1)  and TSXIVc(1), the substituents at 
C1 and the terminal carbon atom of the double bound C6 are eclipsed. This unfavorable eclipsing 
interaction is enhanced in TSXIVc(1), where methyl and vinyl groups are in pseudo-axial positions 
(Figure 1, right upper row). Therefore, for each couple, the transition states displaying the Au and 
Me in “syn” disposition have a lower activation energy than those with both groups in “trans” 
(TSXIVa(1) < TSXIVc(1) and TSXIVb(1) < TSXIVd(1)). These observations led us to conclude, that 
the lower energy reaction path transits from XIVa via TSXIVa(1)  and TSXIVa(2)   yielding (E)-
cyclopentenyl acetate XVa as a major product under kinetic control although the E product (XVa) 
is also thermodynamically more stable than XVc.16  
 The stabilizing effect of the vinylic (or aromatic) substituent by delocalization of the δ+ 
generated upon cyclopropyl ring opening can be easily rationalized looking at the key C-C 
distances in the transition states. In fact the C6-C7 and the C7=C8 distances measured in XIa and 
XIVa are 1.48 Å, 1.47 and 1.33 and 1.34 Å respectively. In contrast, in TSXIVa(1), the distances 
reflect a more allylic character of the vinyl moiety with 1.42 and 1.36 Å values. Furthermore, the 
NBO analysis of TSXIVa(1), shows a strong interaction (63.8 kcal/mol) between the π-orbital of the 
double bond and the empty developing orbital on C6, which is not present neither in XIa nor in 
XIVa. This strong interaction is also reflected in the analysis of the partial charges, which shows 
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an increasing positive charge (+0.2 e) in the  vinyl moiety of the TSXIVa(1) vs. the value measured 
in XIa (+0.06 e). 
 In the second transition states (TSXIVa(2), TSXIVc(2)) a complete rupture of the 
cyclopropyl ring can be observed, with the fully developed carbocation in close interaction with 
the metal-vinyl bond (TSXIVa(2): dC2-C6 = 2.0 Å vs. TSXIVc(2)dC2-C6 = 1.953 Å ) (Figure 1, lower 
row). The four carbon atoms C1-C2-C5-C6 are coplanar and in contrast with steric interactions 
analyzed for TSXIVa(1) vs. TSXIVc(1), the stronger steric congestions occurs between vinyl and 
methyl groups in TSXIVa(2) disfavoring it compared to TSXIVc(2) (Figure 1). Nevertheless, since 
these are the lower energy transition states in the reaction coordinate, they have no influence in 
the structure of the final products. Solvent effects also influence the key C-C distances (C1-C2, C1-
C6, C2-C6, Au-C2), which are a bit shorter in the gas phase (Figure 1).  
AuAcO
H
+
TSXIVa(1)
AuAcO
H
+
TSXIVc(1)
4 4
11
2
2
3 3
6 6C1-C2 1.362 Å (1.359)
Au-C2 2.079 Å (2.077)
C1-C6 2.797 Å (2.875)
C2-C6 3.223 Å (3.274)

C1-C2 1.361 Å (1.359)
Au-C2 2.079 Å (2.077)
C1-C6 3.002 Å (3.006)
C2-C6 3.089 Å (3.112)

7 7
8 8
 
 
TSXIVa(2) TSXIVc(2)
AuAcO
H
+
AuAcO
H
+
6 6
1 1
2 2
C1-C6 2.460 Å (2.445)
C2-C6 2.000 Å (1.988)

C1-C6 2.305 Å (2.316)
C2-C6 1.953 Å (1.952)

 
 
Figure 1. Upper row: structures of transition states TSXIVa(1) and TSXIVc(1) highlighting the 
interaction between the cyclopropyl ring and the vinyl gold moiety and the eclipsed interaction 
between substituents C1 and C6 and relevant distances (in brackets considering solvent effect). 
Lower row: structures of transition states TSXIVa(2) and TSXIVc(2) highlighting the steric 
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interaction between methyl at C1 and vinyl at C6 and relevant distances (in brackets considering 
solvent effect). Au = (IPr)Au 
 
 3.3.3 1,2- vs. 1,3-Acyloxy Migration 
 The results obtained with tertiary acetates and [(IPr)Au(NTf2)] (Schemes 4 and 5), where 
products presumably arising from both 1,2- and 1,3-acyloxy migration paths could be isolated, 
prompted us to study this mechanistic dichotomy more in depth. Previous work in this area has 
shown how minimal changes in the structure of starting materials, catalysts, etc… can play a key 
role in the preference for one of these two reaction manifolds.8 Our computational models were 
the IPrAu-complexes of (S)-4-((1R,2S)-2-p-methoxyphenylcyclopropyl)but-3-yn-2-yl acetate 
(XVIII) and 2-methyl-4-((1R,2S)-2-p-methoxyphenylcyclopropyl)but-3-yn-2-yl acetate (XVIII´) 
respectively (Scheme 10). 
 For secondary acetate XVIII (route in black), the reaction coordinate following a 1,2-
acetoxy migration (left path) has in TSXIX-XX the higher energy barrier (ΔH≠ = 9.6 kcal/mol) 
whereas the 1,3-migration (right path) proceeds smoothly by the previously described 
intermediates, with lower activation energy for the determining step TSXXIV-XXV (ΔH≠ = 7.6 
kcal/mol), which can explain that no products derived of a 1,2-acetoxy migration were found in 
the reaction of secondary acetates. 
 In sharp contrast, for tertiary acetate XVIII´ (route in red) the steric hindrance caused by 
the presence of two methyl groups at the propargylic position raises the activation energy along 
the 1,3 migration pathway (right path) to almost 10.5 Kcal/mol for TS(XXIV-XXV). This barrier is 
now comparable to the energy needed in the 1,2-migration path via TS(XXI-XXII) (11.6 Kcal/mol). 
Since the system can be considered under Curtin-Hammet conditions (from XVIII´ to XXI´-
XXIV´), the product composition will depend on the difference in energies between the respective 
transition states (ΔΔH≠ = 1.1 kcal/mol) thus becoming competitive. It is important to mention that, 
as shown in Scheme 5, products arising from the cyclopropyl ring opening of XVIII´ have been 
isolated in the reaction, which has never been the case for the secondary acetate derivatives 
XVIII. 
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Scheme 10. Reaction coordinate diagrams for the 1,2- vs. 1,3-acyloxy migration of secondary vs. 
tertiary propargyl acetates. Calculations at the B3LYP/6-31G(d) (C, H, O), LANL2DZ (Au) level 
(+ ZPE corrected energies are given in kcal/mol). Au = (IPr)Au 
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 3.4 Chirality transfer 
 The interesting issue of a possible chirality transfer in these systems was addressed both 
experimental and computationally. Optically active substrates 23 and 24 were prepared from 
(1R,3R)-(-)-trans-chrysanthemum acid (99% ee) (Scheme 11).26  
Scheme 11. Chirality transfer of compounds 23 and 24 
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 In sharp contrast with our previous results obtained with 1-cyclopropyl-propargyl 
acetates,13a the cycloisomerization of 23 (dr = 1:1, 99% de) under standard conditions with 
different catalytic systems afforded, after methanolysis, cyclopentanone 25 in 61% ee in the best 
case using pyridine-2-carboxylate gold(III) catalyst. A similar behavior was observed for tertiary 
acetate 24, which upon treatment with [(PhO)3PAu(SbF6)] (5 mol%) and methanolysis, afforded 
26 in only 50% ee.30 
 These results, prompted us to re-examine our mechanistic proposal for these 
cycloisomerizations. According to the calculations presented in Scheme 9, the reaction is 
stereospecific since the ring-opening of the cyclopropyl via gold-stabilized carbocations TSXIVa(1) 
and TSXIVa(2) takes place with retention of the configuration, which in principle, should be 
translated in the final products. A careful 1H-NMR analysis of the reaction of trans-5k in the 
presence of [(IPr)Au(NTf2)] or pyridine-2-carboxylate gold (III) showed that in addition to the 
expected scrambling at the propargylic position as predicted in Scheme 8,31 a partial epimerization 
at the cyclopropyl occurred prior to the cyclization event.26 A computational study revealed a 
reaction pathway that could account for such configurational instability (Scheme 12).26  
Scheme 12. Reaction coordinate diagrams for the cyclopropyl epimerization at of XXIV. 
Calculations at the B3LYP/6-31G(d) (C, H, O), LANL2DZ (Au) level (+ ZPE corrected energies 
are given in kcal/mol; calculations considering solvent effects (CH2Cl2)). Au = (IPr)Au 
 
 First, XXIV can undergo a cyclopropyl ring-opening via TSXXIV-XXVI to give a high 
energy intermediate XXVI. The process is endothermic due to the intrinsic unstable nature of 
such purely carbocationic intermediate even if the calculation takes into account solvent effects 
(ΔH = 8.2 kcal/mol). Upon C-C rotation via TSXXVI-cisXXIV, the minor isomer cis-XXIV is formed. 
The activation barriers to transform XXIV into cis-XXIV are comparable to those obtained for 
the cyclopentannulation process and summarized in Scheme 10. Therefore, we have to assume 
that even if the cycloisomerization is an intrinsically stereospecific process, a competitive 
epimerization at the cyclopropyl moiety can erode the chirality transfer of these transformations. 
To understand the loss of chirality by such mechanism, XXIV should be in equilibrium with 
cyclopropyl propargyl acetate XVIII (or analogously, XIVa with XIa), which seems to be the 
case according to the energy barriers summarized in Schemes 8 and 10). A final requirement 
involves the transformation of cis-XXIV into the final cyclopentenyl acetate ent-XXV, which 
seems to be possible according to the ΔH≠ values obtained for that process, comparable to the 
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ones obtained for the trans product (ΔH≠ TSXXIV-XXV = 8.1 vs. ΔH≠ TScisXXIV-entXXV = 4.0 kcal/mol, 
considering solvent effects in both cases). 
 
 3.4.1 Acetate Fission vs. Cyclopropyl Ring Opening 
  Finally, from intermediates of type XIVa, we decided to study the competitive acetate 
fission process to give α-ylidene-β-diketones XXVIIa as previously described by Zhang and co-
workers.14 The activation energy for the attack of metal vinyl bond into the acetate TSXIVa-XXVIIa is 
aprox. 25-26 kcal/mol, independently of the substituent at the cyclopropyl ring (Scheme 13, 
right). However, the activation barrier for the ring opening of the methyl-substituted cyclopropyl 
rises to more than 27.6 kcal/mol (vs. 19.9 kcal/mol for the vinyl substituted one) thus highlighting 
the importance of the cyclopropyl substituent in the reaction mechanism (Scheme 13, left). 
Scheme 13. Reaction coordinate diagrams for the cyclopentannulation vs. the acetate fission 
reaction. Calculations at the B3LYP/6-31G(d) (C, H, O, P), LANL2DZ (Au) level (+ ZPE 
corrected energies are given in kcal/mol). Au = (IPr)Au 
 
 
 3.5 Conclusion 
 We present here a complete study on the reactivity of 3-cyclopropyl propargylic acetates 
and enol ethers with Au(I) and Au(III) catalysts. The intelligence gathered in the development of 
the gold-catalyzed homo-Rautenstrauch rearrangement previously reported by our group aided the 
selection of substituents at the cyclopropyl ring able to tune the reactivity of these settings in 
favor of a cyclopentannulation vs. an acetate fission process to give α-ylidene-β-diketones. 
Supported by DFT calculations, this study sheds light on the key gold-stabilized “nonclassical 
carbocationic” intermediates involved the stereocontrolled synthesis of 5-(E)-alkylidene-
cyclopentenyl acetates and reveals the intrinsic stereoespecific nature of these transformations. 
Further experimental and computational evidence are disclosed to explain the lack of a complete 
chirality transfer in optically active settings: the cyclopentannulation process competes with a 
gold-triggered cyclopropyl opening/closure prior to the cyclization event. Surprisingly, such 
cyclopropyl scrambling has been found for both cis and trans- settings thus highlighting the 
configurational promiscuity of these motifs. The rearrangement of tertiary acetates has been 
highly illuminative of the competitive nature of the 1,2- and 1,3-acyloxy migration pathways, 
opening the venue for new transformations orchestrated in that regard, which is currently being 
pursued and will be reported in due course.   
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1. General information 
 
All reactions were carried out under a nitrogen atmosphere using Standard Schlenk techniques. 
All reagents were used as received unless otherwise noted. Solvents were purchased in HPLC 
quality, degassed by purging thoroughly with nitrogen and dried over activated molecular sieves 
of appropriate size. Alternatively, they were purged with argon and passed through alumina 
columns in a solvent purification system (Innovative Technology). Reactions were monitored by 
thin layer chromatography (TLC) using Merck TLC silica gel 60 F254. Flash column 
chromatography was performed over silacycle silica gel (230-400 mesh). NMR spectra were 
recorded on AV2 400 or AV2 500 MHz Bruker spectrometers. Chemical shifts are given in ppm. 
The spectra are calibrated to the residual 1H and 13C signals of the solvents. Multiplicities are 
abbreviated as follows: singlet (s), doublet (d), triplet (t), quartet (q), doublet-doublet (dd), 
doublet-doublet-doublet (ddd), quintet (quint), septet (sept), multiplet (m), and broad (br). 
Infrared spectra were recorded on a JASCO FT/IR-4100 spectrometer. High-resolution 
electrospray ionization mass spectrometry was performed on a Finnigan MAT 900 (Thermo 
Finnigan, San Jose, CA; USA) doublefocusing magnetic sector mass spectrometer. 10 spectra 
were acquired. A mass accuracy ≤ 2 ppm was obtained in the peak matching acquisition mode by 
using a solution containing 2 <l PEG200, 2 <l PPG450, and 1.5 mg NaOAc (all obtained from 
Sigma-Aldrich, CH-Buchs) dissolved in 100ml MeOH (HPLC Supra grade, Scharlau, E-
Barcelona) as internal standard. HPLC was performed on Waters 600 instrument using 4.6 x 25 
cm Chiralpack IB and Chiralcel OD-H columns. [α]D  values were recorded on JASCO P-2000 
Polarimeter. IPrAuNTf21 and dichloro(pyridine-2-carboxylato)gold(III) complex2 were prepared 
according to previously reported procedures. 
 
 
 
 
 
 
 
 
 
                                                 
1  Ricard, L.; Gagosz, F. Organometallics 2007, 26, 4704-4707. 
2  Dar, A.; Moss, K.; Cottrill, S. M.; Parish, R. V.; McAuliffe, C. A.; Pritchard, R. G.; Beagley, B.; Sandbank, J. J Chem. Soc., Dalton 
Trans. 1992, 1907-1913. 
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2. Preparation and characterization of 3-cyclopropyl propargyl acetates and cyclization 
products.  Complementary Table 2. 
2.1 General procedure for the preparation of 3-cyclopropyl propargyl acetates 
 
 
1) To a solution of NaH (1.05 equiv.) in THF (0.8 M) at 0 oC, triethyl phosphonoacetate (1.1 
equiv.) was added dropwise. The mixture was stirred at 0 oC for 20 minutes. Then, the 
aldehyde (1.0 equiv.) was added dropwise at 0 oC. The reaction was stirred at room 
temperature for 12 hours and quenched with brine. The volume was reduced to the 1/3 
under reduced pressure. The aqueous layer was extracted with CH2Cl2 and the combined 
organic layers were dried over Na2SO4. The solvent was evaporated under reduced 
pressure and the residue was purified by column chromatography on silica gel (Pentane) 
to give the corresponding (E)-α,β-unsaturated ester in 82-95% yield. 
2)  To a solution of NaH (1.05 equiv.) in THF (0.6 M) at room temperature, 
trimethylsulfoxonium iodine (1.15 equiv.) was added as a solid in small portions. The 
mixture was stirred for 1 hour before a solution of the corresponding ester (1.0 equiv.) in 
DMSO (1.0 M) was added. The mixture was stirred at room temperature for 12 hours. 
The reaction was quenched with brine and extracted several times with diethyl ether. The 
organic layers were dried over Na2SO4. Solvent was evaporated under reduced pressure 
and the residue was purified by column chromatography on silica gel (Pentane) to give 
the corresponding cyclopropyl ester derivate in 62-90% yield. 
3) To a solution of the corresponding cyclopropyl ester (1.0 equiv.) in CH2Cl2 (0.2 M) at -78 
oC, DIBAL-H (1.0 M in hexane, 2.2 equiv.) was added dropwise. The reaction was stirred 
at -78 oC for 1 hour. The reaction was quenched with ethyl acetate (3 equiv.) and diluted 
with diethyl ether. A saturated solution of Na/K-tartrate was added to the mixture and the 
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reaction was stirred for another 3 hours till clear separation of the two phases was 
observed. The aqueous layer was extracted with diethyl ether and the combined organic 
layers were dried over Na2SO4. The solvent was evaporated under reduced pressure and 
the residue was purified by column chromatography on silica gel (Hexane:AcOEt 4:1) to 
give the corresponding alcohol in 60-90% yield. 
4) To a solution of oxalyl chloride (1.5 quiv.) in CH2Cl2 (0.4 M), DMSO (2.3 equiv.) was 
added dropwise. The reaction was stirred at -78 oC for 1 hour. Then, the corresponding 
alcohol was added (1.0 equiv) dropwise in CH2Cl2 (1.4 M). The reaction was stirred at -
78 oC for 1 hour, and triethylamine (5.0 quiv.) was added dropwise and the reaction was 
stirred at -78 oC for another hour. The mixture was warmed up to room temperature for 
another 30 minutes and quenched with a saturated solution of ammonium chloride. The 
aqueous layer was extracted with CH2Cl2 and the combined organic layers were dried 
over Na2SO4. The solvent was evaporated under reduced pressure. The crude product was 
used in the next step without further purification. 
5) To a solution of CBr4 (2.2 equiv.) in CH2Cl2 (1.5 M) at 0 oC, a solution of 
triphenylphosphine (4.4 equiv.) in CH2Cl2 (1.5 M) was added dropwise. The resulting 
dark orange solution was stirred for 5 minutes. A solution of the corresponding 
cyclopropylaldehyde (1.0 equiv.) dissolved in CH2Cl2 (1.0 M) was added dropwise. The 
solution was stirred at 0 oC for 2-3 hours. The reaction mixture was quenched by addition 
of water. The aqueous layers where extracted with CH2Cl2. The combined organic layers 
were washed with water and brine. The organic layer was dried over MgSO4 and the 
crude was purified by column chromatography on silica gel (Hexane) to yield the 
dibromo derivatives in 65-80% yield. 
To a solution of the corresponding cyclopropyl-dibromo derivate (1.0 equiv.) in THF (0.2 
M) at -78 oC, nBuLi (1.0 M in hexane, 2.0 equiv) was added dropwise. The solution was 
stirred at -78 oC for 3 hours and then warmed up to room temperature for 20 minutes. The 
resulting solution was cooled down to -78 oC and the aldehyde (1.05 equiv.) or the ketone 
(1.05 equiv.) was added dropwise. The reaction was stirred at room temperature for 12 
hours. Water was added and the aqueous layer was extracted with EtOAc. The organic 
layers were dried over Na2SO4 and the crude was purified by column chromatography on 
silica gel (Hexane:EtOAc 25:1) to give the corresponding propargyl alcohol in 33-93% 
yield. 
6) To a solution of the corresponding secondary propargyl alcohol (1.0 equiv.) at 0 oC in 
CH2Cl2 (0.4 M), pyridine (20.0 equiv.), DMAP (0.05 equiv.) and AcCl (2.0 equiv.) were 
sequentially added. The resulting mixture was stirred for 1 hour. The solution was filtered 
through Celite and the corresponding solution was evaporated under reduced pressure. 
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The residue was purified by column chromatography on silica gel (Hexane:EtOAc 25:1). 
The desired secondary propargyl acetates were obtained in 58-97% yield. 
7) To a solution of the corresponding tertiary propargyl alcohol (1.0 equiv.) at 0 oC in 
CH2Cl2 (0.2 M), triethylamine (10.0 equiv.), DMAP (0.1 equiv.) and Ac2O (5.0 equiv.) 
were sequentially added. The resulting mixture was stirred for 12 hours. The solution was 
dried under reduced pressure and the residue was purified by column chromatography on 
silica gel (Hexane:EtOAc 25:1). The desired tertiary propargyl acetates were obtained in 
72-89% yield. 
 
2.2 Characterization of secondary acetates3 
3-(2-(2-Methylprop-1-enyl)cyclopropyl)-1-phenylprop-2-ynyl acetate (5b) 
Obtained as a 1:2 diastereomeric mixture in the propargyl position. 1H NMR 
(400 MHz, CDCl3): δ = 7.53-7.49 (m, 2H, major and minor), 7.39-7.32 (m, 3H, major and minor),  
6.48-6.46 (m, 1H, minor), 6.45 (d, J = 1.6 Hz, 1H, major), 4.94 (dd, J = 8.5, 1.2 Hz, 1H, minor), 
4.53 (dd, J = 8.6, 1.2 Hz, 1H, major), 2.08 (s, 3H, major and minor), 1.84-1.78 (m, 1H, major), 
1.75 (s, 3H, major), 1.73 (d, J = 0.9 Hz, 3H, minor), 1.71 (d, J = 0,9 Hz, 3H, minor), 1.68 (s, 3H, 
major), 1.65-1.59 (m, 1H, minor), 1.27-1.17 (m, 1H, major), 1.15-1.06 (m, 1H, major),  0.81-0.75  
(m, 1H, minor), 0.70-0.62 (m, 1H, minor) ppm; 13C NMR (100 MHz, CDCl3) (major isomer): δ = 
169.8, 137.6, 133.5, 128.7, 128.5, 127.7, 125.1, 90.2, 73.0, 66.1, 25.4, 21.2, 21.1, 18.4, 16.6, 8.6 
ppm; (minor isomer): 169.8, 137.6, 134.1, 128.6, 128.4, 127.8, 127.7, 123.1, 88.6, 75.0, 66.1, 
25.6, 21.6, 17.7, 16.1, 7.2  ppm;  IR (neat, ν/cm-1): 2965, 2915, 2359, 2238, 1680, 1494, 1455, 
1369, 1014, 953, 697; MS (ESI) for C18H20NaO2+ m/z: 291.2 [M + Na]+, 559.2 [2M + Na]+. 
3-(2-(2-Methylprop-1-enyl)cyclopropyl)-1-(naphthalene-2-yl)prop-2-ynyl acetate (5c) 
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H 
NMR (400 MHz, CDCl3): δ = 7.95 (s, 2H), 7.87-7.82 (m, 6H), 7.59 (dd, J = 8.5, 1.8 Hz, 2H), 
7.52-7.47 (m, 4H), 6.61 (s, 1H), 6.60 (s, 1H), 4.56-4.53 (m, 2H), 2.10 (s, 6H), 1.88-1.80 (m, 2H), 
1.75 (d, J = 0.9 Hz, 6H), 1.68 (s, 6H), 1.28-1.21 (m, 2H), 1.13-1.08 (m, 2H), 0.82-0.77 (m, 2H) 
                                                 
3 All racemic starting materials were prepared by cyclopropanation of the corresponding (E)-α,β-unsaturated esters. The 
stereochemistry at the propargylic position was not controlled and therefore mixtures of diastereoisomers were obtained in variable 
ratios. In some cases, signals of the major and minor isomers separate and  the corresponding unambiguous assignment could be done. 
In other cases, when most of the signals were overlapped, only the signals that separated have been indicated in the 13C-NMR as (2x 
C). 
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ppm; 13C NMR (100 MHz, CDCl3): δ = 169.8, 134.9 (2xC), 133.5 (2xC), 133.3, 130.0, 128.4, 
128.2, 127.6, 126.9, 126.5, 126.3, 125.1, 90.5 (2xC), 73.1 (2xC), 66.2, 25.4, 21.6 (2xC), 21.2, 
18.4, 16.6 (2xC), 8.63, 8.62 ppm; IR (neat, ν/cm-1): 2966, 2921, 2872, 2359, 2335, 2236, 1739, 
1442, 1368, 1223, 1014, 856, 817; HRMS (ESI): m/z calcd for C22H22NaO2+: 341.1520, found: 
341.1517. 
4-(2-(2-Methylprop-1-enyl)cyclopropyl)but-3-yn-2-yl- acetate (5d) 
Obtained as a 1:1.5 diastereomeric mixture in the propargyl position. 1H NMR 
(400 MHz, CDCl3): δ = 5.47-5.40 (m, 1H, major and minor), 4.92 (d, J = 9.0 Hz, 1H, minor),  
4.52 (d, J = 8.9 Hz, 1H, major), 2.05 (s, 3H, major and minor), 1.75 (s, 3H, major), 1.75 (s, 3H, 
minor), 1.73 (s, 3H, minor), 1.67 (s, 3H, major), 1.56-1.53 (m, 1H, major), 1.45 (d, J = 6.4 Hz, 
3H, minor), 1.43 (d, J = 6.4 Hz, 3H, major), 1.21-1.11 (m, 2H major, 1H minor), 1.07-1.01 (m, 
2H, minor), 0.77-0.72 (m, 1H, major), 0.63-0.56 (m, 1H, minor) ppm; 13C NMR (100 MHz, 
CDCl3) (major isomer): δ = 169.9, 133.4, 125.2, 87.5, 74.9, 60.9, 25.4, 21.8, 21.5, 21.2, 18.4, 
16.5, 8.4  ppm, (minor isomer): 169.9, 133.8, 122.9, 85.8, 74.9, 60.9, 25.7, 21.7, 21.1, 18.4, 17.4, 
16.0, 7.0  ppm;  IR (neat, ν/cm-1): 2986, 2968, 2934, 2872, 2238, 1739, 1447, 1370, 1231, 1042, 
945, 847; HRMS (ESI): m/z calcd for C13H18NaO2+: 229.1205, found: 229.1204. 
4-Methyl-1-(2-(2-methylprop-1-enyl)cyclopropyl)pent-1-yn-3-yl acetate (5e) 
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H NMR 
(400 MHz, CDCl3): δ = 5.20 (dd, J = 5.6, 0.7 Hz, 1H), 5.18 (dd, J = 5.6, 0.7 Hz, 1H), 4.54-4.51 
(m, 2H), 2.07 (s, 6H), 1.98-1.90 (m, 2H), 1.79-1.73 (m, 2H), 1.74 (m, 6H), 1.67 (s, 6H), 1.19-1.14 
(m, 2H), 1.06-1.01 (m, 2H), 0.98 (d, J = 6.7 Hz, 6H), 0.95 (d, J = 6.7 Hz, 6H), 0.77-0.72 (m, 2H); 
13C NMR (100 MHz, CDCl3): δ = 170.1, 133.4, 125.3 (2xC), 88.7, 72.5 (2xC), 69.5, 32.6, 25.4, 
21.6 (2xC), 21.1, 18.4, 18.2, 17.5, 16.6 (2xC), 8.5 ppm;  IR (neat, ν/cm-1): 2965, 2930, 2874, 
2235, 1741, 1468, 1447, 1371, 1232, 1018, 978, 848; HRMS (EI): m/z calcd for C15H22O2+: 
234.1614, found 234.1620. 
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1-(2-(2-Methylprop-1-enyl)cyclopropyl)oct-1-yn-3-yl acetate (5f) 
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H NMR 
(400 MHz, CDCl3): δ = 5.34 (t, J = 6.6 Hz, 1H), 5.33 (t, J = 6.6 Hz, 1H), 4.52 (dq, J = 1.4, 8.9 Hz, 
2H), 2.06 (s, 6H), 1.78-1.65 (m, 4H), 1.75 (m, 6H), 1.67 (s, 6H), 1.44-1.36 (m, 4H), 1.34-1.25 (m, 
10H), 1.19-1.14 (m, 2H), 1.06-1.01 (m, 2H), 0.89 (t, J = 7.0 Hz, 6H), 0.77-0.72 (m, 2H) ppm; 13C 
NMR (100 MHz, CDCl3): δ = 170.1, 133.4 (2xC), 125.2 (2xC), 88.1, 74.0 (2xC), 64.6, 35.1, 31.3, 
25.4, 24.7, 22.5, 21.6, 21.1, 18.4, 16.6, 13.9, 8.5 (2xC) ppm; IR (neat, ν/cm-1): 2955, 2929, 2860, 
2237, 1741, 1455, 1371, 1232, 1018, 954; HRMS (ESI): m/z calcd for C17H26NaO2+: 285.1824, 
found: 285.1825. 
(E)-1-Phenyl-3-(2-(1-phenylprop-1-en-2-yl)cyclopropyl)prop-2-ynyl acetate (5g) 
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H NMR 
(400 MHz, CDCl3): δ = 7.53-7.51 (m, 4H), 7.41-7.29 (m, 10H), 7.22-7.18 (m, 6H), 6.48 (s, 1H), 
6.47 (s, 1H), 6.35 (s, 2H), 2.11 (s, 6H), 1.99-1.93 (m, 2H), 1.75 (s, 6H), 1.54-1.49 (m, 2H), 1.19-
1.09 (m, 4H) ppm; 13C NMR (100 MHz, CDCl3): δ = 169.8, 137.8, 137.6, 136.2, 128.8, 128.7, 
128.6, 128.1, 127.7, 126.1, 125.3 (2xC), 90.2, 72.9, 66.0, 30.8 (2xC), 21.2, 15.6 (2xC), 14.7 
(2xC), 7.2 ppm; IR (neat, ν/cm-1): 3062, 3026, 2926, 2864, 2362, 2335, 2237, 1738, 1493, 1455, 
1396, 1224, 1014, 952, 740, 697; HRMS (ESI): m/z calcd for C23H22NaO2+: 353.1521, found: 
353.1517. 
(E)-1-Phenyl-3-(2-(1-phenylprop-1-en-2-yl)cyclopropyl)prop-2-ynyl benzoate (5h) 
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H NMR 
(400 MHz, CDCl3): δ = 8.10-8.08 (m, 4H), 7.62-7.60 (m, 4H), 7.58-7.54 (m, 2H), 7.45-7.36 (m, 
10H), 7.32-7.29 (m, 4H), 7.21-7.16 (m, 6H), 6.72 (s, 1H), 6.71 (s, 1H), 6.35 (s, 2H), 2.00-1.94 (m, 
2H), 1.74 (d, J = 1.3 Hz, 6H), 1.55-1.50 (m, 2H), 1.19-1.09 (m, 4H) ppm; 13C NMR (100 MHz, 
CDCl3): δ = 165.5, 137.8, 137.7, 136.3, 133.1, 130.0, 129.9, 128.8, 128.7, 128.6, 128.3, 128.1, 
127.6, 126.1, 125.3, 90.4, 73.0, 66.6, 30.8 (2xC), 15.5 (2xC), 14.7, 7.3 ppm; IR (neat, ν/cm-1): 
3062, 3026, 2235, 1723, 1493, 1452, 1384, 1256, 1294, 1093, 1025, 910, 738, 709; HRMS (ESI): 
m/z calcd for C28H24NaO2+: 415.1668, found: 415.1668. 
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3-(2-(4-Methoxyphenyl)cyclopropyl)-1-phenylprop-2-ynyl acetate (5i) 
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H 
NMR (400MHz, CDCl3) δ = 7.53-7.49 (m, 4H), 7.41-7.34 (m, 6H), 7.03-6.99 (m, 4H), 6.83-6.79 
(m, 4H), 6.47 (s, 1H), 6.46 (s, 1H), 3.78 (s, 6H), 2.28-2.23 (m, 2H), 2.10 (s, 6H), 1.53-1.47 (m, 
2H), 1.32-1.27 (m, 2H), 1.23-1.17 (m, 2H); 13C NMR (100 MHz, CDCl3) δ = 169.9, 158.2, 137.6 
(2xC), 132.4, 128.8, 128.6, 127.7, 127.2 (2xC), 113.9, 90.0, 73.1, 66.1, 55.3, 25.6, 21.2, 17.4, 
10.7 (2xC); IR (neat, ν/cm-1): 3035, 2237, 1737, 1514, 1224, 1033, 1014, 951, 912, 747, 697; 
HRMS (EI): m/z calcd for C21H20NaO3+ 343.1310, found: 343.1314. 
1-(4-Methoxyphenyl)-3-(2-(4-metoxyphenyl)cyclopropyl)prop-2-ynyl acetate (5j) 
Obtained as a 1:1 diastereomeric mixture in the propargyl 
position. 1H NMR (400MHz, CDCl3) δ = 7.46-7.43 (m, 4H), 7.03-7.00 (m, 4H), 6.91-6.89 (m, 
4H), 6.82-6.80 (m, 4H), 6.42 (s, 1H), 6.41 (s, 1H), 3.81 (s, 6H), 3.78 (s, 6H), 2.28-2.23 (m, 2H), 
2.08(s, 6H), 1.56-1.47 (m, 2H), 1.32-1.27 (m, 2H), 1.22-1.17 (m, 2H); 13C NMR (100 MHz, 
CDCl3) δ = 169.9, 160.0, 158.2, 132.5, 129.9, 129.3, 127.2 (2xC), 113.9 (2xC), 89.8, 73.3, 65.8, 
55.4, 55.3, 25.7, 21.3, 17.4, 10.8, 10.7; IR (neat, ν/cm-1): 2934, 2835, 2236, 1738, 1611, 1513, 
1247, 1227, 1033, 826; HRMS (ESI): m/z calcd for C22H22NaO4+ 373.1416, found: 373.1412.  
1-(2-(4-Methoxyphenyl)cyclopropyl)-4-methylpent-1-yn-3-yl- acetate (5k) 
OAc
OMe
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H 
NMR (500MHz, CDCl3) δ = 7.02-6.99 (m, 4H), 6.82-6.79 (m, 4H), 5.22 (d, J = 5.6 Hz, 1H), 5.21 
(d, J = 5.6 Hz, 1H), 3.78 (s, 6H), 2.23-2.17 (m, 2H), 2.09 (s, 6H), 2.00-1.92 (m, 2H), 1.47-1.42 
(m,2H), 1.28-1.14 (m, 4H), 0.99 (d, J = 10.8 Hz, 6H), 0.98 (d, J = 10.8 Hz, 6H); 13C NMR (125 
MHz, CDCl3) δ = 170.2, 158.2, 132.6, 127.2 (2xC), 113.8, 88.5, 72.6 (2xC), 69.4, 55.3, 32.6, 25.6 
(2xC), 21.1, 18.3, 17.6, 17.4 (2xC), 10.7 (2xC); IR (neat, ν/cm-1): 3445, 2963, 2874, 2360, 1715, 
1614, 1515, 1247, 1034, 824; HRMS (ESI): m/z calcd for C18H22NaO3+ 309.1467, found: 
309.1465. 
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1-(2-(4-Methoxyphenyl)cyclopropyl)-4-methylpent-1-yn-3-yl- acetate (cis-5k)  
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H 
NMR (400MHz, CD2Cl2) δ = 7.17-7.15 (m, 4H), 6.84-6.81 (m, 4H), 5.01 (dd, J = 6.0, 1.8 Hz, 
1H), 4.99 (dd, J = 5.8, 1.8 Hz, 1H), 3.77 (s, 6H), 2.29-2.23 (m, 2H), 1.97 (s, 6H), 1.77-1.70 (m, 
4H), 1.34-1.28 (m, 2H), 1.13-1.07 (m, 2H), 0.75-0.71 (m, 12H) ppm; 13C NMR (125 MHz, 
CDCl3) δ = 170.3, 158.9, 130.4 (2xC), 130.0 (2xC), 113.9 (2xC), 86.5 (2xC), 76.4 (2xC), 69.7 
(2xC), 55.8, 32.9 (2xC), 23.3 (2xC), 21.3, 18.3, 17.6 (2xC), 14.6 (2xC), 9.5 (2xC) ppm; IR (neat, 
ν/cm-1): 3005, 2964, 2933, 2874, 2835, 2237, 1735, 1613, 1514, 1465, 1370, 1230, 1018, 980, 
943, 829. HRMS (ESI): m/z calcd for C18H22NaO3+ 309.1467, found: 309.1461. 
3-(2-(4-Methoxyphenyl)-2-methylcyclopropyl)-1-phenylprop-2-ynyl- acetate (5l) 
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H 
NMR (400MHz, CDCl3) δ = 7.56-7.54 (m, 4H), 7.42-7.36 (m, 6H), 7.21-7.18 (m, 4H), 6.83-6.81 
(m, 4H), 6.51 (s, 3H), 6.50 (s, 3H), 3.78 (s, 6H), 2.11 (s, 6H), 1.67-1.63 (m, 2H), 1.52 (s, 3H), 
1.50 (s, 3H), 1.40-1.34 (m, 2H), 0.97-0.92 (m, 2H) ppm;  13C NMR (100 MHz, CDCl3) δ = 169.9, 
158.0, 137.6 (2xC), 137.5 (2xC), 128.7 (2xC), 128.6, 128.4 (2xC), 127.7, 113.7, 88.5 (2xC), 75.3 
(2xC), 66.2, 55.2, 27.3 (2xC), 22.9, 22.8, 21.2, 14.9 (2xC) ppm; IR (neat, ν/cm-1): 3067, 3004, 
2956, 2932, 2236, 1736, 1514, 1455, 1369, 1225, 1175, 1032, 904, 727, 649, 548;  HRMS (ESI): 
m/z calcd for C22H22NaO3+: 357.1458, found: 357.1461. 
 
2.3 Characterization of tertiary acetates 
2-Methyl-4-(2-(2-methylprop-1enyl)cyclopropyl)but-3-yn-2-yl acetate (9a) 
1H NMR (400 MHz, CDCl3): δ = 4.97 (dq, J = 9.0, 1.1 Hz, 1H, minor), 4.52 
(dq, J = 8.9, 1.1 Hz, 1H, major), 1.99 (s, 3H, major and minor), 1.77-1.70 (m, 2H, minor), 1.74 (d, 
J = 0.8 Hz, 6H, major), 1.72 (d, J = 0.8 Hz, 3H, minor), 1.66 (d, J = 0.8 Hz, 3H, minor), 1.63 (s, 
3H, minor), 1.62 (s, 3H, minor), 1.61 (s, 6H, major), 1.56-1.51 (m, 1H, minor), 1.17-1.10 (m, 2H, 
major), 1.04-1.00 (m, 1H, major), 0.74-0.70 (ddd, J = 8.5, 5.8, 4.3 Hz, 1H, major), 0.60-0.57 (m, 
1H, minor) ppm; 13C NMR (100 MHz, CDCl3) (major isomer): δ = 169.3, 133.1, 125.4, 86.6, 
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77.6, 72.6, 29.2, 25.4, 22.1, 21.5, 18.4, 16.6, 8.6 ppm, (minor isomer): 169.2, 133.4, 123.3, 85.0, 
79.7, 72.5, 29.3, 29.2, 25.6, 22.0, 17.4, 16.1, 7.1 ppm ; IR (neat, ν/cm-1): 2985, 2925, 2362, 2241, 
1365, 1240, 1132, 1014, 957, 839; HRMS (ESI): m/z calcd for C14H20NaO2+: 220.1462, found: 
220.1463. 
(E)-2-Methyl-4-(2-(1-phenylprop-1-en-2-yl)cyclopropyl)but-3-yn-2-yl acetate (9b) 
1H NMR (400 MHz, CDCl3): δ = 7.32-7.29 (m, 2H), 7.21-7.16 (m, 3H), 6.35 
(s, 1H), 2.02 (s, 3H), 1.92-1.87 (m, 1H), 1.73 (s, 3H), 1.65 (s, 6H), 1.49-1.45 (m, 1H), 1.13-1.03 
(m, 2H) ppm; 13C NMR (100 MHz, CDCl3): δ = 169.2, 137.8, 136.4, 128.7, 127.9, 125.9, 125.0, 
86.5, 77.4, 72.4, 30.6, 29.14, 29.13, 21.9, 15.3, 14.6 ppm; IR (neat, ν/cm-1): 3025, 2985, 2937, 
2854, 2237, 1741, 1440, 1365, 1240, 1135, 1124, 1014, 741, 699; HRMS (ESI): m/z calcd for 
C19H22NaO2+: 305.1518, found: 305.1517. 
4-(2-(4-Methoxyphenyl)cyclopropyl)2-methylbut-3-yn-2-yl acetate (9c) 
1H NMR (400MHz, CDCl3) δ = 7.01-6.99 (m, 2H), 6.81-6.79 (m, 2H), 
3.77 (s, 3H), 2.21-2.16 (m, 1H), 2.01 (s, 3H), 1.64 (s, 6H), 1.47-1.42 (m,1H), 1.26-1.21 (m, 1H), 
1.16-1.11 (m,1H); 13C NMR (100 MHz, CDCl3) δ = 169.4, 158.1, 132.8, 127.1, 113.8, 86.5, 77.7, 
72.6, 55.3, 29.2, 25.6, 22.1, 17.6, 10.7; IR (neat, ν/cm-1): 2987, 2938, 2835, 2235, 1739, 1514, 
1241, 1179, 1135, 823, 803; HRMS (EI): m/z calcd for C17H20O3+: 272.1412, found: 272.1413.  
3-Ethyl-1-(2-(4-methoxyphenyl)cyclopropyl)pent-1-yn-3yl acetate (9d) 
1H NMR (500MHz, CDCl3) δ = 7.02-6.99 (m, 2H), 6.83-6.78 (m, 2H), 
3.78 (s, 3H), 2.21-2.16 (m, 1H), 2.06-1.97 (m, 5H), 1.92-1.83 (m, 2H), 1.50-1.45 (m, 1H), 1.26-
1.22 (m, 1H), 1.17-1.13 (m, 1H), 0.96 (t, J = 7.6 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ = 169.4, 
158.1, 132.9, 127.1, 113.8, 88.4, 80.5, 75.8, 55.3, 30.9, 25.7, 22.0, 17.7, 10.8, 8.5; IR (neat, ν/cm-
1): 2972, 2880, 2237, 1738, 1515, 1459, 1366, 1241, 1036, 831; HRMS (EI): m/z calcd for 
C19H24O3+: 300.1725, found: 300.1725.  
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1-(2-(2-(4-Methoxyphenyl)cyclopropyl)ethynyl)cyclopentyl acetate (9e) 
1H NMR (400MHz, CDCl3) δ = 7.02-6.98 (m, 2H), 6.82-6.78 (m, 2H), 
3.77 (s, 3H), 2.22-2.15 (m, 3H), 2.11-2.05 (m, 2H), 2.02 (s, 3H), 1.79-1.65 (m, 4H), 1.48-1.43 (m, 
1H), 1.25-1.21 (m, 1H), 1.16-1.11 (m, 1H); 13C NMR (100 MHz, CDCl3) δ = 169.6, 158.1, 132.9, 
127.1, 113.8, 87.1, 81.0, 55.3, 40.5, 25.6, 23.3, 21.9, 21.8, 17.6, 10.8; IR (neat, ν/cm-1): 2957, 
2247, 1737, 1514, 1244, 906; HRMS (EI): m/z calcd for C19H22O3+: 298.1569, found: 298.1570.  
1-(2-(2-(4-Methoxyphenyl)cyclopropyl)ethynyl)cyclohexyl acetate (9f) 
1H NMR (400MHz, CDCl3) δ = 7.02-7.00 (m, 2H), 6.81-6.79 (m, 2H), 
3.78 (s, 3H), 2.21-2.17 (m, 1H), 2.10-2.04 (m, 2H), 2.03 (s, 3H), 1.85-1.79 (m, 2H), 1.63-1.56 (m, 
4H), 1.52-1.46 (m, 2H), 1.36-1.30 (m, 1H), 1.27-1.22 (m, 1H), 1.17-1.12 (m,1H); 13C NMR (100 
MHz, CDCl3) δ = 169.3, 158.2, 132.9, 127.1, 113.8, 88.7, 76.4, 75.9, 55.3, 37.3, 25.7, 25.3, 22.7, 
22.1, 17.8, 10.8; IR (neat, ν/cm-1): 2934, 2858, 1740, 1613, 1514, 1445, 1366, 1229, 1035, 824; 
HRMS (EI): m/z calcd for C20H24O3+: 312.1725, found: 312.1723.  
4-(2-(4-Methoxyphenyl)cyclopropyl)-2-phenylbut-3-yn-2-yl acetate (9g) 
1H NMR (400MHz, CDCl3) δ = 7.57-7.54 (m,2H), 7.37-7.33 (m, 2H), 
7.29-7.26 (m, 1H), 7.05-7.03 (m, 2H), 6.86-6.80 (m, 2H), 3.79 (s, 3H), 2.32-2.25 (m, 1H), 2.07 (s, 
3H), 1.86 (s, 3H), 1.60-1.53 (m, 1H), 1.36-1.30 (m, 1H), 1.23-1.19 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ = 168.6, 158.2, 143.2, 133.4, 132.7, 128.3, 127.6, 127.2, 124.9, 113.8, 89.9, 76.0, 55.3, 
32.3, 25.7, 21.9, 17.7, 10.8; IR (neat, ν/cm-1): 2992, 2934, 2239, 1747, 1514, 1447, 1367, 1236, 
1057, 938; HRMS (ESI): m/z calcd for C22H22NaO3+: 357.1467, found: 357.1471. 
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2.4 General procedure for the preparation of cyclopent-1-enyl acetates and cyclopentenones 
from secondary acetates 
 
 
A) To a solution of the corresponding propargyl acetate (1.0 equiv.) in CH2Cl2 (0.05 M), 
IPrAuNTf2 (0.05 equiv.) was added in one portion. The mixture was stirred at room 
temperature for 30 minutes. The reaction was quenched with triethylamine (0.05 equiv.). 
The solvent was evaporated under reduced pressure and the residue was purified by 
column chromatography (Hex:AcOEt 50:1) to give the corresponding cyclopent-1-enyl 
acetates. 
B) To a solution of the corresponding propargyl acetate (1.0 equiv.) in CH2Cl2 (0.05 M), 
dichloro(pyridine-2-carboxylato)gold (III) (0.05 equiv) was added in one portion. The 
mixture was stirred at 50 oC for 30 minutes. The reaction was quenched with  
triethylamine (0.05 equiv.). The solvent was evaporated under reduced pressure and the 
residue was purified by column chromatography (Hex:AcOEt 50:1) to give the 
corresponding cyclopent-1-enyl acetates. 
C) To a solution of the corresponding propargyl acetate (1.0 equiv.) in CH2Cl2 (0.05 M), 
IPrAuNTf2 (0.05 equiv.) was added in one portion. The mixture was stirred at room 
temperature for 30 minutes. The reaction was diluted with methanol and potassium 
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carbonate (2.0 equiv.) was added. The mixture was stirred at room temperature for 60 
minutes. The solvent was evaporated under reduced pressure and the residue was purified 
by column chromatography (Hex:AcOEt 25:1) to give the corresponding 
cyclopentanones. 
D) To a solution of the corresponding propargyl acetate (1.0 equiv.) in CH2Cl2 (0.05 M), 
dichloro(pyridine-2-carboxylato)gold (III) (0.05 equiv) was added in one portion. The 
mixture was stirred at 50 oC for 30 minutes. The reaction was diluted with methanol and 
potassium carbonate (2.0 equiv.) was added. The mixture was stirred at room temperature 
for 60 minutes. The solvent was evaporated under reduced pressure and the residue was 
purified by column chromatography (Hex:AcOEt 25:1) to give the corresponding 
cyclopentanones. 
 
a. Complementary Table 2 including methanolysis examples 
Entry Substrate Conditions [a] Product [b] 
Yield (%)[c] 
(E:Z ratio) [d] 
1 
 
5c 
A 
 
8c 
81 (14:1) 
 
 
2 
 
 
5d 
 
A 
 
8d 
 
78 (10:1) 
 
3 
 
 
5e 
 
B 
 
8e 
 
 
78 (12:1) 
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4  
 
5f 
A 
 
8f 
 
60 (50:1) 
[a] Reaction Conditions A: [(IPr)Au(NTf2)] (5 mol%), CH2Cl2, 25 ºC, 30 min. followed by dilution with 
MeOH and treatment with K2CO3 (2 equiv.). B: dichloro(pyridine-2-carboxylato)gold (III) (5 mol%), 
CH2Cl2, 50 ºC, 30 min. followed by dilution with MeOH and treatment with K2CO3 (2 equiv.). [b] Only 
the major product is shown. [c] Isolated yield after column chromatography. [d] Determined by 1H-NMR 
in the reaction mixture. 
 
 
b. Characterization of cyclopent-1-enyl acetates and cyclopentenones 
2-Benzylidene-1-(2-(2-methylprop-1-enyl)cyclopropyl)butane-1,3-dione (6b) 
1H NMR (400 MHz, CDCl3): δ = 7.59 (s, 1H), 7.45-7.35 (m, 5H), 4.50-4.46 
(m, 1H), 2.39 (s, 3H), 2.30-2.27 (m, 1H), 1.96-1.91 (m, 1H), 1.68 (d, J = 1.0 Hz, 3H), 1.62 (d, J = 
1.0 Hz, 3H), 1.04-0.99 (m, 2H) ppm; HRMS (ESI): m/z calcd for C18H20NaO2+: 291.1353, found: 
291.1355. 
(E)-5-Benzylidene-4-(2-metoxyprop-1-enyl)cyclopent-1-enyl acetate (7b) 
1H NMR (400 MHz, CD2Cl2): δ = 7.35-7.33 (m, 2H), 7.28-7.25 (m, 2H), 7.17-7.14 
(m, 1H), 6.33 (s, 1H), 5.92 (t, J = 3.0 Hz, 1H), 5.13-5.10 (m, 1H), 4.01 (t, J = 7.9 Hz, 1H), 2.96 
(ddd, J = 17.4, 2.7, 0.6 Hz, 1H), 2.27 (s, 3H), 2.27-2.21 (m, 1H), 1.74 (d, J = 1.1 Hz, 3H), 1.62 (d, 
J = 1.1 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 168.1, 149.1, 143.5, 136.7, 131.5, 128.6, 
127.9, 127.7, 126.3, 119.8, 118.2, 37.8, 36.9, 25.3, 21.1, 18.2 ppm; IR (neat, ν/cm-1): 2926, 1759, 
1446, 1369, 1194, 1100, 1077, 1056, 1029, 1012, 802, 755, 693; HRMS (EI): m/z calcd for 
C18H20O2+: 268.1463, found: 268.1463. 
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(E)-2-Benzylidene-3-(2-metoxyprop-1-enyl)cyclopentanone (8b) 
1H NMR (500 MHz, CD2Cl2): δ = 7.49-7.47 (m, 2H), 7.38-7.32 (m, 4H), 5.15-5.12 (m, 
1H), 4.03 (t, J = 8.2 Hz, 1H), 2.48-2.40 (m, 1H), 2.35-2.29 (m, 1H), 2.19-2.12 (m, 1H), 1.86-1.80 
(m, 1H), 1.84 (s, 3H), 1.68 (s, 3H) ppm; 13C NMR (125 MHz, CD2Cl2): δ = 208.0, 140.9, 135.6, 
133.4, 133.2, 131.4, 129.7, 128.8, 126.8, 40.1, 36.8, 29.5, 25.8, 18.5 ppm; IR (neat, ν/cm-1): 2964, 
2915, 2872, 2366, 2354, 2340, 1714, 1618, 1448, 1177, 1102, 1026, 806, 754, 693; HRMS (EI): 
m/z calcd for C16H18O+: 226.1359, found: 226.1358. 
(E)-4-(2-Methylprop-1-enyl)-5-(naphtalen-1-ylmethylene)cyclopent-1-enyl acetate (7c) 
 1H NMR (500 MHz, CDCl3): δ = 7.83 (s, 1H), 7.77-7.76 (m, 1H), 7.73-7.71 (m, 
2H), 7.48-7.39 (m, 3H), 6.49 (s, 1H), 6.00 (t, J = 2.8 Hz, 1H), 5.23-5.20 (m, 1H), 4.10 (t, J =7.7 
Hz, 1H), 3.03-2.97 (m, 1H), 2.32 (s, 3H), 2.31-2.27 (m, 1H), 1.81 (d, J = 1.4 Hz, 3H), 1.61 (d, J = 
1.3 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3): δ = 168.2, 149.2, 144.0, 134.3, 133.5, 132.1, 
131.7, 128.0, 127.9, 127.5, 127.4, 127.3, 127.2, 125.9, 125.5, 120.1, 118.2, 38.0, 37.0, 25.4, 21.2, 
18.4 ppm; IR (neat, ν/cm-1): 3054, 2968, 2925, 2364, 2354, 2337, 1760, 1613, 1437, 1370, 1199, 
1060, 1014, 814, 745; HRMS (ESI): m/z calcd for C22H22NaO2+: 341.1516, found: 341.1517. 
(E)-3-(2-Methylprop-1-enyl)-2-(naphtalen-1-ylmethylene)cyclopentanone (8c) 
1H NMR (400 MHz, CDCl3): δ = 7.98 (s, 1H), 7.83-7.77 (m, 3H), 7.59-7.55 (m, 
2H), 7.51-7.49 (m, 2H), 5.23-5.20 (m, 1H), 4.15-4.11 (m, 1H), 2.57-2.48 (m, 1H), 2.44-2.37 (m, 
1H), 2.28-2.15 (m, 1H), 1.93 (d, J = 1.1 Hz, 3H), 1.91-1.84 (m, 1H), 1.71 (d, J = 1.1 Hz, 3H) 
ppm; 13C NMR (100 MHz, CDCl3): δ = 208.0, 140.3, 133.5, 133.4, 133.1, 132.8, 132.4, 131.3, 
128.5, 127.8, 127.7, 127.6, 127.1, 126.6, 126.4, 39.7, 36.4, 29.0, 25.7, 18.3 ppm; IR (neat, ν/cm-1): 
3053, 2963, 2925, 2854, 1710, 1612, 1375, 1259, 1165, 1091, 1016, 798, 744; HRMS (EI): m/z 
calcd for C20H20O+: 276.1511, found: 276.1514. 
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(E)-5-Ethylidene-4-(2-methylprop-1-enyl)cyclopent-1-enyl acetate (7d) 
 1H NMR (400 MHz, CDCl3): δ = 5.71 (t, J = 2.7 Hz, 1H), 5.36 (dc, J = 7.1, 1.7 Hz, 
1H), 5.11-5.09 (m, 1H), 3.66-3.62 (m, 1H), 2.83-2.77 (m, 1H), 2.20 (s, 3H), 2.12-2.08 (m, 1H), 
1.70 (dd, J = 6.1, 1.4 Hz, 6H), 1.61 (d, J = 7.1 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 
168.2, 148.7, 142.3, 129.8, 127.8, 117.8, 113.2, 36.4, 35.5, 25.5, 20.9, 17.9, 13.3; IR (neat, ν/cm-
1): 2968, 2914, 2853, 2361, 2333, 1768, 1445, 1370, 1203, 1039, 1019, 829; HRMS (EI): m/z 
calcd for C13H18O2+: 296.1306, found 206.1307. 
(E)-2-Ethylidene-3-(2-methylprop-1-enyl)cyclopentanone (8d) 
1H NMR (400 MHz, CDCl3): δ = 6.65 (dc, J = 7.3, 2.5 Hz, 1H), 5.11-5.09 (m, 1H), 
3.73-3.67 (m, 1H), 2.44-2.23 (m, 2H), 2.15-2.06 (m, 1H), 1.76 (dd, J = 7.3, 1.1 Hz, 3H), 1.74 (s, 
3H), 1.71 (s, 3H), 1.67-1.62 (m, 1H) ppm; 13C NMR (100 MHz, CDCl3): δ = 206.8, 141.3, 133.2, 
131.1, 126.7, 38.2, 37.1, 27.7, 25.6, 17.9, 14.3 ppm; IR (neat, ν/cm-1): 2965, 2927, 2355, 1721, 
1645, 1444, 1375, 1214, 1126, 844, 814; HRMS (EI): m/z calcd for C11H16O+: 164.1198, found: 
164.1201. 
(E)-4-(2-Methylprop-1-enyl)-5-(2-methylpropylidene)cyclopent-1-enyl acetate (7e) 
 1H NMR (400 MHz, CDCl3): δ = 5.74 (t, J = 2.9 Hz, 1H), 5.14-5.11 (m, 2H), 3.66-
3.61 (m, 1H), 2.78 (ddd, J = 17.1, 7.9, 2.6 Hz, 1H), 2.49-2.37 (m, 1H), 2.22 (s, 3H), 2.09 (dt, J = 
17.1, 2.6 Hz, 1H), 1.69 (d, J = 1.7 Hz, 3H), 1.68 (d, J = 1.7 Hz, 3H), 0.95 (d, J = 6.6 Hz, 3H), 
0.91 (d, J = 6.6 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 168.2, 148.3, 139.3, 129.3, 128.6, 
126.5, 117.8, 36.2, 35.6, 27.6, 25.5, 23.1, 23.0, 21.1, 17.9 ppm; IR (neat, ν/cm-1): 2963, 2926, 
2869, 2359, 1765, 1644, 1447, 1371, 1203, 1146, 1046, 1010, 913, 735; HRMS (ESI): m/z calcd 
for C15H22NaO2+: 257.1515, found: 257.1517. 
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(E)-3-(2-Methylprop-1-enyl)-2-(2-methylpropylidene)cyclopentanone (8e) 
1H NMR (400 MHz, CDCl3): δ = 6.39 (dd, J = 10.3, 2.5 Hz, 1H), 5.13 (d, J = 9.6 Hz, 
1H), 3.74-3.68 (m, 1H), 2.60-2.50 (m, 1H), 2.44-2.23 (m, 2H), 2.14-2.05 (m, 1H), 1.73 (s, 3H), 
1.71 (s, 3H), 1.67-1.58 (m, 1H), 0.99 (d, J = 6.6 Hz, 3H), 0.96 (d, J = 6.6 Hz, 3H) ppm; 13C NMR 
(100 MHz, CDCl3): δ = 207.7, 144.7, 137.9, 130.8, 127.3, 38.2, 37.1, 28.0, 27.8, 25.6, 21.9, 21.9, 
17.9; ; IR (neat, ν/cm-1): 2964, 2927, 2868, 1721, 1644, 1455, 1277, 1210, 1176, 983, 940; HRMS 
(EI): m/z calcd for C13H20O+: 192.1510, found: 192.1514. 
(E)-5-Hexylidene-4-(2-methylprop-1-enyl)cyclopent-1-enyl acetate (7f) 
1H NMR (400 MHz, CDCl3): δ = 5.72 (t, J = 2.9 Hz, 1H), 5.29 (dt, J = 7.5, 1.7 Hz, 
1H), 5.10 (dt, J = 9.9, 1.4 Hz, 1H), 3.62 (t, J = 8.8 Hz, 1H), 2.79 (ddd, J = 17.1, 7.9, 2.0 Hz, 1H), 
2.21 (s, 3H), 2.09 (dt, J = 17.1, 2.5 Hz, 1H), 2.05-1.93 (m, 2H), 1.68 (dd, J = 4.4, 1.3 Hz, 6H), 
1.36-1.22 (m, 6H), 0.88 (t, J = 6.6 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 168.2, 148.6, 
141.3, 129.4, 128.3, 119.4, 117.8, 36.4, 35.5, 31.7, 29.5, 28.0, 25.5, 22.5, 21.0, 17.9, 14.0 ppm; IR 
(neat, ν/cm-1): 2959, 2923, 2854, 1767, 1446, 1369, 1201, 908, 732; HRMS (ESI): m/z calcd for 
C17H26NaO2+: 285.1822, found: 285.1825. 
(E)-2-Hexylidene-3-(2-methylprop-1-enyl)cyclopentanone (8f) 
1H NMR (400 MHz, CDCl3): δ = 6.58 (dt, J = 7.7, 2.6 Hz, 1H), 5.11-5.08 (m, 1H), 
3.71-3.66 (m, 1H), 2.43-2.23 (m, 2H), 2.20-2.03 (m, 3H), 1.73 (d, J = 1.3 Hz, 3H), 1.71 (d, J = 1.3 
Hz, 3H), 1.66-1.58 (m, 1H), 1.44-1.36 (m, 2H), 1.31-1.23 (m, 4H), 0.87 (t, J = 7.0 Hz, 3H) ppm; 
13C NMR (100 MHz, CDCl3): δ = 207.1, 140.2, 138.7, 130.8, 127.1, 38.3, 37.1, 31.6, 28.5, 28.2, 
27.7, 25.6, 22.4, 17.9, 13.9 ppm; IR (neat, ν/cm-1): 2959, 2926, 2857, 1720, 1643, 1455, 1375, 
1276, 1215, 1181, 979, 840; HRMS (ESI): m/z calcd for C15H24NaO+: 243.1718, found: 243.1719. 
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(E)-5-Benzylidene-4-((E)-1-phenylprop-1-en-2-yl)cyclopent-1-enyl acetate (7g) 
1H NMR (400 MHz, CD2Cl2): δ = 7.39 (d, J = 7.4 Hz, 2H), 7.28-7.22 (m, 4H), 7.17-
7.13 (m, 2H), 7.03 (d, J = 7.4 Hz, 2H), 6.51 (s, 1H), 6.39 (s, 1H), 5.98 (t, J = 3.0 Hz, 1H), 3.97-
3.96 (m, 1H), 3.01 (ddd, J = 17.6, 8.0, 2.9 Hz, 1H), 2.43 (dt, J = 17.5, 2.4 Hz, 1H),  2.32 (s, 3H), 
1.76 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 168.1, 150.0, 140.9, 138.4, 138.3, 136.4, 
128.8, 128.7, 128.0, 127.9, 126.6, 126.0, 125.9, 119.8, 119.6, 47.7, 35.6, 21.1, 15.2 ppm; IR (neat, 
ν/cm-1): 3054, 3022, 2913, 1369, 1761, 1493, 1446, 1369, 1195, 1009, 906, 730, 698; MS (ESI) 
for C23H22NaO2+ m/z: 353.2 [M+ + Na]. 
(E)-5-Benzylidene-4-((E)-1-phenylprop-1-en-2-yl)cyclopent-1-enyl benzoate (7h) 
1H NMR (500 MHz, CDCl3): δ = 8.16-8.15 (m, 2H), 7.58-7.55 (m, 1H), 7.47-7.44 (m, 
2H), 7.32-7.31 (m, 2H), 7.19-7.15 (m, 4H), 7.08-7.05 (m, 2H), 6.98-6.96 (m, 2H), 6.54 (s, 1H), 
6.37 (s, 1H), 6.05 (t, J = 2.9 Hz, 1H), 3.96-3.95 (m, 1H), 3.00 (ddd, J = 17.6, 8.0, 2.8 Hz, 1H), 
2.44-2.40 (m, 1H), 1.72 (d, J = 1.1 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3): δ = 163.8, 150.2, 
141.1, 138.5, 138.3, 136.4, 133.6, 130.1, 129.5, 128.9, 128.8, 128.6, 128.0, 127.9, 126.6, 126.2, 
125.9, 120.1, 119.8, 47.8, 35.8, 15.2 ppm; IR (neat, ν/cm-1): 3056, 3022, 2911, 1738, 1598, 1492, 
1449, 1261, 1227, 1090, 1021, 906, 727, 699; HRMS (ESI): m/z calcd for C28H24NaO2+: 
415.1666, found: 415.1668. 
(E)-5-Benzylidene-4-(4-methoxyphenyl)cyclopent-1-enyl acetate (7i) 
Obtained as a 3:1 mixture of isomers. 1H NMR (500MHz, CDCl3) δ = 7.29-6.96 (m, 
7H, major and minor), 6.76-6.73 (m, 2H, minor), 6.72-6.68 (m, 2H, major), 6.41 (s, 1H, major), 
6.32 (d, J = 1.6 Hz, 1H, minor), 5.83 (t, J = 2.8 Hz, 1H, major), 5.18 (m, 1H, minor), 4.27 (d, J = 
8.0 Hz, 1H, major), 3.84 (m, 1H, minor), 3.67 (s, 3H, minor), 3.66 (s, 3H, major), 3.07 (ddd, J = 
17.2, 7.7, 2.7 Hz, 1H, major), 2.99 (ddd, J = 17.7, 8.3, 2.7 Hz, 1H, minor), 2.42 (ddd, J = 12.4, 
6.8, 2.0 Hz, 1H, minor), 2.31 (ddd, J = 17.2, 3.2, 1.2 Hz, 1H, major), 2.26 (s, 3H, major), 2.13 (s, 
3H, minor); 13C NMR (125 MHz, CDCl3) (major isomer) δ = 168.2, 157.9, 150.1, 142.0, 137.1, 
Chapter 3 
 
 
122 
 
136.3, 128.6, 128.1, 127.9, 126.5, 119.3, 119.2, 114.1, 55.1, 43.5, 39.4, 21.1 ppm; (minor isomer) 
δ: 169.6, 158.4, 147.0, 140.8, 139.3, 133.5, 128.7, 128.4, 127.6, 125.6, 120.5, 113.9, 108.3, 40.2, 
32.0, 29.7, 21.0 ppm; IR (neat, ν/cm-1): 2925, 1757, 1610, 1509, 1246, 1202, 1032, 831; HRMS 
(EI): m/z calcd for C21H20O3+: 320.1412, found: 320.1410.  
(E)-5-(4-Methoxybenzylidene)-4-(4-methoxyphenyl)cyclopent-1-enyl acetate (7j)  
1H NMR (500MHz, CDCl3) δ = 7.22-7.19 (m, 2H), 7.15-7.12 (m, 2H), 6.81-
6.78 (m, 2H), 6.71-6.68 (m, 2H), 6.44 (s, 1H), 5.84 (t, J = 2.5 Hz, 1H), 4.32 (d, J = 8.0 Hz, 1H), 
3.75 (s, 3H), 3.73 (s, 3H), 3.14 (ddd, J = 2.5, 8.0, 17.5 Hz, 1H), 2.38 (dd, J = 3.0, 17.0 Hz, 1H), 
2.34 (s, 3H); 13C NMR (125 MHz, CDCl3) δ = 168.2, 158.3, 157.9, 150.2, 139.7, 137.2, 129.9, 
129.1, 127.9, 118.7, 118.0, 114.1, 113.6, 55.1, 43.5, 39.3, 21.1; IR (neat, ν/cm-1): 3001, 2932, 
2836, 1757, 1606, 1509, 1246, 1201, 1175, 1032, 906, 826; HRMS (ESI): m/z calcd for 
C22H22NaO4+: 373.1416, found: 373.1416.  
(E)-4-(4-Methoxyphenyl)-5-(2-methylpropylidene)cyclopent-1-enyl acetate (7k) 
                                
1H NMR (400MHz, CDCl3) δ = 7.16-7.15 (m, 2H), 6.82-6.80 (m, 2H), 5.77 (t, J = 2.4 Hz, 1H), 
5.20 (dd, J = 10, 1.6 Hz, 1H), 3.95 (dt, J = 12.0, 2.4 Hz, 1H), 3.78 (s, 3H), 3.03 (ddd, J = 17.2, 
8.4, 2.8 Hz, 1H), 2.32-2.17 (m, 5H), 0.89 (d, J = 17.2 Hz, 3H), 0.52 (d, J = 17.2 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ = 168.2, 157.8, 148.9, 139.4, 139.0, 127.9, 127.1, 117.7, 113.8, 55.2, 
42.1, 38.6, 27.8, 22.9, 22.3, 21.1; IR (neat, ν/cm-1): 2956, 2924, 2864, 1763, 1509, 1242, 1201, 
1039, 829; HRMS (ESI): m/z calcd for C18H22NaO3+: 309.1467, found: 309.1462. 
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(E)-5-benzylidene-4-(4-methoxyphenyl)-4-methylcyclopent-1-enyl acetate (E-7l) 
1H NMR (400MHz, CDCl3) δ = 7.48-7.46 (m, 2H), 7.16-7.15 (m, 3H), 7.06-7.04 
(m, 2H), 6.87-6.85 (m, 2H), 6.05 (d, J = 2.0 Hz, 1H), 5.27 (ddd, J = 5.7, 3.5, 2.0 Hz, 1H), 3.79 (s, 
3H), 2.74 (dd, J = 17.1, 3.6 Hz, 1H), 2.55 (dd, J = 17.1, 5.9 Hz, 1H), 2.16 (s, 3H), 1.54 (s, 3H) 
ppm; 13C NMR (100 MHz, CDCl3) δ = 169.5, 158.0, 147.5, 146.5, 140.4, 137.3, 127.8, 127.7, 
127.1, 123.1, 113.5, 109.6, 55.1, 42.1, 41.1, 26.9, 20.9 ppm; IR (neat, ν/cm-1): 3056, 2958, 2932, 
2834, 1754, 1607, 1509, 1370, 1248, 1213, 1136, 1033, 907, 828, 730, 701;  HRMS (ESI): m/z 
calcd for C22H22NaO3+: 357.1459, found: 357.1461. 
(Z)-5-benzylidene-4-(4-methoxyphenyl)-4-methylcyclopent-1-enyl acetate (Z-7l) 
1H NMR (400MHz, CDCl3) δ = 7.46-7.43 (m, 2H), 7.32-7.27 (m, 5H), 6.88-6.86 
(m, 2H), 5.93 (s, 1H), 5.44 (t, J = 4.8 Hz, 1H), 3.79 (s, 3H), 2.73 (dd, J = 17.2, 4.8 Hz, 1H), 2.56 
(dd, J = 17.2, 4.8 Hz, 1H), 1.81 (s, 3H), 1.57 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 
169.1, 158.0, 145.3, 139.7, 137.4, 137.3, 134.7, 128.0, 127.9, 127.3, 127.2, 113.5, 112.2, 55.2, 
38.8, 38.3, 26.4, 20.4 ppm; IR (neat, ν/cm-1): 3062, 2962, 2828, 2254, 1755, 1608, 1510, 1366, 
1249, 1213, 1183, 1143, 1034, 908;  HRMS (ESI): m/z calcd for C22H22NaO3+: 357.1459, found: 
357.1461. 
 
2.6 General procedure for the preparation of cyclopent-1-enyl acetates and cyclohexa-1,5-
dienylethanones 
 
To a solution of the corresponding terciary acetate (1.0 equiv.) in CH2Cl2 (0.05 M), IPrAuNTf2 
(0.05 equiv.) was added in one portion. The mixture was stirred at room temperature for 5 
minutes. The solution was quenched with triethylamine (0.05 equiv.). The solution was filtered 
through a small path of silica gel and the solvent was evaporated under reduced pressure. The 
Chapter 3 
 
 
124 
 
residue was purified by column chromatography (Hex:AcOEt 50:1) to give a mixture of the 
corresponding cyclopentenyl acetates and diketones. 
2.5 Characterization of cyclopent-1-enyl acetates and cyclohexa-1,5-dienylethanones 
4-(2-Methylprop-1-enyl)-5-(propan-2-ylidene)cyclopent-1-enyl acetate (10a) 
1H NMR (400 MHz, CDCl3): δ = 5.64 (m, 1H), 5.16-5.12 (m, 1H), 3.57 (t, J = 9.4 Hz, 
1H), 2.78-2.70 (m, 1H), 2.19 (s, 3H),  2.02-1.98 (m, 1H), 1.82 (s, 3H), 1.68-1.67 (m, 6H), 1.63 (s, 
3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 168.5, 149.8, 134.4, 128.9, 128.8, 123.9, 119.9, 39.2, 
34.5, 25.5, 22.6, 21.3, 19.5, 17.9 ppm; IR (neat, ν/cm-1): 2969, 2913, 2854, 2361, 2339, 1767, 
1621, 1445, 1369, 1331, 1200, 1056, 1010, 795; HRMS (EI): m/z calcd for C14H20O2+: 220.1463, 
found: 220.1463. 
1-(2-Hydroxy-3,3-dimethyl-4-(2-methylprop-1-enyl)cyclohexa-1,5-dienyl)ethanone (11a) 
 1H NMR (400 MHz, CD2Cl2): δ = 15.87 (s, 1H), 6.19 (dd, J = 10.0, 1.0 Hz, 1H), 
5.40 (dd, J = 10.0, 5.1 Hz, 1H), 4.93 (dq, J = 10.5, 1.3 Hz, 1H), 2.98 (ddd, J = 10.5, 5.0, 0.7 Hz, 
1H), 2.10 (d, J = 0.6 Hz, 3H), 1.69 (d, J = 1.3 Hz, 3H), 1.63 (d, J = 1.3 Hz, 3H), 1.14 (s, 3H), 1.02 
(s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 206.5, 179.6, 133.7, 123.7, 123.3, 121.3, 107.4, 
45.8, 44.8, 26.1, 25.1, 20.4, 19.9, 18.3 ppm; IR (neat, ν/cm-1):3046, 2970, 2928, 2864, 1637, 1592, 
1443, 1394, 1257, 1159, 952, 723; HRMS (EI): m/z calcd for C14H20O2+: 220.1464, found: 
220.1463. 
(E)-4-(1-Phenylprop-1-en-2-yl)-5-(propan-2-ylidene)cyclopent-1-enyl acetate (10b) 
1H NMR (400 MHz, CD2Cl2): δ = 7.32-7.28 (m, 2H), 7.24-7.22 (m, 2H), 7.18-7.15 (m, 
1H), 6.36 (s, 1H), 5.63 (t, J = 2.7 Hz, 1H), 3.59 (d, J = 8.5 Hz, 1H), 2.84-2.78 (m, 1H), 2.21-2.16 
(m, 1H), 2.19 (s, 3H), 1.88 (s, 3H), 1.81 (d, J = 1.3 Hz, 3H), 1.71 (s, 3H) ppm; 13C NMR (100 
MHz, CDCl3): δ = 168.9, 151.4, 141.7, 139.2, 132.9, 129.4, 128.5, 126.4, 126.3, 125.0, 120.6, 
50.3, 33.9, 23.2, 21.7, 19.8, 14.8 ppm; IR (neat, ν/cm-1): 3046, 2976, 2363, 1641, 1593, 1444, 
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1396, 1354, 1309, 1260, 1162, 1002, 956, 754; HRMS (ESI): m/z calcd for C19H22NaO2+: 
305.1522, found: 305.1517. 
(E)-1-(2-Hydroxy-3,3-dimethyl-4-(1-phenylprop-1-en-2-yl)cyclohexa-1,5-dienyl)ethanone 
(11b)4 
 1H NMR (400 MHz, CD2Cl2): δ = 15.65 (s, 1H), 7.35-7.31 (m, 2H), 7.24-7.19 
(m, 3H), 6.41-6.38 (m, 2H), 5.50 (dd, J = 9.7, 6.0 Hz, 1H), 2.91 (d, J = 6.0 Hz, 1H), 2.15 (s, 3H), 
1.63 (d, J = 1.3 Hz, 3H), 1.26 (s, 3H), 1.14 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 207.5, 
178.1, 138.9, 138.6, 129.5, 128.7, 128.6, 126.8, 122.9, 121.2, 107.6, 59.4, 44.4, 28.7, 20.7, 19.5, 
14.4 ppm; IR (neat, ν/cm-1): 3051, 3020, 2974, 2932, 2847, 1641, 1592, 1444, 1395, 1309, 1259, 
1162, 998, 955, 754, 699;  HRMS (ESI): m/z calcd for C19H22NaO2+: 305.1521, found: 305.1517. 
4-(4-Methoxyphenyl)-5-(propan-2-ylidene)cyclopent-1-enyl acetate (10c) 
1H NMR (500MHz, CDCl3) δ = 7.21-7.19 (m, 2H), 6.83-6.81 (m, 2H), 5.63 (s, 1H), 
3.94 (d, J = 8.0 Hz, 1H), 3.78 (s, 3H), 2.97 (dd, J = 17.0, 8.0 Hz, 1H), 2.24 (s, 3H), 2.17 (d, J = 
17.0 Hz, 1H), 1.86 (s, 3H), 1.48 (s, 3H); 13C NMR (100 MHz, CDCl3) δ = 168.7, 157.7, 150.5, 
139.2, 134.3, 127.8, 125.2, 119.7, 113.8, 55.2, 45.0, 37.2, 23.2, 21.3, 19.3; IR (neat, ν/cm-1): 2911, 
2850, 1761, 1509, 1242, 1203, 907; HRMS (ESI): m/z calcd for C17H20NaO3+: 295.1310, found: 
295.1312.  
 
 
 
                                                 
4 We also studied the possibility of obtaining 1,3 diketones from intermediate XVIa (Scheme 9). 2D-NMR 
experiments confirmed the structure of 11b ruling out the formation of a regioisomer compound 11b´ (see 
section 8 in this supporting information). 
 
Chapter 3 
 
 
126 
 
1-(2-Hydroxy-4-(4-methoxyphenyl)-3,3-dimethylcyclohexa-1,5-dienyl)ethanone (11c) 
  1H NMR (400MHz, CDCl3) δ = 15.82 (s, 1H), 7.06-7.03 (m, 2H), 6.82-
6.78 (m, 2H), 6.35 (dd, J = 9.6, 1.2 Hz, 1H), 5.65 (dd, J = 10.0, 4.8 Hz, 1H), 3.78 (s, 3H), 3.31 
(dd, J = 14.8, 1.2 Hz, 1H), 2.19 (s, 3H), 1.24 (s, 3H), 0.89 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
= 205.6, 178.7, 158.5, 132.7, 129.9, 123.5, 121.4, 113.6, 106.8, 55.2, 52.3, 45.2, 26.2, 20.8, 19.5; 
IR (neat, ν/cm-1): 2970, 2931, 2835, 1606, 1583, 1509, 1247, 1177, 909; HRMS (EI): m/z calcd 
for C17H20NaO3+: 275.1310, found: 275.1310.  
4-(4-Methoxyphenyl)-5-(pentan-3-ylidene)cyclopent-1-enyl acetate (10d) 
1H NMR (400MHz, CDCl3) δ = 7.21-7.17 (m, 2H), 6.82-6.79 (m, 2H), 5.68 (t, J = 2.8 
Hz, 1H), 3.93 (d, J = 8.4 Hz, 1H), 3.77 (s, 3H), 2.98 (ddd, J = 17.2, 8.4, 2.4 Hz, 1H), 2.32-2.15 
(m, 6H), 1.91-1.77 (m, 2H), 1.00 (t, J = 7.6 Hz, 3H), 0.68 (t, J = 7.6 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ = 168.6, 157.7, 150.2, 139.9, 137.4, 133.7, 127.7, 119.9, 113.8, 55.2, 44.2, 37.4, 
26.9, 23.2, 21.3, 14.2, 12.1; IR (neat, ν/cm-1): 2965, 2933, 2873, 2254, 1757, 1509, 1206, 904, 
726; HRMS (EI): m/z calcd for C19H24O3+: 300.1725, found: 300.1722.  
5-Cyclohexylidene-4-(4-methoxyphenyl)cyclopent-1-enyl acetate (10e) 
1H NMR (400MHz, CDCl3) δ = 7.20-7.16 (m, 2H), 6.83-6.79 (m, 2H), 6.63 (s, 1H), 
3.83 (d, J = 8.4 Hz, 1H), 3.78 (s, 3H), 3.02 (dd, J = 17.2, 8.4 Hz, 1H), 2.49-2.43 (m, 2H), 2.26 (d, 
J = 17.2 Hz, 1H), 2.23 (s, 3H), 2.10-2.03 (m, 1H), 1.79-1.70 (m, 1H), 1.65-1.52 (m, 2H), 1.50-
1.42 (m, 2H); 13C NMR (100 MHz, CDCl3) δ = 168.8, 157.7, 150.4, 138.6, 135.8, 132.1, 128.0, 
118.4, 113.8, 55.2, 45.4, 38.1, 32.4, 30.0, 27.1, 25.7, 21.3; IR (neat, ν/cm-1): 2954, 1754, 1509, 
1213, 905, 726; HRMS (EI): m/z calcd for C19H22O3+: 298.1569, found: 298.1569. 
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5-Cyclohexylidene-4-(4-methoxyphenyl)cyclopent-1-enyl acetate (10f) 
OAc
MeO 1H NMR (400MHz, CDCl3) δ = 7.24-7.20 (m, 2H), 6.84-6.79 (m, 2H), 5.63 (t, J = 
2.8 Hz, 1H), 3.99 (d, J = 8.0 Hz, 1H), 3.78 (s, 3H), 2.97 (ddd, J = 17.2, 8.0, 2.4 Hz, 1H), 2.51-
2.45 (m, 1H), 2.37-2.29 (m, 1H), 2.23 (s, 3H), 2.19-2.14 (m, 1H), 1.95-1.82 (m, 2H), 1.56-1.32 
(m, 5H), 1.19-1.07 (m,1H); 13C NMR (100 MHz, CDCl3) δ =  168.7, 157.6, 150.6, 139.8, 134.2, 
130.9, 127.9, 120.6, 113.8, 55.2, 44.5, 37.0, 33.1, 29.3, 28.2, 27.6, 26.5, 21.3; IR (neat, ν/cm-1): 
2923, 2850, 1763, 1444, 1243, 1201, 1036, 831; HRMS (EI): m/z calcd for C20H24O3+: 312.1725 
found: 312.1725. 
(E)-4-(4-Methoxyphenyl)-5-(1-phenylethylidene)cyclopent-1-enyl acetate (10g) 
OAc
MeO
Ph
Obtained as a 4:1 mixture of isomers. 1H NMR (400MHz, CDCl3) δ = 7.34-7.28 (m, 
1H, major), 7.22-7.18 (m, 2H, minor), 7.15-7.13 (m, 3H, minor), 7.12-7.08 (m, 3H, major), 6.89-
6.86 (m, 2H, minor), 6.79-6.77 (m, 1H major, 2H minor), 6.75-6.72 (m, 2H, major), 6.62-6.58 (m, 
2H, major), 5.87 (t, J = 2.4 Hz, 1H, major), 5.61 (t, J = 2.0 Hz, 1H, minor), 4.14 (d, J = 6.4 Hz, 
1H, minor), 3.80 (s, 3H, minor), 3.75 (d, J = 6.4 Hz, 1H, major), 3.73 (s, 3H, major), 3.08 (dd, J = 
13.6, 6.4 Hz, 1H, minor), 3.92 (dd, J = 14.0, 6.4 Hz, 1H, major), 2.59-2.57 (m, 1H, minor), 2.29 
(s, 3H, major), 2.28-2.16 (m, 1H, minor), 2.13 (s, 3H, major), 1.74 (s, 3H, minor), 1.20 (s, 3H, 
minor); 13C NMR (100 MHz, CDCl3) δ = 168.63, 168.59, 157.87, 157.44, 150.43, 150.05, 144.93, 
143.32, 139.72, 138.69, 137.49, 136.09, 130.18, 129.60, 128.56, 127.92, 127.81, 127.71, 127.63, 
126.22, 126.02, 122.24, 121.78, 114.05, 113.31, 100.00, 55.23, 55.19, 45.49, 45.00, 37.42, 37.14, 
23.48, 21.41, 20.33, 19.61; IR (neat, ν/cm-1): 2933, 2851, 2255, 1756, 1509, 1208, 905, 726; 
HRMS (EI): m/z calcd. for C22H22O3+: 334.1569, found: 334.1571. 
 
3 Preparation and characterization of the compounds in Scheme 5 
3.1 Procedure for the preparation of compound 12  
To a solution of 9b (36.5 mg, 0.129 mmol, 1.0 equiv.) in CH2Cl2 (2.5 ml, 0.05 M), p-anisaldehyde 
(18 mg, 0.129 mmol, 1.0 equiv.) and IPrAuNTf2 (5.7 mg, 0.05 equiv.) was added sequentially. 
The mixture was stirred at room temperature for 30 minutes. The reaction was quenched with 
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triethylamine (0.05 equiv.). The solution was dried under reduced pressure and the residue was 
purified by column chromatography (Hex:AcOEt 25:1) to give the compounds 10b, 11b and 
compound 12 (4.6 mg, 0.011 mmol) in 9% yield. 
3.2 Characterization of compound 12 
(E)-1-(6-(4-Methoxyphenyl)-4-(1-phenylprop-1-en-2-yl)cyclohex-1-enyl)-2-methylprop-1-
enyl acetate (12) (some carbon signals are missing due to overlapping)  
                     
 Obtained as a 2:1 mixture of diastereoisomers. 1H NMR (500 MHz, CDCl3): δ = 7.36-7.28 (m, 
6H, major and minor), 7.24-7.21 (m, 1H, major and minor), 6.88-6.84 (m, 2H, major and minor), 
6.74 (s, 1H, minor), 6.70 (s, 1H, major), 5.13 (d, J = 8.0 Hz, 1H, minor), 5.01 (d, J = 7.1 Hz, 1H, 
major), 4.51-4.64 (m, 1H, major and minor), 3.80 (s, 3H, major), 3.79 (s, 3H, minor), 3.43-3.35 
(m, 1H, major and minor), 2.57-2.52 (m, 1H, major), 2.37-2.32 (m, 1H, minor), 2.10-2.04 (m, 1H, 
major), 2.00 (d, J = 1.1 Hz, 3H, major), 1.96 (d, J = 1.1 Hz, 3H, minor), 1.92-1.82 (m, 1H, minor), 
1.91 (s, 3H, minor), 1.90 (s, 3H, major), 1.68 (s, 3H, minor), 1.55 (m, 3H, minor), 1.37 (s, 3H, 
major), 1.34 (s, 3H, major) ppm; 13C NMR (125 MHz, CDCl3) (major and minor isomer): 192.4, 
169.2, 168.2, 159.0, 158.9, 137.8, 137.7, 137.1, 137.0, 132.4, 131.9, 129.1, 128.3, 128.2, 128.1, 
126.4, 126.3, 125.0, 119.6, 113.1, 113.0, 109.3, 85.7, 84.1, 83.7, 83.1, 82.7, 82.6, 72.1, 55.3, 55.2, 
46.9, 38.5, 36.9, 34.9, 28.8, 21.9, 21.4, 21.2, 21.1, 14.4, 13.9 ppm;  IR (neat, ν/cm-1): 2982, 2937, 
2828, 2253, 1974, 1742, 1614, 1513, 1364, 1245, 1134, 1036, 909, 730, 700; HRMS (ESI): m/z 
calcd for C27H30NaO4+: 441.2035, found: 441.2036. 
 
3.3 Procedure for the preparation of compound 13 
To a solution of 9c (41 mg, 0.15 mmol, 1.0 equiv.) in a mixture 10:1 CH2Cl2:methanol (2.2 ml, 
0.05 M), IPrAuNTf2 (6.5 mg, 0.05 equiv.) was added in one portion. The mixture was stirred at 
room temperature for 30 minutes. The reaction was quenched with triethylamine (0.05 equiv.). 
The solution was dried under reduced pressure and the residue was purified by column 
chromatography (Hex:EtOAc 25:1) to give the compound 13 (13 mg, 0.043 mmol) in 28% of 
yield. 
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3.4 Characterization of compound 13 
(E)-7-Methoxy-7-(4-methoxyphenyl)-2-methylhepta-2,4-dien-3yl acetate (13) 
 Obtained as a mixture 1:1 of isomers. 1H NMR (500 MHz, CDCl3) δ = 
7.20-7.17 (m, 4H), 6.90-6.87 (m, 4H), 6.26 (d, J = 15.5 Hz, 2H), 5.44 (t, J = 7.6 Hz, 1H), 5.41 (t, 
J = 7.6 Hz, 1H), 4.08 (t, J = 7.0 Hz, 2H), 3.81 (s, 6H), 3.18 (s, 6H), 2.63-2.57 (m, 2H), 2.44-2.38 
(m, 2H), 2.16 (s, 6H), 1.80 (s, 6H), 1.61 (s, 6H); 13C NMR (125 MHz, CDCl3) δ = 168.9, 159.1, 
140.3, 133.6, 127.9, 125.1, 122.9, 122.3, 113.8, 83.4, 56.5, 55.3, 41.3, 20.5, 18.5, 18.4; IR (neat, 
ν/cm-1): 2934, 2836, 1753, 1610, 1510, 1245, 1209, 1175, 1098, 1034, 910, 831, 729; HRMS (EI): 
m/z calcd for C18H24NaO4+: 327.1572, found: 327.1575.  
4 Preparation and characterization of 3-cyclopropyl propargyl vinyl ethers and 
cyclization products 
4.1 General procedure for the preparation of secondary and tertiary propargyl vinyl ethers5 
 
To a solution of the corresponding propargyl alcohol (1.0 equiv.) in ethyl vinyl ether (0.4 M), 
mercury (II) acetate (0.67 equiv.) was added in one portion. The mixture was stirred at room 
temperature for 12-24 hours. The reaction was poured into 5% potassium hydroxide solution and 
extracted several times with hexane. The organic layers were dried over Na2SO4. The solvent was 
dried under reduced pressure. The residue was purified by column chromatography (Hexane) to 
give the corresponding propargyl vinyl ethers in 29-84% yield. 
 
4.2 Characterization of secondary propargyl vinyl ethers3 
1-(4-Methyl-3-(vynyloxy)pent-1-ynyl)-2-(2-methylprop-1enyl)cyclopropane (16a) 
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H NMR 
(400 MHz, CDCl3): δ = 6.42 (dd, J = 14.1, 6.5 Hz, 2H), 4.55-4.53 (m, 2H), 4.37 (dd, J = 14.1, 1.6 
                                                 
5 K. Nososhita, H. Banno, K. Maruoka, H. Yamamoto; J. Am. Chem. Soc. 1990, 112, 316-322. 
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Hz, 2H), 4.16 (d, J = 5.8 Hz, 1H), 4.15 (d, J = 5.8 Hz, 1H), 4.07 (dd, J = 6.6, 1.6 Hz, 2H), 1.99-
1.91 (m, 2H), 1.79-1.72 (m, 2H), 1.75 (s, 6H), 1.67 (d, J = 1.3 Hz, 6H), 1.21-1.15 (m, 2H), 1.06-
0.96 (m, 2H), 1.00 (d, J = 6.7 Hz, 6H), 0.96 (d, J = 6.7 Hz, 6H), 0.77-0.73 (m, 2H) ppm; 13C 
NMR (100 MHz, CDCl3): δ = 150.2 (2xC), 133.4 (2xC), 125.3 (2xC), 89.8 (2xC), 89.0, 74.8 
(2xC), 73.0, 33.1, 25.4, 21.7, 21.6, 18.3 (2xC), 17.7, 16.7 (2xC), 8.5 ppm; IR (neat, ν/cm-1): 2963, 
2927, 2873, 2230, 1634, 1614, 1468, 1385, 1188, 1132, 1047, 1003, 908, 816, 732; HRMS (EI): 
m/z calcd for C15H22O+: 218.1669, found: 218.1671. 
(E)-1-(2-(2-(3-(Vinyloxy)oct-1-ynyl)cyclopropyl)prop-1-enyl)benzene (16b) 
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H 
NMR (400 MHz, CDCl3): δ = 7.37-7.29 (m, 4H), 7.22-7.17 (m, 6H), 6.44 (dd, J = 14.2, 6.6 Hz, 
2H), 6.34 (s, 2H), 4.41 (dd, J = 14.2, 1.5 Hz, 2H), 4.40 (t, J = 6.6 Hz, 1H), 4.39 (t, J = 6.6 Hz, 
1H), 4.11 (dd, J = 6.7, 1.5 Hz, 2H), 1.92-1.84 (m, 2H), 1.79-1.71 (m, 2H), 1.74 (d, J = 1.3 Hz, 
6H), 1.50-1.42 (m, 6H), 1.38-1.26 (m, 10H), 1.16-1.11 (m, 2H), 1.08-1.02 (m, 2H), 0.91 (t, J = 
6.9 Hz, 6H) ppm; 13C NMR (100 MHz, CDCl3): δ = 149.9, 137.9, 136.4, 129.3, 128.8, 128.1, 
126.1, 125.1, 89.2 (2xC), 74.4, 69.4, 35.6, 31.4, 30.8 (2xC), 24.8, 22.5, 15.6, 14.7, 13.9, 7.2 ppm; 
IR (neat, ν/cm-1): 3015, 2929, 2859, 2232, 1635, 1614, 1444, 1339, 1186, 1041, 909, 818, 733, 
698;  HRMS (ESI): m/z calcd for C22H28NaO+: 331.2032, found: 331.2032. 
(E)-1-(2-(2-(4-Methyl-3-(vinyloxy)pent-1-ynyl)cyclopropyl)prop-1-enyl)benzene (16c) 
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H 
NMR (400 MHz, CDCl3): δ = 7.33-7.29 (m, 4H), 7.22-7.17 (m, 6H), 6.44 (dd, J = 13.9, 6.4 Hz, 
2H), 6.34 (s, 2H), 4.40 (dd, J = 13.9, 1.5 Hz, 2H), 4.19 (d, J = 5.8 Hz, 1H), 4.18 (d, J = 5.8 Hz, 
1H), 4.10 (dd, J = 6.4, 1.5 Hz, 2H), 2.04-1.94 (m, 2H), 1.92-1.86 (m, 2H), 1.75 (d, J = 1.3 Hz, 
6H), 1.50-1.43 (m, 2H), 1.17-1.11 (m, 2H), 1.08-1.02 (m, 2H), 1.02 (d, J = 6.8 Hz, 6H), 1.00 (d, J 
= 6.8 Hz, 6H) ppm; 13C NMR (100 MHz, CDCl3): δ = 150.2, 137.9, 136.5, 128.8, 128.1, 126.1, 
125.1, 89.8, 89.1, 74.8, 73.0, 33.1, 30 8 (2xC), 18.4, 17.7, 15.6, 14.8 (2xC), 7.2 ppm; IR (neat, 
ν/cm-1): 3020, 2963, 2926, 2829, 2354, 1635, 1608, 1467, 1447, 1187, 1048, 912, 818, 736, 699; 
HRMS (EI): m/z calcd for C20H24O+: 280.1830, found: 280.1827. 
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4.3 Characterization of tertiary propargyl vinyl ethers 
1-(2-(2-(2-Methylprop-1-enyl)cyclopropyl)ethynyl)1-(vinyloxy)cyclopentane (16f) 
1H NMR (400 MHz, CDCl3): δ = 6.55 (dd, J = 13.9, 6.3 Hz, 1H), 4.55-4.52 
(m, 1H), 4.42 (d, J = 14.0 Hz, 1H), 4.10 (d, J = 6.4 Hz, 1H), 2.07-2.01 (m, 2H), 1.88-1.79 (m, 
2H), 1.78-1.68 (m, 5H), 1.75 (s, 3H), 1.67 (s, 3H), 1.19-1.14 (m, 1H), 1.04-1.00 (m, 1H), 0.74 
(ddd, J = 8.5, 5.8, 4.3 Hz, 1H) ppm; 13C NMR (100 MHz, CDCl3): δ = 147.6, 133.3, 125.3, 91.3, 
88.3, 82.0, 76.9, 40.23, 40.22, 25.4, 23.4, 23.4, 21.6, 18.4, 16.7, 8.5 ppm; IR (neat, ν/cm-1): 2965, 
2874, 2234, 1632, 1439, 1375, 1306, 1166, 1011, 946, 910, 831, 731; HRMS (EI): m/z calcd for 
C16H22O+: 230.1668, found: 230.1671. 
1-(3-Methyl-3-(vinyloxy)but-1-ynyl)-2-(2-methylprop-1-enyl)cyclopropane (16g) 
1H NMR (400 MHz, CDCl3): δ = 6.68 (dd, J = 13.8, 6.3 Hz, 1H, minor), 6.64 
(dd, J = 13.8, 6.3 Hz, 1H, major), 4.95-4.93 (m, 1H, minor), 4.55-4.53 (m, 1H, major), 4.44 (d, J 
= 13.8 Hz, 1H, major and minor), 4.10 (d, J = 6.3 Hz, 1H, major), 4.09 (d, J = 6.3 Hz, 1H, minor), 
1.78-1.67 (m, 1H, major), 1.75 (s, 3H, major), 1.74 (s, 3H, major), 1.68 (s, 6H, minor), 1.58-1.50 
(m, 1H, minor), 1.49 (s, 3H, minor), 1.48 (s, 3H, minor), 1.47 (s, 6H, major) ppm; 13C NMR (100 
MHz, CDCl3) (major isomer): δ = 147.4, 133.4, 125.3, 90.9, 87.9, 77.6, 72.5, 29.5 (2xC), 25.4, 
21.6, 18.4, 16.7, 8.4; (minor isomer): 147.5, 134.0, 123.1, 90.8, 86.3, 79.7, 72.5, 29.5, 29.4, 25.7, 
18.4, 17.3, 16.1, 7.0 ppm; IR (neat, ν/cm-1): 2984, 2931, 2361, 2237, 1632, 1442, 1378, 1362, 
1262, 1200, 1133, 1011, 949, 835; HRMS (ESI): m/z calcd for C14H20NaO+: 227.1410, found: 
227.1412. 
(E)-1-(2-(2-(3-Methyl-3-(vinyloxy)but-1-ynyl)cyclopropyl)prop-1-enyl)benzene (16h) 
1H NMR (400 MHz, CDCl3): δ = 7.34-7.30 (m, 2H), 7.22-7.18 (m, 3H), 6.67 
(dd, J = 14.0, 6.3 Hz, 1H), 6.35 (s, 1H), 4.47 (d, J = 14.0 Hz, 1H), 4.13 (d, J = 6.3 Hz, 1H), 1.91-
1.86 (m, 1H), 1.75 (s, 3H), 1.50 (s, 6H), 1.48-1.43 (m, 1H), 1.17-1.12 (m, 1H), 1.07-1.02 (m, 1H) 
ppm; 13C NMR (100 MHz, CDCl3): δ = 147.4, 137.9, 136.4, 128.8, 128.1, 126.1, 125.2, 91.1, 
87.9, 77.5, 72.4, 30.8, 29.5, 29.5, 15.6, 14.7, 7.0 ppm; IR (neat, ν/cm-1): 3022, 2984, 2934, 2235, 
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1632, 1493, 1440, 1362, 1261, 1200, 1138, 1123, 1010, 910, 827, 798, 732, 697; HRMS (EI): m/z 
calcd for C19H22O+: 266.1668, found: 266.1671.  
4.4 General procedure for the preparation of acrylates 16d and 16e 
To a solution of the corresponding propargyl alcohol (1.0 equiv.) in THF (0.15 M), NMM (4.0 
equiv.) and methylpropiolate (2.0 equiv.) were added sequentially. The mixture was stirred for 12 
hours. The reaction was quenched with water and extracted with diethyl ether. The organic layers 
were dried over Na2SO4. The residue was purified by column chromatography (Hex:AcOEt 8:1) 
to give the corresponding 2-(2-methylenecyclopentylidene)-3-oxopropanoates. 
 
 
4.5 Characterization of the acrylates 16d and 16e 
(E)-Methyl 3-(1-(2-((E)-1-pnehylprop-1-en-2-yl)cyclopropyl)oct-1-yn-3-yloxy)acrylate (16d) 
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H 
NMR (500 MHz, CDCl3): δ = 7.63 (d, J = 12.5 Hz, 2H), 7.32-7.29 (m, 4H), 7.21-7.17 (m, 6H), 
6.34 (s, 2H), 5.37 (d, J = 12.5 Hz, 2H), 4.54 (t, J = 6.5 Hz, 1H), 4.53 (t, J = 6.5 Hz, 1H), 3.71 (s, 
6H), 1.93-1.88 (m, 2H), 1.84-1.77 (m, 2H), 1.75 (d, J = 1.3 Hz, 6H), 1.48-1.41 (m, 6H), 1.36-1.26 
(m, 10H), 1.18-1.14 (m, 2H), 1.08-1.04 (m, 2H), 0.92-0.88 (m, 6H) ppm; 13C NMR (125 MHz, 
CDCl3): δ = 168.2, 160.8, 137.8, 136.1, 128.8, 128.1, 126.1, 125.3, 98.1, 90.9, 72.9, 72.3, 51.1, 
35.6, 31.2, 30.9 (2xC), 24.6, 22.4, 15.6, 14.7, 13.9, 7.08 ppm; IR (neat, ν/cm-1): 2952, 2926, 2859, 
2232, 1714, 1643, 1622, 1435, 1328, 1284, 1188, 1132, 954, 915, 831, 739, 699; HRMS (ESI): 
m/z calcd for C24H30NaO3+: 389.2091, found: 389.2087. 
(E)-Methyl-3-(4-methyl-1-(2-((E)-1-phenylprop-1-en-2-yl)cyclopropyl)pent-1-yn-3-
yloxy)acrylate (16e) 
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H 
NMR (500 MHz, CDCl3): δ = 7.64 (d, J = 12.5 Hz, 2H), 7.33-7.30 (m, 4H), 7.22-7.17 (m, 6H), 
6.34 (s, 2H), 5.37 (d, J = 12.5 Hz, 2H), 4.33 (d, J = 5.7 Hz, 1H), 4.32 (d, J = 5.7 Hz, 1H), 3.71 (s, 
6H), 2.05-1.99 (m, 2H), 1.93-1.88 (m, 2H), 1.75 (d, J = 1.2 Hz, 6H), 1.49-1.45 (m, 2H), 1.18-1.14 
(m, 2H), 1.09-1.04 (m, 2H), 1.02 (d, J = 6.7 Hz, 6H), 1.00 (d, J = 6.7 Hz, 6H) ppm; 13C NMR 
(125 MHz, CDCl3): δ = 168.3, 161.1, 137.8, 136.2, 128.8, 128.1, 126.1, 125.3, 97.9, 91.7, 77.6, 
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71.5, 51.0, 33.2, 30.9 (2xC), 18.1, 17.6, 15.6, 14.8 (2xC), 7.1 ppm; IR (neat, ν/cm-1): 3082, 2964, 
2874, 2233, 1713, 1643, 1622, 1435, 1327, 1284, 1192, 1123, 983, 833, 740, 699; HRMS (ESI): 
m/z calcd for C22H26O3Na+: 361.1777, found: 361.1774. 
4.5 General procedure for the cyclization of 3-cyclopropyl propargylic vinyl ethers 
O
R2
R3
R5
R4
IPrAuNTf2 (5 mol%)
CH2Cl2, 25 oC, 30 min.
R3
R2
CHO
R1
R5
R4
1) IPrAuNTf2 (5 mol%)
CH2Cl2, 25 oC, 30 min.
R3
R2
R1
R5
R4
2) NaBH4, MeOH
OH
A)
B)
R1
O
R2
R3
R5
R4
R1
 
 
A) To a solution of the corresponding 3-cyclopropyl propargyl enol ether (1.0 equiv.) in 
CH2Cl2 (0.05 M), IPrAuNTf2 (0.05 equiv.) was added in one portion. The mixture was 
stirred at room temperature for 30 minutes. The reaction was quenched with triethylamine 
(0.05 equiv.). The solvent was evaporated under reduced pressure and the residue was 
purified by column chromatography (Hex:AcOEt 25:1) to give the corresponding 
acetaldehyde. 
B) To a solution of the corresponding 3-cyclopropyl propargyl enol ether (1.0 equiv.) in 
CH2Cl2 (0.05 M), IPrAuNTf2 (0.05 equiv.) was added in one portion. The mixture was 
stirred at room temperature for 30 minutes. The reaction was diluted with MeOH and 
NaBH4 (1.0 equiv) was added in one portion. The mixture was stirred at room 
temperature for 30 minutes. The solvent was evaporated under reduced pressure. The 
residue was purified by column chromatography (Hex:AcOEt 10:1) to give the 
corresponding alcohol. 
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4.6 Characterization of cyclization products from 3-cyclopropyl propargylic vinyl ethers 
 2-(4-(2-Methylprop-1-enyl)-5-(2-methylpropylidene)cyclopent-1-enyl)acetaldehyde (17a) 
 Obtained as a 1:1 mixture of isomers. 1H NMR (400 MHz, CDCl3): δ = 9.62 (t, J 
= 2.5 Hz, 1H, minor), 9.59 (t, J = 2.5 Hz, 1H, major), 5.87 (s, 1H, major), 5.51(s, 1H, minor), 
5.47-5.45 (m, 1H, minor), 5.20-5.17 (m, 1H, minor), 5.06-4.97 (m, 2H, major), 3.72-3.67 (m, 1H, 
major and minor), 3.16 (s, 2H, major), 3.08 (s, 2H, minor), 2.99-2.94 (m, 1H, minor), 2.83-2.76 
(m,1H, major), 2.48-2.39 (m, 1H, major), 2.27-2.19 (m, 1H, minor), 2.14-2.09 (m, 1H, major and 
minor), 1.69 (s, 3H, major), 1.67 (s, 3H, major), 1.66-1.65 (m, 6H, minor), 1.03 (t, J = 6.8 Hz, 6H, 
minor), 0.94 (d, J = 6.5 Hz, 3H, major), 0.90 (d, J = 6.5 Hz, 3H, major) ppm; 13C NMR (100 
MHz, CDCl3) (major isomer): δ = 220.1, 146.7, 135.1, 134.4, 129.1, 129.0, 127.9, 42.3, 39.2, 
38.7, 28.1, 25.5, 23.2, 23.1, 17.9 ppm, (minor isomer): 200.6, 151.6, 131.2, 127.1, 126.2, 121.6, 
117.5, 50.36, 34.2, 32.7, 31.6, 30.9, 25.8, 22.5, 21.2 ppm; IR (neat, ν/cm-1): 2964, 2925, 2865, 
2718, 1726, 1445, 1376, 1038, 908, 852, 731; HRMS (EI): m/z calcd for C15H22O+: 218.1667, 
found: 218.1671. 
2-(4-(2-Methylprop-1-enyl)-5-(2-methylpropylidene)cyclopent-1-enyl)ethanol (18a) 
Obtained as a 2:1 mixture of isomers. 1H NMR (400 MHz, CDCl3): δ = 5.75 (s, 
1H, major), 5.56 (s, 1H, minor), 5.39-5.37 (m, 1H, minor), 5.17-5.14 (m, 1H, minor), 5.07 (dd, J 
= 9.7, 1.8 Hz, 1H, major), 5.05-5.02 (m, 1H, major), 3.76 (t, J = 6.4 Hz, 2H, major and minor), 
3.72-3.63 (m, 2H, major and minor), 2.97-2.92 (m, 1H, minor), 2.77-2.70 (m, 1H, major), 2.47-
2.39 (m, 3H, major and minor), 2.31 (t, J = 6.5 Hz, 1H, major), 2.24-2.21 (m, 1H, minor), 2.07-
2.03 (m, 1H, major and minor), 1.69-1.65 (m, 6H, major and minor), 1.43 (br, 1H, major and 
minor), 1.03 (dd, J = 10.6, 6.8 Hz, 6H, minor), 0.93 (dd, J = 16.9, 6.6 Hz, 6H, major) ppm; 13C 
NMR (100 MHz, CDCl3) (major isomer): δ = 146.7, 140.2, 131.5, 129.5, 128.6, 126.9, 61.1, 38.9, 
38.8, 30.6, 28.0, 25.5, 23.3, 23.2, 17.9 ppm, (minor isomer): δ = 151.1, 132.1, 131.0, 126.6, 119.1, 
117.5, 60.9, 38.9, 38.8, 34.4, 32.7, 30.8, 25.8, 22.5, 21.3 ppm; HRMS (EI): m/z calcd for 
C15H24O+: 220.1825, found: 220.1827. 
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2-((E)-5-Hexylidene-4-((E)-1-phenylprop-1-en-2-yl)cyclopent-1-enyl)ethanol (18b) 
1H NMR (400 MHz, CD2Cl2): δ = 7.32-7.28 (m, 2H), 7.22-7.15 (m, 3H), 6.25 (s, 
1H), 5.79 (s, 1H), 5.39-5.37 (m, 1H), 3.68-3.58 (m, 2H), 2.87 (dd, J = 9.8, 4.1 Hz, 1H), 2.56-2.34 
(m, 2H), 2.28 (t, J = 6.4 Hz, 2H), 2.07 (t, J = 7.7 Hz, 2H), 1.85 (d, J = 1.3 Hz, 3H), 1.59-1.43 (m, 
3H), 1.37-1.27 (m, 4H), 0.92-0.88 (m, 3H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 142.7, 139.2, 
138.9, 132.7, 129.4, 128.5, 126.4, 125.4, 123.0, 119.7, 61.3, 46.4, 39.5, 36.0, 32.3, 29.3, 28.5, 
23.2, 16.7, 14.4 ppm; IR (neat, ν/cm-1): 3332, 2952, 2924, 2854, 1598, 1493, 1446, 1045, 916, 
858, 746, 699; HRMS (ESI): m/z calcd for C22H30NaO+: 333.2186, found: 333.2189. 
2-((E)-5-(2-Methylpropylidene)-4-((E)-1-phenylprop-1-en-2-yl)cyclopent-1-enyl)ethanol 
(18c, major isomer) 
1H NMR (400 MHz, CD2Cl2): δ = 7.32-7.28 (m, 2H), 7.25-7.15 (m, 3H), 6.36 (s, 
1H), 5.79 (s, 1H), 5.26-5.23 (m, 1H), 3.77-3.69 (m, 3H), 2.84-2.77 (m, 1H), 2.74-2.65 (m, 1H), 
2.45-2.42 (m, 2H), 2.27-2.21 (m, 1H), 1.71 (d, J = 1.3 Hz, 3H), 1.27 (m,1H), 0.96 (d, J = 6.6 Hz, 
3H), 0.92 (d, J = 6.6 Hz, 3H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 144.9, 142.3, 142.2, 139.2, 
132.1, 129.3, 128.6, 128.5, 126.4, 125.0, 61.5, 50.2, 38.4, 31.2, 28.4, 23.5, 23.3, 14.2 ppm; IR 
(neat, ν/cm-1): 3370, 3025, 2957, 2921, 2869, 2025, 1733, 1488, 1444, 1379, 1358, 1044, 743, 
699; HRMS (ESI): m/z calcd for C20H26NaO+: 305.1873, found: 305.1876. 
2-((Z)-5-(2-Methylpropylidene)-4-((E)-1-phenylprop-1-en-2-yl)cyclopent-1-enyl)ethanol 
(18c, minor isomer) 
1H NMR (400 MHz, CD2Cl2): δ = 7.33-7.29 (m, 2H), 7.22-7.16 (m, 3H), 6.26 (s, 
1H), 5.85 (s, 1H), 5.39-5.36 (m, 1H), 3.69-3.62 (m, 2H), 2.92 (dd, J = 9.5, 2.9 Hz, 1H), 2.58-2.51 
(m, 1H), 2.44-2.38 (m, 1H), 2.35-2.26 (m, 3H), 1.87 (d, J = 1.3 Hz, 3H), 1.44-1.42 (m, 1H), 1.12 
(d, J = 6.8 Hz, 3H), 1.10 (d, J = 6.8 Hz, 3H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 148.5, 
139.2, 138.7, 132.8, 129.4, 128.5, 126.4, 125.3, 120.9, 119.8, 61.3, 45.1, 39.6, 33.8, 29.6, 23.2, 
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21.8, 17.0 ppm; IR (neat, ν/cm-1): 3370, 3025, 2957, 2921, 2869, 2025, 1733, 1488, 1444, 1379, 
1358, 1044, 743, 699; HRMS (ESI): m/z calcd for C20H26NaO+: 305.1873, found: 305.1875. 
(Z)-Methyl 2-((E)-2-hexylidene-3-((E)-1-phenylprop-1-en-2-yl)cyclopentylidene)-3-
oxopropanoate (17d) 
1H NMR (400 MHz, CD2Cl2): δ = 10.10 (s, 1H), 7.34-7.31 (m, 3H), 7.25-7.18 (m, 
3H), 6.24 (s, 1H), 3.79 (s, 3H), 3.11 (t, J = 5.4 Hz, 1H), 2.74-2.51 (m, 2H), 2.26-2.21 (m, 2H), 
1.97-1.90 (m, 2H), 1.86 (d, J = 1.1 Hz, 3H), 1.63-1.47 (m, 2H), 1.36-1.30 (m, 4H), 0.91-0.88 (m, 
3H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 188.4, 167.9, 161.0, 157.5, 138.5, 138.2, 129.4, 
128.6, 128.2, 126.9, 126.7, 121.6, 52.4, 49.3, 37.7, 32.2, 28.3, 27.3, 26.9, 23.1, 17.6, 14.3 ppm; IR 
(neat, ν/cm-1): 2952, 2928, 2857, 1731, 1681, 1660, 1609, 1539, 1433, 1130, 750, 700; HRMS 
(ESI): m/z calcd for C24H30NaO3+: 389.2083, found: 389.2087. 
(Z)-Methyl 2-((E)-2-(2-methylpropylidene)-3-((E)-1-1phenylprop-1-en-2-yl)cyclopent 
ylidene)-3-oxopropanoate (17e) 
1H NMR (400 MHz, CD2Cl2): δ = 10.00 (s, 1H), 7.34-7.30 (m, 2H), 7.23-7.18 (m, 
3H), 6.63 (s, 1H), 6.19 (s, 1H), 3.83 (s, 3H), 3.18 (t, J = 4.7 Hz, 1H), 3.05-2.99 (m, 1H), 2.90-2.81 
(m, 1H), 2.46 (sept, J = 6.7 Hz, 1H), 2.02-1.89 (m, 2H), 1.90 (d, J = 1.3 Hz, 3H), 1.14 (d, J = 6.7 
Hz, 3H), 1.10 (d, J = 6.7 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 188.9, 167.7, 166.6, 
156.9, 138.6, 137.9, 129.4, 128.6, 128.2, 127.9, 126.9, 122.3, 52.5, 48.0, 35.2, 27.2, 23.1, 22.9, 
21.3, 18.2 ppm; IR (neat, ν/cm-1): 2959, 2926, 2869, 1733, 1661, 1608, 1539, 1433, 1330, 1240, 
1139, 743, 701; HRMS (ESI): m/z calcd for C22H26NaO3+: 361.1775, found: 361.1774. 
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(Z)-Methyl 2-((E)-2-(2-methylpropylidene)-3-((E)-1-1phenylprop-1-en-2-yl)cyclopent 
 ylidene)-3-oxopropanoate (17e) 
1H NMR (400 MHz, CD2Cl2): δ = 10.12 (s, 1H), 7.40 (s, 1H), 7.34-7.30 (m, 2H), 
7.26-7.18 (m, 3H), 6.20 (s, 1H), 3.78 (s, 3H), 3.17 (t, J = 4.9 Hz, 1H), 2.74-2.65 (m, 1H), 2.60-
2.53 (m, 1H), 2.48 (sept, J = 7.0 Hz, 1H), 1.97-1.90 (m, 2H), 1.89 (t, J = 1.3 Hz, 3H), 1.18 (d, J = 
7.0 Hz, 3H), 1.12 (d, J = 7.0 Hz, 3H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 188.4, 167.9, 
166.4, 157.6, 138.6, 129.4, 128.6, 128.2, 126.9, 126.8, 119.2, 52.4, 48.3, 35.2, 27.3, 26.4, 23.1, 
21.4, 18.0 ppm; IR (neat, ν/cm-1): 2959, 2926, 2869, 1733, 1661, 1608, 1539, 1433, 1330, 1240, 
1139, 743, 701; HRMS (ESI): m/z calcd for C22H26NaO3+: 361.1775, found: 361.1774. 
2-(5-Cyclopentylidene-4-(2-methylprop-1-enyl)cyclopent-1-enyl)ethanol (18f) 
1H NMR (400 MHz, CD2Cl2): δ = 5.67 (s, 1H), 4.98-4.94 (m, 1H), 3.72-3.71 (m, 
2H), 3.53-3.49 (m, 1H), 2.73-2.53 (m, 3H), 2.48 (t, J = 6.9 Hz, 2H), 2.32-2.11 (m, 2H), 1.95 (d, J 
= 17.1 Hz, 1H), 1.67 (d, J = 1.3 Hz, 3H), 1.66 (d, J = 1.3 Hz, 3H), 1.64-1.55 (m, 4H), 1.48-1.46 
(m, 1H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 141.5, 139.9, 134.4, 132.3, 129.2, 129.1, 62.2, 
43.1, 39.0, 34.0, 33.3, 31.5, 28.2, 26.5, 25.8, 18.2 ppm; IR (neat, ν/cm-1): 3322, 2950, 2932, 2864, 
1733, 1447, 1374, 1043, 957, 802; HRMS (EI): m/z calcd for C16H24O+: 232.1825, found: 
232.1827. 
2-(5-Cyclopentenyl-4-(2-methylallyl)cyclopent-1-enyl)ethanol (18f’) 
1H NMR (400 MHz, CD2Cl2): δ = 5.69 (s, 1H), 5.63-5.62 (m, 1H), 4.79-4.77 (m, 
2H), 3.67-3.62 (m, 2H), 3.55-3.51 (m, 1H), 3.04-3.02 (m, 1H), 2.74-2.09 (m, 9H), 1.97 (d, J = 
17.1 Hz, 1H), 1.75-1.55 (m, 6H), 1.48-1.44 (m, 1H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 
148.3, 148.1, 142.1, 126.7, 115.9, 112.0, 63.7, 61.9, 39.9, 39.8, 39.2, 36.4, 32.1, 27.5, 26.6, 19.3 
ppm; IR (neat, ν/cm-1): 3322, 2950, 2932, 2864, 1733, 1447, 1374, 1043, 957, 802; HRMS (EI): 
m/z calcd for C16H24O+: 232.1825, found: 232.1827. 
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2-(4-(2-Methylprop-1-enyl)-5-(propan-2-ylidene)cyclopent-1-enyl)ethanol (18g) 
1H NMR (400 MHz, CD2Cl2): δ = 5.73 (s, 1H), 5.00 (ddt, J = 9.6, 2.8, 1.4 Hz, 1H), 
3.73 (m, 2H), 3.59 (t, J = 8.7 Hz, 1H), 2.72-2.59 (m, 3H), 1.93-1.90 (m, 1H), 1.86 (s, 3H), 1.67 
(d, J = 1.1 Hz, 3H), 1.66-1.65 (m, 6H), 1.44 (s, 1H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 
142.4, 141.2, 134.1, 130.1, 128.9, 123.3, 62.1, 42.8, 38.5, 35.4, 25.8, 23.7, 21.3, 18.2 ppm; IR 
(neat, ν/cm-1): 3307, 2968, 2912, 2854, 1444, 1374, 1038, 795; HRMS (EI): m/z calcd for 
C14H22O+: 206.1671, found: 206.1671.  
2-(4-(2-Methylprop-1-enyl)-5-(prop-1-en-2-yl)cyclopent-1-enyl)ethanol (18g’) 
1H NMR (400 MHz, CD2Cl2): δ = 5.59 (s, 1H), 5.47 (s, 1H), 4.76-4.74 (m, 2H), 
3.70-3.59 (m, 2H), 2.99-2.97 (m, 1H), 2.66-2.60 (m, 1H), 2.17-2.03 (m, 2H), 1.79 (s, 3H), 1.77 (s, 
3H), 1.75-1.62 (m, 2H), 1.59 (m, 3H), 1.27 (s, 1H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 148.1, 
141.8, 136.2, 127.9, 120.9, 111.9, 63.9, 61.9, 39.8, 39.7, 39.2, 27.2, 20.3, 19.2 ppm; IR (neat, 
ν/cm-1): 3364, 2963, 2923, 2858, 2360, 1644, 1448, 1379, 1260, 1055, 884, 799; HRMS (EI): m/z 
calcd for C14H22O+: 206.1670, found: 206.1671.  
(E)-2-(4-(1-Phenylprop-1-en-2-yl)-5-(propan-2-ylidene)cyclopent-1-enyl)acetaldehyde (17h) 
1H NMR (400 MHz, CDCl3): δ = 9.72 (t, J = 2.2 Hz, 1H), 7.33-7.29 (m, 2H), 7.23-
7.16 (m, 3H), 6.29 (s, 1H), 5.83 (s, 1H), 3.65 (d, J = 8.6 Hz, 1H), 3.52 (m,  2H), 2.83 (dd, J = 
18.0, 8.8 Hz, 1H), 2.21 (d, J = 17.4 Hz, 1H), 1.85 (s, 3H), 1.78 (d, J = 1.1 Hz, 3H), 1.74 (s, 3H) 
ppm; 13C NMR (100 MHz, CDCl3): δ = 200.6, 144.2, 139.5, 138.6, 136.9, 136.5, 128.8, 128.0, 
125.8, 125.3, 124.2, 52.5, 46.4, 37.2, 23.7, 21.0, 14.8 ppm; IR (neat, ν/cm-1): 3021, 2976, 2910, 
2850, 2717, 2366, 2340, 1724, 1598, 1491, 1444, 1260, 1025, 911, 796, 731, 699; HRMS (EI): 
m/z calcd for C19H22O+: 266.1667, found: 266.1671. 
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(E)-2-(4-(1-Phenylprop-1-en-2-yl)-5-(propan-2-ylidene)cyclopent-1-enyl)ethanol (18h) 
1H NMR (400 MHz, CDCl3): δ = 7.32-7.28 (m, 2H), 7.22-7.15 (m, 3H), 6.24 (s, 1H), 
7.76 (s, 1H), 3.85-3.78 (m, 2H), 3.60 (d, J = 8.3 Hz, 1H), 2.83-2.67 (m, 3H), 2.17-2.13 (m, 1H), 
1.93 (s, 3H), 1.76 (d, J = 1.5 Hz, 3H), 1.74 (s, 3H), 1.50 (s, 1H) ppm; 13C NMR (100 MHz, 
CDCl3): δ = 141.6, 141.5, 139.5, 138.7, 133.8, 128.8, 127.9, 125.8, 124.8, 123.7, 61.5, 52.5, 36.8, 
34.8, 23.8, 21.1, 15.0 ppm; IR (neat, ν/cm-1): 3386, 2973, 2927, 2356, 2332, 1702, 1445, 1359, 
1156, 1047, 746, 700; HRMS (ESI): m/z calcd for C19H24NaO+: 291.1725, found: 291.1725.  
(E)-6-Methoxy-2,2-dimethyl-4-(2-(1-phenylprop-1-en-2-yl)cyclopropyl)-5,6-dihydro-2H-
pyran (19) (carbon signals are missing due to overlapping) 
Obtained as a 1:1 mixture of isomers. 1H NMR (400 MHz, CDCl3): δ = 7.32-7.28 
(m, 4H), 7.23-7.15 (m, 6H), 6.31 (s, 2H), 5.40-5.37 (m, 2H), 4.77 (t, J = 5.8 Hz, 1H), 4.76 (t, J = 
5.8 Hz, 1H), 3.47 (s, 6H), 2.16-1.98 (m, 4H), 1.78 (d, J = 1.5 Hz, 3H), 1.77 (d, J = 1.5 Hz, 3H), 
1.63-1.50 (m, 4H), 1.32 (d, J = 3.5 Hz, 6H), 1.27 (d, J = 4.7 Hz, 6H), 1.00-0.95 (m, 2H), 0.94-
0.89 (m,2H) ppm; 13C NMR (100 MHz, CDCl3): δ = 138.3, 138.2, 138.2, 131.4, 131.3, 128.8, 
128.0, 126.8, 126.6, 125.9, 124.0, 123.9, 93.4 (2xC), 73.4, 55.6, 55.5, 32.2, 31.9, 29.7 (2xC), 
27.8, 27.7, 27.5, 24.7, 24.6, 16.0, 15.9, 10.8, 10.6 ppm. 
5 Preparation and characterization of cyclopropyl allenes and cyclization products 
5.1 General procedure for the preparation of cyclopropyl allenes 
CuBr.Me2S, LiBr
MeMgBr,
THF, -78 oC
OMe
R1
AcO
R2 R2
OMe
R1
 
To a solution of CuBr.Me2S (3.0 equiv.) and LiBr (3.0 equiv.) in THF (0.6 M) at -78 oC, MeMgBr 
(1.0 M in butylether, 2.0 equiv.) was added dropwise. The mixture was stirred at -78 oC for 20 
minutes. A solution of the corresponding acetate (1.0 equiv.) in THF (0.6 M) was added dropwise. 
The mixture was stirred at -78 oC for 15 minutes and then warmed up to room temperature and 
stirred for 2 hours. The reaction was quenched with an aqueous NH4Cl/NH4OH (1/1) solution. 
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The resulting mixture was extracted with diethyl ether and the combined organic layers were 
washed with brine. The organic layer was dried over MgSO4. The solvent was evaporated under 
reduced pressure. The residue was purified by column chromatography (Hexane) to give the 
corresponding allenes. 
 
5.2 Characterization of the cyclopropyl allenes 
1-Methoxy-4-(2-(3-methylbuta-1,2-dienyl)cyclopropyl)benzene (20a) 
1H NMR (400 MHz, CDCl3): δ = 7.00 (d, J = 8.8 Hz, 2H), 6.81 (d, J = 8.8 
Hz, 2H), 4.98 (m, 1H), 3.78 (s, 3H), 1.82-1.76 (m, 1H), 1.71 (d, J = 3.3 Hz, 3H), 1. 70 (d, J = 3.3 
Hz, 3H) 1.45-1.38 (m, 1H), 1.08-1.03 (m, 1H), 1.00-0.92 (m, 1H) ppm; 13C NMR (100 MHz, 
CDCl3): δ = 201.0, 157.6, 134.8, 126.7, 113.8, 97.2, 92.2, 55.3, 24.9, 21.9, 20.9, 20.8, 16.5 ppm; 
IR (neat, ν/cm-1): 2994, 2978, 2933, 2907, 2833, 1612, 1512, 1442, 1244, 1178, 1035, 821, 543; 
HRMS (EI): m/z calcd for C15H18O+: 214.1357, found: 214.1358. 
1-Methoxy-4-2-(3-phenylbuta-1,2-dienyl)cyclopropyl)benzene (20b)                           
(carbon signals are missing due to overlapping) 
Ph
OMe
Obtained as a 1:1 diastereomeric mixture. 1H NMR (400 MHz, CDCl3): δ = 
7.43-7.41 (m, 4H), 7.35-7.30 (m, 4H), 7.22-7.18 (m, 2H), 7.04-7.01 (m, 4H), 6.84-6.81 (m, 4H), 
5.54-5.47 (m, 2H), 3.78 (s, 6H), 2.12 (d, J = 2.9 Hz, 3H), 2.11 (d, J = 2.9 Hz, 3H), 1.95-1.89 (m, 
2H), 1.58-1.52 (m, 2H), 1.16-1.05 (m, 4H) ppm; 13C NMR (100 MHz, CDCl3): δ = 203.8, 203.7, 
157.8, 137.4, 137.3, 134.5, 134.4, 128.3, 128.2, 126.8, 126.7, 126.6, 125.7, 125.6, 113.8, 102.6, 
102.5, 96.4, 96.3, 55.3, 25.2, 24.9, 21.5, 21.2, 17.3, 16.7, 16.5 ppm; IR (neat, ν/cm-1): 3056, 2999, 
2935, 2246, 1612, 1514, 1492, 1442, 1247, 1178, 1035, 907, 730; HRMS (EI): m/z calcd for 
C20H20O+: 276.1516, found: 276.1514. 
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1-Methoxy-4-(2-(4-phenylpenta-2,3-dien-2-yl)cyclopropyl)benzene (20c) 
(carbon signals are missing due to overlapping) 
Obtained as a 1:1 mixture of isomers. 1H NMR (400 MHz, CD2Cl2): δ = 7.39-
7.36 (m, 4H), 7.32-7.28 (m, 4H), 7.20-7.16 (m, 2H), 7.03-7.01 (m, 4H), 6.81-6.79 (m, 4H), 3.76 
(s, 6H), 2.08 (s, 6H), 1.96-1.91 (m, 2H), 1.89 (s, 3H), 1.88 (s, 3H), 1.49-1.45 (m, 2H), 1.11-1.02 
(m, 4H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 201.5, 201.4, 158.4, 138.9, 138.8, 135.4, 135.3, 
128.8, 128.7, 127.4, 126.9, 126.2, 126.1, 114.3, 104.4, 104.3, 102.1, 102.0, 55.8, 26.3, 26.1, 25.2, 
25.0, 18.7, 18.6, 17.8, 17.7, 16.2, 16.1 ppm; IR (neat, ν/cm-1): 2994, 2924, 2854, 1610, 1513, 
1491, 1442, 1245, 1177, 1037, 952, 824, 759, 694; HRMS (EI): m/z calcd for C21H22O+: 
290.1672, found: 290.1671. 
1-(2-(3,4-Dimethylpenta-1,2,4-trienyl)cyclopropyl)-4-methoxybenzene (20d) 
Obtained as a mixture 1:1 of isomers. 1H NMR (500 MHz, CD2Cl2): δ = 7.02-
7.00 (m, 4H), 6.83-6.80 (m, 4H), 5.38-5.37 (m, 2H), 4.94-4.92 (m, 4H), 3.77 (s, 6H), 1.92-1.90 
(m, 2H), 1.90 (d, J = 2.7, Hz, 3H), 1.89 (d, J = 2.7 Hz, 3H), 1.86 (d, J = 7.5 Hz, 6H), 1.50-1.45 
(m, 2H), 1.14-1.07 (m, 2H), 1.04-1.00 (m, 2H) ppm; 13C NMR (125 MHz, CD2Cl2): δ = 205.5, 
205.4, 158.4, 141.8, 141.7, 135.1, 127.4, 127.3, 114.3, 114.3, 111.2, 111.1, 105.3, 95.6, 95.5, 
55.8, 25.3, 25.1, 22.0, 22.0, 21.9, 21.8, 17.3, 17.2, 16.8, 16.7 ppm; IR (neat, ν/cm-1): 3010, 2949, 
2834, 1615, 1513, 1441, 1299, 1245, 1177, 1036, 907, 882, 823; HRMS (EI): m/z calcd for 
C17H20O+: 240.1517, found: 240.1517. 
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5.3 General procedure for the cyclization of 3-cyclopropyl allenes 
 
A) To a solution of the corresponding 3-cyclopropyl allene (1.0 equiv.) in CH2Cl2 (0.05 M), 
IPrAuNTf2 (0.05 equiv.) was added in one portion. The mixture was stirred at room 
temperature for 30 minutes. The reaction was quenched with triethylamine (0.05 equiv.). 
The solution was dried under reduced pressure and the residue was purified by column 
chromatography (Hex:AcOEt 25:1) to give the corresponding cyclopentenes in 67-92% 
yield. 
B) To a solution of 1-(2-(3,4-dimethylpenta-1,2,4-trienyl)cyclopropyl)-4-methoxybenzene 
(20d) (1.0 equiv.) in CH2Cl2 (0.05 M), dichloro(pyridine-2-carboxylato)gold (III) (0.05 
equiv.) was added in one portion. The mixture was stirred at room temperature for 5 
minutes. The reaction was quenched with triethylamine (0.05 equiv.). The solution was 
dried under reduced pressure and the residue was purified by column chromatography 
(Hex:AcOEt 25:1) to give the 22 in 96% yield. 
5.4 Characterization of cyclization products 
1-Methoxy-4-(2-(propan-2-ylidene)cyclopent-3-enyl)benzene (21a) 
1H NMR (400 MHz, CDCl3): δ = 7.09-7.05 (m, 2H), 6.81-6.78 (m, 2H), 6.51 (dt, J = 
5.5, 2.1 Hz, 1H), 5.91-5.89 (m, 1H), 3.92-3.90 (d, J = 8.6 Hz, 1H), 3.78 (s, 3H), 3.08 (dd, J = 
17.8, 8.6 Hz, 1H), 2.32 (dd, J = 17.8, 1.0 Hz, 1H), 1.81 (s, 3H), 1.48 (s, 3H) ppm; 13C NMR (100 
MHz, CDCl3): δ = 157.5, 143.3, 139.9, 132.5, 131.5, 127.8, 123.3, 113.7, 55.2, 44.8, 43.8, 21.3, 
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21.2 ppm; IR (neat, ν/cm-1): 3062, 2984, 2953, 2908, 2840, 1609, 1509, 1441, 1176, 1037, 907, 
730; HRMS (EI): m/z calcd for C15H18O+: 214.1359, found: 214.1358. 
(Z)-1-Methoxy-4-(2-(1-phenylethylidene)cyclopent-3-enyl)benzene (21b) 
1H NMR (400 MHz, CDCl3): δ = 7.13-7.07 (m, 3H), 6.88-6.86 (m, 2H), 6.65-6.63 (m, 
3H), 6.59-6.56 (m, 2H), 6.13 (dt, J = 5.5, 2.6 Hz, 1H), 3.84 (d, J = 8.1 Hz, 1H), 3.72 (s, 3H), 3.07-
3.00 (m, 1H), 2.39-2.34 (m, 1H), 2.09 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 157.2, 
146.2, 144.1, 140.0, 135.3, 131.8, 127.8, 127.7, 127.6, 125.8, 113.2, 55.2, 44.7, 43.4, 21.9 ppm; 
IR (neat, ν/cm-1): 3056, 2921, 2832, 2366, 1509, 1301, 1243, 1176, 1037, 916, 827, 745, 700; 
HRMS (EI): m/z calcd for C20H20O+: 276.1508, found: 276.1514. 
(E)-1-Methoxy-4-(3-methyl-2-(1-phenylethylidene)cyclopent-3-enyl)benzene (21c) 
1H NMR (400 MHz, CD2Cl2): δ = 7.14-7.06 (m, 3H), 6.83-6.81 (m, 2H), 6.61-6.55 
(m, 4H), 5.82 (s, 1H), 3.82-3.76 (m, 1H), 3.71 (s, 3H), 2.83-2.76 (m, 1H), 2.23 (d, J = 1.6 Hz, 
3H), 2.18 (s, 3H), 2.08-2.03 (m, 1H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 157.9, 147.0, 145.9, 
141.9, 141.3, 135.4, 129.8, 128.4, 128.3, 128.2, 126.1, 113.6, 55.6, 48.4, 41.0, 21.9, 18.8 ppm; IR 
(neat, ν/cm-1): 3025, 2926, 2834, 1609, 1509, 1440, 1242, 1175, 1036, 828, 762, 700; HRMS (EI): 
m/z calcd for C21H22O+: 290.1670, found: 290.1671. 
1-(2-(3,4-Dimethylcyclopenta-1,3-dienyl)cyclopropyl)-4-methoxybenzene (22) 
1H NMR (500 MHz, CD2Cl2): δ = 7.02-7.00 (m, 2H), 6.82-6.80 (m, 2H), 5.96 (s, 
1H), 3.77 (s, 3H), 2.76 (s, 2H), 1.94-1.90 (m, 1H), 1.89 (s, 3H), 1.86-1.82 (m, 1H), 1.81 (d, J = 
0.8 Hz, 3H), 1.22-1.18 (m, 1H), 1.17-1.13 (m, 1H) ppm; 13C NMR (125 MHz, CD2Cl2): δ = 158.4, 
146.7, 135.4, 134.9, 132.8, 129.7, 127.1, 114.3, 55.8, 45.9, 26.9, 25.1, 17.9, 13.4, 12.8 ppm; IR 
(neat, ν/cm-1): 3041, 2998, 2955, 2910, 2855, 2833, 1612, 1512, 1440, 1376, 1243, 1177, 1035, 
872, 824, 526; HRMS (EI): m/z calcd for C17H20O+: 240.1517, found: 240.1514. 
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6 Preparation and characterization of chiral probes including HPLC chromatograms 
6.1 Preparation of chiral propargyl acetates 
 
1) To a solution of LiAlH4 (1.0 equiv) in THF (0.3 M) at 0 oC, a solution of trans-
Chrysanthemic acid (1.0 equiv) in THF (0.6 M) was added dropwise. The mixture was 
stirred at 0 oC for 10 minutes. Then the reaction was heating to reflux and stirred for 12 
hours. The reaction was quenched with water, a solution of NaOH (15% v/v) and water 
again. The mixture was extracted with diethyl ether. The combined organic layers were 
dried over Na2SO4 and the solvent was evaporated under reduced pressure. The residue 
was purified by column chromatography (Hex:AcOEt 3:1) to give the corresponding 
alcohol in 96% yield. 
2) The remaining steps for the formation of the corresponding secondary and tertiary 
propargyl acetates were performed according to previously described general procedures. 
 
6.2 Characterization of propargyl acetates 
(1R,3R)-3-(2,2,-Dimethyl-3-(2-methylprop-1-enyl)cyclopropyl)-1-phenylprop-2-ynyl acetate 
(23) 
Obtained as a 1:1 diastereomeric mixture in the propargyl position. 1H NMR 
(400 MHz, CD2Cl2): δ = 7.53-7.51 (m, 4H), 7.39-7.31 (m, 6H), 6.48 (m, 2H), 4.84-4.82 (m, 2H), 
2.09 (s, 3H), 2.08 (s, 3H), 1.71 (s, 12H), 1.55-1.50 (m, 2H), 1.23 (s, 3H), 1.22 (s, 3H), 1.09-1.07 
(m, 2H), 1.06 (s, 6H) ppm; 13C NMR (100 MHz, CDCl3): δ =169.9, 137.8 (2xC), 135.1 (2xC), 
128.7 (2xC), 128.5, 127.7 (2xC), 121.7 (2xC), 88.9 (2xC), 75.3 (2xC), 66.3, 33.8 (2xC), 25.6, 
25.3 (2xC), 23.2 (2xC), 22.2 (2xC), 21.2, 21.0, 18.5 ppm; IR (neat, ν/cm-1): 2923, 2362, 2323, 
2235, 1740, 1455, 1369, 1014, 955, 754, 697; HRMS (ESI): m/z calcd for C20H24NaO2+: 
319.1674, found: 319.1674.  
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(1R,3R)-4-(2,2-Dimethyl-3-(2-methylprop-1-enyl)cyclopropyl)-2-methylbut-3-yn-2-yl acetate 
(24) 
1H NMR (500 MHz, CDCl3): δ = 4.82-4.80 (m, 1H), 1.99 (s, 3H), 1.70 (s, 6H), 
1.64-1.63 (m, 1H), 1.63 (s, 6H), 1.45 (dd, J = 7.9, 5.1 Hz, 1H), 1.21 (s, 3H), 1.03 (s, 3H), 1.00 (d, 
J = 5.1 Hz, 1H) ppm; 13C NMR (125 MHz, CDCl3): δ = 169.9, 135.4, 122.6, 85.7, 80.5, 73.4, 
34.3, 30.0, 29.9, 26.2, 25.6, 23.6, 22.8, 22.7, 21.6, 19.1 ppm; IR (neat, ν/cm-1): 2973, 2927, 2858, 
2249, 1735, 1369, 1251, 1136, 1017, 907, 731, 648; [α]D24 = 67.5o (c = 0.81, CHCl3); HRMS 
(ESI): m/z calcd for C16H24NaO2+: 271.1667, found: 271.1668. 
 
6.3 General procedure for the preparation of ketones 25 and 26 
 
A) To a solution of 23 (1.0 equiv.) in CH2Cl2 (0.05 M) at room temperature, gold catalyst 
(0.05 equiv.) was added. The solution was stirred at room temperature for 30 minutes. 
The reaction was diluted with methanol. Then, potassium carbonate (2.0 equiv.) was 
added. The mixture was stirred at room temperature for 15 minutes. The solvent was 
evaporated under reduced pressure and the residue was purified by column 
chromatography (Hex:AcOEt 50:1) to give 25. 
B) To a solution of 24 (1.0 equiv.) in CH2Cl2 (0.05 M) at room temperature, (PhO)3PAuSbF6 
(0.05 equiv.) was added. The solution was stirred at room temperature for 30 minutes. 
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The reaction was diluted with methanol. Then, potassium carbonate (2.0 equiv.) was 
added. The mixture was stirred at room temperature for 15 minutes. The solvent was 
evaporated under reduced pressure and the residue was purified by column 
chromatography (Hex:AcOEt 50:1) to give 26. 
 
6.4 Characterization of ketones 25 and 26 
(2R)-(E)-2-Benzylidene-4,4-dimethyl-3-(2-methylprop-1-enyl)cyclopentanone (25) 
O
Ph
1H NMR (500 MHz, CDCl3): δ = 7.46-7.43 (m, 3H), 7.36-7.32 (m, 2H), 4.93 (dq, J = 
10.4, 1.4 Hz, 1H), 3.58 (d, J = 10.7 Hz, 1H), 2.34 (d, J = 17.3 Hz, 1H), 2.16 (dd, J = 17.4, 1.1 Hz, 
1H), 1.84 (d, J = 1.3 Hz, 3H), 1.73 (d, J = 1.4 Hz, 3H), 1.04 (s, 6H) ppm; 13C NMR (125 MHz, 
CDCl3): δ = 207.2, 141.0, 134.9, 133.9, 133.7, 130.7, 129.0, 128.2, 123.0, 51.0, 50.8, 38.7, 29.4, 
25.7, 24.4, 18.5 ppm; IR (neat, ν/cm-1): 2954, 2921, 2869, 2249, 1715, 1621, 1448, 1188, 909, 
731, 694; [α]D25 = 59.9o (c = 0.53, CHCl3); HRMS (ESI): m/z calcd for C18H22NaO+: 277.1564, 
found: 277.1563. 
(2R)-4,4-Dimethyl-3-(2-methylprop-1-enyl)-2-(propan-2-ylidene)cyclopentanone (26) 
1H NMR (400 MHz, CDCl3): δ = 4.93-4.90 (m, 1H), 3.23 (d, J = 10.8 Hz, 1H), 2.27 (d, 
J = 17.2 Hz, 1H), 2.21 (s, 3H), 2.04 (dd, J = 17.2, 0.7 Hz, 1H), 1.73 (s, 6H), 1.71 (d, J = 1.1 Hz, 
3H), 1.01 (s, 3H), 0.94 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 207.0, 149.3, 135.9, 131.4, 
124.2, 53.2, 51.5, 36.7, 29.7, 25.8, 24.6, 23.7, 21.1, 18.0 ppm; IR (neat, ν/cm-1): 2954, 2926, 2874, 
1702, 1626, 1445, 1367, 1266, 1188, 908, 731, 648; [α]D23 = - 20.5o (c = 0.30, CHCl3); HRMS 
(EI): m/z calcd for C14H22O+: 206.1673, found: 206.1671. 
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6.5 HPLC chromatograms 
rac-3-(2,2,-Dimethyl-3-(2-methylprop-1-enyl)cyclopropyl)-1-phenylprop-2-ynyl acetate (23) 
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(1R,3R)-3-(2,2,-Dimethyl-3-(2-methylprop-1-enyl)cyclopropyl)-1-phenylprop-2-ynyl acetate 
(23) 
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rac-4-(2,2-Dimethyl-3-(2-methylprop-1-enyl)cyclopropyl)-2-methylbut-3-yn-2-yl acetate (24) 
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(1R,3R)-4-(2,2-Dimethyl-3-(2-methylprop-1-enyl)cyclopropyl)-2-methylbut-3-yn-2-yl acetate 
(24)
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rac-2-Benzylidene-4,4-dimethyl-3-(2-methylprop-1-enyl)cyclopentanone (25) 
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(2R)-(E)-2-Benzylidene-4,4-dimethyl-3-(2-methylprop-1-enyl)cyclopentanone (25) 
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rac-4,4-Dimethyl-3-(2-methylprop-1-enyl)-2-(propan-2-ylidene)cyclopentanone (26) 
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(2R)-4,4-Dimethyl-3-(2-methylprop-1-enyl)-2-(propan-2-ylidene)cyclopentanone (26) 
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7. Computational Methods 
Full Reference 20. 
Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M.A.; Cheeseman, J. R.; 
Montgomery, J. A. Jr.; Vreven, T.; Kudin, K. N.; Burant, J.C.; Millam, J. M.; Iyengar, S. S.; 
Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; 
Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, 
T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; 
Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; 
Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; 
Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; 
Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. 
G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, 
I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; 
Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. 
A. Gaussian 03, Revision E.01, Gaussian, Inc., Wallingford CT, 2004. 
7.1 General Considerations 
All reported structures were optimized at DFT level by using the B3LYP6 hybrid functional as 
implemented in Gaussian 03.7 Optimizations were carried out by using the standard 6-31G** 
basis set for C, H, O, N and P. The LANL2DZ basis set, which includes the relativistic effective 
core potential (ECP) of Hay and Wadt and employs a split-valence (double-) basis set was used 
for Au.8 All energy minima and transition structures were characterized by harmonic frequency 
analysis at the same level. The energies reported in this work include thermal and zero-point 
vibrational energy corrections (ZPVE). As corresponds to an intramolecular reaction, computed H 
and G values are within a narrow 0-2 kcal/mol energy difference for all stationary points, and 
point out the same reactivity trend. Therefore, only H values have been shown along the 
accompanying paper, and G values are listed in Table S1 and S2 of the present Supporting 
                                                 
6 (a) Lee, C.; Yang, W.; Parr, R. G. Phys. Rev. B 1988, 37, 785–789. (b) Becke, A. D. J. Chem. Phys. 1993, 
98, 5648–5652. (c) Kohn, W.; Becke, A. D.; Parr, R. G. J. Phys. Chem. 1996, 100, 12974–12980. 
7 See Full Reference 20 in this page. 
8 (a) Hay, P. J.; Wadt, W. R. J. Chem. Phys. 1985, 82, 270-283. (b) Wadt, W. R.; Hay, P. J. J. Chem. Phys. 
1985, 82, 284-298. (c) Hay, P. J.; Wadt, W. R. J. Chem. Phys. 1985, 82, 299-310. 
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Information. The stationary points were characterized by frequency calculations in order to verify 
that they have the right number of imaginary frequencies. The intrinsic reaction coordinates 
(IRC)9 were followed to verify the energy profiles connecting each TS to the correct associated 
local minima. Solvent effects were included by single point energy calculations of the gas-phase 
structures with the self-consistent reaction field (SCRF) based on the IEF-PCM solvation model 
(CH2Cl2, as solvent,  = 8.93, radii = UA0). In some cases, i.e. Scheme 12, the reoptimization of 
the structures was prohibitive due to the large number of atoms involved (Au = IPr), and single-
point calculations were performed on the previously gas-phase optimized structures instead.10  
7.2 Complementary Scheme 8 
A more detailed version of Scheme 8 explaining the loss of chiral information at the propargylic 
position is presented here: Au(I)-complex of (S)-acetate XIa evolves to a gold coordinated allene 
XIIIa in an slightly endothermic process (ΔH = 0.4 kcal/mol) (Scheme 1). XIIIa shows a clear 
“allene” character, with gold coordinated to the more external double bond and the four allenyl 
substituents disposed perpendicularly. 
XIIIa is in equilibrium with two derivatives XIVa and XIVd, in which gold is coordinated to the 
internal double bond of the allene. These structures are more distorted and resemble an allylic 
carbocation although the substituents are located in perpendicular planes rather than in a common 
plane as one would expect from a normal cabocation. As summarized in the following scheme, 
XIVa and XIVd are thermodynamically more stable than XIIIa and XIIIc. Furthermore, only 
XIVa is reactive enough, since the rigidity of the double bond in XIIIa-c places the cyclopropyl 
unit and the cationic C atom in a non-reacting distance. From the (R) configured acetate in the 
starting material XIb, an analogous reaction pathway is observed. However, as indicated in 
Scheme 8 of the accompanying paper, the stereochemical information of the acetate at the 
propargylic position is lost by a low barrier transition state TSXIVa-XIVb (ΔH = 3.2 kcal/mol), 
                                                 
9 Gonzalez, C.; Schlegel, H. B. J. Phys. Chem. 1990, 94, 5523–5527. 
10 (a) Cancès, E.; Mennucci, B.; Tomasi, J. J. Chem. Phys. 1997, 107, 3032–3047. (b) Cossi, M.; Barone, 
V.; Mennuci, B.; Tomasi, J. Chem. Phys. Lett. 1998, 286, 253–260. (c) Tomasi, J.; Mennucci, B.; Cancès, 
E. J. Mol. Struct. (Theochem), 1999, 464, 211–226. 
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which converts XVIa into its enantiomer XIVb in a thermoneutral transformation (ΔH = -0.7 
kcal/mol).  
Complementary Scheme 8. Reaction coordinate diagram for the [3,3]-acetoxy migration of XIa 
to cationic intermediate XIVa-d. Calculations at the B3LYP/6-31G(d) (C, H, O, P), LANL2DZ 
(Au) level (+ ZPE corrected energies are given in kcal/mol). Au = (IPr)Au 
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7.3 Further studies on the non-complete chirality transfer (Complementary to Schemes 9 
and 12) 
Transition states TSXIVa-d(1) and TSXVIa-d(2) shown in Scheme 9 retain the configuration at C6 
bearing the vinyl stabilizing substituent. However, a potential mechanism where the cyclopropyl 
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ring opening takes place inverting the configuration at C6, if comparable in energy to the one 
summarized in Scheme 9, could also explain the lack of complete chirality transfer observed 
experimentally in these transformations. Thus, a new transition state ent-TSXIVa(1) was studied. 
ent-TSXIVa(1)  involves a slight rotation of the cyclopropyl compared to TSXIVa(1), which 
increases the strain (Hent-TSXIVa(1) = 20.8 kcal/mol vs. HTSXIVa(1) = 12.7 kcal/mol; see Newman 
projections below). Thus, the activation energy for the cyclopropyl ring opening process raised to 
27.5 kcal/mol (8 kcal/mol higher in energy than the ring opening with retention of configuration), 
which makes this mechanistic pathway unlikely, thus favoring the hypothesis of epimerization via 
cyclopropyl ring opening/ring closure summarized in Scheme 12 of the accompanying paper. 
Complementary Scheme 9. Reaction coordinate diagram for the cyclopentannulation of XIVa. 
Calculations at the B3LYP/6-31G(d) (C, H, O, P), LANL2DZ (Au) level (+ ZPE corrected 
energies are given in kcal/mol. Au = (Me3P)Au 
 
Complementary calculations were performed using XIVa as a model to study the epimerization 
via ring-opening/ring closing reaction. The results, in agreement with those reported in Scheme 
12 have been summarized below. 
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 Complementary Scheme 12. Reaction coordinate diagrams for the cyclopropyl epimerization 
of XIVa. Calculations at the B3LYP/6-31G(d) (C, H, O, P), LANL2DZ (Au) level (+ ZPE 
corrected energies are given in kcal/mol; calculations considering solvent effects (CH2Cl2)). Au = 
(Me3P)Au 
 
7.4  Table S1. Absolute and relative enthalpies (H) and free Gibbs energies (G) of stationary 
points shown in the manuscript and in complementary scheme 8 of the supporting 
information 
 Absolute 
enthalpy (H)a 
 
Relative 
enthalpy 
(H)b 
Absolute Free 
energy (G)c 
 
Relative 
Free 
energy 
(G)d 
Imaginary 
frequencies 
XIa -1872.546869 0 -1872.688997 0  
XIb -1872.550349 -2.2 -1872.692087 -1.9  
TSXIa-XIIa -1872.536507 6.5 -1872.674659 9.0 -204.4 
XIIa -1872.547365 -0.3 -1872.685207 2.4  
TSXIIa-XIIIa -1872.542863 2.5 -1872.680716 5.2 -172.9 
XIIIa -1872.546170 0.4 -1872.685262 2.3  
XIIIb -1872.546136 0.5 -1872.685453 2.2  
XIIIc -1872.545405 0.9 -1872.680514 5.3  
XIIId -1872.546587 0.2 -1872.685320 2.3  
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TSXIIIa-XIVa -1872.540824 3.8 -1872.679951 5.7 -202.6 
XIVa -1872.553847 -4.4 -1872.690872 -1.2  
dcmXIVa -1873.448375 -3.5    
XIVb -1872.554962 -5.1 -1872.692305 -2.1  
dcmXIVb -1873.451200 -5.3    
XIVc -1872.551405 -2.9 -1872.690017 -0.6  
dcmXIVc -1873.446855 -2.6    
XIVd -1872.553681 -4.3 -1872.692743 -2.3  
dcmXIVd -1873.449612 -4.3    
TSXIVa-XIVb -1872.548877 -1.3 -1872.684792 2.6 -32.2 
TSXIVa(1) -1872.522096 15.5 -1872.658183 19.3 -125.9 
dcmTSXIVa(1) -1873.420775 13.8    
TSXIVb(1) -1872.509989 23.1 -1872.644644 27.8 -128.9 
dcmTSXIVb(1) -1873.412154 19.2    
TSXIVc(1) -1872.517992 18.1 -1872.655293 21.1 -167.0 
dcmTSXIVc(1) -1873.415873 16.9    
TSXIVd(1) -1872.508512 24.1 -1872.643759 28.4 -51.5 
dcmTSXIVd(1) -1873.410405 20.3    
TSXIVa(2) -1872.529568 10.9 -1872.663164 16.2 -291.0 
dcmTSXIVa(2) -1872.531863 9.6    
TSXIVb(2) -1872.532733 8.9 -1872.666883 13.9 -130.8 
dcmTSXIVb(2) -1873.432071 6.7    
TSXIVc(2) -1872.534129 8.0 -1872.667986 13.2 -222.9 
dcmTSXIVc(2) -1873.429564 8.3    
TSXIVd(2) -1872.531919 9.4 -1872.668280 13.0 -148.0 
dcmTSXIVd(2) -1873.429078 8.6    
XVa -1872.605308 -36.7 -1872.738215 -36.7  
dcmXVa -1873.501920 -37.1    
XVb -1872.604841 -36.4 -1872.740542 -36.4  
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dcmXVb -1873.502515 -37.5    
XVc -1872.601765 -34.4 -1872.740406 -32.3  
dcmXVc -1873.499228 -35.4    
XVd -1872.603278 -35.4 -1872.735110 -28.9  
dcmXVd -1873.499843 -35.8    
XVIa -1872.574145 -17.1 -1872.709645 -13.0  
dcmXVIa -1873.473589 -19.3    
TSXVIa-XVIIa -1872.555709 -5.5 -1872.689324 -0.2 -684.3 
dcmTSXVIa-XVIIa -1873.457296 -9.1    
XVIIa -1872.603443 -35.5 -1872.739149 -31.5  
dcmXVIIa -1873.501957 -37.2    
XVIII -2140.645252 0 -2140.794002 0  
TSXVIII-XIX -2140.632990 7.7 -2140.783154 6.8 -189.7 
XIX -2140.641683 2.2 -2140.789399 2.9  
TSXIX-XX -2140.629876 9.6 -2140.776984 10.7 -390.2 
XX -2140.658710 -8.4 -2140.810151 -10.1  
TSXX-XXI -2140.634048 7.0 -2140.781677 7.7 -39.7 
XXI -2140.676398 -19.5 -2140.822623 -18.0  
TSXXI-XXII -2140.632552 8.0 -2140.780153 8.7 -304.0 
XXII -2140.695682 -31.6 -2140.838795 -28.1  
TSXVIII-XXIII -2140.633900 7.1 -2140.782831 7.1 -202.3 
XXIII -2140.644909 0.2 -2140.793916 0.0  
TSXXIII-XXIV -2140.639292 3.7 -2140.786892 4.5 -165.5 
XXIV -2140.649919 -2.9 -2140.799737 -3.6  
dcmXXIV -2141.630771 -2.9    
TSXXIV-XXV -2140.633115 7.6 -2140.782270 7.4 -28.9 
dcmTSXXIV-XXV -2141.617801 5.2    
XXV -2140.701890 -35.5 -2140.849249 -34.7  
ent-XXV -2140.697645 -32.9 -2140.843326 -30.9  
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XVIII’ -2179.935440 0 -2180.088307 0  
TS(XVIII-XIX)’ -2179.922967 7.8 -2180.074334 8.8 -165.3 
XIX’ -2179.933769 1.0 -2180.084402 2.4  
TS(XIX-XX)’ -2179.922973 7.8 -2180.072245 10.1 -266.1 
XX’ -2179.942990 -4.7 -2180.096279 -5.0  
TS(XX-XXI)’ -2179.925194 6.4 -2180.075182 8.2 -37.7 
XXI’ -2179.958868 -14.7 -2180.107158 -11.8  
TS(XXI-XXII)’ -2179.916910 11.6 -2180.064924 14.7 -290.9 
XXII’ -2179.976221 -25.6 -2180.124070 -22.4  
TS(XVIII-XXIII)’ -2179.924876 6.6 -2180.075970 7.7 -207.2 
XXIII’ -2179.936977 -1.0 -2180.088753 -0.3  
TS(XXIII-XXIV)’ -2179.935071 0.2 -2180.086197 1.3 -121.9 
XXIV’ -2179.938361 -1.8 -2180.090958 -1.7  
TS(XXIV-XXV)’ -2179.918741 10.5 -2180.069464 11.8 -49.9 
XXV’ -2179.984110 -30.5 -2180.134620 -29.1  
dcmTSXXIV-XXVI -2141.616203 6.2    
dcmXXVI -2141.617609 5.3    
dcmTSXXVI-cisXXIV -2141.616857 5.8    
dcmcis-XXIV -2141.625560 0.3    
dcmTScisXXIV-
entXXV 
-2141.619656 4.0    
TSXIVa-XXVIIa -1872.511780 22.0 -1872.648829 25.2 -359.1 
XIVa (R=Me) -1834.480459 0 -1834.617858 0  
TSXIVa (1) (R=Me) -1834.436391 27.6 -1834.571636 29.0 -244.4 
TSXIVa-XXVIIa 
(R=Me) 
-1834.440021 25.4 -1834.574564 27.2 -367.0 
a) Sum of electronic and thermal enthalpies in hartrees. In the case of solvent energies (dcm) it 
refers to E electronic energies b) Enthalpy in kcal/mol, relative to compounds XIa, XVIII or 
XVIII’. c) Sum of electronic and thermal Free Energies in hartrees. d) Free energy in kcal/mol, 
relative to compounds XIa, XVIII or XVIII’. 
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Table S2. Absolute and relative enthalpies (H) and free Gibbs energies (G) of stationary 
points for complementary Schemes 9 and 12 in the Supporting Information 
 Absolute 
enthalpy (H)a 
 
Relative 
enthalpy 
(H)b 
Absolute Free 
energy (G)c 
 
Relative 
Free 
energy 
(G)d 
Imaginary 
frequencies 
XIVa -1174.038448 -6.7 -1174.123853 -6.8  
dcmXIVa -1174.455331 -5.1    
TSXIVa (1) -1174.007528 12.7 -1174.090987 13.8 -93.0 
dcmTSXIVa(1) -1174.426689 12.9    
ent-TSXIVa (1) -1173.994680 20.8 -1174.078343 21.7 -145.2 
XVa -1174.087856 -37.7 -1174.171878 -37.0  
dcmXVa -1174.506704 -37.3    
ent-XVa -1174.088666 -38.2    
dcmTSXIVa-XXVIIIa -1174.418852 17.8    
dcmXXVIIIa -1174.424125 14.5    
dcmTSXXVIIIa-
cisXIVa 
-1174.421723 16.0    
dcmcis-XIVa -1174.451036 -2.4    
dcmTScisXIVa(1) -1174.426922 12.7    
a) Sum of electronic and thermal enthalpies in hartrees. In the case of solvent energies (dcm) it 
refers to E electronic energies. b) Enthalpy in kcal/mol, relative to compounds XIa. c) Sum of 
electronic and thermal Free Energies in hartrees. d) Free energy in kcal/mol, relative to 
compounds XIa. 
 
7.5 List of coordinates 
For list of coordinates see supporting information 
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8. Isomerization experiments for cis- and trans-5k 
 
 
 
 ppm (t1)
1.02.03.04.05.06.07.0
t = 0 min cis isomer
t = 38 min
t = 158 min
t = 416 min
7l
trans isomer
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ppm (t1)
4.004.505.005.506.006.507.007.50
trans
trans
trans
7l
7l
7l
t = 0 min
t = 38 min
t = 158 min
t = 416 min
7l
cis isomer
trans isomer
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 ppm (t1)
1.02.03.04.05.06.07.0
t = 0 min
t = 5 min
t = 30 min
t = 40 min
t = 60 min
t = 70 min
t = 80 min
7l
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 ppm (t1)
1.02.03.04.05.06.07.0
t = 0 min
t = 20 min
t = 65 min
t = 94 min
t = 106 min
7k
cis isomer
trans isomer
Chapter 3 
 
 
172 
 
 
 
 
 
 
 
 
 
 
 
ppm (t1)
1.001.50
cis
cis
cis
cis
cis
cis
t = 0 min
t = 20 min
t = 65 min
t = 94 min
t = 106 min
7k
trans isomer
cis isomer
Chapter 3 
 
 
173 
 
 
 ppm (t1)
1.02.03.04.05.06.07.0
t = 0 min
t = 2 min
t = 5 min
t = 6 min
t = 9 min
t = 12 min
7k
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CHAPTER 4 
Gold-Catalyzed Cyclopenta/heptannulation Cascades: A 
Stereocontrolled Approach to the Scaffold of Frondosins A and B  
D. Garayalde, K. Krüger and C. Nevado* 
(Angew. Chem. Int. Ed. 2011, 50, 911-915) 
 4.1 Introduction  
 Seven-membered ring carbocycles are ubiquitous motives in a wide variety of natural 
products including guanascaterpenes, colchicines, phorbols and frondosins among many others.1 
Since direct cyclizations have proved to be inefficient to construct this particular ring size, 
alternative strategies have been devised mainly focused on cycloaddition reactions.2 Both, inter- 
and intramolecular Rh-mediated [5+2] cycloadditions between vinylcyclopropanes and 
unsaturated moieties have been successfully developed.3 Another widespread method uses 
rhodium-vinyl carbenoids and dienes through formal [4+3] cycloadditions.4 However, this 
methodology still presents several drawbacks: first, the metal carbenes are generated from the 
corresponding diazo compounds, which need to be pre-synthesized adding extra steps to the 
overall process and secondly, only donor-acceptor carbenoids provide high levels of selectivity. 
The development of versatile gold complexes in recent years has revealed gold catalysis as a 
powerful tool to build up molecular complexity.5 As a representative example, the gold-catalyzed 
1,2-acyloxy migration of propargyl esters generates a gold carbene, which can undergo a broad 
palette of transformations such as nucleophilic attack,6 annulation,7 subsequent acyloxy 
rearrangement8 or olefin cyclopropanation.9 Recently, gold-catalyzed ring expansions of 
stabilized cyclopropyl rings have also been reported.10 We envisioned that a reaction sequence 
involving propargyl esters and dienes could be orchestrated in which gold not only catalyzed the 
1,2-acetoxy migration and subsequent cyclopropanation, but could also re-activate the in situ 
generated vinyl acetate triggering a formal “Homo-Cope” rearrangement to give 7-membered 
rings in a highly straightforward manner (eq. 1).11  
 Furthermore, if alkenes instead of dienes were used, upon cyclopropyl ring opening 
highly substituted cyclopentenyl acetates could be obtained (eq. 2). Herein, we report the 
realization of these concepts and an application in a formal enantioselective synthesis of marine 
secondary metabolites Frondosins A and B. 
Scheme 1. Design of a Gold-Catalyzed 1,2-Acyloxy-Rearrangement/Cyclopropanation/ 
Cycloisomerization Cascades 
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 4.2 Results and discussion  
The reaction of p-methoxyphenylpropargyl acetate (1a) and (E)-(2-methylbuta-1,3-
dienyl)benzene (A) in the presence of IPrAuNTf2 cleanly delivered cyclopropane 2aA and 
cycloheptenylacetate 4aA in a 1:2 ratio (Table 1, entry 1). In the presence of a more electrophilic 
phosphite ligand, 5- and 7-membered rings 3aA and 4aA could be detected (Table 1, entry 2). 
Tris-(2,4-di-tertbutylphenyl)phosphite-gold complex afforded similar results upon heating to 80ºC 
(Conditions I, entry 3), whereas Ph3PAuSbF6, provided a mixture of cyclopropyl 2aA and 7-
membered ring 4aA in a 1:2 ratio (Table 1, entry 4). A combination of 2.5% IPrAuNTf2 followed 
by 2.5% (PhO)3PAuSbF6 delivered 4aA in 69% yield (Conditions II, entry 5). Finally, [(2-
biphenyl)di-tertbutylphosphine]-gold complex selectively afforded 4aA in 85% yield providing 
the optimal reaction conditions (Conditions III, entry 6).  
  Table 1. Reaction Optimization[a] 
 
Entry [Au]/Solvent/Time[a] Con. Ratio
[b] 
[2/3/4]aA 
1 IPrAuNTf2, DCM, 30 min. - 1/0/2
2 (PhO)3PAuSbF6, DCM, 30 min. - 0/1/5
3 [(2,4-di-tBu-C6H3O)3P]AuSbF6, 1,2-DCE, 80 ºC, 30 min. I 0/1/3 
4 Ph3PAuSbF6, DCM, 30 min. - 1/0/2
5 
IPrAuNTf2 (2.5%), DCM, 10 min. 
then (PhO)3PAuSbF6 (2.5%), DCM, 
30 min.
II 1/1/10 (69) 
6 [(2-Biphenyl)di-tBu-phosphine]AuSbF6, DCM, 30 min. III 0/0/1 (85) 
[a] Reaction Conditions: 1a (1 equiv.), A (1.1 equiv.), [Au] (5 
mol%), T= 25ºC, concentration: 0.1 M. [b] Determined by 1H-
NMR (isolated yield).  
 We then set out to explore the scope of this gold-catalyzed intermolecular 
cycloheptannulation (Table 2). Using 1a as benchmark substrate we evaluated the influence of the 
dienic counterpart in the reaction. Congested alkenes reacted efficiently providing access to 
complex bicyclic scaffolds such as 4aB (Table 2, entry 2), whereas more reactive monosubstituted 
dienes such as C and D partially polymerized under these conditions. The bi-catalytic system 
(Conditions II, Table 1) proved to be highly efficient for this type of substrates affording the 
corresponding cycloheptenylacetates 4aC-D in high yields (Table 2, entries 3 and 4). Geranyl 
derivative E reacted with 1a upon heating to give 4aE in moderate yield (Table 2, entry 5). 
Acetates bearing 2-naphthyl-, phenyl- and 3,5-dimethoxyphenyl substitutents in the propargylic 
position (1b-d) reacted smoothly under conditions II to give the corresponding 7-membered rings 
4(b-d)C/D (Table 2, entries 6-11). 1,1-Dialkylsubstituted propargyl acetates 1e and 1f could also 
be transformed  into the corresponding cycloheptenones 5eC and 5fC upon hydrolysis of the 
reaction mixture under basic conditions  (Table 2, entries 12 and 13). This cycloheptannulation 
process is highly stereoselective, affording only cis-cycloheptenylacetates as major products.12,13 
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Table 2. Au-Catalyzed Cycloheptannulation: Reaction Scope 
 
Entry  Dienes Product [4/5] 
Cond.[a] 
Yield [b] (%) 
1 1a  
A 4aA 
III, 85 
 
 
2 1a  
B 4aB 
 
III, 59 
3 1a 
 
C  
4aC ( R2 = Ph, R3=H ) 
II, 92 
4 1a 
 
D 
4aD R2 = p-OMe-C6H4, 
R3=H 
II, 77 
5 1a 
 
E 
4aE R2 = -(CH2)2-
CH=C(Me)2, R3 = Me 
IV, 37 
6 1b C 
 
II, 72 
 
4bC R1 = 2-Napht, R2 = Ph 
7 1b D 
4bD R1= 2-Napht, 
R2 = p-OMe-C6H4- 
II, 55 
8 1c C 4cC R1 = Ph, R2 = Ph II, 80 
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9 1c D 
4cD R1 = Ph,R2 = p-OMe-
C6H4 
II, 50 
10 1d C 
4dC R1= 3,5-
dimethoxyphenyl, 
R2 = Ph 
II, 74 
11 1d D 
4dD R1=3,5-
dimethoxyphenyl, R2 = p-
OMe-C6H4 
II, 44 
12 1e C  
5eC R1 = Me 
V, 52 
13 1f C 5fC R1 = -(CH2)5- V, 79 
[a] Conditions II and III from Table 1. Cond. IV: As III but heating to 120 ºC in 1,2-
DCE; Cond. V: As IV followed by K2CO3/MeOH. [b] Isolated yields.  
 The chemoselectivity of the reaction is also remarkable, as neither cyclopropane 
intermediates (2)14 nor products of a competitive intramolecular hydroarylation could be detected 
under these conditions.15 
 We hypothesized that alkenes could also participate in this gold-catalyzed cascade (Table 
3). The reaction of 1a with 4-methoxystyrene (F) (1 equiv.) in the presence of tris-(2,4-di-
tertbutylphenyl)phosphite-gold complex under conditions I proved to be extremely efficient 
affording cyclopentenone 6aF in 90% yield. 6aF is formed upon in situ hydrolysis of the 
corresponding cyclopentenylacetate under the reaction conditions (Table 3, entry 1).16 Different 
substitution patterns in the olefinic counterpart were then examined. 1-Methoxy-4-(prop-1-en-2-
yl)benzene (G), (Z)-1-methoxy-4-(prop-1-enyl)benzene (H) and 5-vinylbenzo-[d]-[1,3]-dioxole 
(I) reacted with 1a affording ketones 6aG-I in good yields (Table 3, entries 2-4). Alcoxy vinyl 
ethers (J-K) reacted smoothly with 1a at room temperature furnishing the corresponding 
cyclopentenyl acetates 3aJ-K (Table 3, entries 5 and 6). A bulkier pivaloyl ester (1g) was also 
tolerated affording 3gJ in 82% yield (Table 3, entry 7). Comparable results were also obtained for 
2-naphthyl (1b), 3-methoxyphenyl (1h) and benzo-[d]-1,3-dioxole (1i) substituted propargyl 
acetates as shown in entries 8 to 14 of Table 3. The reaction is also highly diastereoselective 
since, in most cases, only trans-2,3-disubstituted cyclopentenyl derivatives were observed.12 
Table 3. Au-Catalyzed Cyclopentannulation: Reaction Scope 
 
Entry  Olefin 
Product 
[3/6] 
Yield [a](%) 
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1 1a 
 
 
F 
 
6aF (R2= p-OMe-C6H4, R3= R4=H) 
90 
2 1a 
p-OMe-C6H4  
G 
6aG (R2= p-OMe-C6H4, R3= Me, 
R4=H) 
82[b] 
3 1a 
p-OMe-C6H4
 
H 
6aH (R2= p-OMeC6H4, R3= H, 
R4= Me) 
78 
4 1a 
O
O  
I 
6aI (R2 =  , R3=R4=H) 63 
5 1a 
 
J 
 
3aJ (X = OAc, R2 = OBn) 
83[c] 
6 1a 
 
K 
3aK (X = OAc,  R2 = OEt) 75[c,d] 
7 1g J 3gJ (X = OPiv, R2 = OBn) 82[c] 
8 1b J  
3bJ (R2 = OBn) 
79[c] 
9 1b K 3bK (R2 = OEt) 73[c,d] 
10 1h K  
3hK 
60[c,d] 
11 1i J 
 
3iJ (R2 = OBn) 
87[c] 
12 1i K 3iK (R2 = OEt) 87[c,d] 
13 1i 
 
L 
3iL (R2 = OBu) 59[c] 
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14 1i 
 
M 
3iM (R2 = OtBu) 87[c,d] 
[a] Isolated yields of compounds obtained as single diastereoisomers unless 
otherwise stated. [b] Upon hydrolysis of the crude mixture with K2CO3 (2 
equiv.), MeOH, rt, 30 min (d.r. 7:1). rt, 1 h. [c] Reaction at room temperature. 
[d] Olefin (5 equiv.). 
 A possible mechanism for these transformations is shown in Scheme 2. The gold-
mediated isomerization of the propargyl ester leads to Au-carbene, which reacts with the olefinic 
counterpart to form a cis-cyclopropane intermediate.9 Subsequent gold re-activation of the vinyl 
acetate moiety triggers the cyclopropyl ring opening provided stabilization of the in situ generated 
δ+ is present, forming a 1,5-dipole.10 An envelope conformation is proposed for the transition state 
with substituents disposed in a trans-pseudodiaxial fashion to minimize torsional/steric 
interactions yielding trans-2,3-disubstituted cyclopentannulation products 3 (Path a).17 In contrast, 
when 1,4-dienes were used, the cyclopropyl system undergoes a Au-catalyzed Cope 
rearrangement delivering cis-2,3-disubstituted cycloheptenyl acetates 4 (Path b).11 A boat-like 
transition state is proposed in this case to account for the observed cis-relative stereochemistry. 
Scheme 2. Mechanistic Proposal 
 
 To capitalize on the structural complexity built up in the formal Au- catalyzed [4+3] 
cycloaddition, we envisioned a synthetic application towards the core of Frondosins, marine 
norsesquiterpenoids with promising biological activities, particularly Frondosin A, the most 
potent member of the series.18 Several approaches towards the core of Frondosins have been 
disclosed but only one enantioselective synthesis of (+)-Frondosin A has been reported so far.19 
Treatment of acetate 1j and 6,6-dimethyl-1-vinyl cyclohexene (N) with (S)-OMe-DTBM-
BIPHEP-gold(I) complex afforded, quantitatively, the corresponding bicyclic cycloheptenyl 
pivaloate. In situ hydrolysis and subsequent equilibration with NaOMe/MeOH yielded 
thermodynamically favored ketone 7 in 68% yield and >90% ee (eq. 3).12 Since this bicyclic 
enone has been recently elaborated to Frondosins A and B,20 our approach represents a 
streamlined formal enantioselective synthesis of both molecules.   
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Scheme 3. Formal Total Synthesis of Frondosins A and B 
 
  
 4.3 Conclusion 
 In summary, we report here two highly diastereoselective, gold-catalyzed 3-steps-cascade 
processes for the synthesis of highly substituted five and seven-membered rings from propargyl 
acetates and alkenes or 1,4-dienes, respectively. The reaction favors trans-2,3-disubstituted 
cyclopentenylacetates through a tightly bound carbocationic transition state whereas the gold-
catalyzed Cope rearrangement delivers cis-2,3-disubstituted cyclopheptenylacetates.  This gold-
catalyzed formal [4+3] cycloaddition represents an attractive alternative to previously reported 
Rh-catalyzed methodology both in terms of atom-economy and functional group tolerance. In 
addition, the concerted nature of the process has allowed an alternative, formal enantioselective 
synthesis of both Frondosins A and B.  
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1. General information 
 
 All reactions were carried under non-inert atmosphere. All reagents were used as received 
unless otherwise noted. Solvents were purchased in HPLC quality, degassed by purging 
thoroughly with nitrogen and dried over activated molecular sieves of appropriate size. 
Alternatively, they were purged with argon and passed through alumina columns in a solvent 
purification system (Innovative Technology). The olefins C, F, K, L, and M are commercially 
available by Aldrich. The following compounds were prepared according to previously reported 
procedures:  (1a, 1b, 1c)1; 1e2; 1f3; 1g4; (1i, 1h, 1d)5; A6; B7; D8; E9; G10; H11; I12; J13; N14. 
Reactions were monitored by thin layer chromatography (TLC) using Merck TLC silica gel 60 
F254. Flash column chromatography was performed over silacycle silica gel (230-400 mesh). 
NMR spectra were recorded on AV2 400 or AV2 500 MHz Bruker spectrometers. Chemical 
shifts are given in ppm. The spectra are calibrated to the residual 1H and 13C signals of the 
solvents. Multiplicities are abbreviated as follows: singlet (s), doublet (d), triplet (t), quartet (q), 
doublet-doublet (dd), doublet-doublet-doublet (ddd), quintet (quint), septet (sept), multiplet (m), 
and broad (br). Infrared spectra were recorded on a JASCO FT/IR-4100 spectrometer. High-
resolution electrospray ionization mass spectrometry was performed on a Finnigan MAT 900 
(Thermo Finnigan, San Jose, CA; USA) doublefocusing magnetic sector mass spectrometer 10 
spectra were acquired. A mass accuracy ≤ 2 ppm was obtained in the peak matching acquisition 
mode by using a solution containing 2 <l PEG200, 2 <l PPG450, and 1.5 mg NaOAc (all obtained 
from Sigma-Aldrich, CH-Buchs) dissolved in 100ml MeOH (HPLC Supra grade, Scharlau, E-
Barcelona) as internal standard. HPLC was performed on Jasco PU-2089 plus instrument using a 
MD-2018 plus photodiode array detector and 0.46 x 25 cm Chiralcel OD-H columns 
(hexane/isopropanol). [α]D  value was recorded on JASCO P-2000 Polarimeter at 25 oC. 
 
2. Experimental Procedures 
All reactions were run between 0.1 and 0.5 mmol scale. 
 
 
I. To a solution of the corresponding propargyl acetate (1.0 equiv.) and diene (1.1 equiv.) in 
1,2-DCE (0.1 M), (1,4-di-tBu-C6H3O)3PAuSbF6  (0.05 equiv.) was added. The mixture 
was stirred at 80 0C for 30 minutes. The reaction was quenched with triethylamine (0.05 
equiv.). The solvent was removed under reduce pressure giving the corresponding 
cyclopenten- and cycloheptenylacetates in 1:3 ratio. 
 
II. To a solution of the corresponding propargyl acetate (1.0 equiv.) and diene (1.1 equiv.) in 
DCM (0.1 M), IPrAuNTf2 (0.025 equiv.) was added. The mixture was stirred at room 
temperature for 10 minutes. Then (PhO)3PAuSbF6 (0.025 equiv.) was added and the 
mixture was stirred at room temperature for 30 minutes. The reaction was quenched with 
triethylamine (0.05 equiv.) and the solvent was removed under reduce pressure. The 
residue was purified by column chromatography (Hex:AcOEt) to give the corresponding 
cycloheptenylacetates in 44-92% yield. 
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III. To a solution of the corresponding propargyl acetate (1.0 equiv.) and diene (1.1 equiv.) in 
DCM (0.1 M), [(2-biphenyl)-di-tert-butyl-phosphine]AuSbF6 (0.05 equiv.) was added. 
The mixture was stirred at room temperature for 30 minutes. The reaction was quenched 
with triethylamine (0.05 equiv. The solvent was removed under reduce pressure. The 
residue was purified by column chromatography (Hex:AcOEt) to give the corresponding 
cycloheptenylacetate in 59-85% yield. 
 
IV. To a solution of the corresponding propargyl acetate (1.0 equiv.) and the corresponding 
diene (1.1 equiv.) in 1,2-DCE (0.1 M), [(2-biphenyl)-di-tert-butyl-phosphine]AuSbF6 
(0.05 equiv.) was added. The mixture was stirred at room temperature for 30 minutes and 
the mixture was stirred at 120 oC for 12 hours. The solvent was removed under reduce 
pressure. The residue was purified by column chromatography (Hex:AcOEt) to give the 
corresponding cycloheptenylacetate in 37% yield. 
 
V. To a solution of the corresponding propargyl acetate (1.0 equiv.) and the corresponding 
diene (1.1 equiv.) in 1,2-DCE (0.1 M), [(2-biphenyl)-di-tert-butyl-phosphine]AuSbF6 
(0.05 equiv.) was added. The mixture was stirred at room temperature for 30 minutes and 
the mixture was stirred at 120 oC for 12 hours. The solvent was removed under reduce 
pressure. Then K2CO3 (2 equiv.) and methanol were added and the mixture was stirred at 
room temperature for 30 minutes. The mixture was filtrated over Celite®. The solvent 
was removed under reduce pressure. The residue was purified by column chromatography 
(Hex:AcOEt) to give the corresponding cyclohept-4-enones in 52-79% yield. 
 
For 5-membered rings: 
 
 
 To a solution of the corresponding propargyl acetate (1.0 equiv.) and the corresponding 
olefin (1.1 equiv.) in 1,2-DCE (0.1M), (1,4-di-tBu-C6H3O)3PAuSbF6 (0.05 equiv.) was added. 
The mixture was stirred at 80 oC for 12 hours. The reaction was quenched with triethylamine (0.05 
equiv.). The solvent was evaporated under reduce pressure and the residue was purified by 
column chromatography (Hex:AcOEt) to give the corresponding cyclopentanones in 56-90% 
yield. 
 
 
 
 To a solution of the corresponding propargyl ester (1.0 equiv.) and the corresponding 
olefin (1.1 equiv.) in 1,2-DCE (0.1 M), (1,4-di-tBu-C6H3O)3PAuSbF6 (0.05 equiv.) was added. 
The mixture was stirred at room temperature for 1 hour. The reaction was quenched with 
triethylamine (0.05 equiv.). The solvent was evaporated under reduce pressure and the residue 
was purified by column chromatography (gradient Hex:AcOEt) to give the corresponding 
cyclopent-1-enyl esters in 59-87% yield. 
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 To a solution of the corresponding propargyl acetate (1.0 equiv.) and ethyl vinyl ether 
(5.0 equiv.) in 1,2-DCE (0.1M), (1,4-di-tBu-C6H3O)3PAuSbF6 (0.05 equiv.) was added. The 
mixture was stirred at room temperature for 1 hour. The reaction was quenched with triethylamine 
(0.05 equiv.). The solvent was evaporated under reduce pressure and the residue was purified by 
column chromatography (Hex:AcOEt 8:1) to give the corresponding cyclopent-1-enyl acetates in 
60-87% yield. 
 
 
 
 To a solution of propargyl acetate 1a (0.060 mmol, 1.0 equiv.) and olefin G (0.066 mmol, 
1.1 equiv.) in 1,2-DCE (1.18 mL, 0.1M), (2,4-di-tBu-C6H3O)3PAuSbF6 (0.003 mmol, 0.05 equiv.) 
was added. The mixture was stirred at 80 oC for 12 hours. The reaction was quenched with 
triethylamine (0.05 equiv.). The solvent was evaporated under reduce pressure. Then K2CO3 and 
methanol were added and the mixture was stirred at room temperature for 1 hour. The reaction 
was quenched with brine and extracted with DCM (3 x 5 mL). The combined organic layers were 
dried over Na2SO4 and the solvent was removed under reduce pressure. The residue was purified 
by column chromatography (Hex: AcOEt 10:1) to give the corresponding cyclopentanone 6aG 
(15 mg) in 82% yield.  
 
3. Additional Experiments (Ref. 13, 14, 16) 
Ref. 14 
Equations 1, 2 and 3 confirm that cyclopropane intermediates (2) are not transformed into 
the corresponding 7-membered rings in the absence of gold-catalyst, thus ruling out a 
metal-free Cope rearrangement pathway. 
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AcO
Ph
MeO
2aA
(from the reaction of 1a + A in presence of IPrAuNTf2)
1,2-DCE
25ºC to 80ºC
s. m.
AcO
MeO
2aB
(from the reaction of 1a + B in presence of IPrAuNTf2)
1,2-DCE
25ºC to 80ºC
s. m.
AcO
Ph
MeO
2aC
(from the reaction of 1a + C in presence of IPrAuNTf2)
1,2-DCE
25ºC to 80ºC
s. m.
(eq. 1)
(eq. 2)
(eq. 3)
 
 
Cyclopropyl 2aB can be transformed into cyclopentenylacetate 4aB upon stirring in the 
presence of [(2-Biphenyl)(tBu)2]PAuSbF6 (eq. 4). 
 
 
 
Ref. 13 
Equations 5 and 6 are representative of a one-pot procedure for the hydrolysis of the “in 
situ” generated cis-disubstituted cycloheptenyl acetates (4) to the corresponding trans-
cycloheptenones (5). 
 
 
 
Ref. 16 
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To confirm that cis-cyclopropanes are the actual intermediates in the gold-catalyzed 
cyclopentannulation, cyclopropane 2aF was submitted to the standard reaction conditions 
affording cyclopentanone 6aF (Equation 7). 
 
 
 
A mixture of cyclopentylacetate 3aF and cyclopentanone 6aF (1:3) was transformed into 
6aF under the standard reaction conditions confirming that the observed 5-membered ring 
ketones (6) were produced by hydrolysis of the corresponding cyclopentenyl acetates (3) 
under the reaction conditions. 
 
 
 
Assignment of the Relative Stereochemistry for compounds 4-5 
 
When acetate 4aC was hydrolyzed to the corresponding ketone with K2CO3/MeOH over 2 
hours, 5aC was the only product detected in the reaction mixture. Based on the value of 
the J3 coupling constant between H1 and H2 (JH1-H2 = 10 Hz) we assumed a trans-relative 
configuration for cyclopentenone 5aC (confirmed by X-Ray diffraction of 5aA (JH1-H2 = 
10 Hz), see forthcoming section 4 in this SI). However, when the hydrolysis reaction was 
stopped after only 40 min, the formation of two different ketones was observed: 5aC but 
also cis-5aC (JH1-H2 = 4 Hz) was present in the mixture (eq. 9). This result indicates that 
the relative stereochemistry in the starting cyclopentenyl acetates is “cis” and, as a result 
of the direct hydrolysis of 4aC, cis-5aC is detected after short reaction times, whereas 5aC 
is obtained as a result of the hydrolysis + equilibration to the thermodynamically favored 
trans-2,3-disubstituted product. A similar outcome was observed for acetate 4dA (eq. 10).  
 
OAc
Ph
MeO
K2CO3 (2 equiv.),
MeOH, rt, 40min
4aC
O
Ph
MeO
O
Ph
MeO
+
cis-5aC 5aCratio 1:0.65
H1
H2
H1
H2
(JcisH1-H2 = 4 Hz) (JtransH1-H2 = 10 Hz)
(eq. 9)
OAc
Ph
K2CO3 (2 equiv.),
MeOH, rt, 40min
4dA
O
Ph
O
Ph
+
cis-5dA 5dAratio 1:1.29
H1
H2
H1
H2 (eq. 10)
MeO
OMe OMe
MeO
OMe
MeO
(JcisH1-H2 = 4 Hz) (JtransH1-H2 = 10 Hz)  
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In addition, NOE-experiments were performed on key cycloheptenyl acetates to confirm 
the cis-relative stereochemistry of products 4 (Scheme 1). All traces of NOE-experiments 
can be found in Section 9 of this SI. 
 
 
(Scheme 1) 
 
Assignment of the Relative Stereochemistry for compounds 3-6 
 
 One of the few examples where two isomers were observed in the cyclopentannulation 
reaction was compound 3cF which was obtained in a 3:1 diastereomeric ratio. The NOE studies 
confirmed the “trans” relationship between the two aromatic substituents in the major isomer 
(Scheme 2). Upon hydrolysis of this mixture with K2CO3/MeOH only one compound was 
obtained (6cF), which was assigned to the thermodynamically more stable trans-2,3-disubstituted 
cyclopentanone. 
 
 
 
 In accordance with the previous result, the hydrolysis of cyclopentenyl acetates 3aF, 3aH 
and 3aI (single diastereoisomers) with K2CO3/MeOH gave the corresponding “trans” ketones 
6aF, 6aH and 6aI. Analysis of the hydrolysis mixtures at shorter reaction times only showed the 
presence of the “trans” cyclopentenones, thus confirming that in this case, the starting 
cyclopentenyl acetates are the “trans”-2,3-disubstituted diastereoisomers. In addition NOE 
experiments also confirmed the 2,3-“trans” relative stereochemistry in ketone 6aH (Scheme 3). 
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(Scheme 3) 
 
 
 
4. X-Ray Structure of 5aA 
 
List of Tables 
 1. Experimental Details 
 2. Positional and Equivalent Isotropic Displacement Parameters for Non-H Atoms 
 3. Bond Lengths 
 4. Bond Angles 
 5. Torsional Angles 
 6. General Atomic Displacement Parameter Expressions, Uij's 
 7. Positional and Displacement Parameters for Hydrogen Atoms 
 
Figure Captions 
 1. ORTEP1 representation of the molecule (50% probability ellipsoids; H-atoms 
given 
  arbitrary displacement parameters for clarity) 
 
Definition of Terms 
 Function minimized:  w(Fo2 – Fc2)2 
   where w = [ 2(Fo2) + (aP)2 + bP]-1 and P = (Fo2 + 2Fc2) / 3 
O
O
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    Fo2 = S(C – RB) / Lp 
   and  2(Fo2) = S2(C + R2B) / Lp2 
   S  = Scan rate 
   C  = Total integrated peak count 
   R  = Ratio of scan time to background counting time 
   B  = Total background count 
   Lp = Lorentz-polarization factor 
 
 R-factors: Rint = |<Fo2> – Fo2| / Fo2 summed only over reflections for which more 
than one symmetry equivalent was measured. 
 R(F) = ||Fo| – |Fc|| / |Fo| summed over all observed reflections. 
 wR(F2) = [w(Fo2 – Fc2)2 / w(Fo2)2]1/2 summed over all reflections. 
 Standard deviation of an observation of unit weight (goodness of fit):  [w(Fo2 – Fc2)2 / 
(No – Nv)]1/2 where  No = number of observations;  Nv = number of variables. 
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NOTES 
 The structure of C21H22O2 (NBC-NA-311) has been solved and refined successfully 
with no unusual features.  Since the space group is centrosymmetric, the compound in the crystal 
is racemic.  The phenyl substituents are trans-disposed. 
 
EXPERIMENTAL 
 Crystal-Structure Determination. – A crystal of C21H22O2, obtained from CH2Cl2 / 
pentane, was mounted on a glass fibre and used for a low-temperature X-ray structure 
determination.  All measurements were made on a Nonius KappaCCD area-detector 
diffractometer2 using graphite-monochromated Mo K radiation ( = 0.71073 Å) and an Oxford 
Cryosystems Cryostream 700 cooler.  The unit cell constants and an orientation matrix for data 
collection were obtained from a least-squares refinement of the setting angles of 3352 reflections 
in the range 4° < 2 < 50°.  The mosaicity was 1.047(1)°.  A total of 685 frames were collected 
using  and  scans with  offsets, 26 seconds exposure time and a rotation angle of 0.6° per 
frame, and a crystal-detector distance of 36.7 mm. 
 Data reduction was performed with HKL Denzo and Scalepack3.  The intensities were 
corrected for Lorentz and polarization effects, but not for absorption.  The space group was 
uniquely determined by the systematic absences.  Equivalent reflections were merged.  The data 
collection and refinement parameters are given in Table 1.  A view of the molecule is shown in 
the Figure. 
 The structure was solved by direct methods using SHELXS97 4, which revealed the 
positions of all non-hydrogen atoms.  The non-hydrogen atoms were refined anisotropically.  All 
of the H-atoms were placed in geometrically calculated positions and refined by using a riding 
model where each H-atom was assigned a fixed isotropic displacement parameter with a value 
equal to 1.2Ueq of its parent atom (1.5Ueq for the methyl groups).  The refinement of the 
structure was carried out on F2 by using full-matrix least-squares procedures, which minimised 
the function w(Fo2 – Fc2)2.  The weighting scheme was based on counting statistics and 
included a factor to downweight the intense reflections.  Plots of w(Fo2 – Fc2)2 versus 
Fc/Fc(max) and resolution showed no unusual trends.  A correction for secondary extinction was 
applied.  Five reflections, whose intensities were considered to be extreme outliers, were omitted 
from the final refinement. 
 Neutral atom scattering factors for non-hydrogen atoms were taken from Maslen, Fox and 
O'Keefe5a, and the scattering factors for H-atoms were taken from Stewart, Davidson and 
Simpson6.  Anomalous dispersion effects were included in Fc7; the values for f' and f" were those 
of Creagh and McAuley5b.  The values of the mass attenuation coefficients are those of Creagh 
and Hubbel5c.  The SHELXL97 program8 was used for all calculations. 
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Table 1.  Crystallographic Data 
 
Crystallised from CH2Cl2 / pentane  
Empirical formula C21H22O2  
Formula weight [g mol-1] 306.40  
Crystal colour, habit colourless, prism  
Crystal dimensions [mm] 0.20  0.20  0.25  
Temperature [K] 160(1)  
Crystal system orthorhombic  
Space group Pbca  (#61)  
Z 8  
Reflections for cell determination 3352  
2 range for cell determination [°] 4 – 50  
Unit cell parameters a [Å] 9.0944(3)  
 b [Å] 15.1241(6)  
 c [Å] 24.6533(9)  
  [°] 90  
  [°] 90  
   [°] 90  
 V [Å3] 3390.9(2)  
F(000) 1312  
Dx [g cm-3] 1.200  
(Mo K) [mm-1] 0.0754  
Scan type  and   
2(max) [°] 50  
Total reflections measured 36262  
Symmetry independent reflections 2973  
Rint 0.112  
Reflections with I > 2(I) 1910  
Reflections used in refinement 2968  
Parameters refined 211  
Final R(F) [I > 2(I) reflections] 0.0564  
 wR(F2) (all data) 0.1374  
Weights: w = [2(Fo2) + (0.0473P)2 + 0.6876P]-1 where P = (Fo2 + 
2Fc2)/3  
Goodness of fit 1.136  
Secondary extinction coefficient 0.0029(8)  
Final max/ 0.001  
Chapter 4 
 
 
200 
 
 (max; min) [e Å-3] 0.18; -0.20  
(d(C – C)) [Å] 0.003 – 0.004  
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TABLE 2.  Fractional atomic coordinates and equivalent isotropic 
displacement 
          parameters (Å2) with standard uncertainties in parentheses. 
 
* Ueq is defined as one third of the trace of the orthogonalized U
ij 
tensor. 
 
ATOM          x             y             z            Ueq
* 
 
O(1)       1.0955(2)     0.7621(1)     0.36004(6)    0.0506(5) 
O(2)       0.9888(2)     0.8913(1)     0.59864(6)    0.0534(5) 
C(1)       0.9665(2)     0.7467(1)     0.35171(9)    0.0399(6) 
C(2)       0.8445(2)     0.7947(1)     0.38190(9)    0.0373(6) 
C(3)       0.7984(2)     0.8783(1)     0.34881(9)    0.0376(6) 
C(4)       0.7786(2)     0.8672(2)     0.28812(9)    0.0414(6) 
C(5)       0.7644(2)     0.7917(2)     0.2614(1)     0.0475(6) 
C(6)       0.7722(2)     0.6993(2)     0.2834(1)     0.0475(6) 
C(7)       0.9210(2)     0.6797(2)     0.30976(9)    0.0466(6) 
C(8)       0.8831(2)     0.8183(1)     0.43996(9)    0.0360(6) 
C(9)       1.0029(2)     0.8724(1)     0.45257(9)    0.0385(6) 
C(10)      1.0352(2)     0.8943(1)     0.50509(9)    0.0401(6) 
C(11)      0.9474(2)     0.8646(1)     0.54732(9)    0.0402(6) 
C(12)      0.8266(2)     0.8118(1)     0.53622(9)    0.0427(6) 
C(13)      0.7972(2)     0.7894(1)     0.48262(9)    0.0413(6) 
C(14)      0.8908(3)     0.8736(2)     0.64224(9)    0.0520(7) 
C(15)      0.6607(2)     0.9189(1)     0.37434(9)    0.0387(6) 
C(16)      0.6676(3)     0.9952(2)     0.40487(9)    0.0450(6) 
C(17)      0.5422(3)     1.0282(2)     0.4300(1)     0.0551(7) 
C(18)      0.4097(3)     0.9851(2)     0.4247(1)     0.0570(7) 
C(19)      0.4021(3)     0.9103(2)     0.3934(1)     0.0616(8) 
C(20)      0.5259(2)     0.8774(2)     0.3682(1)     0.0518(7) 
C(21)      0.7714(3)     0.9544(2)     0.2582(1)     0.0638(8) 
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TABLE 3.  Bond lengths (Å) with standard uncertainties in parentheses. 
 
O(1)  -C(1)     1.214(2)                    C(8)  -C(13)    1.381(3) 
O(2)  -C(11)    1.381(3)                    C(8)  -C(9)     1.398(3) 
O(2)  -C(14)    1.422(3)                    C(9)  -C(10)    1.369(3) 
C(1)  -C(7)     1.506(3)                    C(10) -C(11)    1.387(3) 
C(1)  -C(2)     1.520(3)                    C(11) -C(12)    1.385(3) 
C(2)  -C(8)     1.517(3)                    C(12) -C(13)    1.390(3) 
C(2)  -C(3)     1.563(3)                    C(15) -C(16)    1.380(3) 
C(3)  -C(4)     1.516(3)                    C(15) -C(20)    1.385(3) 
C(3)  -C(15)    1.530(3)                    C(16) -C(17)    1.390(3) 
C(4)  -C(5)     1.326(3)                    C(17) -C(18)    1.377(4) 
C(4)  -C(21)    1.512(3)                    C(18) -C(19)    1.371(3) 
C(5)  -C(6)     1.501(3)                    C(19) -C(20)    1.379(3) 
C(6)  -C(7)     1.530(3) 
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TABLE 4.  Bond angles (°) with standard uncertainties in parentheses. 
 
C(11) -O(2)  -C(14)    117.9(2)             C(13) -C(8)  -C(2)     
120.9(2) 
O(1)  -C(1)  -C(7)     120.7(2)             C(9)  -C(8)  -C(2)     
121.9(2) 
O(1)  -C(1)  -C(2)     122.1(2)             C(10) -C(9)  -C(8)     
121.3(2) 
C(7)  -C(1)  -C(2)     117.2(2)             C(9)  -C(10) -C(11)    
120.5(2) 
C(8)  -C(2)  -C(1)     113.9(2)             O(2)  -C(11) -C(12)    
124.5(2) 
C(8)  -C(2)  -C(3)     111.3(2)             O(2)  -C(11) -C(10)    
115.9(2) 
C(1)  -C(2)  -C(3)     109.0(2)             C(12) -C(11) -C(10)    
119.7(2) 
C(4)  -C(3)  -C(15)    110.7(2)             C(11) -C(12) -C(13)    
118.7(2) 
C(4)  -C(3)  -C(2)     117.2(2)             C(8)  -C(13) -C(12)    
122.5(2) 
C(15) -C(3)  -C(2)     109.2(2)             C(16) -C(15) -C(20)    
118.6(2) 
C(5)  -C(4)  -C(21)    120.3(2)             C(16) -C(15) -C(3)     
121.6(2) 
C(5)  -C(4)  -C(3)     126.7(2)             C(20) -C(15) -C(3)     
119.8(2) 
C(21) -C(4)  -C(3)     112.9(2)             C(15) -C(16) -C(17)    
120.4(2) 
C(4)  -C(5)  -C(6)     128.2(2)             C(18) -C(17) -C(16)    
120.3(2) 
C(5)  -C(6)  -C(7)     112.1(2)             C(19) -C(18) -C(17)    
119.3(2) 
C(1)  -C(7)  -C(6)     113.9(2)             C(18) -C(19) -C(20)    
120.6(2) 
C(13) -C(8)  -C(9)     117.2(2)             C(19) -C(20) -C(15)    
120.7(2) 
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TABLE 5.  Torsion angles (°) with standard uncertainties in parentheses. 
 
O(1)  -C(1)  -C(2)  -C(8)    -33.7(3)      C(2)  -C(8)  -C(9)  -C(10)   
179.0(2) 
C(7)  -C(1)  -C(2)  -C(8)    147.4(2)      C(8)  -C(9)  -C(10) -C(11)    
-1.2(3) 
O(1)  -C(1)  -C(2)  -C(3)     91.4(2)      C(14) -O(2)  -C(11) -C(12)    
-8.8(3) 
C(7)  -C(1)  -C(2)  -C(3)    -87.5(2)      C(14) -O(2)  -C(11) -C(10)   
170.9(2) 
C(8)  -C(2)  -C(3)  -C(4)    171.2(2)      C(9)  -C(10) -C(11) -O(2)   -
179.3(2) 
C(1)  -C(2)  -C(3)  -C(4)     44.6(2)      C(9)  -C(10) -C(11) -C(12)     
0.4(3) 
C(8)  -C(2)  -C(3)  -C(15)   -62.0(2)      O(2)  -C(11) -C(12) -C(13)  -
179.8(2) 
C(1)  -C(2)  -C(3)  -C(15)   171.5(2)      C(10) -C(11) -C(12) -C(13)     
0.5(3) 
C(15) -C(3)  -C(4)  -C(5)   -110.3(2)      C(9)  -C(8)  -C(13) -C(12)    
-0.3(3) 
C(2)  -C(3)  -C(4)  -C(5)     15.9(3)      C(2)  -C(8)  -C(13) -C(12)  -
178.1(2) 
C(15) -C(3)  -C(4)  -C(21)    68.0(2)      C(11) -C(12) -C(13) -C(8)     
-0.5(3) 
C(2)  -C(3)  -C(4)  -C(21)  -165.8(2)      C(4)  -C(3)  -C(15) -C(16)  -
124.5(2) 
C(21) -C(4)  -C(5)  -C(6)    178.3(2)      C(2)  -C(3)  -C(15) -C(16)   
105.0(2) 
C(3)  -C(4)  -C(5)  -C(6)     -3.5(4)      C(4)  -C(3)  -C(15) -C(20)    
57.3(3) 
C(4)  -C(5)  -C(6)  -C(7)    -60.2(3)      C(2)  -C(3)  -C(15) -C(20)   
-73.2(3) 
O(1)  -C(1)  -C(7)  -C(6)   -150.3(2)      C(20) -C(15) -C(16) -C(17)     
1.7(3) 
C(2)  -C(1)  -C(7)  -C(6)     28.6(3)      C(3)  -C(15) -C(16) -C(17)  -
176.6(2) 
C(5)  -C(6)  -C(7)  -C(1)     52.4(3)      C(15) -C(16) -C(17) -C(18)    
-0.1(4) 
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C(1)  -C(2)  -C(8)  -C(13)  -122.9(2)      C(16) -C(17) -C(18) -C(19)    
-1.3(4) 
C(3)  -C(2)  -C(8)  -C(13)   113.2(2)      C(17) -C(18) -C(19) -C(20)     
1.1(4) 
C(1)  -C(2)  -C(8)  -C(9)     59.3(3)      C(18) -C(19) -C(20) -C(15)     
0.5(4) 
C(3)  -C(2)  -C(8)  -C(9)    -64.5(2)      C(16) -C(15) -C(20) -C(19)    
-1.9(4) 
C(13) -C(8)  -C(9)  -C(10)     1.2(3)      C(3)  -C(15) -C(20) -C(19)   
176.4(2) 
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TABLE 6.  Anisotropic atomic displacement parameters (Å2). 
 
ATOM     U11         U22         U33         U23         U13         U12 
 
O(1)   0.028(1)    0.073(1)    0.051(1)   -0.0025(8)   0.0016(7)   
0.0038(8) 
O(2)   0.049(1)    0.075(1)    0.037(1)   -0.0044(8)   0.0010(8)  -
0.0125(8) 
C(1)   0.031(1)    0.048(1)    0.041(1)    0.006(1)    0.002(1)    
0.003(1) 
C(2)   0.024(1)    0.044(1)    0.044(1)    0.001(1)    0.004(1)   -
0.002(1) 
C(3)   0.027(1)    0.041(1)    0.045(1)    0.001(1)   -0.002(1)   -
0.002(1) 
C(4)   0.034(1)    0.047(2)    0.043(2)    0.002(1)    0.001(1)    
0.005(1) 
C(5)   0.039(1)    0.061(2)    0.042(2)    0.000(1)   -0.003(1)    
0.007(1) 
C(6)   0.039(1)    0.055(2)    0.048(2)   -0.009(1)    0.002(1)   -
0.005(1) 
C(7)   0.042(1)    0.048(2)    0.050(2)   -0.002(1)    0.004(1)    
0.004(1) 
C(8)   0.027(1)    0.041(1)    0.039(1)    0.002(1)    0.001(1)    
0.002(1) 
C(9)   0.027(1)    0.046(1)    0.042(2)    0.002(1)    0.003(1)   -
0.004(1) 
C(10)  0.027(1)    0.047(1)    0.046(2)   -0.002(1)   -0.002(1)   -
0.003(1) 
C(11)  0.036(1)    0.046(1)    0.039(2)    0.000(1)   -0.001(1)    
0.002(1) 
C(12)  0.036(1)    0.049(1)    0.043(2)    0.001(1)    0.007(1)   -
0.004(1) 
C(13)  0.031(1)    0.044(1)    0.048(2)    0.000(1)    0.001(1)   -
0.006(1) 
C(14)  0.047(2)    0.070(2)    0.039(2)   -0.001(1)    0.001(1)    
0.004(1) 
C(15)  0.028(1)    0.047(1)    0.041(1)    0.002(1)   -0.002(1)    
0.002(1) 
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C(16)  0.043(2)    0.051(2)    0.042(2)   -0.003(1)   -0.003(1)    
0.002(1) 
C(17)  0.067(2)    0.055(2)    0.044(2)   -0.002(1)    0.001(1)    
0.014(1) 
C(18)  0.046(2)    0.070(2)    0.055(2)    0.008(2)    0.010(1)    
0.017(1) 
C(19)  0.033(2)    0.070(2)    0.081(2)    0.000(2)    0.004(1)    
0.002(1) 
C(20)  0.032(2)    0.052(2)    0.072(2)   -0.009(1)    0.005(1)   -
0.001(1) 
C(21)  0.075(2)    0.063(2)    0.053(2)    0.005(1)    0.000(1)    
0.013(1) 
 
The anisotropic displacement parameter exponent takes the form: 
 
-2•2(h2a*2U11+k2b*2U22+ ... +2hka*b*U12) 
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TABLE 7.  Hydrogen atom coordinates and displacement parameters. 
 
ATOM          x             y             z            Uiso 
 
H(2)       0.758         0.754         0.383         0.045 
H(3)       0.879         0.922         0.354         0.045 
H(5)       0.747         0.797         0.223         0.057 
H(61)      0.755         0.657         0.253         0.057 
H(62)      0.693         0.691         0.311         0.057 
H(71)      0.917         0.621         0.327         0.056 
H(72)      0.997         0.677         0.281         0.056 
H(9)       1.063         0.894         0.424         0.046 
H(10)      1.118         0.930         0.513         0.048 
H(12)      0.765         0.791         0.565         0.051 
H(13)      0.715         0.753         0.475         0.050 
H(141)     0.795         0.900         0.634         0.078 
H(142)     0.930         0.899         0.676         0.078 
H(143)     0.880         0.810         0.647         0.078 
H(16)      0.758         1.025         0.409         0.054 
H(17)      0.548         1.081         0.451         0.066 
H(18)      0.324         1.007         0.442         0.068 
H(19)      0.311         0.881         0.389         0.074 
H(20)      0.519         0.826         0.346         0.062 
H(211)     0.761         0.943         0.219         0.096 
H(212)     0.862         0.988         0.265         0.096 
H(213)     0.687         0.988         0.271         0.096 
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5. Characterization of 7-membered rings 
(1E,4Z)-7-(4-Methoxyphenyl)-5-methyl-6-phenylcyclohepta-1,4-dienyl acetate (4aA) 
Obtained in 85% yield using conditions III. 1H NMR (400 MHz, CDCl3): δ = 
7.23-7.21 (m, 3H), 7.05-7.00 (m, 4H), 6.76 (dt, J = 2.0, 8.8 Hz, 2H), 5.71 (d, J = 7.6 Hz, 1H), 5.57 
(dd, J = 2.8, 8.4 Hz, 1H), 4.09 (s, 1H), 4.03 (s, 1H), 3.80 (s, 3H), 3.34 (dd, J = 2.8, 19.6 Hz, 1H), 
2.80 (dt, J = 8.0, 19.6 Hz, 1H), 1.77 (s, 3H), 1.41 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 
169.4, 158.6, 150.8, 141.3, 139.8, 131.6, 131.5, 130.4, 127.7, 126.6, 122.8, 115.9, 113.1, 55.1, 
51.8, 50.5, 24.9, 24.8, 20.7 ppm; IR (neat, ν/cm-1): 3028, 2961, 2835, 2359, 2335, 1749, 1682, 
1608, 1510, 1447, 1302, 1254, 1223, 1181, 1087, 1035, 832, 806, 701, 535; HRMS (ESI): m/z: 
calcd for C23H24NaO3+: 371.1618, found: 371.1617. 
 
(6E,9Z)-2,3,4,4a,5,8-Hexahydro-5-(4-methoxyphenyl)-1,1,4a-trimethyl-1H-benzo[7]annulen-
6-yl acetate (4aB) 
Obtained in 59% yield using conditions III. 1H NMR (400 MHz, CDCl3): δ = 
7.14 (dt, J = 3.2, 8.8 Hz, 2H), 6.76 (dt, J = 3.2, 8.8 Hz, 2H), 5.65 (dd, J = 2.8, 7.2 Hz, 1H), 5.36 
(d, J = 9.2 Hz, 1H),  3.77 (s, 3H), 3.19-3.11 (m, 1H), 3.10-3.00 (m, 2H), 1.99 (s, 3H), 1.83-1.74 
(m, 1H), 1.65-1.54 (m, 1H), 1.45-1.35 (m, 4H), 1.32-1.25 (m, 1H), 1.18-1.12 (m,1H), 1.03 (s, 
3H), 1.00-0.95 (m, 1H), 0.65 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 169.8, 158.4, 150.3, 
149.9, 133.5, 131.7, 119.8, 114.1, 112.7, 59.6, 55.1, 42.3, 36.9, 36.8, 35.4, 33.4, 30.5, 27.9, 27.8, 
21.3, 16.9 ppm; IR (neat, ν/cm-1): 2958, 2935, 2869, 1763, 1608, 1509, 1463, 1366, 1251, 1181, 
1094, 1034, 830, 734; HRMS (ESI): m/z: calcd for C23H30NaO3+: 377.2087, found: 377.2084. 
 
(1E,4Z)-7-(4-Methoxyphenyl)-6-phenylcyclohepta-1,4-dienyl acetate (4aC) 
Obtained in 92% yield using conditions II. 1H NMR (400 MHz, CDCl3): δ = 
7.21-7.17 (m, 3H), 6.90-6.87 (m, 2H), 6.75 (dt, J = 2.8, 9.2 Hz, 2H), 6.68 (dt, J = 2.8, 9.2 Hz, 
2H), 6.01-5.96 (m, 1H), 5.87-5.81 (m, 1H), 5.61 (dd, J = 2.8, 8.0 Hz, 1H), 4.44 (s, 1H), 3.77 (s, 
3H), 3.64 (t, J = 3.2 Hz, 1H), 3.33 (d, J = 20.0 Hz, 1H), 2.87 (dt, J = 8.0, 19.6 Hz, 1H), 1.93 (s, 
3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 169.9, 158.6, 150.9, 142.2, 133.0, 131.4, 129.6, 
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128.7, 128.5, 127.9, 126.4, 116.4, 112.6, 55.1, 53.5, 47.0, 25.0, 21.0 ppm; IR (neat, ν/cm-1): 3031, 
2930, 2834, 1748, 1682, 1607, 1509, 1455, 1368, 1246, 1214, 1176, 1101, 1034, 907, 820, 736, 
700, 583, 519; HRMS (ESI): m/z: calcd for C22H22NaO3+: 357.1461, found: 357.1461. 
 
(1E,4Z)-6,7-Bis(4-methoxyphenyl)cyclohepta-1,4-dienyl acetate (4aD) 
Obtained in 77% yield using conditions II. 1H NMR (400 MHz, CDCl3): δ = 
6.80-6.68 (m, 8H), 5.99-5.93 (m, 1H), 5.80-5.75 (m, 1H), 5.76 (dd, J = 2.8, 7.6 Hz, 1H), 4.38 (s, 
1H), 3.77 (s, 6H), 3.61 (t, J = 3.2 Hz, 1H), 3.31 (d, J = 20.0 Hz 1H), 2.85 (dt, J = 7.6, 20.0 Hz, 
1H), 1.92 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 169.8, 158.5, 158.1, 150.9, 134.4, 
133.4, 131.4, 129.7, 129.6, 128.3, 116.3, 113.2, 112.5, 55.2, 55.1, 53.6, 46.1, 24.9, 20.9 ppm; IR 
(neat, ν/cm-1): 3034, 2997, 2934, 2834, 1745, 1609, 1509, 1462, 1368, 1244, 1215, 1176, 1099, 
1032, 907, 828, 792, 732, 527; HRMS (ESI): m/z: calcd for C23H24NaO4+: 387.1567, found: 
387.1566. 
 
(1E,4Z)-7-(4-Methoxyphenyl)-6-methyl-6-(4-methylpent-3-enyl)cyclohepta-1,4-dienyl 
acetate (4aE) 
 Obtained in 37% yield using conditions IV.1H NMR (400 MHz, CDCl3): δ = 
7.19 (d, J = 8.8 Hz, 2H), 6.78 (d, J = 8.8 Hz, 2H), 5.74-5.69 (m, 1H), 5.45 (dd, J = 2.8, 11.6 Hz, 
1H), 5.40-5.38 (m, 1H), 4.95 (t, J = 7.2 Hz, 1H), 3.78 (s, 3H), 3.28 (s, 1H), 3.17-3.09 (m, 1H), 
2.93 (t, J = 6.4, 22.4 Hz, 1H), 2.06-1.84 (m, 5H), 1.63 (s, 3H), 1.55 (s, 3H), 1.39 (s, 3H), 1.14-
1.06 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3): δ = 169.7, 158.4, 150.3, 138.3, 132.6, 131.1, 
131.0, 126.2, 124.6, 114.7, 113.0, 57.3, 55.1, 42.0, 40.5, 26.9, 25.7, 24.3, 22.5, 21.1, 17.6  ppm; 
IR (neat, ν/cm-1): 2965, 2926, 2854, 1748, 1608, 1509, 1454, 1302, 1220, 1178, 1097, 1065, 1036, 
816, 692; HRMS (ESI): m/z: calcd for C23H30NaO3+: 377.2087, found: 377.2089. 
 
(1E,4Z)-7-(Naphthalen-3-yl)-6-phenylcyclohepta-1,4-dienyl acetate (4bC) 
Obtained in 72% yield using conditions II. 1H NMR (400 MHz, CDCl3): δ = 7.80-
7.78 (m, 1H), 7.66-7.61 (m, 2H), 7.46-7.40 (m, 2H), 7.23 (s, 1H), 7.19-7.13 (m, 3H), 7.02 (dd, J = 
2.0, 8.8 Hz, 1H), 6.87 (dd, J = 2.0, 8.0 Hz, 2H), 6.08-6.02 (m, 1H), 5.87-5.83 (m, 1H), 5.71 (dd, J 
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= 2.8, 8.0 Hz, 1H), 4.56 (s, 1H), 3.89 (t, J = 3.6 Hz, 1H), 3.40 (d, J = 20.0 Hz, 1H), 2.96 (dt, J = 
8.0, 20.0 Hz, 1H), 1.89 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 169.8, 150.5, 141.9, 135.1, 
132.8, 132.7, 132.6, 129.4, 128.8, 128.7, 128.7, 128.0, 127.9, 127.5, 126.5, 126.5, 125.6, 125.5, 
116.9, 54.5, 47.0, 24.9, 20.9 ppm; IR (neat, ν/cm-1): 3057, 3030, 2926, 2360, 2342, 1731, 1598, 
1453, 1369, 1214, 1041, 859, 819, 735, 700, 478; HRMS (ESI): m/z: calcd for C25H22NaO2+: 
377.1512, found: 377.1511. 
 
(1E,4Z)-6-(4-Methoxyphenyl)-7-(naphthalen-3-yl)cyclohepta-1,4-dienyl acetate (4bD) 
 Obtained in 55% yield using conditions II.1H NMR (400 MHz, CDCl3): δ = 
7.80-7.78 (m, 1H), 7.68-7.66 (m, 1H), 7.62 (d, J = 8.4 Hz, 1H), 7.45-7.40 (m, 2H), 7.26 (s, 1H), 
7.02 (dd, J = 8.4 Hz, J = 1.6 Hz, 1H), 6.77 (dt, J = 8.8 Hz, J = 2.4 Hz, 2H), 6.69 (dt, J = 8.8 Hz, J 
= 2.4 Hz, 2H), 6.05-5.99 (m, 1H), 5.81-5.77 (m, 1H), 5.70 (dd, J = 8.0 Hz, J = 2.8 Hz, 1H), 4.51 
(s, 1H), 3.85 (t, J = 3.2 Hz, 1H), 3.76 (s, 3H), 3.37 (d, J = 19.6 Hz, 1H), 2.93 (dt, J = 20.0 Hz, J = 
7.6 Hz, 1H), 1.88 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 169.9, 158.2, 150.6, 135.3, 
134.2, 133.3, 132.7, 132.6, 129.7, 129.4, 128.8, 128.5, 127.9, 127.5, 126.5, 125.6, 125.5, 116.9, 
113.3, 55.2, 54.6, 46.2, 24.9, 21.0 ppm; IR (neat, ν/cm-1): 3053, 2936, 2834, 1748, 1610, 1511, 
1368, 1247, 1217, 1179, 1101, 1035, 909, 800, 748, 733, 478; HRMS (ESI): m/z: calcd for 
C26H24NaO3+: 407.1618, found: 407.1618. 
 
(1E,4Z)-6,7-Diphenylcyclohepta-1,4-dienyl acetate (4cC) 
Obtained in 80% yield using conditions II. 1H NMR (400 MHz, CDCl3): δ = 7.23-
7.12 (m, 6H), 6.89-6.83 (m, 4H), 6.04-5.98 (m, 1H), 5.87-5.82 (m, 1H), 5.65 (dd, J = 3.2, 8.0 Hz, 
1H), 4.49 (s, 1H), 3.72 (t, J = 3.2 Hz, 1H), 3.34 (d, J = 20.0 Hz, 1H), 2.89 (dt, J = 8.0, 20.0 Hz, 
1H), 1.93 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 169.9, 150.6, 142.0, 137.5, 132.8, 
130.4, 128.7, 128.6, 127.9, 127.2, 126.9, 126.5, 116.6, 54.3, 46.8, 24.9, 20.9 ppm; IR (neat, ν/cm-
1): 3059, 3029, 2356, 2331, 1749, 1600, 1492, 1453, 1214, 1101, 1051, 907, 738, 698, 514; 
HRMS (ESI): m/z: calcd for C21H20NaO2+: 327.1356, found: 327.1358. 
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(1E,4Z)-6-(4-Methoxyphenyl)-7-phenylcyclohepta-1,4-dienyl acetate (4cD) 
 Obtained in 50% yield using conditions II. 1H NMR (400 MHz, CDCl3): δ = 
7.16-7.12 (m, 1H), 7.11-7.06 (m, 2H), 6.80-6.77 (m, 2H), 6.74-6.70 (m, 2H), 6.68-6.65 (m, 2H), 
5.95-5.89 (m, 1H), 5.75-5.70 (m, 1H), 5.57 (dd, J = 2.8, 7.6 Hz, 1H), 4.38-4.35 (m, 1H), 3.71 (s, 
3H), 3.61 (t, J = 3.6 Hz, 1H), 3.27 (d, J = 19.6 Hz, 1H), 2.81 (dt, J = 7.6, 20.0 Hz, 1H), 1.86 (s, 
3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 169.9, 158.2, 150.7, 137.7, 134.3, 133.3, 130.5, 
129.6, 128.4, 127.2, 126.8, 116.6, 113.3, 55.2, 54.3, 46.0, 24.9, 21.0 ppm; IR (neat, ν/cm-1): 3029, 
2999, 2834, 2360, 2340, 1750, 1610, 1511, 1442, 1367, 1247, 1217, 1102, 1034, 827, 742, 702, 
541; HRMS (ESI): m/z: calcd for C22H22NaO3+: 357.1461, found: 357.1461. 
 
(1E,4Z)-7-(3,5-Dimethoxyphenyl)-6-phenylcyclohepta-1,4-dienyl acetate (4dC) 
Obtained in 74% yield using conditions II. 1H NMR (400 MHz, CDCl3): δ = 
7.23-7.15 (m, 3H), 6.95-6.93 (m, 2H), 6.31 (t, J = 2.0 Hz, 1H), 6.01-5.86 (m, 3H), 5.90-5.86 (m, 
1H), 5.63 (dd, J = 2.8, 7.6 Hz, 1H), 4.46 (s, 1H), 3.65 (t, J = 3.2 Hz, 1H), 3.61 (s, 6H), 3.32 (d, J = 
19.2 Hz, 1H), 2.86 (dt, J = 7.6, 19.6 Hz, 1H), 1.96 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 
170.0, 159.5, 150.4, 142.1, 139.9, 132.8, 128.7, 128.5, 127.9, 126.5, 116.8, 108.6, 99.3, 55.1, 
54.6, 46.7, 24.9, 21.0 ppm; IR (neat, ν/cm-1): 3002, 2958, 2939, 2836, 2359, 2337, 1748, 1594, 
1455, 1429, 1368, 1290, 1203, 1154, 1102, 1063, 840, 801, 752, 700; HRMS (ESI): m/z: calcd for 
C23H24NaO4+: 387.1567, found: 387.1569. 
 
(1E,4Z)-7-(3,5-Dimethoxyphenyl)-6-(4-methoxyphenyl)cyclohepta-1,4-dienyl acetate (4dD) 
 Obtained in 44% yield (90% purity) using conditions II. 1H NMR (400 MHz, 
CDCl3): δ = 6.86-6.82 (m, 2H), 6.76-6.73 (m, 2H), 6.31 (t, J = 2.4 Hz, 1H), 6.01 (d, J = 2.4 Hz, 
2H), 5.99-5.93 (m, 1H), 5.85-5.79 (m, 1H), 5.62 (dd, J = 3.2, 8.0 Hz, 1H), 4.40 (s, 1H), 3.76 (s, 
3H), 3.64-3.60 (m, 7H), 3.35-3.26 (m, 1H), 2.86 (dt, J = 7.6, 20.0 Hz, 1H), 1.95 (s, 3H) ppm; 13C 
NMR (100 MHz, CDCl3): δ = 170.0, 159.6, 158.24, 150.5, 140.1, 134.3, 133.3, 129.7, 128.3, 
116.8, 113.3, 108.7, 99.2, 55.3, 55.2, 54.7, 45.9, 24.9, 21.1 ppm; IR (neat, ν/cm-1): 2999, 2956, 
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2936, 2835, 1748, 1594, 1512, 1460, 1428, 1368, 1291, 1247, 1204, 1155, 1102, 1058, 912, 826, 
793, 714; HRMS (ESI): m/z: calcd for C24H26NaO5+: 417.1672, found: 417.1670. 
 
(Z)-2,2-Dimethyl-3-phenylcyclohept-4-enone (5eC)  
Obtained in 52% yield using conditions V. 1H NMR (400 MHz, CDCl3): δ = 7.35-
7.23 (m, 5H), 65.94-5.89 (m, 1H), 5.68-5.62 (m, 1H), 4.16-4.13 (m, 1H), 3.50-3.43 (m, 1H), 2.60-
2.40 (m, 3H), 1.04 (s, 3H), 0.93 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 216.1, 140.7, 
133.9, 130.0, 128.7, 127.9, 126.7, 55.2, 50.2, 36.8, 27.6, 25.4, 18.6 ppm; IR (neat, ν/cm-1): 3027, 
2972, 2929, 2904, 1702, 1493, 1465, 1450, 1377, 1317, 1240, 1194, 1135, 1094, 1032, 894, 759, 
727, 705, 646; HRMS (ESI): m/z: calcd for C15H18NaO+: 237.1250, found: 237.1247. 
 
(Z)-(2,2-Spirocyclohexyl)-3-phenylcyclohept-4-enone (5fC)  
 Obtained in 79% yield using conditions V. 1H NMR (400 MHz, CDCl3): δ = 7.32-
7.22 (m, 3H), 7.16-7.14 (m, 2H), 5.93-5.91 (m, 2H), 3.28 (t, J = 2.8 Hz, 1H), 2.79-2.73 (m, 1H), 
2.68-2.62 (m, 1H), s.53-2.45 (m, 1H), 2.32-2.24 (m, 1H), 2.19-2.10 (m, 2H), 1.62-1.47 (m, 4H), 
1.29-1.20 (m, 4H) ppm; 13C NMR (100 MHz, CDCl3): δ = 216.0, 141.0, 134.5, 129.9, 129.2, 
127.9, 126.7, 57.6, 53.8, 38.7, 34.3, 30.3, 26.1, 25.8, 23.5, 23.3 ppm; IR (neat, ν/cm-1): 3025, 
2929, 2852, 2360, 1691, 1492, 1448, 1191, 1082, 914, 751, 703, 640, 483; HRMS (EI): m/z: calcd 
for C18H22NaO+: 254.1671, found: 254.1672. 
 
6. Characterization of 5-membered rings 
4-(Benzyloxy)-5-(4-methoxyphenyl)cyclopent-1-enyl acetate (3aJ) 
Obtained as a single diastereoisomer in 83% yield. 1H NMR (400MHz, CDCl3) 
δ = 7.33-7.26 (m, 5H), 7.13-7.11 (m, 2H), 6.88-6.85 (m, 2H), 5.64-5.63 (m, 1H), 4.56 (dd, J = 
11.9 Hz, 1H), 4.46 (d, J = 11.9 Hz, 1H), 4.13-4.08 (m, 2H), 3.81 (s, 3H), 2.83-2.77 (m, 1H), 2.53-
2.49 (m, 1H), 1.96 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 168.2, 158.5, 149.2, 138.2, 
132.4, 128.8, 128.3, 127.6, 127.5, 114.0, 111.6, 85.4, 71.0, 56.0, 55.2, 34.9, 20.9 ppm; IR (neat, 
ν/cm-1): 3031, 2942, 2908, 2836, 1754, 1611, 1510, 1369, 1246, 1204, 1176, 1034, 906, 727; MS 
(ESI): m/z  for C21H22NaO4+: 361.2. 
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4-Ethoxy-5-(4-methoxyphenyl)cyclopent-1-enyl acetate (3aK) 
Obtained as a single diastereoisomer in 75% yield. 1H NMR (400MHz, CDCl3) 
δ = 7.12-7.09 (m, 2H), 6.86-6.83 (m, 2H), 5.62 (dd, J = 2.3, 4.2 Hz, 1H), 4.01-3.99 (m, 1H), 3.98-
3.94 (m, 1H), 3.79 (s, 3H), 3.55-3.36 (m, 2H), 2.82-2.75 (m, 1H), 2.44-2.38 (m, 1H), 1.94 (s, 3H), 
1.16 (t, J = 7.0 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 168.2, 158.4, 149.2, 132.6, 128.8, 
113.9, 111.6, 85.7, 64.4, 55.9, 55.2, 35.0, 20.9, 15.4 ppm; IR (neat, ν/cm-1): 2974, 2932, 2901, 
2832, 1755, 1611, 1509, 1369, 1246, 1201, 1175, 1088, 1033, 827; HRMS (ESI): m/z calcd for 
C16H20NaO4+: 299.1254, found: 299.1253. 
 
4-(Benzyloxy)-5-(naphthalene-2-yl)cyclopent-1-enyl acetate (3bJ) 
Obtained as a single diastereoisomer in 79% yield. 1H NMR (400MHz, CDCl3) δ = 
7.86-7.82 (m, 3H), 7.67 (s, 1H), 7.52-7.46 (m, 2H), 7.35-7.24 (m, 6H), 5.75-5.74 (m, 1H), 4.59 (d, 
J = 11.9 Hz, 1H), 4.49 (d, J = 11.9 Hz, 1H), 4.37-4.36 (m, 1H), 4.23 (m, 1H), 2.92-2.86 (m, 1H), 
2.61-2.57 (m, 1H), 1.92 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 168.2, 148.9, 138.2, 137.9, 
133.5, 132.5, 128.4, 128.3, 127.7, 127.6, 127.6, 127.5, 126.6, 126.1, 126.0, 125.6, 112.1, 85.3, 
71.2, 57.1, 35.1, 20.9 ppm; IR (neat, ν/cm-1): 3054, 3025, 2912, 2856, 1757, 1648, 1600, 1454, 
1368, 1198, 1091, 1071, 1012, 817, 740, 698; HRMS (ESI): m/z calcd for C24H22NaO3+: 
381.1461, found: 381.1461. 
 
4-Ethoxy-5-(naphthalene-2-yl)cyclopent-1-enyl acetate (3bK) 
Obtained as a single diastereoisomer in 73% yield. 1H NMR (400MHz, CDCl3) δ = 
7.83-7.80 (m, 3H), 7.66 (d, J = 1.1 Hz, 1H), 7.46 (m, 2H), 7.33 (dd, J = 1.7, 8.5 Hz, 1H), 5.72 (dd, 
J = 2.3, 4.4 Hz, 1H), 4.24-4.23 (m, 1H), 4.09 (td, J = 3.9, 7.6 Hz, 1H), 3.58-3.37 (m, 2H), 2.88 
(tdd, J = 2.2, 7.2, 16.4 Hz, 1H), 2.49 (dddd, J = 1.6, 2.4, 4.0, 16.5 Hz, 1H), 1.90 (s, 3H), 1.17 (t, J 
= 7.0 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 168.2, 148.9, 138.1, 133.5, 132.5, 128.4, 
127.7, 127.6, 126.6, 126.1, 125.9, 125.6, 112.1, 85.6, 64.6, 57.0, 35.3, 20.9, 15.4 ppm; IR (neat, 
ν/cm-1): 3050, 2975, 2870, 1759, 1648, 1600, 1508, 1369, 1201, 1092, 906, 818, 730; HRMS 
(ESI): m/z calcd for C19H20NaO3+: 319.1305, found: 319.1304. 
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4-(Benzyloxy)-5-(4-methoxyphenyl)cyclopent-1-enyl pivalate (3gJ) 
Obtained as a single diastereoisomer in 82% yield. 1H NMR (400MHz, 
CDCl3) δ = 7.33-7.24 (m, 5H), 7.14-7.10 (m, 2H), 6.87-6.83 (m, 2H), 6.56-6.55 (m, 1H), 4.55 (d, 
J = 11.9 Hz, 1H), 4.44 (d, J = 11.9 Hz, 1H), 4.20-4.17 (m, 2H), 3.81 (s, 3H), 2.83-2.76 (m, 1H), 
2.55-2.47 (m, 1H), 0.99 (s, 9H) ppm; 13C NMR (100 MHz, CDCl3) δ = 175.7, 158.5, 149.4, 138.3, 
132.6, 129.1, 128.2, 127.5, 127.4, 113.8, 111.0, 85.8, 71.1, 55.7, 55.2, 38.8, 34.8, 26.7 ppm; IR 
(neat, ν/cm-1): 3031, 2972, 2933, 2907, 2871, 1747, 1611, 1510, 1455, 1248, 1177, 1109, 908, 
827, 698; HRMS (ESI): m/z calcd for C24H28NaO4+: 403.1882, found: 403.1879. 
 
4-Ethoxy-5-(3-methoxyphenyl)cyclopent-1-enyl acetate (3hK) 
Obtained as a single diastereoisomer in 60% yield. 1H NMR (400MHz, CDCl3) 
δ = 7.23 (t, J = 7.9 Hz, 1H), 6.80-6.74 (m, 3H), 5.65 (dd, J = 2.2, 4.2 Hz, 1H), 4.02-3.96 (m, 2H), 
3.80 (s, 3H), 3.58-3.38 (m, 2H), 2.80 (tdd, J = 2.3, 7.1, 16.4 Hz, 1H), 2.46-2.40 (m, 1H), 1.96 (s, 
3H), 1.17 (t, J = 7.0 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 168.2, 159.8, 148.8, 142.3, 
129.6, 120.2, 113.5, 112.1, 112.0, 85.4, 64.4, 56.9, 55.2, 35.2, 20.9, 15.4 ppm; IR (neat, ν/cm-1): 
2974, 2942, 2896, 2837, 1757, 1599, 1584, 1486, 1369, 1264, 1202, 1091, 1045, 783, 700; HRMS 
(ESI): m/z calcd for C16H20NaO4+: 299.1257, found: 299.12534. 
 
5-(Benzo[d][1,3]dioxol-5-yl)-4-(benzyloxy)cyclopent-1-enyl acetate (3iJ) 
Obtained as a single diastereoisomer in 87% yield. 1H NMR (400MHz, CDCl3) δ 
= 7.34-7.27 (m, 5H), 6.78-6.76 (m, 1H), 6.69-6.67 (m, 2H), 5.95 (s, 2H), 5,65-5.64 (m, 1H), 4.56 
(d, J = 11.9 Hz, 1H), 4.48 (d, J = 11.9 Hz, 1H), 4.10-4.06 (m, 2H), 2.79 (tdd, J = 2.0, 6.8, 16.3 
Hz, 1H), 2.53-2.48 (m, 1H), 1.99 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 168.1, 148.9, 
147.8, 146.4, 138.2, 134.2, 128.3, 127.5, 127.4, 121.0, 111.8, 108.3, 107.9, 100.9, 85.3, 71.0, 
56.5, 34.8, 20.9 ppm; IR (neat, ν/cm-1): 3029, 2902, 1755, 1503, 1486, 1441, 1368, 1199, 1094, 
1071, 1037, 932, 807, 737, 698; HRMS (ESI): m/z calcd for C21H20NaO5+: 375.1201, found: 
375.1203. 
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5-(Benzo[d][1,3]dioxol-5-yl)-4-ethoxycyclopent-1-enyl acetate (3iK) 
Obtained as a single diastereoisomer in 87% yield. 1H NMR (400MHz, CDCl3) δ 
= 6.74 (d, J = 7.7 Hz, 1H), 6.67-6.64 (m, 2H), 5.94-5.93 (m, 2H), 5.62 (dd, J = 2.2, 4.2 Hz, 1H). 
3.97-3.96 (m, 1H), 3.93 (td, J = 3.8, 7.5 Hz, 1H), 3.54-3.38 (m, 2H), 2.77 (tdd, J =2.3, 7.1, 16.4 
Hz, 1H), 2.42-2.38 (m, 1H), 1.97 (s, 3H), 1.17 (t, J = 7.0 Hz, 3H) ppm; 13C NMR (100 MHz, 
CDCl3) δ = 168.2, 149.0, 147.8, 146.4, 134.5, 121.0, 111.8, 108.3, 107.9, 100.9, 85.6, 64.4, 56.5, 
35.0, 20.9, 15.4 ppm; IR (neat, ν/cm-1): 2974, 2886, 1756, 1504, 1486, 1441, 1369, 1202, 1098, 
1038, 931, 807, 729; HRMS (ESI): m/z calcd for C16H18NaO5+: 313.1048, found: 313.1046. 
 
5-(Benzo[d][1,3]dioxol-5-yl)-4-butoxycyclopent-1-enyl acetate (3iL) 
Obtained as a single diastereoisomer in 59% yield. 1H NMR (400MHz, CDCl3) δ 
= 6.74 (d, J = 7.7 Hz, 1H), 6.66-6.64 (m, 2H), 5.93 (s, 2H), 5.61 (m, 1H), 3.96-3.95 (m, 1H), 3.91 
(td, J = 3.8, 7.4 Hz, 1H), 3.39 (tdd, J = 6.6, 9.1, 35.3 Hz, 2H), 2.76 (tdd, J = 2.1, 7.1, 16.4 Hz, 
1H), 2.41-2.37 (m, 1H), 1.97 (s, 3H), 1.45-1.48 (m, 2H), 1.39-1.30 (m, 2H), 0.89 (t, J = 7.4 Hz, 
3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 168.2, 149.0, 147.8, 146.3, 134.5, 121.0, 111.9, 108.3, 
107.9, 100.9, 85.8, 68.9, 56.5, 34.9, 31.9, 20.9, 19.3, 13.8 ppm; IR (neat, ν/cm-1): 2957, 2931, 
2872, 1757, 1504, 1486, 1441, 1368, 1246, 1200, 1095, 1038, 1012, 934, 807, 578; HRMS (ESI): 
m/z calcd for C18H22NaO5+: 341.1359, found: 341.1359. 
 
5-(Benzo[d][1,3]dioxol-5-yl)-4-tert-butoxycyclopent-1-enyl acetate (3iM) 
Obtained as a single diastereoisomer in 87% yield. 1H NMR (400MHz, CDCl3) δ 
= 6.73 (d, J = 7.8 Hz, 1H), 6.65-6.61 (m, 2H), 5.93 (dd, J = 1.4, 2.9 Hz, 2H), 5.57 (dd, J = 2.4, 4.5 
Hz, 1H), 4.00 (td, J = 4.8, 7.4 Hz, 1H), 3.86-3.84 (m, 1H), 2.76-2.69 (m, 1H), 2.35 (tdd, J = 2.1, 
4.5, 16.1 Hz, 1H), 1.95 (s, 3H), 1.04 (s, 9H) ppm; 13C NMR (100 MHz, CDCl3) δ = 168.1, 148.6, 
147.7, 146.2, 134.4, 121.2, 111.9, 108.1, 108.0, 100.8, 79.1, 73.6, 58.1, 37.9, 28.4, 20.9 ppm; IR 
(neat, ν/cm-1): 2972, 2933, 2900, 1757, 1659, 1504, 1486, 1440, 1364, 1249, 1204, 1186, 1080, 
1038, 931, 872, 806, 727, 633, 575; HRMS (ESI): m/z calcd for C18H22NaO5+: 341.1359, found: 
341.1359. 
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2,3-Bis(4-methoxyphenyl)cyclopentanone (6aF) 
Obtained as a single diastereoisomer in 90% yield. 1H NMR (400MHz, CDCl3) 
δ = 7.11-7.08 (m, 2H), 6.97-6.94 (m, 2H), 6.83-6.79 (m, 4H), 3.77 (s, 3H), 3.75 (s, 3H), 3.45-3.33 
(m, 2H), 2.71-2.63 (m, 1H), 2.51-2.40 (m, 2H), 2.17-2.00 (m, 1H) ppm; 13C NMR (100 MHz, 
CDCl3) δ = 217.1, 158.5, 158.4, 133.7, 129.6, 129.1, 128.0, 114.0, 113.9, 62.3, 55.2, 55.1, 49.7, 
38.6, 29.5 ppm; IR (neat, ν/cm-1): 2999, 2951, 2932, 2837, 1733, 1670, 1598, 1509, 1461, 1248, 
1168, 1030, 825; HRMS (ESI): m/z calcd for C19H20NaO3+: 319.1305, found: 319.1305. 
 
2,3-Bis(4-methoxyphenyl)-3-methylcyclopentanone (6aG) 
Obtained as a 7:1 mixture of diastereoisomers in 82% yield. (Major isomer): 1H 
NMR (400MHz, CDCl3) δ = 7.22-7.18 (m, 2H), 6.87-6.83 (m, 2H), 6.80-6.73 (m, 4H), 3.81 (s, 
3H), 3.76 (s, 3H), 3.66 (s, 1H), 2.66-2.50 (m, 3H), 2.15-2.09 (m, 1H), 1.18 (s, 3H) ppm; 13C NMR 
(125 MHz, CDCl3) δ = 217.4, 158.6, 157.9, 138.5, 131.4, 127.1, 126.7, 113.5, 113.4, 67.6, 55.2, 
55.1, 47.3, 35.9, 34.6, 21.4 ppm; IR (neat, ν/cm-1): 3037, 2957, 2835, 1734, 1610, 1511, 1462, 
1245, 1180, 1132, 1031, 827, 733, 581; HRMS (ESI): m/z calcd for C20H22NaO3+: 333.1461, 
found: 333.1461. 
 
2,3-Bis(4-methoxyphenyl)-4-methylcyclopentanone (6aH) 
Obtained as a single diastereoisomer in 78% yield. 1H NMR (400MHz, 
CDCl3) δ = 7.09-7.06 (m,2H), 6.92-6.89 (m, 2H), 6.84-6.75 (m, 4H), 3.77 (s, 3H), 3.73 (s, 3H), 
3.46 (d, J = 12.5 Hz, 1H), 2.89-2.78 (m, 2H), 2.44-2.32 (m, 1H), 2.16-2.04 (m, 1H), 1.09 (d, J = 
6.4 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ = 216.3, 158.5, 158.4, 132.1, 129.5, 129.2, 
128.5, 113.9, 113.9, 63.8, 58.3, 55.2, 55.1, 47.0, 36.8, 17.9 ppm; IR (neat, ν/cm-1): 3002, 2955, 
2920, 2869, 2835, 1740, 1612, 1513, 1246, 1178, 1031, 881, 827; HRMS (ESI): m/z calcd for 
C20H22NaO3+: 333.1464, found: 333.1461. 
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3-(Benzo[d][1,3]dioxol-5-yl)-2-(4-methoxyphenyl)cyclopentanone (6aI) 
Obtained as a single diastereoisomer in 63% yield. 1H NMR (400MHz, CDCl3) 
δ = 6.96 (d, J = 8.6 Hz, 2H), 6.81 (d, J = 8.6 Hz, 2H), 6.71-6.69 (m, 2H), 6.63-6.61 (m, 1H), 5.91 
(s, 2H), 3.75 (s, 3H), 3.42-3.30 (m, 2H), 2.70-2.62 (m, 1H), 2.49-2.39 (m, 2H), 2.09-1.97 (m, 1H) 
ppm; 13C NMR (100 MHz, CDCl3) δ = 216.6, 158.6, 147.8, 146.3, 135.6, 129.6, 128.9, 120.2, 
114.1, 108.3, 107.2, 100.9, 62.2, 55.1, 50.2, 38.5, 29.6 ppm; IR (neat, ν/cm-1): 2957, 2934, 2897, 
1737, 1611, 1512, 1505, 1441, 1403, 1243, 1179, 1115, 1034, 863, 824, 727, 549; HRMS (ESI): 
m/z calcd for C19H18NaO4+: 333.1097, found: 333.1095. 
 
    7.  Characterization of Frondosin derivatives including ligand optimization 
 
 
 
 To a solution of the 1-(2,5-dimethoxyphenyl)prop-2-ynyl pivalate (1j) (0.05 mmol, 1.0 
equiv.) and 6,6-dimethyl-1-vinylcyclohex-1-ene (N) (0.055 mmol, 1.1 equiv.) in 1,2-DCE (0.01 
M), (S)-MeO-DBTM-BIPHEP(AuSbF6)2 (0.025 equiv.) was added. The mixture was stirred at 
room temperature for 90 minutes. The reaction was quenched with triethylamine (0.05 equiv.) and 
the solvent was removed under reduce pressure. Then NaOMe (3.0 equiv.) and methanol were 
added and the mixture was stirred at room temperature for 3 days. The reaction was quenched 
with a saturated solution of NH4Cl and extracted with DCM (3 x 10 mL). The combined organic 
layers were dried over Na2SO4 and the solvent was removed under reduce pressure. The residue 
was purified by column chromatography (Hex: AcOEt 10:1) to give the corresponding ketone 7 
(11.1 mg) in 68% yield (major isomer). 
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(4aS,5R,E)-5-(2,5-Dimethoxyphenyl)-1,1-dimethyl-1,2,3,4,4a,5,7,8-octahydrobenzo[7] 
annulen-6-one (Major Isomer-7) 
 (Major isomer, 68% yield): 1H NMR (400MHz, CDCl3) δ = 7.06 (d, J = 2.5 Hz, 
1H), 6.78-6.73 (m, 2H), 5.64 (dd, J = 5.0, 8.8 Hz, 1H), 4.93 (d, J = 10.8 Hz, 1H), 3.80 (s, 3H), 
3.74 (s, 3H), 2.95-2.86 (m, 1H), 2.80 (t, J = 11.3 Hz, 1H), 2.71-2.54 (m, 2H), 2.23-2.15 (m, 1H), 
1.78-1.74 (m, 1H), 1.66-1.48 (m, 4H), 1.28-1.22 (m, 1H), 1.08 (s, 3H), 1.06 (s, 3H) ppm; 13C 
NMR (100 MHz, CDCl3) δ = 211.0, 153.6, 151.7, 150.4, 128.5, 117.4, 115.5, 111.3, 111.0, 56.1, 
55.7, 49.6, 45.3, 42.4, 42.4, 38.5, 34.1, 30.4, 26.0, 22.7, 21.0 ppm; IR (neat, ν/cm-1): 2927, 2861, 
2834, 2369, 1709, 1589, 1493, 1462, 1278, 1216, 1049, 913, 806, 714; HRMS (ESI): m/z calcd 
for C21H28NaO3+: 351.1932, found: 351.1931; [D -55.1 (c 0.37, CHCl3). 
(4aR,5R,E)-5-(2,5-Dimethoxyphenyl)-1,1-dimethyl-1,2,3,4,4a,5,7,8-octahydrobenzo[7] 
annulen-6-one (Minor Isomer-7) 
O
MeO
OMe
H
 (Minor isomer, 12% yield): 1H NMR (400 MHz, CDCl3): δ = 7.16 (d, J = 2.8 
Hz, 1H), 6.81-6.74 (m, 2H), 5.65 (dd, J = 2.4, 9.6 Hz, 1H), 5.17 (d, J = 2.4 Hz, 1H), 3.80 (s, 3H), 
3.73 (s, 3H), 2.93-2.83 (m, 2H), 2.67 (dt, J = 3.6, 18.8 Hz, 1H), 2.57-2.48 (m, 1H), 2.30-2.21 (m, 
1H), 2.10-2.04 (m, 1H), 1.67-1.59 (m, 2H), 1.55-1.49 (m, 1H), 1.30-1.22 (m, 1H), 1.11 (s, 3H), 
1.09 (s, 3H), 1.04-0.96 (m, 1H) ppm; 13C NMR (100 MHz, CDCl3): δ = 211.2, 153.3, 151.3, 
151.3, 129.3, 117.6, 116.3, 111.1, 111.0, 56.1, 55.7, 48.1, 44.0, 42.9, 40.3, 38.8, 32.2, 30.3, 26.1, 
23.1, 22.9 ppm; IR (neat, ν/cm-1): 2927, 2861, 2834, 2369, 2338, 1709, 1589, 1493, 1462, 1428, 
1355, 1278, 1216, 1179, 1049, 1026, 913, 838, 714; HRMS (ESI): m/z: calcd for C21H28NaO3+: 
351.1932, found: 351.1931. 
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(4aR,5R,6E,9E)-5-(2,5-Dimethoxyphenyl)-1,1-dimethyl-2,3,4,4a,5,8-hexahydro-1H-
benzo[7]annulen-6-yl pivalate 
OPiv
MeO
OMe
H
1H NMR (400 MHz, CDCl3): δ = 6.97 (d, J = 2.8 Hz, 1H), 6.71-6.67 (m, 2H), 
5.70-5.67 (m, 1H), 5.52 (dd, J = 3.6, 8.0 Hz, 1H), 4.34 (t, J = 2.8 Hz, 1H), 3.73 (s, 3H), 3.72 (s, 
3H), 3.23-3.19 (m, 1H), 3.13-3.05 (m, 1H), 2.70 (dt, J = 8.0, 18.8 Hz, 1H), 1.88-1.80 (m, 1H), 
1.70-1.61 (m, 1H), 1.50-1.35 (m, 2H), 1.27-1.21 (m, 1H), 1.03 (s, 3H), 0.99-0.93 (m, 10H), 0.76 
(s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ =  176.7, 152.9, 152.5, 151.3, 149.8, 130.1, 119.1, 
117.5, 114.9, 111.5, 110.5, 55.8, 55.7, 42.8, 39.4, 39.0, 38.8, 36.4, 31.1, 30.4, 29.1, 26.8, 24.4, 
20.5 ppm; IR (neat, ν/cm-1): 2955, 2934, 2866, 2832, 1740, 1495, 1462, 1417, 1364, 1278, 1216, 
1177, 1126, 1050, 1028, 903, 803, 706; HRMS (ESI): m/z: calcd for C26H36NaO4+: 435.2506, 
found: 435.2501. 
Table 4. Optimization of Chiral Ligands for reaction shown in Eq. 3. 
 
 The reaction conditions are those shown in Eq. 3: 1j (1 equiv.), N (1.1 equiv.),  [Au] (5 
mol%), 1,2-DCE, r.t., 1.5 h (concentration 0.1 M), followed by in situ hydrolysis/equilibration to 
ketone 7 upon treatment with excess of NaOMe/MeOH at 25ºC for 48 h. 
 
Ligand ee (%) 
19 
7 
33 
33 
O
O O
Ph
Ph
O
Ph Ph
P N
(R,R,R)
AuSbF6
O
O O
Ph
Ph
O
Ph Ph
P N
(R,S,S)
AuSbF6
O
O
P N
AuSbF6
(S,S,S)
P
P
(R) (AuSbF6)2
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65 (>90)a 
a Reaction concentration: 0.01 M 
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CHAPTER 5 
Gold-Catalyzed Cycloisomerization of 1-Cyclopropyl-alkynes 
D. Garayalde and C. Nevado* 
(Unpublished results) 
 5.1 Introduction  
 Transition metal-catalyzed hydroarylation of C-C multiple bonds has attracted 
considerable attention as an efficient approach to the functionalization of arenes. This interest has 
led to the development of a number of effective protocols for the hydroarylation of alkenes1 and 
alkynes.2 In this context, gold can act as a Lewis acid for the activation of alkynes towards a 
variety of nucleophiles under homogeneous catalysis conditions.3 Reetz4 and He5 found 
independently that gold complexes are active catalysts for the intermolecular hydroarylation of 
electron-deficient alkynes.  
 Indoles and bis(indolyl)alkanes are important entities present in a large variety of natural 
products,6 and have thus been already targeted in the context of gold catalysis. For example, 
Echavarren7 and He8 have developed methods where simple indoles 1 react intermoleculary with 
terminal alkynes in the presence of cationic gold(I) and gold(III) complexes respectively affording 
bisindolyl derivatives 2 (Scheme 1, eq. 1). Sierra and co-workers have expanded this chemistry 
using platinum catalysts with allenes as reaction counterparts (Scheme 1, eq. 2).9 The mechanism 
of the addition of two molecules of indole to the terminal carbon atom of the allene seems to 
proceed via Pt-carbene intermediates in a similar manner than the previously reported platinum-
catalyzed dihydroalkoxylation of monosubstituted allenes.10  
Scheme 1. Gold- and silver-catalyzed synthesis of indolyl derivates    
 
 An intramolecular version of the reaction summarized in Scheme 1, eq. 1 has also been 
studied.7 C2-substituted indoles react with alkynes in the presence of gold catalysts to give 7- and 
8-membered rings (Scheme 1, eq. 3). The reaction outcome changes dramatically whether the 
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catalyst is gold(I) or gold(III). Substrates 4 cyclize readily with cationic gold(I) complexes to give 
azepino[4,5-b]indole derivates 511 whereas the use of AuCl3 leads to indoloazocines 6. 
 In the context of nucleophilic additions onto gold-activated alkynes, a well developed 
research area is the activation of propargyl carboxylates towards 1,2-acyloxy migration and/or 
[3,3]-sigmatropic rearrangement. This different reactivity is highly dependent on the substitution 
pattern of the alkyne.12 In the last years, our research group has studied 3- and 1-substituted 
cyclopropyl propargyl acetates I and II, which in the presence of catalytic amounts of gold 
provided access to 5- and 6-membered ring respectively (III and IV).13 Furthermore, two highly 
diastereoselective gold-catalyzed three-step cascade process for the synthesis of highly substituted 
5- and 7-membered rings (V and VI) from propargyl acetates and alkenes or 1,4-dienes, have 
been also developed (Scheme 2).14  
Scheme 2. Gold-catalyzed synthesis o f 5-, 6-, and 7-membered rings 
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 Tetrahydrocarbazoles are common motifs found in many natural products and bioactive 
molecules.15 Recently, a highly efficient method for the synthesis of substituted 
tetrahydrocarbazoles from pent-4-ynal and indoles using silver(I) catalysts has been reported 
(Scheme 3).16  The mechanism associated to this transformation seems to involve the coordination 
of the silver salt onto the oxygen atom of the carbonyl group in 7 triggering the intermolecular 
nucleophilic attack of the indole and dehydration to give intermediate 10.  The attack of a second 
molecule of indole forms intermediate 11, which cyclizes to give the spirocyclic iminium ion 12. 
Intermediate 12, undergoes a 1,2-carbon shift process to give the carbazole 13 in which the silver 
salt promotes the hydroarylation with a third molecule of indole to afford the final products 8 
(trans) and 9 (cis) in a 59% and 23% yield respectively. 
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Scheme 3. Silver-catalyzed tandem reaction of acetylenic aldehydes 7 with indoles 
 
  5.2 Results and discussion 
 With this background in hand, we decided to investigate more in depth the formation of 
highly substituted carbocycles using heteroaromatic nucleophiles such as indoles and stabilized 
cyclopropyl alkynes. Our study commenced with the optimization of the model reaction of 1-(2-
ethynylcyclopropyl)-4-methoxybenzene with different N-protected indoles 14 in the presence of 
various gold catalysts. The results are summarized in Table 1. 
Table 1. Screening of catalysts 
 
Entry R1 Conditions 
Product 15/15’ 
Yield(%) / (d.r.) 
1 (14a) Bn IPrAuNTf2, DCM, r.t, 48 h No reaction 
2 (14a) Bn Ph3PAuNTf2, DCM, r.t. 48 h Traces (15/15’)a 
3 (14a) Bn (t-Bu)3PAuNTf2, DCM, r.t 48 h Traces (15/15’)a 
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4 (14a) Bn (PhO)3PAuSbF6, DCM, r.t. 3 h Traces (15/15’)a 
5 (14a) Bn (PhO)3PAuSbF6, DCM, 50 oC, 72 h Traces (15/15’)a 
6 (14a) Bn 
 Toluene, r.t. 24 h 
95% yield / (2:1) 
6:1 regioisomeric ratio 15a:15’a 
7 (14b) Me 16,Toluene, r.t. 24 h 
60 % yield / (2:1) 
2:1 regioisomeric ratio 15b:15’b 
8 (14b) Me 16,Toluene, 80 oC, 12 h 
88 % yield / (2:1) 
4:1 regioisomeric ratio 15b:15’b 
9 (14c) H 16, Toluene, r.t. 24 h No reaction 
10 (14c) H 16, DCM, r.t. 24 h No reaction 
11 (14c) H 16, 1,2-DCE, 80 oC, 24 h No reaction 
12 (14c) H 16,THF, 100 oC, 12 h 
92 % yield (1:1) 
1:1 regioisomeric ratio 15c:15’c 
 
 The reaction of 1-(2-ethynylcyclopropyl)-4-methoxybenzene with N-benzyl protected 
indole afforded no conversion or only traces of the desired products 15a and 15’a using gold 
catalysts either bearing σ-donating groups such as IPr (IPr = 1,3-bis(diisopropylphenyl)imidazol-
2- ylidene) (entry 1), or better π-acceptors such as phosphine- and phosphite-based ligands (entry 
2-5). We were pleased to find that using cationic gold complex 16 in toluene, a complete 
conversion of the starting materials into tetrahydrocarbazoles 15a and 15’a was observed (entry 
6). The reaction was highly regioselective (6:1) favoring the 1-p-MeO-phenyl substituted 
tetrahydrocarbazole 15a. Both 15a and 15’a where isolated as an unseparable 2:1 mixture of 
diastereoisomers. The same conditions were used for methyl-protected indole 14b affording a 2:1 
ratio of regioisomers 15b and 15’b isolated in 60% yield (entry 7). Upon heating the reaction to 
80 oC a 4:1 regioisomeric mixture of the corresponding tetrahydrocarbazoles was obtained in 88% 
yield (entry 8). 
 Having stablished cationic gold complex 16 as catalyst, we decided also to test these 
reaction conditions for non-protected indoles. Using the cationic gold complex 16 in toluene, 
dichloromethane and 1,2-dichloroethane as solvents, the reaction of parent indole showed no 
conversion to the products 15c and 15’c after prolongued stirring/heating (entries 9-11). Heating 
up the reaction to 100 oC in dry THF afforded a 1:1 mixture of regioisomers 15c and 15’c isolated 
in overall 92% yield (entry 12). 
 With the best conditions in hand, using catalyst 16 in toluene at 80 oC for N-protected 
indoles and catalyst 16 in THF at 100 oC for the non-protected ones, we then set out to explore the 
scope of this transformation. We focused on different N-protected indoles 14 in the presence of 1-
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ethynylcyclopropyl derivates bearing substituents that are able to stabilize the positive electron 
density developed during the cyclopropyl-ring-opening process. The results are summarized in 
Table 2. 
Table 2. Scope of the reaction with N-protected indoles 
 
Entry X R2 Alkyne Product Yielda (d.r.) / (r.r)d Yieldb,c (d.r.) / (r.r.)d
1 H Bn (14a) 
 
(15a) 95%  (2:1) / (6:1) 83%b  (2:1) / (12:1) 
2 H Me (14b) “ (15b) 88%  (2:1) / (4:1) 74%c (2:1) / (6:1) 
3 H 
p-MeOC6H5 
(14d) “ (15d) 76% (2:1) / (7:1) 63%
b (2:1) / (7:1) 
4 H 
Cynnamyl 
(14e) “ (15e) 78% (2:1) / (10:1) ---- ---- 
5 H C5H11 (14f) “ (15f) 79% (2:1) / (6:1) 75%c (2:1) / (6:1) 
6 OMe Me (14g) “ (15g) 86% (2:1) / (2:1) 54%c  (2:1) / (2:1) 
7 OMe Bn (14h) “ (15h) 56%  (2:1) / (3:1) 60%b  (2:1) /(3:1) 
8 Br Me (14i) “ (15i) 72% (2:1) / (8:1) 73%c (2:1) / (8:1) 
9 Br Bn (14j) “ (15j) 68%  (2:1) / (5:1) 76%b  (2:1) / (7:1) 
10 Me Me (14k) “ (15k) 84% (2:1) / (5:1) 77%c (2:1) / (7:1) 
11 Me Bn (14l) “ (15l) 42% 
 (2:1) / 
(3.5:1) 45%
b (2:1) / (5:1) 
12 CN Me (14m) “ (15m) 52%  (2:1) / (2:1) 45%c (2:1) / (5:1) 
13 H Bn (14n) (15n) 81% (1:1) / (5:1) 70%b (1:1) / (5:1) 
14 CN Me (14o) “ (15o) 79%  (5:1) / (7:1) 34%c (5:1) / (7:1) 
15 Br Me (14p) “ (15p) 82% (1:1) / (5:1) 80 % (1:1) / (12:1) 
16 H Bn (14q) (15q) 57% (1:1) / (5:1) ---- ---- 
17 Br Me (14r) “ (15r) 69% (1:1) / (5:1) ---- ---- 
18 H Bn (14s) (15s) 63% (1:1) / (5:1) 70%b (1:1) / (8:1) 
19 H Me (14t) “ (15t) 63% (1:1) / (5:1) 56%c  (1:1) / (6:1) 
      [a] Reaction conditions: Toluene (0.1M), 5 mol% catalyst 16, 80 oC for 12h. 
    [b] Reaction conditions: Toluene (0.1M), 5 mol% catalyst 16, 1.0 equiv. NaHCO3, 80 oC for 12h. 
    [c] Reaction conditions: Toluene (0.1 M), 5 mol% catalyst 16, 0.5 equiv. NaHCO3, 80 oC for 12h. 
    [d] regioisomeric ratio. 
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 The reaction tolerates different protecting groups at the nitrogen atom as well as different 
substituents at the 5-position of the indole counterpart. First, we tested the reaction of 1-(2-
ethynylcyclopropyl)-4-methoxybenzene with different indoles, which yielded the corresponding 
tetrahydrocarbazoles 15a-m/15’a-m in good yields (42-86% yield, entries 1-12) as 2:1 mixture of 
diastereoisomers with regioselectivities up to 12:1.  
 The scope of the reaction was expanded to study the effect of different stabilizing groups 
in the cyclopropyl alkyne upon reaction with benzyl- or methyl-protected indoles 14a and 14b 
respectively. When (E)-1-(2-(2-ethynylcyclopropyl)prop-1-enyl)benzene was tested, the reaction 
afforded the tetrahydrocarbazole derivates 15n-p/15’n-p in yields up to 79% (entries 13-15). 1-
Ethynyl-2-(2-methylprop-1-enyl)cyclopropane was also tested affording the corresponding 
products 15q-r/16’q-r  in yields up to 69% (entries 16-17). An additional methyl group at the 
cyclopropyl ring in the starting material was also tested affording, in the standard reaction 
conditions, the desired products 15s-t/15’s-t in 63% yield (entries 18-19). In these cases, the 
tetrahydrocarbazoles where obtained as a 1:1 mixture of diastereoisomers except for 15o/15’o 
which gave a 5:1 diastereomeric mixture under the standard reaction conditions. 
 We then decided to run the reaction in presence of base in order to check if there could be 
an influence in the selectivity of the process. Remarkably, in all cases, the ratio between the 
regioisomers 15 and 15’ improve by the addition of 0.5 or 1.0 equivalents of NaHCO3 depending 
on the substitution pattern on the indole. However, no improvement in the diastereoselectivity of 
the reaction was observed. The structure of the major regioisomer 15 was confirmed by 
bidimensional NMR experiments and X-ray diffraction analysis on compound 15i (Figure 1). 
 
Figure 1. X-Ray structure of tetrahydrocarbazole 15i (Table 2, entry 8) 
N
N
Br
Br
OMe15i  
 The scope of the reaction was expanded using indoles 14 without protecting group at the 
nitrogen atom. The results are summarized in Table 3. 
Table 3. Scope of the reaction for non-protected indoles 
N
H
X
+
P Au NCMe
+
SbF6
-
(5 mol%)
THF, 100 oC
12 h
N
H
X
HN
X
N
H
X
NH
X
+
MeO
OMe
MeO
14
16
15 15'  
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Entry X Product Yield 15/15’a,b 
1 H  14c 92% 
2 Br  14u 71% 
3 Me  14v 86% 
4 CN  14w 68% 
    a 1:1 diastereomeric ratio, b 1:1 regioisomeric ratio. 
 Again, different substituents at the 5-position of the indole were tolerated for the reaction 
and the structure of the minor regioisomer 15’d was confirmed by X-ray diffraction analysis 
(Figure 2). In sharp contrast with the reaction of N-protected indoles, the reaction of the non-
protected indoles 14 showed to be no regioselective affording in all the cases a 1:1 mixture of the 
corresponding tetrahydrocarbazoles 15c,u-w and their regioisomers 15’c,u-w.  
Figure 2. X-Ray structure of tetrahydrocarbazole 15’c (Table 3, entry 1)  
N
H
NH
MeO
15'c  
 
 
5.3 Mechanistic study 
 Based on the previously summarized experimental results, we decided to carry out a 
mechanistic study that takes into account the possibility of both gold- acid-catalyzed three step 
cascade reaction for the formation of tetrahydrocarbazoles 15 and 15’.  we considered that the 
reaction media becomes acidic upon the incorporation of the first indole molecule and as shown 
in Table 2 the use of base seems to influence the regioselectivity of the process. 
 These transformations might commence with the nucleophilic attack of the indole 14 onto 
the gold- or acid-activated 1-(2-ethynylcyclopropyl)-4-methoxybenzene. Two distinct mechanistic 
scenarios arise from the different regioselectivity of the nucleophilic attack of the indole 
counterpart. Intermediate 18 can be formed by attack onto the internal position of the alkyne 
(Scheme 4, black arrow) whereas allene intermediate 17 would arise by attack of the indole onto 
the position 2 of the cyclopropyl ring (Scheme 4, red arrow).  
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Scheme 4. Divergent synthesis of 17 and 18 
N
R1
+
N
R1 N
R1
MeO
[H+]
[Au]OMe
MeO
18 17
14
[Au]
[H+]
 
 We thus decided to run the reaction between 1-(2-ethynylcyclopropyl)-4-methoxybenzene 
and methyl- or benzyl-indole 14a-b in the presence of different amounts of protic acids (Scheme 
5).17 Using catalytic amounts of trifluoroacetic acid (10 mol%) allene 17 was detected although no 
total conversion could be achieved in spite of prolongued heating. However, the reaction with 
substoichiometric amounts of acid (80 mol%) was stirred in toluene for 12 hours at 80oC 
affording the allene intermediates 17 in good yields with total conversion of the starting materials.  
Scheme 5. Synthesis of allene 17a-b 
 
 These reactions in presence of catalytic and substoichiometric amounts of acid do not 
evolve to the tetrahydrocarbazoles products confirming that these transformations cannot be a 
fully acid-catalyzed process. To confirm this hypothesis we decided to isolate allene intermediate 
17a and submit it to acidic conditions. The reaction of allene 17a in presence of catalytic (10 
mol%) and substoichiometric (80 mol%) amounts of TFA afforded no conversion even in the 
presence of 1 equivalent of methyl indole after heating the mixture at 80 oC for 12 hours (Scheme 
6).  
Scheme 6. Reaction of allene intermediate 17a with acid 
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 We then decided to run the reaction of allene intermediate 17a in the presence of 5 mol% 
of the gold catalyst 16 (Scheme 7) heating in toluene at 80 oC. Total conversion into intermediate 
19a as a 2:1 regioisomeric mixture of exo and endo olefin was observed after one hour of 
reaction.  
Scheme 7. Gold-catalyzed formation of 19a 
 
 The fact that the formation of carbazole 19a cannot be achieved by protic acid, confirms 
our hypothesis for the need of the gold catalyst in these transformations. Interestingly, the reaction 
of the allenyl intermediates 17a and 17b in presence of one equivalent of the corresponding 
indole and the gold catalyst 16 afforded, after 12 hours of reaction at 80oC, tetrahydrocarbazoles 
15a-b as single regioisomer in 60% to 82% yield as a 2:1 mixture of diastereoisomers (Scheme 
8). Regioisomer 15 is the major one obtained in the reactions showed in Table 2.   
Scheme 8. Gold-catalyzed reaction of allenes 17a-b to form tetrahydrocarbazole 15a-b 
 
 Interestingly, intermediate 19a, obtained as a single regioisomer with a 2:1 exo:endo ratio 
of the olefin, reacted in presence of 10 mol% and 80 mol% of TFA and one equivalent of methyl 
indole to give the corresponding tetrahydrocarbazole 15a as single regioisomer and 6:1 and 2:1 
diastereomeric ratio respectively (Scheme 9). However, the reaction in presence of catalytic 
amounts of the gold catalyst afforded the tetrahydrocarbazole 15a in 79% yield with a 2:1 
diastereomeric ratio. 
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Scheme 9. Gold- and acid-catalyzed synthesis of tetrahydrocarbazole 15a.  
 
 The non concordance with previous results, where the final products were obtained as a 
2:1 diastereomeric mixture (Table 2), prompted us to think about the possibility of acid- or gold-
catalyzed epimerization reaction at the benzylic position in the products. To corroborate this 
hypothesis, a 6:1 diastereomeric mixture of the tetrahydrocarbazole 15a, obtained from the 
reaction of intermediate 19a with 10 mol% of TFA, was treated with 80 mol% of acid (Scheme 
10, a). After 12 hours at room temperature, epimerization at the benzylic position of the 
tetrahydrocarbazole 15a was observed affording a 2:1 diastereomeric mixture. On the other hand, 
gold was also able to epimerize the benzylic position in 15a (Scheme 10 b) from a diastereomeric 
ratio of 6:1 to 4:1. However, when 1 equivalent of NaHCO3 was used in the later case (Scheme 10 
c) no epimerization was observed confirming the need of acid to achieve this isomerization. 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5 
 
 
235 
 
Scheme 10. Acid- and gold-catalyzed synthesis of tetrahydrocarbazole 15a. Epimerization 
experiments 
  
 The experiment shown in Scheme 6 suggests that protic acid alone cannot explain the 
synthesis of tetrahydrocarbazoles 15 (showed in Table 1-3). However, as it was shown in Scheme 
8, allene 17 might be involved in the formation of tetrahydrocarbazole 15 via 19 whose formation 
can only be achieved using gold catalysts (Scheme 7). In addition, the experiments with allene 17 
in presence of acid and gold catalyst 16 cannot explain the formation of the minor regioisomer 15’ 
observed in Table 1-3. Thus, the alternative to explain the formation of the corresponding minor 
regioisomer 15’ is to look at intermediate 18. As it was shown in Scheme 4, the possibility of a 
regioselective attack of the indole to the alkyne is an important issue.The formation of 
intermediates 19 and 19’ could be also explained from intermediate 18 (Scheme 11). As it was 
demonstrated in Schemes 5-8, allenyl intermediate 17 can only be transformed into carbazole 
intermediate 19 and tetrahydrocarbazoles 15 by gold catalysis (Scheme 11, red arrow). On the 
other hand, intermediate 18 can be activated in presence of both gold and acid triggering the 
cyclopropyl-ring opening and cyclizing intramoleculary to afford the spyrocyclic intermediate 20. 
The lack of regioselectivity in the isomerization of this compound could explain a mixture of 
regioisomers 19 and 19’ (Scheme 11, black arrow) as intermediates for the synthesis of 
tetrahydrocarbazoles 15 and 15’.  
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Scheme 11. Gold- and/or acid-catalyzed formation of carbazoles 19 and 19’ 
  
 In order to study how intermediates 19 and 19’ are generated from 18, we decided to run 
the following experiments. Intermediate 18 was synthetized and submitted independently to gold 
and acid catalysis (Schemes 12 and 13). The reaction of intermediate 18 in presence of catalytic 
amounts of the gold catalyst afforded different regioisomeric mixtures of intermediates 19 and 19’ 
after 1 hour of reaction at 80 oC (Scheme 12). N-Methyl protected intermediate 18a afforded a 4:1 
regioisomeric mixture of carbazole 19a and 19’a whereas N-benzyl protected intermediate 18b 
afforded a 6:1 regioisomeric mixture of 19b and 19’b. On the other hand, the reaction of 
intermediate 18 in the presence of catalytic amounts of TFA afforded a 1:1 regioisomeric mixture 
of carbazoles 19a and 19’a after heating the reaction at 80 oC for 1 hour. 
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Scheme 12. Gold-catalyzed synthesis of 19 and 19’ 
 
 The possibility of a competitive acid-catalyzed mechanism for the formation of 
intermediates 19 and 19’ was confirmed through the following experiments. Intermediate 18a was 
submitted under catalytic (10 mol%) and substoichiometric amounts of TFA (80 mol%) affording 
in both cases, after heating the reaction to 80 oC for 12 hours, a 1:1 regioisomeric mixture of 
tetrahydrocarbazoles 15a and 15’a (Scheme 13). The conversion of the reaction in presence of 10 
mol% of TFA was not complete affording the mixture of products in 24% yield. However, the 
reaction in presence of substoichiometric amounts of TFA afforded total conversion after 12 
hours of reaction and the mixture of products were obtained quantitatively. The formation of 
tetrahydrocarbazoles 15a and 15’a showed in Scheme 15 can be explained through the formation 
of carbazoles 19’ and 19 respectively. Further acid activation of the double bond in 19 and 19’ 
triggers the nucleophilic attack of a second molecule of indole affording the final products 15a 
and 15’a. Interestingly, the reaction of intermediate 18a in the presence of 5 mol% of the gold 
catalyst 16 afforded a 4:1 regioisomeric mixture of tetrahydrocarbazoles 15a and 15’a isolated in 
71% and 15% yield respectively.  
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Scheme 13. Acid-catalyzed synthesis of tetrahydrocarbazoles 15a and 15’a 
 
 For the last step of our mechanism, we hypothesize that the formation of 
tetrahydrocarbazoles 15 and 15’ can be catalyzed by the presence of acid and/or gold catalysts via 
regioisomeric mixture of carbazoles 19 and 19’ (Scheme 14). Gold and/or acid activate the 
unsaturated moiety in 19 or 19’ triggering a nucleophilic attack of a second molecule of indole to 
form the corresponding products.  
Scheme 14. Gold- and/or acid-catalyzed synthesis of tetrahydrocarbazoles 15 and 15’ 
N
R1
N
R1
+
N
N
R1
R1
N N
R1 R1
MeO MeO
OMe
OMe
[Au] or [H+] [Au] or [H+]
15' 19 19' 15  
 Further evidences for the need of gold and acid in the success of this mechanistic pathway 
were obtained with the following experiments (Scheme 15). A 4:1 regioisomeric mixture of 
intermediates 19 and 19’ was submitted with one equivalent of methyl indole in the presence of 
catalytic amounts of the gold catalyst. Heating up the reaction in toluene for 12 hours afforded a 
4:1 regioisomeric mixture of the desired products 15 and 15’. The selectivity observed in this 
transformation as well as the regioselectivy observed in the formation of intermediates 19 and 19’ 
(Scheme 12) are in agreement with the results observed for the reaction with methyl indole and 
the corresponding 1-cyclopropyl alkyne under the standard reactions conditions (Table 1, entry 8). 
The same regioselective pattern was observed for intermediates 19 and 19’, bearing a benzyl 
group at the nitrogen atom of the indole, affording a 6:1 regioisomeric mixture of 
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tetrahydrocarbazoles 15 and 15’. Moreover, the reaction of intermediate 23, which was previously 
synthesized, in presence of one equivalent of methyl indole afforded the tetrahydrocabazol 24 in 
82% yield as a single regioisomer. 
Scheme 15. Gold-catalyzed reaction of carbazoles 19 and 19’ 
 
 
 In summary, a complete mechanistic picture can be formulated using the above collected 
datas (Scheme 16). We propose a mechanism that involves three main steps. In the first step, both 
gold and acid catalyzed the formation of intermediates 17 and 18 in a divergent process. Gold-
coordination of the alkyne in 1-(2-ethynylcyclopropyl)-4-methoxybenzene triggers the 
nucleophilic attack of the C3 of the indole delivering intermediate 18. Furthermore, intermediate 
18 can be influenced by the presence of gold or acid. After gold- or acid-activation in 18, that 
triggers the formation of the 1,5-dipole 22, spyrocyclic intermediate 20 is formed. The no 
regioselectivity observed for the ring expansion process affords regioisomeric mixtures of 19 and 
19’. Then, gold- or acid-activation of the double bond in 19 and 19’ followed by the nucleophilic 
attack of a second molecule of indole afford the corresponding tetrahydrocarbazoles 15 and 15’. 
On the other hand, acid can promote the activation of the position 2 of the cyclopropyl ring 
triggering the nucleophilic attack of the indole onto this position affording allene 17. Then, after 
gold activation of the allene 17, the intramolecular attack of the indole delivers the formation of 
the spyrocyclic intermediate 21 which selectively isomerizes to form 19’.  
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Scheme 16. Mechanistic proposal 
N
R1
+
N
R1
N
R1
N
R1
[Au]
N
R1
[H][Au]
N
R1
N
R1
+
N
N
R1
R1
N N
R1 R1
MeO
[Au][H+]
[Au][H+]
OMe
N
R1
[H][Au]
OMe
MeO
OMe
MeO
MeO MeO
OMe
OMe
[Au]
[Au] or [H+]
[H+]
[Au] or [H+]
[Au] or [H+][Au] or [H+]
14
18
22
17
20 21
19 19'15' 15  
 
 5.4 Conclusion 
 This work deeply describes the reactivity of 1-ethynylcyclopropyl derivates and indoles 
under gold catalysts. Highly substituted tetrahydrocarbazoles were obtained in good yields. The 
regioselectivity of the process is remarkable for N-protected indoles with ratios between 4:1, for 
methyl-protected indoles, and 12:1 for benzyl-protected indoles. In contrast, the process seems to 
be no regioselective for non-protected indoles. Remarkably, as it was shown in Table 2, the 
reaction in presence of stoichiometric amounts of base improves considerably the regioselectivity 
of this transformation. We hypothesize that the presence of traces of acid in the reaction mixture 
plays a drastical role in the selectivity of the cycloisomerization of the spyrocyclic intermediates 
to form the corresponding tetrahydrocarbazole products. We also found out that the formation of 
the tetrahydrocarbazole products can be explained via gold-catalysis and/or via combination of 
gold- and acid-catalysis. A plausible reaction mechanism, where both gold and acid are involved 
(Scheme 6), cannot be ruled out based on experimental evidences. 
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1. General information 
 All reactions were carried under non-inert atmosphere. All reagents were used as received 
unless otherwise noted. Solvents were purchased in HPLC quality, degassed by purging 
thoroughly with nitrogen and dried over activated molecular sieves of appropriate size. 
Alternatively, they were purged with argon and passed through alumina columns in a solvent 
purification system (Innovative Technology). Reactions were monitored by thin layer 
chromatography (TLC) using Merck TLC silica gel 60 F254. Flash column chromatography was 
performed over silacycle silica gel (230-400 mesh). NMR spectra were recorded on AV2 400 or 
AV2 500 MHz Bruker spectrometers. Chemical shifts are given in ppm. The spectra are calibrated 
to the residual 1H and 13C signals of the solvents. Multiplicities are abbreviated as follows: 
singlet (s), doublet (d), triplet (t), quartet (q), doublet-doublet (dd), doublet-doublet-doublet (ddd), 
quintet (quint), septet (sept), multiplet (m), and broad (br). Infrared spectra were recorded on a 
JASCO FT/IR-4100 spectrometer. High-resolution electrospray ionization mass spectrometry was 
performed on a Finnigan MAT 900 (Thermo Finnigan, San Jose, CA; USA) doublefocusing 
magnetic sector mass spectrometer 10 spectra were acquired. A mass accuracy ≤ 2 ppm was 
obtained in the peak matching acquisition mode by using a solution containing 2 <l PEG200, 2 <l 
PPG450, and 1.5 mg NaOAc (all obtained from Sigma-Aldrich, CH-Buchs) dissolved in 100ml 
MeOH (HPLC Supra grade, Scharlau, E-Barcelona) as internal standard. 
 
2. Experimental Procedures 
 2.1 Experimental procedure for tetrahydrocarbazols 15 and 15’ 
 
[{(2-Biphenyl)di-tBu-phosphine}Au(CH3CN)]SbF6 (0.0058 mmol, 0.05 equiv.) was added to a 
solution of the corresponding indol (0.232 mmol, 2.0 equiv.) and the cyclopropyl alkyne (0.116 
mmol, 1.0 equiv.) in toluene (0.1M). The mixture was stirred at 80 oC for 12 h. Then, Et3N (0.05 
equiv.) was added to the reaction. The mixture was evaporated in vacuum and the residue was 
purified by flash chromatography (Hexane:EtOAc) affording the corresponding 
tetrahydrocarbazol in 42-92% yield. 
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 2.2. Experimental procedure for tetrahydrocarbazols 15 and 15’ with base 
 
[{(2-Biphenyl)di-tBu-phosphine}Au(CH3CN)]SbF6 (0.0058 mmol, 0.05 equiv.) was added to a 
solution of the corresponding indol (0.232 mmol, 2.0 equiv.), the cyclopropyl alkyne (0.116 
mmol, 1.0 equiv.) and NaHCO3 (0.5-1.0 equiv.) in toluene (0.1M). The mixture was stirred at 80 
oC for 12 h. Then, Et3N (0.05 equiv.) was added to the reaction. The mixture was evaporated in 
vacuum and the residue was purified by flash chromatography (Hexane:EtOAc) affording the 
corresponding tetrahydrocarbazol in 34-83% yield. 
 2.3. Experimental procedure for allene 17 
 
TFA (0.186 mmol) was added to a solution of indole (0.232 mmol) and cyclopropyl alkyne (0.232 
mmol) in dry toluene (0.1 M). The mixture was heated up to 80 oC and stirred until consumption 
of the starting materials. Then, water was added and extracted with DCM. The combined organic 
layers were dried over anhydrous MgSO4 and the solvent was evaporated under vacuum. The 
residue was purified by flash chromatography (Hexane:EtOAc). 
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3. Analytical data N-protected tetrahydrocarbazoles 
9-Benzyl-4-(1-benzyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-4-methyl-2,3,4,9-tetrahydro-1H-
carbazole (15a) 
 Obtained as 2:1 diastereomeric mixture. Characterization of a 1:0.70 
diastereomeric ratio. 1H NMR (400 MHz, CDCl3): δ = 7.77 (d, J = 8.1 Hz, 1H, minor isomer), 
7.65 (d, J = 8.0 Hz, 1H, major isomer), 7.53-7.48 (m, 1H, major and minor isomer), 7.28-6.80 (m, 
20H major isomer and 19H minor isomer), 6.68 (d, J = 8.7 Hz, 2H, minor isomer), 6.59 (s, 1H, 
major isomer), 5.31-5.12 (m, 3H, major and minor isomer), 4.76 (d, J = 17.0 Hz, 1H, major and 
minor isomer), 4.02-3.97 (m, 1H, major and minor isomer), 3.80 (s, 3H major isomer), 3.75 (s, 
3H, minor isomer), 2.46-2.42 (m, 1H, minor isomer), 2.40-2.34 (m, 1H, major isomer), 2.30-2.20 
(m, 1H, minor isomer), 2.14 (s, 3H, major isomer), 2.12-2.07 (m, 1H, major isomer), 2.06 (s, 3H, 
minor isomer), 2.03-1.99 (m, 1H, minor isomer), 1.96-1.89 (m, 1H, major isomer), 1.83-1.76 (m, 
1H, minor isomer), 1.74-1.68 (m, 1H, major isomer) ppm; 13C NMR (100 MHz, CDCl3) (major 
and minor isomer): δ = 158.2, 158.1, 138.4, 138.3, 138.1, 137.9, 137.6, 137.5, 137.5, 136.5, 
136.4, 136.2, 136.1, 129.1, 128.8, 128.6, 128.6, 128.6, 128.5, 127.8, 127.5, 127.3, 127.2, 127.0, 
126.9, 126.5, 126.4, 126.3, 126.0, 125.9, 124.1, 123.3, 121.4, 121.3, 121.2, 121.1, 121.0, 120.9, 
120.8, 119.5, 119.3, 118.7, 118.6, 118.4, 113.8, 109.9, 109.8, 109.3, 109.2, 55.2, 55.2, 49.7, 49.6, 
46.5, 46.3, 38.9, 38.1, 36.7, 36.4, 34.6, 31.3, 30.4, 29.0, 28.1 ppm (eight carbon are missing due to 
overlapping); IR (neat, ν/cm-1): 3028, 2929, 2852, 1605, 1507, 1455, 1356, 1321, 1240, 1176, 
1037, 835, 736, 695, 562; MS (ESI): m/z (M+): 609.4. 
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1-(4-Methoxyphenyl)-4,9-dimethyl-4-(1-methyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-
carbazole (15b) 
 Obtained as 2:1 diastereomeric mixture. Characterization of a 1:0.50 
diastereomeric ratio. 1H NMR (400 MHz, CDCl3): δ = 7.75 (d, J = 8.0 Hz, 1H, major isomer), 
7.70 (d, J = 7.9 Hz, 1H, minor isomer), 7.54 (d, J = 7.9 Hz, 1H, major isomer), 7.42 (d, J = 7.9 
Hz, 1H, minor isomer), 7.31 (d, J = 8.2 Hz, 1H, major isomer), 7.27 (d, J = 8.5 Hz, 1H, major 
isomer), 7.19 (t, J = 7.6 Hz, 2H, major isomer), 7.17-7.13 (m, 2H, minor isomer), 7.08-7.05 (m, 
1H major isomer and 2H minor isomer), 7.02-6.98 (m, 2H major isomer and 3H minor isomer), 
6.94 (t, J = 7.5 Hz, 1H, minor isomer), 6.83 (d, J = 8.6 Hz, 2H, major isomer), 6.79 (d, J = 8.7 Hz, 
2H, minor isomer), 6.72 (s, 1H, minor isomer), 6.33 (s, 1H, major isomer), 4.22-4.18 (m, 1H, 
major and minor isomer), 3.79 (s, 3H, major isomer), 3.76 (s, 3H, minor isomer), 3.67 (s, 3H, 
minor isomer), 3.58 (s, 3H, major isomer), 3.99 (s, 3H, major isomer), 3.35 (s, 3H, minor isomer), 
2.43-2.26 (m, 2H, major isomer), 2.14-2.05 (m, 2H, minor isomer), 2.10 (s, 3H, major isomer), 
1.99 (s, 3H, minor isomer), 1.97-1.79 (m, 1H major isomer and 2H minor isomer), 1.73-1.69 (m, 
1H, major isomer) ppm; 13C NMR (100 MHz, CD2Cl2) (major and minor isomer): δ = 158.1, 
158.0, 138.0, 137.9, 137.4, 136.8, 136.6, 136.2, 136.1, 129.1, 128.9, 128.8, 127.8, 126.3, 126.1, 
125.8, 123.3, 122.3, 121.3, 121.2, 121.1, 121.0, 120.8, 120.7, 120.5, 120.4, 118.8, 118.6, 118.4, 
118.3, 118.1, 118.0, 113.9, 113.7, 109.3, 109.2, 108.6, 108.5, 55.2, 39.0, 37.8, 36.8, 36.5, 36.5, 
33.9, 32.6, 32.5, 31.2, 29.9, 29.8, 29.4, 29.3, 28.1 ppm; IR (neat, ν/cm-1): 3048, 2921, 2840, 1611, 
1509, 1467, 1370, 1244, 1176, 1089, 1031, 907, 835, 731, 562; HRMS (ESI): m/z: calcd for 
C30H30N2NaO+: 457.2250, found: 457.2247. 
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4-(4-Methoxyphenyl)-1,9-dimethyl-1-(1-methyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-
carbazole (15’b) minor diastereoisomer 
 Obtained as 2:1 diastereomeric mixture. 1H NMR (400 MHz, CDCl3): δ = 
7.28-7.26 (m, 1H), 7.20 (d, J =  8.3 Hz, 2H), 7.15-7.12 (m, 2H), 7.07 (t, J = 7.4 Hz, 1H), 6.88-
6.84 (m, 7H), 4.32 (dd, J = 8.2, 5.6 Hz, 1H), 3.81 (s, 3H), 3.78 (s, 3H), 3.30 (bs, 3H), 2.43-2.37 
(m, 1H), 2.19-2.12 (m, 1H), 1.98 (s, 3H), 1.93-1.88 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3): δ 
= 157.9, 142.1, 138.7, 137.7, 137.5, 129.2, 126.4, 126.3, 126.0, 125.8, 121.4, 120.5, 120.5, 119.9, 
119.0, 118.4, 113.6, 111.6, 109.1, 108.5, 55.2, 40.6, 40.4, 35.8, 32.7, 32.3, 30.7, 26.9 ppm; IR 
(neat, ν/cm-1): 3043, 2931, 2846, 2249, 1610, 1508, 1468, 1364, 1324, 1240, 1173, 1035, 1015, 
906, 829, 727, 647, 567; MS (ESI): m/z [M+Na]+: 457.2. 
4-(4-Methoxyphenyl)-1,9-dimethyl-1-(1-methyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-
carbazole (15’b) major diastereoisomer 
 Obtained as 2:1 diastereomeric mixture. 1H NMR (400 MHz, CDCl3): δ = 
7.35-6.85 (m, 13H), 4.38-4.34 (m, 1H), 3.82 (s, 3H), 3.79 (s, 3H), 3.51 (bs, 3H), 2.51-2.46 (m, 
1H), 2.39-2.28 (m, 1H), 2.04 (s, 3H), 1.99-1.90 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3): δ = 
157.7, 142.2, 138.3, 137.6, 137.5, 129.2, 126.7, 126.6, 125.9, 122.0, 121.3, 120.8, 120.7, 119.7, 
118.7, 118.7, 113.5, 111.6, 109.2, 108.6, 55.1, 39.9, 36.2, 32.6, 31.3, 30.9, 30.7, 27.2 ppm; IR 
(neat, ν/cm-1): 3043, 2931, 2846, 2249, 1610, 1508, 1468, 1364, 1324, 1240, 1173, 1035, 1015, 
906, 829, 727, 647, 567; MS (ESI): m/z [M+Na]+: 457.2. 
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9-(4-Methoxybenzyl)-4-(1-(4-methoxybenzyl)-1H-indol-3-yl)-1-(4-methoxyphenyl)-4-methyl-
2,3,4,9-tetrahydro-1H-carbazole (15d) 
 Obtained as 2:1 diastereomeric mixture. Characterization of a 1:0.63 
diastereomeric ratio. 1H NMR (400 MHz, CDCl3): δ = 7.72 (d, J = 8.2 Hz, 1H, minor isomer), 
7.59 (d, J = 7.9 Hz, 1H, major isomer), 7.47-7.43 (m, 1H major and minor isomer), 7.22-6.52 (m, 
16H major isomer and 13H minor isomer), 6.52 (s, 1H, major isomer), 5.19-5.01 (m, 6H, major 
and minor isomer), 4.68-4.63 (m, 2H, major and minor isomer), 3.99-3.94 (m, 1H, major and 
minor isomer), 3.76 (s, 3H, major isomer), 3.72 (s, 3H, minor isomer), 3.71 (s, 3H, major isomer), 
3.71 (s, 3H, major isomer), 3.70 (s, 3H, minor isomer), 3.70 (s, 3H, minor isomer), 2.41-2.29 (m, 
1H, major and minor isomer), 2.23-2.14 (m, 1H, major isomer), 2.09 (s, 3H, major isomer), 2.06-
2.4 (m, 1H, minor isomer), 2.00 (s, 3H, minor isomer), 1.97-1.94 (m, 1H, minor isomer), 1.92-
1.88 (m, 1H, major isomer), 1.77-1.64 (m, 2H, major isomer) ppm; 13C NMR (100 MHz, CD2Cl2) 
(major and minor isomer): δ = 158.9, 158.8, 158.7, 158.6, 158.2, 158.1, 157.9, 137.5, 137.5, 
137.5, 137.4, 136.5, 136.5, 136.2, 136.1, 130.5, 130.3, 130.1, 129.9, 129.1, 128.8, 127.8, 127.7, 
127.4, 127.2, 127.1, 126.8, 126.5, 126.4, 126.4, 126.3, 124.0, 123.2, 121.4, 121.3, 121.2, 121.1, 
121.0, 120.9, 120.8, 120.7, 119.5, 119.3, 118.6, 118.5, 118.4, 114.1, 114.1, 114.0, 113.9, 113.9, 
113.8, 109.9, 109.8, 109.3, 109.2, 55.2, 55.2, 55.1, 49.2, 49.1, 45.9, 45.8, 38.9, 38.1, 36.7, 36.4, 
34.6, 31.3, 30.4, 29.7, 29.1, 28.1 ppm; IR (neat, ν/cm-1): 3048, 3002, 2931, 2834, 1610, 1509, 
1462, 1353, 1326, 1243, 1173, 1033, 828, 731, 535; HRMS (ESI): m/z: calcd for C44H42N2NaO3+: 
669.3087, found: 669.3087. 
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9-Cinnamyl-4-(1-cinnamyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-4-methyl-2,3,4,9-
tetrahydro-1H-carbazole (15e) 
 Obtained as 2:1 diastereomeric mixture. Characterization of a 1:0.57 
diastereomeric ratio. 1H NMR (400 MHz, CDCl3): δ = 7.78 (d, J = 8.0 Hz, 1H, minor isomer), 
7.74 (d, J = 8.0 Hz, 1H, major isomer), 7.55 (d, J = 7.9 Hz, 1H, major isomer), 7.50 (d, J= 7.9 
Hz, 1H, minor isomer), 7.36-6.92 (m, 22H major isomer and 18H minor isomer), 6.84-6.82 (m, 
2H major isomer and 1H minor isomer), 6.65 (d, J = 8.6 Hz, 2H, minor isomer), 6.51 (s, 1H, 
major isomer), 6.35-5.87 (m, 4H, major and minor isomer), 4.86-4.63 (m, 3H, major and minor 
isomer), 4.50-4.39 (m, 1H, major and minor isomer), 4.24 (dd, J = 5.4, 2.5 Hz, 1H, major isomer), 
4.21 (t, J = 6.1 Hz, 1H, minor isomer), 3.74 (s, 3H, major isomer), 3.56 (s, 3H, minor isomer), 
2.50-2.38 (m, 1H, major and minor isomer), 2.34-2.27 (m, 1H, minor isomer), 2.20-2.12 (m, 1H, 
major isomer), 2.15 (s, 3H, major isomer), 2.06 (s, 3H, minor isomer), 2.02-1.94 (m, 1H, major 
and minor isomer), 1.87-1.80 (m, 1H, minor isomer), 1.77-1.72 (m, 1H, major isomer) ppm; 13C 
NMR (100 MHz, CDCl3) (major and minor isomer): 158.2, 158.1, 137.5, 137.4, 137.1, 137.0, 
136.7, 136.5, 136.5, 136.4, 136.4, 136.4, 136.2, 136.0, 131.5, 131.3, 131.1, 131.0, 129.4, 129.0, 
128.5, 128.5, 128.4, 128.4, 127.9, 127.6, 127.6, 127.5, 127.5, 127.2, 127.2, 126.6, 126.4, 126.4, 
126.4, 126.3, 126.3, 126.3, 125.5, 125.4, 125.3, 125.3, 123.9, 122.9, 121.4, 121.3, 121.2, 121.2, 
121.0, 120.9, 120.7, 120.7, 119.2, 118.9, 118.6, 118.5, 118.4, 118.3, 113.9, 113.8, 109.8, 109.6, 
109.3, 109.2, 55.1, 55.0, 48.0, 47.8, 45.5, 45.0, 39.1, 37.9, 36.7, 36.5, 34.2, 30.1, 29.4, 28.1, 22.3, 
14.0 ppm; IR (neat, ν/cm-1): 3056, 3020, 2952, 2932, 2854, 1609, 1509, 1463, 1355, 1327, 1246, 
1176, 1032, 965, 908, 833, 733, 692; HRMS (ESI): m/z: calcd for C46H42N2NaO+: 661.3189, 
found: 661.3187. 
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1-(4-Methoxyphenyl)-4-methyl-9-pentyl-4-(1-pentyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-
carbazole (15f) 
 Obtained as 2:1 diastereomeric mixture. Characterization of a 1:1 
diastereomeric ratio. 1H NMR (400 MHz, CDCl3): δ = 7.76 (d, J = 8.0 Hz, 1H), 7.72 (d, J = 8.0 
Hz, 1H), 7.51 (d, J = 7.9 Hz, 1H), 7.45 (d, J = 7.9 Hz, 1H), 7.31-7.27 (m, 4H), 7.18-7.11 (m, 4H), 
7.07-7.00 (m, 6H), 6.98-6.92 (m, 2H), 6.83 (d, J = 8.7 Hz, 2H), 6.78-6.74 (m, 3H), 6.37 (s, 1H), 
4.20-4.16 (m, 2H), 4.00 (t, J = 7.2 Hz, 2H), 3.94-3.89 (m, 2H), 3.88-3.82 (m, 2H), 3.80 (s, 3H), 
3.75 (s, 3H), 3.73-3.60 (m, 2H), 2.42-2.24 (m, 3H), 2.11 (s, 3H), 2.09-2.02 (m, 1H), 2.00 (s, 3H), 
1.92 (dt, J = 13.0, 2.1 Hz, 1H), 1.80-1.63 (m, 7H), 1.42-1.06 (m, 20H), 0.87-0.81 (m, 12H) ppm; 
13C NMR (100 MHz, CDCl3): δ = 158.2, 158.1, 137.2, 137.1, 136.9, 136.8, 136.7, 136.4, 136.3, 
135.9, 130.9, 129.2, 128.9, 127.9, 127.2, 126.5, 126.4, 126.2, 126.1, 123.2, 122.6, 122.2, 121.4, 
121.3, 121.1, 120.6, 120.5, 120.3, 118.6, 118.4, 118.2, 118.1, 117.9, 117.9, 113.8, 113.7, 109.5, 
109.4, 109.1, 109.0, 55.2, 55.2, 47.7, 46.1, 45.9, 43.6, 43.2, 39.2, 38.1, 36.6, 36.5, 34.0, 31.3, 
31.3, 30.0, 29.9, 29.9, 29.7, 29.5, 29.4, 29.4, 29.2, 29.1, 29.1, 29.0, 28.1, 22.4, 22.3, 22.291, 22.2, 
13.9, 13.9  ppm; IR (neat, ν/cm-1): 3046, 2955, 2929, 2870, 1609, 1509, 1464, 1363, 1327, 1244, 
1174, 1104, 1035, 906, 831, 728, 648; HRMS (ESI): m/z: calcd for C38H46N2NaO+: 569.3502, 
found: 569.3496. 
6-Methoxy-4-(5-methoxy-1-methyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-4,9-dimethyl-
2,3,4,9-tetrahydro-1H-carbazole (15g) 
1H NMR (400 MHz, CDCl3): δ = 7.20-7.15 (m, 3H), 7.01-6.97 (m, 
3H), 6.88-6.82 (m, 4H), 6.35 (s, 3H), 4.18-4.17 (m, 1H), 3.81 (s, 3H), 3.80 (s, 3H), 3.74 (s, 3H), 
3.57 (s, 3H), 3.36 (s, 3H), 2.36-2.29 (m, 1H), 2.13-2.05 (m, 1H), 2.07 (s, 3H), 1.86 (dt, J = 13.0, 
1.65 Hz, 1H), 1.73-1.69 (m, 1H) ppm; 13C NMR (100 MHz, CDCl3): δ = 158.1, 153.2, 152.9, 
136.9, 136.1, 133.6, 132.9, 129.6, 129.1, 126.6, 126.1, 121.4, 118.2, 113.7, 110.4, 110.2, 109.8, 
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109.1, 103.9, 103.9, 56.1, 56.1, 55.2, 37.9, 36.4, 33.8, 32.6, 29.9, 29.4, 29.1 ppm; IR (neat, ν/cm-
1): 2932, 2832, 1614, 1577, 1509, 1484, 1452, 1245, 1213, 1176, 1150, 1040, 910, 837, 790, 727; 
HRMS (ESI): m/z: calcd for C32H34rN2NaO3+: 517.2462, found: 517.2461. 
9-Benzyl-4-(1-benzyl-5-methoxy-1H-indol-3-yl)-6-methoxy-1-(4-methoxyphenyl)-4-methyl-
2,3,4,9-tetrahydro-1H-carbazole (15h) 
 Obtained as 2:1 diastereomeric mixture. Characterization of a 1:0.40 
diastereomeric ratio. 1H NMR (400 MHz, CDCl3): δ = 7.25-6.18 (m, 20H, major and minor 
isomer), 6.68 (d, J = 8.7 Hz, 2H, minor isomer), 6.57 (s, 1H, major isomer), 5.23 (d, J = 6.6 Hz, 
1H, minor isomer), 5.16 (s, 2H, major isomer), 5.07 (d, J = 17.0 Hz, 1H, major and minor 
isomer), 4.77 (d, J = 17.0 Hz, 1H, major isomer), 4.74 (d, J = 17.1 Hz, 1H, minor isomer), 4.02 
(dd, J = 5.4, 2.9 Hz, 1H, major isomer), 3.98 (t, J = 5.7 Hz, 1H, minor isomer), 3.80 (s, 3H, major 
isomer), 3.78 (s, 3H, major isomer), 3.77 (s, 3H, minor isomer), 3.74 (s, 3H, minor isomer), 3.68 
(s, 3H, major isomer), 3.62 (s, 3H, minor isomer), 2.43-2.35 (m, 1H, major and minor isomer), 
2.30-2.22 (m, 1H, minor isomer), 2.12 (s, 3H, major isomer), 2.10-2.04 (m, 1H, major isomer), 
2.03 (s, 3H, minor isomer), 2.01-1.96 (m, 1H, minor isomer), 1.91 (dt, J =12.9, 1.9 Hz, 1H, major 
isomer), 1.82-1.77 (m, 1H, minor isomer), 1.73-1.68 (m, 1H, major isomer) ppm; 13C NMR (100 
MHz, CDCl3) (major and minor isomer): 158.2, 158.1, 153.3, 153.2, 153.1, 138.4, 138.4, 138.2, 
138.0, 137.2, 136.9, 136.6, 136.1, 133.0, 132.9, 132.7, 132.6, 129.1, 128.9, 128.8, 128.6, 128.6, 
128.5, 128.4, 128.1, 127.3, 127.3, 127.0, 126.9, 126.8, 126.7, 126.6, 126.6, 126.4, 126.3, 125.9, 
123.3, 122.3, 119.1, 118.8, 113.8, 113.8, 111.0, 110.7, 110.6, 110.5, 110.4, 110.4, 109.9, 109.8, 
104.2, 104.0, 103.5, 103.5, 56.0, 56.0, 55.8, 55.7, 55.2, 55.2, 49.9, 49.8, 46.6, 46.5, 39.0, 38.1, 
36.4, 36.3, 34.1, 31.2, 30.2, 29.7, 28.9, 27.7 ppm (two carbon are missing due to overlapping); IR 
(neat, ν/cm-1): 3054, 3031, 2931, 2829, 1616, 1575, 1509, 1482, 1451, 1353, 1299, 1245, 1215, 
1175, 1035, 909, 834, 793, 732, 702; HRMS (ESI): m/z: calcd for C44H42N2NaO3+: 669.3087, 
found: 669.3086. 
 
Chapter 5 
 
 
 
256 
 
6-Bromo-4-(5-bromo-1-methyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-4,9-dimethyl-2,3,4,9-
tetrahydro-1H-carbazole (15i) 
Obtained as 2:1 diastereomeric mixture. 1H NMR (400 MHz, CD2Cl2): δ = 
7.72 (s, 1H, major isomer), 7.63 (s, 1H, minor isomer), 7.56 (s, 1H, major isomer), 7.30 (s, 1H, 
minor isomer), 7.25-7.15 (m, 4H, major and minor isomer), 7.09 (d, J = 8.3 Hz, 2H, minor 
isomer), 6.97 (d, J = 8.4 Hz, 2H, major isomer), 6.91 (s, 1H, major isomer), 6.89 (s, 1H, minor 
isomer), 6.84 (d, J = 8.4 Hz, 2H, major isomer) 6.39 (s, 1H, major isomer), 4.26-4.21 (m, 1H, 
major and minor isomer), 3.78 (s, 3H, major isomer), 3.77 (s, 3H, minor isomer), 3.59 (s, 3H, 
major isomer), 3.37 (s, 3H, minor isomer), 3.35 (s, 3H, major isomer), 2.46-2.39 (m, 1H, minor 
isomer), 2.31-2.19 (m, 1H, major and minor isomer), 2.11-2.06 (m, 1H, major and minor isomer), 
2.03 (s, 3H, major isomer), 1.96-1.89 (m, 1H, major and minor isomer), 1.86 (s, 3H, minor 
isomer), 1.76-1.71 (m, 1H, major and minor isomer) ppm; 13C NMR (100 MHz, CD2Cl2) (major 
and minor isomer): δ = 158.9, 158.8, 138.5, 138.4, 137.3, 137.2, 136.8, 136.7, 136.4, 136.2, 
130.3, 129.6, 129.3, 129.1, 128.4, 128.2, 128.1, 124.2, 124.1, 123.8, 123.8, 123.7, 123.6, 123.5, 
123.4, 122.8, 122.4, 118.5, 114.7, 114.4, 112.2, 112.1, 112.1, 111.9, 111.5, 111.4, 110.9, 55.7, 
38.6, 38.4, 36.7, 36.5, 36.3, 34.9, 33.3, 33.2, 31.1, 30.4, 30.3, 30.1, 29.5, 27.9 ppm; IR (neat, 
ν/cm-1): 2931, 2855, 1609, 1509, 1469, 1420, 1370, 1245, 1176, 1096, 1035, 986, 907, 788, 730; 
HRMS (ESI): m/z: calcd for C30H28Br2N2NaO+: 613.0457, found: 613.0460. 
9-Benzyl-4-(1-benzyl-5-bromo-1H-indol-3-yl)-6-bromo-1-(4-methoxyphenyl)-4-methyl-
2,3,4,9-tetrahydro-1H-carbazole (15j) 
 Obtained as 2:1 diastereomeric mixture. 1H NMR (500 MHz, CDCl3): δ 
= 7.8 (s, 1H, minor isomer), 7.68 (s, 1H, major isomer), 7.55 (s, 1H, major isomer), 7.48 (s, 1H, 
Chapter 5 
 
 
 
257 
 
minor isomer), 7.35-7.32 (m, 2H, major and minor isomer),  7.27-6.97 (m, 12H major isomer and 
13H minor isomer), 6.85-6.77 (m, 4H, major and minor), 6.66 (s, 1H, major isomer), 5.33-5.19 
(m, 2H major and minor isomer), 5.12 (d, J = 17.1 Hz, 1H, minor isomer), 5.07 (d, J = 17.1 Hz, 
1H, major isomer), 4.82 (d, J = 17.1 Hz, 1H, minor isomer), 4.73 (d, J = 17.1 Hz, 1H, major 
isomer), 4.04-4.02 (m, 1H major and minor isomer), 3.82 (s, 3H, major isomer), 3.77 (s, 3H, 
minor isomer), 2.37-2.29 (m, 2H, major isomer), 2.12-2.09 (m, 2H, minor isomer), 2.06 (s, 3H, 
major isomer), 1.95 (s, 3H, minor isomer), 1.92-1.81 (m, 1H major isomer and 2H minor isomer), 
1.78-1.76 (m, 1H, major isomer) ppm; 13C NMR (125 MHz, CD2Cl2) (major and minor isomer): δ 
= 158.2, 158.1, 137.7, 137.6, 137.5, 137.4, 137.2, 136.1, 136.0, 136.0, 135.6, 135.5, 128.9, 128.9, 
128.8, 128.7, 128.6, 128.5, 127.9, 127.8, 127.8, 127.5, 127.4, 127.2, 127.1, 126.2, 126.1, 125.8, 
125.7, 124.1, 124.0, 123.8, 123.7, 123.5, 123.3, 122.9, 122.8, 122.6, 118.6, 118.5, 114.1, 113.9, 
112.1, 112.0, 111.9, 111.4, 111.3, 110.9, 110.8, 55.2, 55.2, 49.9, 49.9, 46.6, 46.5, 38.2, 38.0, 35.9, 
35.8, 35.6, 34.9, 30.5, 28.8, 27.6 ppm; IR (neat, ν/cm-1): 3062, 3028, 2930, 2857, 2835, 1606, 
1508, 1463, 1452, 1353, 1245, 1176, 1031, 988, 907, 831, 790, 696; HRMS (ESI): m/z: calcd for 
C42H36Br2N2NaO+: 765.1087, found: 765.1088. 
4-(1,5-Dimethyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-4,6,9-trimethyl-2,3,4,9-tetrahydro-1H-
carbazole (15k) 
 Obtained as 2:1 diastereomeric mixture. Characterization of a 1:0.63 
diastereomeric ratio. 1H NMR (400 MHz, CDCl3): δ = 7.61 (s, 1H, major isomer), 7.55 (s, 1H, 
minor isomer), 7.38 (s, 1H, major isomer), 7.06-6.96 (m, 4H major isomer and 5H minor isomer), 
7.22-7.14 (m, 3H major isomer and 2H minor isomer), 6.83-6.78 (m, 2H major and minor 
isomer), 6.67 (s, 1H, minor isomer), 6.25 (s, 1H, major isomer), 4.18-4.15 (m, 1H, major and 
minor isomer), 3.79 (s, 3H, major isomer), 3.77 (s, 3H, minor isomer), 3.65 (s, 3H, minor isomer), 
3.55 (s, 3H, major isomer), 3.37 (s, 3H, major isomer), 3.30 (s, 3H, minor isomer), 2.48 (s, 3H, 
major isomer), 2.44 (s, 3H, minor isomer), 2.39 (s, 3H, major isomer), 2.35 (s, 3H, minor isomer), 
2.31-2.21 (m, 1H, major and minor isomer), 2.11 (s, 3H, major isomer), 2.09-2.03 (m, 1H, major 
isomer), 1.99 (s, 3H, minor isomer), 1.96-1.92 (m, 1H, minor isomer), 1.89-1.77 (m, 1H, major 
and minor isomer), 1.70-1.66 (m, 1H, major isomer) ppm; 13C NMR (100 MHz, CD2Cl2) (major 
and minor isomer): δ = 158.1, 158.0, 137.0, 136.8, 136.5, 136.4, 136.3, 136.2, 135.9, 135.8, 
129.4, 129.2, 128.8, 128.2, 127.4, 127.3, 127.2, 127.1, 126.5, 126.4, 125.9, 122.7, 122.4, 122.3, 
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122.0, 121.9, 121.6, 121.2, 121.0, 121.0, 120.8, 118.4, 118.2, 113.9, 113.7, 110.0, 109.1, 108.9, 
108.3, 108.2, 55.3, 55.2, 39.3, 39.3, 37.7, 36.9, 36.6, 36.6, 33.5, 32.6, 32.5, 31.4, 30.1, 29.7, 29.5, 
29.3, 28.2, 21.7, 21.6, 21.5 ppm; IR (neat, ν/cm-1): 3032, 2929, 2866, 1609, 1508, 1486, 1461, 
1371, 1245, 1175, 1092, 1034, 908, 833, 790, 731; HRMS (ESI): m/z: calcd for C22H34N2NaO+: 
485.2563, found: 485.2560. 
9-Benzyl-4-(1-benzyl-5-methyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-4,6-dimethyl-2,3,4,9-
tetrahydro-1H-carbazole (15l) major diastereoisomer 
Obtained as 2:1 diastereomeric mixture. 1H NMR (500 MHz, 
CDCl3)(major diastereoisomer): δ = 7.52 (s, 1H), 7.34 (s, 1H), 7.23 (d, J = 7.5 Hz, 2H), 7.20 (d, J 
= 7.1 Hz, 1H), 7.17-7.16 (m, 3H), 7.09 (t, J = 7.8 Hz, 2H), 7.0-6.97 (m, 3H), 6.95-6.90 (m, 2H), 
6.86-6.84 (m, 2H), 6.81 (d, J = 8.6 Hz, 2H), 6.52 (s, 1H), 5.20-5.13 (m, 2H), 5.08 (d, J = 17.0 Hz, 
1H), 4.74 (d, J = 17.0 Hz, 1H), 4.00 (dd, J = 5.4, 2.8 Hz, 1H), 3.80 (s, 3H), 2.43 (s, 3H), 2.41-2.34 
(m, 1H), 2.34 (s, 3H), 2.13 (s, 3H), 2.10-2.04 (m, 1H), 1.90 (dt, J = 13.0, 2.1 Hz, 1H), 1.69-1.65 
(m, 1H) ppm; 13C NMR (125 MHz, CD2Cl2): 158.2, 138.6, 138.1, 136.2, 136.2, 136.0, 135.8, 
129.2, 128.6, 128.6, 128.4, 127.7, 127.5, 127.2, 126.9, 126.7, 126.5, 126.3, 125.9, 122.6, 122.5, 
122.3, 121.1, 120.9, 118.8, 113.8, 109.6, 109.0, 55.2, 49.7, 46.3, 37.9, 36.4, 34.2, 30.2, 29.2, 21.7, 
21.5 ppm; IR (neat, ν/cm-1): 3056, 3025, 2928, 2858, 1608, 1508, 1495, 1481, 1453, 1372, 1354, 
1300, 1246, 1177, 1033, 909, 834, 789, 732, 701; HRMS (ESI): m/z: calcd for C44H42N2NaO+: 
637.3189, found: 637.3192. 
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9-Benzyl-4-(1-benzyl-5-methyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-4,6-dimethyl-2,3,4,9-
tetrahydro-1H-carbazole (15l) minor diastereoisomer 
 Obtained as 2:1 diastereomeric mixture. 1H NMR (500 MHz, 
CDCl3)(major diastereoisomer): δ = 7.59 (s, 1H), 7.30 (s, 1H), 7.24-6.80 (m, 17H), 6.68 (d, J = 
8.3 Hz, 2H), 5.23 (dd, J = 30.4, 16.5 Hz, 2H), 5.09 (d, J = 17.0 Hz, 1H), 4.74 (d, J = 17.1 Hz, 
1H), 3.97 (t, J = 5.8 Hz, 1H), 3.74 (s, 3H), 2.45-2.40 (m, 1H), 2.42 (s, 3H), 2.32 (s, 3H), 2.28-2.19 
(m, 1H), 2.03 (s, 3H), 2.00-1.95 (m, 1H), 1.82-1.77 (m, 1H) ppm; 13C NMR (125 MHz, CDCl3): 
158.0, 138.5, 138.3, 136.6, 136.5, 135.9, 135.9, 128.9, 128.6, 128.5, 127.7, 127.6, 127.4, 127.1, 
126.8, 126.6, 126.5, 126.2, 125.9, 123.4, 122.7, 122.2, 121.1, 121.1, 119.1, 113.8, 109.5, 108.9, 
55.2, 49.6, 46.5, 38.8, 36.6, 36.4, 31.2, 28.0, 21.5, 21.5 ppm (one carbon is missing due to 
overlapping); IR (neat, ν/cm-1): 3056, 3025, 2928, 2858, 1608, 1508, 1495, 1481, 1453, 1372, 
1354, 1300, 1246, 1177, 1033, 909, 834, 789, 732, 701; HRMS (ESI): m/z: calcd for 
C44H42N2NaO+: 637.3189, found: 637.3192. 
5-(5-Cyano-1-methyl-1H-indol-3-yl)-8-(4-methoxyphenyl)-5,9-dimethyl-6,7,8,9-tetrahydro-
5H-carbazole-3-carbonitrile (15m) major diastereoisomer 
1H NMR (400 MHz, CDCl3): δ = 7.71 (s, 1H), 7.62 (s, 1H), 7.40-7.36 
(m, 2H), 7.33-7.30 (m, 2H), 6.99 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 6.63 (s, 1H), 4.26 
(t, J = 4.8 Hz, 1H), 3.81 (s, 3H), 3.72 (s, 3H), 3.40 (s, 3H), 2.27-2.22 (m, 1H), 2.18-2.10 (m, 1H), 
2.02 (s, 3H), 1.96-1.83 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3): δ = 158.4, 139.4, 139.0, 
135.2, 129.6, 128.8, 126.3, 125.6, 125.5, 124.1, 123.9, 123.7, 121.1, 121.0, 118.9, 114.2, 110.3, 
109.7, 101.5, 101.4, 55.3, 38.3, 35.8, 35.6, 32.9, 30.4, 30.1, 29.1(two carbon missing due to 
overlapping) ppm; IR (neat, ν/cm-1): 2963, 2926, 2858, 2217, 1609, 1509, 1482, 1375, 1245, 
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1176, 1091, 1033, 907, 801, 718; HRMS (ESI): m/z: calcd for C32H28N4NaO+: 507.2155, found: 
507.22151. 
5-(5-Cyano-1-methyl-1H-indol-3-yl)-8-(4-methoxyphenyl)-5,9-dimethyl-6,7,8,9-tetrahydro-
5H-carbazole-3-carbonitrile (15m) minor diastereoisomer 
1H NMR (400 MHz, CDCl3): δ = 7.73 (s, 1H), 7.39 (s, 1H), 7.35-7.29 
(m, 4H), 7.09-7.07 (m, 3H), 6.96 (d, J = 8.6 Hz, 2H), 4.29 (dd, J = 5.7. 3.1 Hz, 1H), 3.83 (s, 3H), 
3.81 (s, 3H), 3.49 (s, 3H), 2.56-2.48 (m, 1H), 2.32-2.23 (m, 1H), 2.11-2.07 (m, 1H), 1.85 (s, 3H), 
1.72-1.68 (m, 1H) ppm; 13C NMR (100 MHz, CDCl3): δ = 158.5, 139.3, 138.9, 138.6, 134.6, 
128.7, 128.6, 126.5, 125.6, 125.1, 124.3, 124.1, 124.0, 121.2, 120.9, 118.8, 114.4, 110.3, 109.7, 
101.4, 101.3, 55.3, 37.3, 37.3, 35.5, 33.1, 30.1, 29.9, 27.4 ppm; IR (neat, ν/cm-1): 2963, 2926, 
2858, 2217, 1609, 1509, 1482, 1375, 1245, 1176, 1091, 1033, 907, 801, 718; HRMS (ESI): m/z: 
calcd for C32H28N4NaO+: 507.2155, found: 507.22151. 
(E)-9-Benzyl-4-(1-benzyl-1H-indol-3-yl)-4-methyl-1-(1-phenylprop-1-en-2-yl)-2,3,4,9-
tetrahydro-1H-carbazole (15n) 
 Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.5 
diastereomeric ratio. 1H NMR (400 MHz, CDCl3): δ = 7.79 (d, J = 8.0 Hz, 1H, major isomer), 
7.63 (d, J = 7.5 Hz, 1H, minor isomer), 7.47-7.38 (m, 1H, major and minor isomer), 7.33-6.91 (m, 
23H, major and minor isomer), 6.84 (s, 1H, major isomer), 6.61 (s, 1H, minor isomer), 6.24 (s, 
1H, major isomer), 6.08 (s, 1H, minor isomer), 5.41-5.16 (m, 4H, major and minor isomer), 3.55 
(t, J = 5.6 Hz, 1H, major isomer), 3.49-3.47 (m, 1H, minor isomer), 2.61-2.55 (m, 1H, major 
isomer), 2.48-2.42 (m, 1H, minor isomer), 2.09 (s, 3H, minor isomer), 2.06-2.00 (m, 1H, major 
isomer), 2.02 (s, 3H, major isomer), 1.95 (s, 3H, minor isomer), 1.92-1.86 (m, 1H, minor isomer), 
1.77 (s, 3H, major isomer) ppm; 13C NMR (125 MHz, CDCl3): δ = 139.8, 139.5, 138.5, 138.4, 
138.1, 138.0, 137.9, 137.9, 137.6, 137.5, 137.4, 135.8, 135.7, 128.9, 128.8, 128.7, 128.6, 128.6, 
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128.5, 128.3, 128.2, 128.0, 128.0, 127.9, 127.7, 127.4, 127.3, 127.2, 127.1, 127.0, 126.4, 126.2, 
126.1, 126.0, 126.0, 125.8, 125.6, 123.9, 121.4, 121.2, 121.1, 121.1, 120.8, 120.8, 119.7, 119.5, 
118.6, 118.4, 109.9, 109.8, 109.3, 109.3, 49.7, 46.6, 43.4, 42.6, 36.6, 36.5, 36.3, 35.2, 29.7, 28.9, 
28.2, 28.1, 26.1, 25.4, 17.6, 16.6 ppm (eight carbon are missing due to overlapping); IR (neat, 
ν/cm-1): 3084, 3047, 3027, 2929, 2857, 1604, 1463, 1453, 1354, 1327, 1178, 1074, 1027, 908, 
729, 697; HRMS (ESI): m/z: calcd for C44H40N2Na+: 619.3083, found: 619.3080. 
(E)-5-(5-Cyano-1-methyl-1H-indol-3-yl)-5,9-dimethyl-8-(1-phenylprop-1-en-2-yl)-6,7,8,9-
tetrahydro-5H-carbazole-3-carbonitrile (15o) major diastereoisomer 
 1H NMR (400 MHz, CDCl3): δ = 7.70 (s, 1H), 7.59 (s, 1H), 7.40-7.31 
(m, 6H), 7.23-7.22 (m, 3H), 6.63 (s, 1H), 6.01 (s, 1H), 3.75-3.69 (m, 1H), 3.72 (s, 6H), 2.33-2.28 
(m, 1H), 2.09-1.94 (m, 3H), 2.01 (s, 3H), 1.99 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3): δ = 
139.3, 139.0, 138.7, 138.6, 137.6, 129.6, 128.7, 128.3, 128.2, 126.5, 126.3, 125.6, 124.1, 123.9, 
123.6, 121.1, 121.0, 119.0, 110.3, 109.6, 101.5, 101.4, 42.5, 35.9, 35.8, 32.9, 29.9, 29.0, 25.2, 
17.4 (two carbon missing due to overlapping) ppm; IR (neat, ν/cm-1): 2932, 2858, 2216, 1609, 
1482, 1446, 1375 1228, 1139, 1087, 909, 802, 730; HRMS (ESI): m/z: calcd for C34H30N4Na+: 
517.2363, found: 517.2362. 
(E)-5-(5-Cyano-1-methyl-1H-indol-3-yl)-5,9-dimethyl-8-(1-phenylprop-1-en-2-yl)-6,7,8,9-
tetrahydro-5H-carbazole-3-carbonitrile (15o) minor diastereoisomer 
1H NMR (400 MHz, CDCl3): δ = 7.72 (s, 1H), 7.44 (s, 1H), 7.38-7.30 
(m, 6H), 7.24-7.18 (m, 3H), 6.90 (s, 1H), 6.19 (s, 1H), 3.78 (s, 3H), 3.71 (s, 3H), 3.71-3.68 (m, 
1H), 2.43-2.36 (m, 1H), 2.29-2.20 (m, 1H), 2.02-1.95 (m, 1H), 2.00 (s, 3H), 1.87 (s, 3H), 1.85-
1.83 (m, 1H) ppm; 13C NMR (125 MHz, CDCl3): δ = 139.2, 138.9, 138.8, 138.4, 137.3, 128.9, 
128.8, 128.2, 126.6, 126.1, 125.5, 125.4, 125.3, 124.3, 124.1, 124.0, 121.2, 120.8, 119.1, 110.3, 
109.7, 101.4, 101.3, 42.4, 36.5, 35.7, 33.0, 29.9, 27.7, 25.4, 17.4 ppm; IR (neat, ν/cm-1): 2933, 
Chapter 5 
 
 
 
262 
 
2854, 2217, 1728, 1610, 1483, 1447, 1375, 1289, 1234, 1148, 1095, 910, 802, 730, 699; HRMS 
(ESI): m/z: calcd for C34H30N4Na+: 517.2363, found: 517.2362. 
(E)-6-Bromo-4-(5-bromo-1-methyl-1H-indol-3-yl)-4,9-dimethyl-1-(1-phenylprop-1-en-2-yl)-
2,3,4,9-tetrahydro-1H-carbazole (15p) 
 1H NMR (400 MHz, CDCl3): δ = 7.76 (s, 1H), 7.44 (s, 1H), 7.31-7.27 
(m, 2H), 7.24-7.12 (m, 7H), 6.62 (s, 1H), 6.24 (s, 1H), 3.69 (t, J = 5.9 Hz, 1H), 3.66 (s, 3H), 3.65 
(s, 3H), 2.47-2.41 (m, 1H), 2.13-2.06 (m, 1H), 1.93-1.84 (m, 2H), 1.90 (s, 3H), 1.87 (s, 3H) ppm; 
13C NMR (100 MHz, CD3Cl): δ = 139.7, 137.8, 137.4, 136.6, 136.2, 128.9, 128.8, 128.0, 127.8, 
127.6, 127.4, 126.3, 123.9, 123.5, 123.4, 122.9, 122.6, 118.3, 111.8, 111.7, 110.8, 110.1, 43.5, 
36.8, 36.2, 32.8, 29.9, 28.0, 26.1, 16.7 ppm; IR (neat, ν/cm-1): 3020, 2937, 2856, 1737, 1472, 
1362, 1281, 1229, 1147, 1095, 1049, 904, 794, 742; HRMS (ESI): m/z: calcd for 
C32H30Br2N2NaO+: 623.0668, found: 623.0662. 
(E)-6-Bromo-4-(5-bromo-1-methyl-1H-indol-3-yl)-4,9-dimethyl-1-(1-phenylprop-1-en-2-yl)-
2,3,4,9-tetrahydro-1H-carbazole (15p) 
1H NMR (400 MHz, CDCl3): δ = 7.82 (s, 1H), 7.58 (s, 1H), 7.33-7.27 
(m, 3H), 7.25-7.22 (m, 6H), 6.28 (s, 1H), 5.84 (s, 1H), 3.61 (s, 3H), 3.58 (s, 3H), 3.58-3.55 (m, 
1H), 2.35-2.31 (m, 1H), 2.08-2.04 (m, 1H), 2.03 (s, 3H), 2.01 (s, 3H), 1.83-1.80 (m, 2H) ppm; 13C 
NMR (100 MHz, CD3Cl): δ = 138.8, 137.9, 137.5, 136.7, 136.2, 129.8, 128.8, 128.2, 128.1, 
127.7, 127.4, 126.3, 123.7, 123.4, 123.3, 123.2, 121.7, 118.1, 111.9, 111.8, 110.9, 110.2, 41.9, 
36.3, 34.4, 32.7, 29.4, 29.2, 24.4, 18.0  ppm; IR (neat, ν/cm-1): 3020, 2937, 2856, 1737, 1472, 
1362, 1281, 1229, 1147, 1095, 1049, 904, 794, 742; HRMS (ESI): m/z: calcd for 
C32H30Br2N2NaO+: 623.0668, found: 623.0662. 
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9-Benzyl-4-(1-benzyl-1H-indol-3-yl)-4-methyl-1-(2-methylprop-1-enyl)-2,3,4,9-tetrahydro-
1H-carbazole (15q) 
 Obtained as 1:1 diastereomeric mixture. Characterization of a 1:1 
diastereomeric ratio. 1H NMR (400 MHz, CDCl3): δ = 7.60 (d, J = 8.0 Hz, 1H), 7.49 (d, J = 8.0 
Hz, 1H), 7.40 (d, J = 7.8 Hz, 1H), 7.31-7.27 (m, 3H), 7.25-7.16 (m, 13H), 7.13-6.96 (m, 11H), 
6.94-6.87 (m, 6H), 6.84-6.80 (m, 1H), 6.63 (s, 1H), 5.36-5.15 (m, 10H), 3.72-3.67 (m, 1H), 3.64-
3.59 (m, 1H), 2.58 (ddd, J= 13.4, 11.1, 2.6 Hz, 1H), 2.48 (ddd, J = 13.0, 7.1, 2.4 Hz, 1H), 2.15-
2.09 (m, 1H), 2.07 (s, 3H), 2.05-1.96 (m, 1H), 1.95 (s, 3H), 1.92-1.77 (m, 3H), 1.68-1.60 (m, 1H), 
1.66 (d, J = 1.1 Hz, 3H), 1.63 (d, J = 1.1 Hz, 3H), 1.62 (d, J = 1.0 Hz, 3H), 1.51 (d, J = 1.1 Hz, 
3H) ppm; 13C NMR (125 MHz, CDCl3): δ = 138.7, 138.6, 138.1, 138.0, 137.9, 137.6, 137.5, 
137.4, 137.3, 137.2, 131.6, 131.4, 128.7, 128.7, 128.6, 128.5, 128.5, 128.4, 127.6, 127.3, 127.3, 
127.2, 126.8, 126.7, 126.6, 126.6, 126.5, 126.4, 126.3, 125.8, 125.7, 124.5, 123.6, 121.2, 121.1, 
121.0, 121.0, 120.8, 120.5, 120.5, 120.4, 120.4, 118.5, 118.4, 118.3, 118.3, 117.4, 117.3, 109,8, 
109.7, 109.1, 109.0, 49.7, 49.6, 46.3, 46.2, 36.8, 36.2, 36.1, 35.9, 32.4, 32.3, 28.6, 28.2, 28.1, 
27.5, 25.6, 25.5, 17.8,17.7 ppm; IR (neat, ν/cm-1): 3060, 3025, 2962, 2928, 2857, 1605, 1463, 
1452, 1369, 1326, 1178, 1027, 907, 729, 695; HRMS (ESI): m/z: calcd for C39H38N2Na+: 
557.2927, found: 557.2924. 
6-Bromo-4-(5-bromo-1-methyl-1H-indol-3-yl)-4,9-dimethyl-1-(2-methylprop-1-enyl)-2,3,4,9-
tetrahydro-1H-carbazole (15r) 
 Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.45 
diastereomeric ratio. 1H NMR (400 MHz, CDCl3): δ = 7.80 (d, J = 1.7 Hz, 1H, major isomer), 
7.59 (d, J = 0.8 Hz, 1H, minor isomer), 7.52 (d, J = 1.7 Hz, 1H, major isomer), 7.32 (d, J = 1.4 
Hz, 1H, minor isomer), 7.27 (d, J = 1.8 Hz, 1H, minor isomer), 7.25 (d, J = 1.8 Hz, 1H, minor 
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isomer), 7.22 (d, J = 1.8 Hz, 1H, minor isomer), 7.20 (d, J = 1.8 Hz, 1H, major isomer), 7.16 (s, 
1H, major isomer), 7.14-7.11 (m, 2H major isomer and 1H minor isomer), 6.69 (s, 1H, minor 
isomer), 6.26 (s, 1H, major isomer), 5.37-5.34 (m, 1H, major and minor isomer), 3.81-3.75 (m, 
1H, minor isomer), 3.73-3.69 (m, 1H, major isomer), 3.69 (s, 3H, minor isomer), 3.60 (s, 3H, 
minor isomer), 3.58 (s, 3H, major isomer), 3.57 (s, 3H, major isomer), 2.48-2.42 (m, 1H, minor 
isomer), 2.35 (ddd, J = 13.1, 5.4, 2.3 Hz, 1H, major isomer), 2.10-2.04 (m, 1H, minor isomer), 
2.02-1.95 (m, 1H, major isomer), 1.98 (s, 3H, major isomer), 1.85 (s, 3H, minor isomer), 1.83 (d, 
J = 1.1 Hz, 3H, minor isomer), 1.82-1.81 (m, 1H, major isomer), 1.79 (d, J = 1.1 Hz, 3H major 
isomer), 1.77 (bs, 1H, major and minor isomer), 1.74-1.73 (m, 1H, minor isomer), 1.63-1.56 (m, 
1H, major and minor isomer) ppm; 13C NMR (100 MHz, CDCl3) (major and minor isomer): δ = 
139.7, 139.2, 136.7, 136.6, 136.1, 135.9, 132.0, 131.9, 129.7, 128.4, 128.4, 128.4, 128.3, 127.9, 
127.7, 127.6, 127.4, 126.7, 126.6, 123.7, 123.7, 123.4, 123.3, 123.0, 122.9, 122.5, 122.0, 116.0, 
115.9, 111.8, 111.6, 110.8, 110.7, 110.0, 36.9, 36.3, 35.7, 35.4, 32.8, 32.7, 32.6, 31.9, 29.7, 29.7, 
29.4, 29.0, 27.8, 27.7, 25.8, 25.8, 17.9, 17.9 ppm (two carbon are missing due to overlapping); IR 
(neat, ν/cm-1): 2962, 2921, 2852, 1471, 1420, 1370, 1275, 1229, 1141, 1089, 1049, 985, 906, 786, 
729, 637, 585; HRMS (ESI): m/z: calcd for C27H28Br2N2Na+: 561.0511, found: 561.0506. 
9-Benzyl-4-(1-benzyl-1H-indol-3-yl)-1-(4-methoxyphenyl)-1,4-dimethyl-2,3,4,9-tetrahydro-
1H-carbazole (15s) 
Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.70 
diastereomeric ratio. 1H NMR (400 MHz, CDCl3): δ = 7.89 (d, J = 7.8 Hz, 1H, minor isomer), 
7.62 (d, J = 7.5 Hz, 1H, minor isomer), 7.49 (d, J = 7.5 Hz, 1H, major isomer), 7.35-6.83 (m, 
21H, major isomer and 17H minor isomer), 6.78 (d, J = 6.7 Hz, 2H, minor isomer), 6.70 (s, 1H, 
major isomer), 6.64 (d, J = 8.3 Hz, 2H, minor isomer), 5.38-4.79 (m, 4H, major and minor 
isomer), 3.82 (s, 3H, major isomer), 3.75 (s, 3H, minor isomer), 2.65-2.53 (m, 1H, major and 
minor isomer), 2.19 (s, 3H, minor isomer), 2.18-2.13 (m, 1H, minor isomer), 2.06 (s, 3H, major 
isomer), 2.06-1.99 (m, 1H, major isomer), 1.97-1.89 (m, 1H, major and minor isomer), 1.84-1.79 
(m, 1H, major isomer), 1.72-1.68 (m, 1H, minor isomer), 1.67 (s, 3H, major isomer), 1.66 (s, 3H, 
minor isomer) ppm; 13C NMR (100 MHz, CDCl3) (major and minor isomer): 157.9, 157.7, 141.3, 
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141.1, 140.7, 140.1, 138.4, 138.3, 138.1, 138.0, 137.7, 137.7, 137.6, 137.5, 128.6, 128.6, 128.4, 
128.4, 127.6, 127.6, 127.5, 127.3, 127.3, 127.2, 127.2, 127.1, 126.7, 126.6, 126.5, 126.4, 126.4, 
126.2, 126.0, 125.8, 125.7, 124.3, 123.3, 121.4, 121.3, 121.2, 121.1, 120.9, 120.8, 120.7, 118.9, 
118.7, 118.6, 118.5, 118.4, 118.3, 113.7, 113.7, 109.9, 109.9, 109.8, 109.8, 55.2, 55.1, 49.7, 49.5, 
47.6, 47.5, 42.0, 41.8, 40.1, 40.0, 37.4, 36.3, 36.0, 36.0, 29.7, 29.3, 27.9, 25.7 ppm; IR (neat, 
ν/cm-1): 3056, 3025, 2963, 2928, 2854, 1606, 1509, 1463, 1350, 1327, 1299, 1245, 1181, 1074, 
1029, 908, 828, 730, 696; HRMS (ESI): m/z: calcd for C43H40N2NaO+: 623.3033, found: 
623.3032. 
1-(4-Methoxyphenyl)-1,4,9-trimethyl-4-(1-methyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-
carbazole (15t) 
Obtained as 2:1 diastereomeric mixture. Characterization of a 1.5:1 
diastereomeric ratio 1H NMR (400 MHz, CDCl3): δ = 7.83 (d, J = 8.0 Hz, 1H, minor isomer), 
7.55 (d, J = 8.0 Hz, 1H, minor isomer), 7.53-7.51 (m, 1H, major isomer), 7.37 (d, J = 7.9 Hz, 
major isomer), 7.28-7.25 (m, XH), 7.21-7.05 (m, xH), 7.02-6.95 (m, 2H), 6.93-6.89 (m, 1H), 6.84 
(d, J = 8.8 Hz, 2H, major isomer),  6.78 (d, J = 8.8 Hz, 2H, minor isomer), 6.62 (s, 1H, major 
isomer), 6.52 (s, 1H, minor isomer), 3.81 (s, 3H, major isomer), 3.77 (s, 3H, minor isomer), 3.67 
(s, 3H, major isomer), 3.62 (s, 3H, minor isomer), 3.36 (s, 3H, major isomer), 3.24 (s, 3H, minor 
isomer), 2.59-2.54 (m, 1H, major isomer), 2.43-2.37 (m, 1H, major isomer), 2.14-2.07 (m, 1H, 
minor isomer), 2.09 (s, 3H, minor isomer), 2.03 (s, 3H, major isomer), 1.95-1.65 (m, 1H major 
isomer and 3H minor isomer), 1.86 (s, 3H, major isomer), 1.85 (s, 3H, minor isomer) ppm; 13C 
NMR (100 MHz, CD2Cl2) (major and minor isomer): δ = 157.8, 157.6, 141.4, 141.1, 140.5, 140.3, 
138.1, 137.9, 137.8, 137.7, 128.8, 127.9, 127.6, 127.2, 127.2, 126.1, 126.0, 126.0, 125.7, 122.9, 
122.6, 121.4, 121.1, 121.0, 120.9, 120.8, 120.8, 120.5, 118.4, 118.4, 118.3, 118.1, 118.1, 117.8, 
113.7, 113.6, 109.3, 109.2, 108.5, 108.4, 55.2, 55.1, 41.6, 41.2, 39.9, 37.1, 36.5, 36.1, 35.8, 32.5, 
32.5, 31.6, 31.1, 29.4, 28.7, 28.7, 28.7, 25.1 ppm; IR (neat, ν/cm-1): 3051, 2963, 2930, 2837, 
2358, 1744, 1608, 1509, 1468, 1371, 1326 1247, 1180, 1094, 1032, 908, 828; HRMS (ESI): m/z: 
calcd for C31H32N2NaO+: 471.2406, found: 471.2409. 
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4. Analytical data non-protected tetrahydrocarbazoles 
4-(1H-Indol-3-yl)-1-(4-methoxyphenyl)-4-methyl-2,3,4,9-tetrahydro-1H-carbazole (15c) 
 Obtained as 1:1 diastereomeric mixture. Characterization of a 1: 0.81 
diastereomeric ratio. 1H NMR (400 MHz, CDCl3): δ = 7.88 (d, J = 8.0 Hz, 1H, major isomer), 
7.85 (s, 1H, minor isomer), 7.78 (s, 1H, major isomer), 7.52 (d, J = 8.0 Hz, 1H, major isomer), 
7.49 (d, J = 8.6 Hz, 2H, minor isomer), 7.40-6.81 (m, 9H major isomer and 12H minor isomer), 
6.60 (d, J = 2.3 Hz, 1H, major isomer), 4.25-4.22 (m, 1H, minor isomer), 4.10 (dd, J = 10.5, 5.7 
Hz, 1H, major isomer), 3.84 (s, 3H, minor isomer), 3.80 (s, 3H, major isomer), 2.73-2.69 (m, 1H, 
major isomer), 2.53-2.48 (m, 1H, minor isomer), 2.22-2.15 (m, 1H, major isomer), 2.12 (s, 3H, 
major isomer), 2.04 (s, 3H, minor isomer), 2.02-1.97 (m, 1H major isomer and 3H minor isomer), 
1.80-1.71 (m, 1H, major isomer) ppm; 13C NMR (100 MHz, CDCl3): δ = 158.5 (2x), 137.4, 137.2, 
136.6, 136.2, 136.1, 136.0, 135.9, 135.4, 129.3, 129.2, 127.3, 126.9, 126.8, 125.930, 125.4, 125.0, 
124.3, 124.2, 121.9, 121.3, 121.3, 121.0, 120.9, 120.9, 120.8, 120.3, 118.9, 118.8, 118.7, 118.7, 
118.5, 114.1, 114.0, 111.4, 111.1, 110.6, 110.5, 55.3, 55.2, 41.7, 40.7, 38.6, 37.6, 36.8, 35.6, 30.9, 
30.7, 28.8, 27.7 (one carbon missing due to overlapping) ppm; IR (neat, ν/cm-1): 3408, 3054, 
2933, 2846, 1611, 1509, 1455, 1304, 1240, 1175, 1101, 1031, 1013, 906, 830, 728; HRMS (ESI): 
m/z: calcd for C28H26N2NaO+: 429.1937, found: 429.1935. 
1-(1H-Indol-3-yl)-4-(4-methoxyphenyl)-1-methyl-2,3,4,9-tetrahydro-1H-carbazole (15’c) 
1H NMR (500 MHz, CDCl3): δ = 7.84 (s, 1H), 7.78 (s, 1H), 7.47 (d, J = 8.1 
Hz, 1H), 7.27 (d, J = 8.1 Hz, 1H), 7.18-7.16 (m, 1H), 7.13 (d, J = 8.5 Hz, 2H), 7.09 (t, J = 7.6 Hz, 
1H), 7.01 (t, J = 7.3 Hz, 1H), 6.95 (t, J = 7.5 Hz, 1H), 6.88-6.82 (m, 2H), 6.75-7.72 (m, 3H), 4.15 
(t, J = 6.7 Hz, 1H), 3.70 (s, 3H), 2.52-2.47 (m, 1H), 2.16-2.11 (m, 1H), 1.88-1.83 (m, 1H), 1.85 (s, 
3H), 1.78-1.72 (m, 1H) ppm; 13C NMR (125 MHz, CDCl3): δ = 157.8, 141.4, 138.3, 137.1, 135.9, 
129.1, 127.3, 125.2, 123.6, 122.8, 121.8, 121.2, 120.7, 119.9, 119.3, 119.0, 113.6, 112.0, 111.4, 
110.6, 55.2, 39.3, 36.9, 36.2, 31.4, 27.7 ppm; IR (neat, ν/cm-1): 3400, 3051, 2926, 2854, 1614, 
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1508, 1457, 1332, 1306, 1240, 1175, 1103, 1031, 1012, 831, 735; HRMS (ESI): m/z: calcd for 
C28H26N2NaO+: 429.1937, found: 429.1936. 
1-(1H-Indol-3-yl)-4-(4-methoxyphenyl)-1-methyl-2,3,4,9-tetrahydro-1H-carbazole (15’c) 
1H NMR (400 MHz, CDCl3): δ = 7.96 (s, 1H), 7.64 (s, 1H), 7.35 (d, J = 8.2 
Hz, 1H), 7.23 (d, J = 8.6 Hz, 2H), 7.16-7.08 (m, 3H), 7.04-7.01 (m, 2H), 6.92-6.84 (m, 5H), 4.33 
(dd, J = 8.3, 5.7 Hz, 1H), 3.83 (s, 3H), 2.57-2.50 (m, 1H), 2.27-2.19 (m, 1H), 2.06-1.90 (m, 2H), 
1.95 (s, 3H)  ppm; 13C NMR (125 MHz, CDCl3): δ = 157.9, 141.9, 138.5, 136.9, 135.9, 129.0, 
127.2, 125.5, 123.4, 121.9, 121.8, 120.9, 120.5, 119.9, 119.6, 118.8, 113.7, 111.7, 111.2, 110.6, 
55.2, 39.9, 37.6, 35.6, 32.3, 27.6  ppm; IR (neat, ν/cm-1): 3405, 3051, 2926, 2854, 1614, 1508, 
1455, 1327, 1265, 1240, 1175, 1103, 1030, 1011, 835, 739; HRMS (ESI): m/z: calcd for 
C28H26N2NaO+: 429.1937, found: 429.1936. 
6-Bromo-4-(5-bromo-1H-indol-3-yl)-1-(4-methoxyphenyl)-4-methyl-2,3,4,9-tetrahydro-1H-
carbazole (15u) 
  Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.76 
ratio of diastereoisomers. 1H NMR (400 MHz, CDCl3): δ = 7.96 (bs, 1H, minor isomer), 7.91 (s, 
1H, major isomer), 7.88 (bs, 1H, major isomer), 7.56 (d, J = 1.3 Hz, 1H, major isomer), 7.54 (d, J 
= 7.5 Hz, 2H, minor isomer), 7.41 (s, 1H, minor isomer), 7.28-7.04 (m, 7H major isomer, 9H 
minor isomer) , 6.98 (d, J = 2.0 Hz, 1H, minor isomer), 6.91 (d, J = 8.6 Hz, 2H, minor isomer), 
6.86 (d, J = 8.6 Hz, 2H, major isomer), 6.62 (d, J = 2.3 Hz, 1H, major isomer), 4.22 (dd, J = 8.0, 
5.7 Hz, 1H, minor isomer), 4.08 (dd, J = 10.2, 5.5 Hz, 1H, major isomer), 3.83 (s, 3H, minor 
isomer), 3.79 (s, 3H, major isomer), 2.61-2.57 (m, 1H, major isomer), 2.46-2.39 (m, 1H, minor 
isomer), 2.20-2.13 (m, 1H, major isomer), 2.06-1.94 (m, 1H major isomer, 3H minor isomer), 
2.02 (s, 3H, major isomer), 1.96 (s, 3H, minor isomer), 177-1.68 (m, 1H, major isomer) ppm; 13C 
NMR (100 MHz, CDCl3): δ = 158.7, 158.6, 138.0, 137.0, 136.0, 135.9, 135.4, 135.3, 134.7, 
134.7, 129.3, 129.1, 128.5, 128.3, 127.5, 127.1, 124.9, 124.4, 124.4, 124.4, 123.9, 123.8, 123.8, 
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123.4, 123.1, 123.1, 123.0, 122.4, 118.0, 117.9, 114.3, 114.2, 112.8, 112.7, 112.3, 112.3, 112.2, 
112.1, 112.0, 55.3, 55.3, 41.5, 40.7, 38.5, 37.7, 36.4, 35.4, 30.7, 30.4, 28.7, 27.5 ppm (one carbon 
missing due to overlapping); IR (neat, ν/cm-1): 3420, 2962, 2933, 2852, 1605, 1507, 1455, 1310, 
1235, 1170, 1025, 910, 800, 730; HRMS (ESI): m/z: calcd for C28H24Br2N2NaO+: 585.0147, 
found: 585.0140. 
6-Bromo-1-(5-bromo-1H-indol-3-yl)-4-(4-methoxyphenyl)-1-methyl-2,3,4,9-tetrahydro-1H-
carbazole (15’u) 
 Obtained as 1:1 diastereomeric mixture. Characterization of a 1:1 ratio 
of diastereoisomers. 1H NMR (400 MHz, CDCl3): δ = 8.03 (bs, 2H), 7.83 (s, 1H), 7.71 (s, 1H), 
7.65 (s, 1H), 7.28 (s, 1H), 7.25-7.21 (m, 4H), 7.19-7.10 (m, 8H), 7.05-7.01 (m, 2H), 6.91 (d, J = 
2.3 Hz, 1H), 6.87-6.85 (m, 5H), 4.26 (t, J = 6.5 Hz, 1H), 4.20 (t, J = 6.0 Hz, 1H), 3.82 (s, 3H), 
3.79 (s, 3H), 2.50-2.45 (m, 1H), 2.43-2.36 (m, 1H), 2.30-2.23 (m, 1H), 2.20-2.14 (m, 1H), 1.94-
1.80 (m, 4H), 1.91 (s, 3H), 1.87 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): δ = 158.0, 157.9, 
142.6, 142.4, 137.6, 137.3, 135.7, 135.6, 134.6, 134.5, 129.2, 128.9, 128.9, 127.0, 126.8, 125.0, 
124.9, 124.2, 124.0, 123.8, 123.3, 123.1, 122.9, 122.8, 122.7, 122.3, 122.2, 113.9, 113.8, 112.8, 
112.8, 112.7, 112.7, 112.4, 112.3, 112.1, 112.0, 111.7, 111.6, 55.2, 55.2, 38.9, 38.4, 36.5, 36.1, 
36.0, 35.7, 31.6, 31.0, 27.6, 27.4 ppm (one carbon missing due to overlapping); IR (neat, ν/cm-1): 
3425, 2933, 2846, 1605, 1508, 1461, 1298, 1240, 1175, 1106, 1031, 905, 795, 727, 581; HRMS 
(ESI): m/z: calcd for C28H24Br2N2NaO+: 585.0147, found: 585.0139. 
1-(4-Methoxyphenyl)-4,6-dimethyl-4-(5-methyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-
carbazole (15v) 
N
H
HN
OMe  Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.78 ratio 
of diastereoisomers. 1H NMR (400 MHz, CDCl3): δ = 7.73 (bs, 1H, minor isomer), 7.71 (bs, 1H, 
major isomer), 7.68 (s, 1H, major isomer), 7.43 (s, 1H, minor isomer), 7.36 (s, 1H major, 1H 
minor), 7.31 (s, 1H, major isomer), 7.24 (s, 1H, major isomer), 7.22 (s, 1H, minor isomer), 7.13-
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7.08 (m, 3H major isomer and 4H minor isomer), 7.03-6.82 (m, 4H major isomer and 3H minor 
isomer), 6.75 (d, J = 1.7 Hz, 1H, minor isomer), 6.57 (d, J = 2.2 Hz, 1H, major isomer), 4.18 (t, J 
= 6.0 Hz, 1H, minor isomer), 4.07 (dd, J = 10.6, 5.6 Hz, 1H, major isomer), 3.82 (s, 3H, minor 
isomer), 3.79 (s, 3H, major isomer), 2.70-2.66 (m, 1H, major isomer), 2.50 (s, 3H, major isomer), 
2.46-2.42 (m, 1H, minor isomer), 2.39 (s, 3H, minor isomer), 2.34 (s, 3H, major isomer), 2.29 (s, 
3H, minor isomer), 2.18-2.08 (m, 1H, major isomer), 2.10 (s, 3H, major isomer), 2.05 (s, 3H, 
minor isomer), 2.04-1-86 (m, 1H major and 3H minor), 1.78-1.69 (m, 1H, major isomer) ppm; 13C 
NMR (100 MHz, CDCl3): δ = 158.5, 158.4, 136.7, 136.2, 136.1, 135.8, 135.6, 135.4, 134.5, 
134.5, 129.3, 129.2, 129.0, 128.2, 127.9, 127.9, 127.7, 127.7, 127.1, 127.0, 126.0, 125.6, 124.6, 
124.1, 123.7, 122.9, 122.4, 122.3, 120.8, 120.7, 120.6, 120.5, 118.6, 118.1, 114.0, 113.9, 111.0, 
110.8, 110.2, 110.1, 55.3, 55.2, 41.8, 40.2, 38.5, 36.7, 36.6, 35.9, 30.7, 30.5, 29.7, 28.7, 27.9, 
21.7, 21.5, 21.5 ppm; IR (neat, ν/cm-1): 3408, 2962, 2927, 2857, 1507, 1460, 1298, 1240, 1164, 
1031, 921, 806, 732, 419; HRMS (ESI): m/z: calcd for C30H30N2NaO+: 457.2250, found: 
457.2252. 
4-(4-Methoxyphenyl)-1,6-dimethyl-1-(5-methyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-
carbazole (15’v) 
 Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.57 ratio 
of diastereoisomers. 1H NMR (400 MHz, CDCl3): δ = 7.87 (bs, 2H major and minor isomer), 7.72 
(s, 1H, minor isomer), 7.62 (s, 1H, major isomer), 7.34 (s, 1H, minor isomer), 7.25-7.21( m, 1H 
major isomer and 2H minor isomer), 7.19 (d, J = 8.5 Hz, 2H, major isomer), 7.14 (d, J = 8.2 Hz, 
1H, minor isomer), 7.08 (d, J = 8.2 Hz, 1H, major isomer), 7.05 (s, 1H, major isomer), 7.00-6.95 
(m, 1H, minor isomer), 6.97 (dd, J = 8.3, 1.2 Hz, 1H major), 6.91 (dd, J = 8.2, 1.2 Hz, 1H, minor 
isomer) 6.88 (s, 1H, minor isomer), 6.78 (s, 1H, minor isomer), 6.88-6.82 (m, 3H major isomer 
and 5H minor isomer), 6.69 (s, 1H, major isomer), 4.28 (t, J = 6.3 Hz, 1H, major isomer), 4.23 (t, 
J = 6.0 Hz, 1H, minor isomer), 3.82 (s, 3H, major isomer), 3.79 (s, 3H, minor isomer), 2.59-2.53 
(m, 1H, minor isomer), 2.50-2.45 (m, 1H major isomer and minor isomer), 2.36 (s, 3H, minor 
isomer), 2.30 (s, 3H, major isomer), 2.29 (s, 3H, minor isomer), 2.27 (s, 3H, major isomer), 2.22-
2.14 (m, 1H major and minor isomer), 1.94-1.83 (m, 2H major isomer, 1H minor isomer), 1.92 (s, 
3H, major isomer), 1.88 (s, 3H, minor isomer) ppm; 13C NMR (100 MHz, CDCl3): δ = 157.7, 
157.6, 142.1, 141.8, 138.5, 138.2, 135.4, 135.3, 134.2, 134.1, 129.1, 129.0, 128.5, 128.3, 128.2, 
127.9, 127.7, 127.4, 125.6, 125.4, 123.5, 123.4, 122.9, 122.8, 122.7, 122.6, 122.5, 122.4, 120.5, 
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120.2, 119.4, 119.4, 113.5, 113.5, 111.0, 110.9, 110.9, 110.8, 110.3, 110.2, 55.2, 55.2, 39.1, 38.5, 
36.2, 36.1, 35.9, 35.8, 31.8, 31.1, 27.9, 27.5, 21.7, 21.5, 21.4, 21.4 ppm; IR (neat, ν/cm-1): 3405, 
2927, 2846, 1611, 1509, 1460, 1300, 1243, 1174, 1031, 908, 795, 732; HRMS (ESI): m/z: calcd 
for C30H30N2NaO+: 457.2250, found: 457.2249. 
5-(5-Cyano-1H-indol-3-yl)-8-(4-methoxyphenyl)-5-methyl-6,7,8,9-tetrahydro-5H-carbazole-
3-carbonitrile (15w) 
 Obtained as 1:1 diastereomeric mixture. 1H NMR (400 MHz, CDCl3): δ 
= 8.63 (s, 1H), 8.49 (s, 1H), 8.09 (s, 1H), 8.05 (s, 1H), 7.97 (s, 1H), 7.73 (s, 1H), 7.49-7.34 (m, 
8H), 7.31 (s, 1H), 7.28 (d, J = 5.4 Hz, 2H), 7.15 (d, J = 8.5 Hz, 1H), 6.99 (d, J = 8.5 Hz, 2H), 6.94 
(d, J = 8.5 Hz, 2H), 6.87 (s, 1H), 4.36 (dd, J = 10.1, 5.6 Hz, 1H), 4.20 (dd, J = 8.7, 5.8 Hz, 1H), 
3.89 (s, 3H), 3.83 (s, 3H), 2.61-2.58 (m, 1H), 2.55-2.50 (m, 1H), 2.33-2.30 (m, 1H), 2.23-2.16 (m, 
2H), 2.10-2.00 (m, 2H), 2.06 (s, 3H), 2.00 (s, 3H), 1.85 (dd, J = 22.2, 10.1 Hz, 1H) ppm; 13C 
NMR (100 MHz, CDCl3): δ = 158.8, 158.7, 139.0, 138.8, 138.3, 137.8, 137.6, 134.6, 134.5, 
129.3, 129.0, 129.0, 128.2, 126.4, 126.3, 126.1, 125.8, 125.7, 125.6, 125.4, 125.1, 125.0, 124.9, 
124.7, 124.6, 124.5, 124.3, 124.2, 123.1, 121.0, 120.9, 120.9, 118.5, 118.4, 114.4, 114.3, 112.4, 
112.3, 111.6, 111.5, 102.0, 102.0, 101.8, 101.6, 55.3, 55.3, 41.2, 40.7, 39.0, 38.1, 36.1, 34.9, 31.0, 
30.0, 28.6, 27.2,  ppm; IR (neat, ν/cm-1): 3316, 2927, 2852, 2218, 1613, 1509, 1469, 1339, 1310, 
1245, 1177, 1033, 908, 807, 731, 647; HRMS (ESI): m/z: calcd for C30H24N4NaO+: 479.1842, 
found: 479.1845. 
8-(5-Cyano-1H-indol-3-yl)-5-(4-methoxyphenyl)-8-methyl-6,7,8,9-tetrahydro-5H-carbazole-
3-carbonitrile (15’w) 
N
H
NC
NH
MeO
CN
 Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.79 
ratio of diastereoisomers. 1H NMR (400 MHz, CDCl3): δ = 8.48 (s, 1H, minor isomer), 8.42 (s, 
1H, major isomer), 8.19 (s, 1H, major isomer), 7.91 (s, 1H major and minor), 7.43-7.24 (m, 4H 
major isomer and 6H minor isomer), 7.21 (d, J = 2.1 Hz, 1H, minor isomer), 7.17-7.15 (m, 3H, 
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major isomer), 7.12 (d, J = 8.5 Hz, 2H, major isomer),  6.94 (d, J = 2.2 Hz, 1H, major isomer), 
6.89-6.86 (m, 4H, minor isomer),  4.32 (dd, J = 8.4, 5.9 Hz, 1H, minor isomer), 4.23 (t, J = 6.52, 
1H, major isomer), 3.84 (s, 3H, minor isomer), 3.80 (s, 3H, major isomer), 2.51-2.41 (m, 2H, 
major isomer), 2.30-2.19 (m, 2H, major isomer), 2.04-1.93 (m, 2H, minor isomer), 1.95 (s, 3H, 
minor isomer), 1.92 (s, 3H, major isomer), 1.87-1.79 (m, 2H, minor isomer) ppm; 13C NMR (100 
MHz, CDCl3): δ = 158.3, 158.2, 143.0, 142.9, 141.6, 141.5, 141.3, 138.8, 138.7, 137.7, 137.6, 
136.9, 136.5, 128.8, 128.7, 127.2, 126.8, 126.1, 125.7, 125.6, 125.3, 125.2, 125.1, 124.9, 124.8, 
124.7, 124.6, 124.1, 123.9, 123.7, 120.9, 120.8, 120.4, 114.1, 113.3, 113.2, 112.4, 112.3, 111.5, 
111.3, 102.9, 102.7, 102.4, 102.2, 55.2, 39.6, 38.5, 37.6, 36.4, 36.2, 35.5, 31.9, 30.9, 27.4, 27.4 
ppm; IR (neat, ν/cm-1): 3321, 2926, 2857, 2218, 1614, 1509, 1471, 1244, 1176, 1031, 907, 806, 
730; HRMS (ESI): m/z: calcd for C30H24N4NaO+: 479.1842, found: 479.1840. 
 
5. Analytical data intermediates: 
1-(4-Methoxyphenyl)-4,9-dimethyl-2,9-dihydro-1H-carbazole  
   1H NMR (400 MHz, CD2Cl2): δ = 7.29 (d, J = 8.3 Hz, 1H), 7.17-7.15 (m, 
2H), 7.10 (ddd, J = 8.2, 6.6, 1.5 Hz, 1H), 6.94-6.87 (m, 1H), 6.81-6.79 (m, 2H), 5.68 (dt, J = 4.8, 
1.6 Hz, 1H), 4.22 (t, J = 8.0 Hz, 1H), 3.92 (s, 3H), 3.77 (s, 3H), 7.79-7.71 (m, 1H), 2.57-2.49 (m, 
1H), 2.32 (d, J = 1.7 Hz, 3H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 158.8, 138.8, 137.7, 137.2, 
129.3, 129.3, 127.9, 126.3, 124.7, 121.6, 119.7, 119.4, 114.1, 109.6, 55.7, 38.3, 34.9, 32.6, 21.2 
ppm; IR (neat, ν/cm-1): 3051, 2999, 2929, 2858, 2837, 1609, 1508, 1461, 1451, 1365, 1301, 1240, 
1175, 1033, 829, 738, 549; HRMS (ESI): m/z: calcd for C21H21NNaO+: 326.1515, found: 
326.1512. 
3-(1-(2-(4-Methoxyphenyl)cyclopropyl)vinyl)-1-methyl-1H-indole (18a) 
1H NMR (400 MHz, CD2Cl2): δ = 7.92 (d, J = 8.0 Hz, 1H), 7.34 (d, J 
= 8.1 Hz, 1H), 7.25 (t, J = 7.5 Hz, 1H), 7.18-7.12 (m, 4H), 6.89 (d, J = 8.6 Hz, 2H), 5.47 (s, 3H), 
5.08 (s, 3H), 3.81 (s, 3H), 3.72 (s, 3H), 2.07-1.97 (m, 2H), 1.47-1.42 (m, 1H), 1.21 (td, J = 8.6, 
5.3 Hz, 1H) ppm; 13C NMR (100 MHz, CD2Cl2): δ = 158.5, 143.2, 138.2, 135.5, 128.5, 127.2, 
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126.5, 122.3, 121.2, 120.3, 117.0, 114.4, 110.0, 106.2, 55.8, 33.3, 29.3, 25.6, 15.5 ppm; IR (neat, 
ν/cm-1): 3043, 3008, 2927, 2834, 1612, 1512, 1472, 1464, 1244, 1225, 1177, 1103, 1034, 833, 
806, 737, 539; HRMS (ESI): m/z: calcd for C21H22NO+: 304.1696, found: 304.1694. 
3-(1-(4-Methoxyphenyl)penta-3,4-dienyl)-1-methyl-1H-indole (17a) 
1H NMR (400 MHz, CD2Cl2): δ = 7.38 (d, J = 7.9 Hz, 1H), 7.28 (d, J = 8.2 
Hz, 1H), 7.22 (d, J = 8.6 Hz, 2H), 7.15 (t, J = 7.6 Hz, 1H), 6.97 (t, J = 7.4 Hz, 1H), 6.93 (s, 1H), 
6.82 (d, J = 8.6 Hz, 2H), 5.09 (q, J = 7.0 Hz, 1H), 4.66-4.56 (m, 1H), 4.24 (t, J = 7.6 Hz, 1H), 
3.76 (s, 3H), 3.75 (s, 3H), 2.91-2.83 (m, 1H), 2.74-2.66 (m, 1H) ppm; 13C NMR (100 MHz, 
CD2Cl2): δ = 209.6, 158.6, 137.8, 137.6, 129.4, 127.9, 126.6, 122.000, 119.8, 119.1, 118.7, 114.1, 
109.7, 89.1, 74.7, 55.7, 42.7, 35.9, 33.1  ppm; IR (neat, ν/cm-1): 3048, 2991, 2927, 2898, 2834, 
1947, 1609, 1509, 1482, 1466, 1327, 1244, 1175, 1034, 841, 738, 550; HRMS (ESI): m/z: calcd 
for C21H21NNaO+: 326.1515, found: 326.1512. 
1-Benzyl-3-(1-(4-methoxyphenyl)penta-3,4-dienyl)-1H-indole (17b) 
1H NMR (400 MHz, CDCl3): δ = 7.37 (d, J = 7.9 Hz, 1H), 7.27-7.23 (m, 3H), 
7.21-7.16 (m, 3H), 7.09-7.05 (m, 3H), 6.98-6.93 (m, 2H), 6.77 (d, J = 8.6 Hz, 2H), 5.24 (s, 2H), 
5.03 (q, J = 7.0 Hz, 1H), 4.52-4.49 (m, 2H), 4.23 (t, J = 7.5 Hz, 1H), 3.72 (s, 3H), 2.86-2.78 (m, 
1H), 2.69-2.61 (m, 1H)  ppm; 13C NMR (100 MHz, CDCl3): δ = 209.0, 157.9, 137.8, 136.9, 136.7, 
128.9, 128.7, 127.7, 127.5, 126.6, 125.5, 121.7, 119.7, 118.9, 118.9, 113.6, 109.5, 88.6, 74.4, 
55.2, 49.9, 42.2, 35.5 ppm; IR (neat, ν/cm-1): 3048, 2991, 2927, 2898, 2834, 1947, 1609, 1509, 
1482, 1466, 1327, 1244, 1175, 1034, 841, 738, 550; HRMS (ESI): m/z: calcd for C27H25NNaO+: 
402.1828, found: 402.1823. 
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9-Benzyl-4-(4-methoxyphenyl)-1-methyl-4,9-dihydro-3H-carbazole (X) 
1H NMR (400 MHz, Toluene-d8): δ = 7.19 (d, J = 8.6 Hz, 2H), 7.14 (d, J = 8.0 Hz, 
2H), 7.04-6.94 (m, 5H), 6.80 (d, J = 7.0 Hz, 2H), 6.73 (d, J = 8.6 Hz, 2H), 5.44-5.41 (m, 1H), 
5.13 (s, 2H), 4.27-4.22 (m, 1H), 3.33 (s, 3H), 2.68-2.48 (m, 2H), 1.91 (d, J = 1.6 Hz, 3H) ppm; 
13C NMR (100 MHz, Toluene-d8): δ = 158.8, 139.2, 138.9, 136.4, 129.2, 127.4, 127.2, 126.8, 
125.7, 122.1, 120.3, 120.2, 114.1, 109.7, 54.6, 48.2, 38.9, 35.1 ppm (five carbon are missing due 
to overlapping); IR (neat, ν/cm-1): 3060, 3025, 2933, 2829, 1608, 1508, 1463, 1452, 1353, 1300, 
1245, 1176, 1033, 830, 740; MS (ESI): m/z [M+1]+ = 380.2. 
9-Benzyl-1-(4-methoxyphenyl)-4-methyl-4-(1-methyl-1H-indol-3-yl)-2,3,4,9-tetrahydro-1H-
carbazole (24) 
 Obtained as 1:1 diastereomeric mixture. Characterization of a 1:0.70 
diastereomeric ratio. 1H NMR (500 MHz, CDCl3): δ = 7.72 (d, J = 8.0 Hz, 1H, minor isomer), 
7.66 (d, J = 8.0 Hz, 1H, major isomer), 7.54 (d, J = 7.9 Hz, 1H, major isomer), 7.46 (d, J = 7.9 
Hz, 1H, minor isomer), 7.30-6.75 (m, 15H major isomer and 16 H minor isomer), 6.44 (s, 1H, 
major isomer), 5.17-5.13 (m, 1H, major and minor isomer), 4.80-4.76 (m, 1H, major and minor 
isomer), 4.02 (dd, J = 5.5, 2.7 Hz, 1H, major isomer), 3.99 (t, J = 5.8 Hz, 1H, minor isomer), 3.81 
(s, 3H, major isomer), 3.76 (s, 3H, minor isomer), 3.71 (s, 3H, minor isomer), 3.64 (s, 3H, major 
isomer), 2.41-2.36 (m, 1H, minor isomer), 2.34-2.30 (m, 1H, major isomer), 2.27-2.21 (m, 1H, 
minor isomer), 2.14 (s, 3H, major isomer), 2.11-2.05 (m, 1H, major isomer), 2.03 (s, 3H, minor 
isomer), 2.00-1.95 (m, 1H, minor isomer), 1.94-1.89 (m, 1H, major isomer), 1.81-1.76 (m, 1H, 
minor isomer), 1.68-1.64 (m, 1H, major isomer) ppm; 13C NMR (125 MHz, CDCl3) (major and 
minor isomer): δ = 158.1, 158.1, 138.4, 138.3, 137.9, 137.8, 137.4, 137.4, 136.5, 136.4, 136.2, 
136.0, 129.1, 128.8, 128.6, 128.6, 128.5, 128.3, 127.8, 127.7, 127.1, 126.9, 126.5, 126.4, 126.3, 
126.3, 126.1, 126.0, 125.9, 123.3, 122.5, 121.3, 121.1, 120.8, 120.8, 120.7, 119.6, 119.3, 118.6, 
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118.5, 118.1, 118.0, 113.8, 113.8, 109.3, 109.3, 109.2, 109.2, 55.2, 55.2, 46.5, 46.3, 37.9, 36.7, 
36.5, 36.4, 34.5, 32.6, 32.6, 31.1, 30.1, 29.7, 29.2, 28.2 ppm (one carbon is missing due to 
overlapping); IR (neat, ν/cm-1): 3046, 2926, 2858, 1603, 1509, 1462, 1453, 1374, 1327, 1244, 
1176, 1031, 908, 832, 806, 734, 699, 561; HRMS (ESI): m/z: calcd for C36H34N2NaO+: 533.2563, 
found: 533.2563. 
 
6. X-ray of structure (16h) 
 
 
Figure Captions 
 1. ORTEP1 representation of the molecule (50% probability ellipsoids; H-atoms  
  given 
  arbitrary displacement parameters for clarity) 
 
Definition of Terms 
  Function minimized:  Sw(Fo2 – Fc2)2 
N
Br
O
N
Br
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      where w = [s 2(Fo2) + (aP)2 + bP]-1 and P = (Fo2 + 2Fc2) / 3 
    Fo2 = S(C – RB) / Lp 
   and s 2(Fo2) = S2(C + R2B) / Lp2 
   S  = Scan rate 
   C  = Total integrated peak count 
   R  = Ratio of scan time to background counting time 
   B  = Total background count 
   Lp = Lorentz-polarization factor 
 
  R-factors: Rint = S|<Fo2> – Fo2| / SFo2 summed only over reflections for which 
more 
       than one symmetry equivalent was 
measured. 
   R(F) = S||Fo| – |Fc|| / S|Fo|  summed over all observed reflections. 
   wR(F2) = [Sw(Fo2 – Fc2)2 / Sw(Fo2)2]1/2  summed over all 
reflections. 
 
 Standard deviation of an observation of unit weight (goodness of fit):   
   [Sw(Fo2 – Fc2)2 / (No – Nv)]1/2 
   where  No = number of observations;  Nv = number of variables 
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NOTES 
 
 The structure of C30H28Br2N2O (GA12-GO-30-2-F4) has been solved and refined 
successfully.  The structure is not quite that which was expected.  The five-membered ring fused 
to the central six-membered ring is connected the other way around.  Since the space group is 
centrosymmetric, the compound in the crystal is racemic.  There are two molecules in the 
asymmetric unit and these have the same configuration and almost identical conformations.  The 
r.m.s. fit of the non-hydrogen atoms of the two molecules is 0.13 Å. 
 
EXPERIMENTAL 
  Crystal-Structure Determination. – A crystal of C30H28Br2N2O, obtained from 
diethyl ether, was mounted on a glass fibre and used for a low-temperature X-ray structure 
determination.  All measurements were made on an Agilent Technologies SuperNova area-
detector diffractometer2 using Mo Ka radiation (l = 0.71073 Å) from a micro-focus X-ray source 
and an Oxford Instruments Cryojet XL cooler.  The unit cell constants and an orientation matrix 
for data collection were obtained from a least-squares refinement of the setting angles of 20471 
reflections in the range 4° < 2q < 61°.  A total of 728 frames were collected using w scans with k 
offsets, 35.0 seconds exposure time and a rotation angle of 1.0° per frame, and a crystal-detector 
distance of 55.0 mm. 
 
 Data reduction was performed with CrysAlisPro2.  The intensities were corrected for 
Lorentz and polarization effects, and an empirical absorption correction using spherical 
harmonics2 was applied.  The space group was determined from packing considerations, a 
statistical analysis of intensity distribution, and the successful solution and refinement of the 
structure.  Equivalent reflections were merged.  The data collection and refinement parameters are 
given in Table 1.  A view of the molecule is shown in the Figure. 
 
 The structure was solved by direct methods using SHELXS97 3, which revealed the 
positions of all non-hydrogen atoms.  There are two symmetry-independent molecules in the 
asymmetric unit.  The atomic coordinates of the two molecules were tested carefully for a 
relationship from a higher symmetry space group using the program PLATON8, but none could be 
found.  The non-hydrogen atoms were refined anisotropically.  All of the H-atoms were placed in 
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geometrically calculated positions and refined by using a riding model where each H-atom was 
assigned a fixed isotropic displacement parameter with a value equal to 1.2Ueq of its parent atom 
(1.5Ueq for the methyl groups).  The refinement of the structure was carried out on F2 by using 
full-matrix least-squares procedures, which minimised the function Sw(Fo2 – Fc2)2.  The 
weighting scheme was based on counting statistics and included a factor to downweight the 
intense reflections.  Plots of Sw(Fo2 – Fc2)2 versus Fc/Fc(max) and resolution showed no unusual 
trends.  A correction for secondary extinction was not applied. 
 
 Neutral atom scattering factors for non-hydrogen atoms were taken from Maslen, Fox and 
O'Keefe4a, and the scattering factors for H-atoms were taken from Stewart, Davidson and 
Simpson5.  Anomalous dispersion effects were included in Fc6; the values for f' and f" were those 
of Creagh and McAuley4b.  The values of the mass attenuation coefficients are those of Creagh 
and Hubbel4c.  The SHELXL97 program7 was used for all calculations. 
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Table 1.  Crystallographic Data 
 
Crystallised from diethyl ether  
Empirical formula C30H28Br2N2O  
Formula weight [g mol-1] 592.37  
Crystal colour, habit colourless, tablet  
Crystal dimensions [mm] 0.10  0.25  0.28  
Temperature [K] 160(1)  
Crystal system triclinic  
Space group P
_
1  (#2)  
Z 4  
Reflections for cell determination 20471  
2q range for cell determination [°] 4 – 61  
Unit cell parameters a [Å] 9.7972(2)  
 b [Å] 13.3959(3)  
 c [Å] 19.9928(4)  
 a [°] 74.5823(19)  
 b [°] 88.9965(17)  
 g  [°] 89.8679(18)  
 V [Å3] 2529.09(9)  
F(000) 1200  
Dx [g cm-3] 1.556  
m(Mo Ka) [mm-1] 3.241  
Scan type w  
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2q(max) [°] 61.0  
Transmission factors (min; max) 0.663; 1.000  
Total reflections measured 50270  
Symmetry independent reflections 13851  
Rint 0.033  
Reflections with I > 2s(I) 11178  
Reflections used in refinement 13851  
Parameters refined 639  
Final R(F) [I > 2s(I) reflections] 0.0555  
 wR(F2) (all data) 0.1358  
Weights: w = [s2(Fo2) + (0.0360P)2 + 9.0208P]-1 where P = (Fo2 + 
2Fc2)/3  
Goodness of fit 1.106  
Final Dmax/s 0.001  
Dr (max; min) [e Å-3] 1.88; -1.19  
s(d(C – C)) [Å] 0.00 – 0.00  
Chapter 5 
 
 
 
281 
 
TABLE 2.  Bond lengths (Å) with standard uncertainties in parentheses. 
 
Br(1) -C(9)     1.915(4)                    Br(3) -C(39)    1.913(4) 
Br(2) -C(19)    1.910(4)                    Br(4) -C(49)    1.908(4) 
O(1)  -C(27)    1.368(4)                    O(2)  -C(57)    1.366(5) 
O(1)  -C(30)    1.424(6)                    O(2)  -C(60)    1.421(5) 
N(1)  -C(12)    1.376(5)                    N(3)  -C(42)    1.381(5) 
N(1)  -C(1)     1.390(5)                    N(3)  -C(31)    1.387(4) 
N(1)  -C(13)    1.449(5)                    N(3)  -C(43)    1.451(5) 
N(2)  -C(22)    1.368(5)                    N(4)  -C(52)    1.374(5) 
N(2)  -C(15)    1.379(5)                    N(4)  -C(45)    1.382(5) 
N(2)  -C(23)    1.453(5)                    N(4)  -C(53)    1.455(5) 
C(1)  -C(2)     1.359(5)                    C(31) -C(32)    1.373(5) 
C(1)  -C(6)     1.496(5)                    C(31) -C(36)    1.498(5) 
C(2)  -C(7)     1.443(5)                    C(32) -C(37)    1.443(5) 
C(2)  -C(3)     1.521(5)                    C(32) -C(33)    1.519(5) 
C(3)  -C(16)    1.522(5)                    C(33) -C(46)    1.517(5) 
C(3)  -C(14)    1.541(5)                    C(33) -C(44)    1.534(5) 
C(3)  -C(4)     1.554(5)                    C(33) -C(34)    1.543(5) 
C(4)  -C(5)     1.514(6)                    C(34) -C(35)    1.524(6) 
C(5)  -C(6)     1.545(5)                    C(35) -C(36)    1.544(6) 
C(6)  -C(24)    1.517(5)                    C(36) -C(54)    1.522(5) 
C(7)  -C(8)     1.405(5)                    C(37) -C(38)    1.404(5) 
C(7)  -C(12)    1.419(5)                    C(37) -C(42)    1.414(5) 
C(8)  -C(9)     1.388(5)                    C(38) -C(39)    1.384(5) 
C(9)  -C(10)    1.403(5)                    C(39) -C(40)    1.374(6) 
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C(10) -C(11)    1.372(5)                    C(40) -C(41)    1.396(6) 
C(11) -C(12)    1.391(5)                    C(41) -C(42)    1.391(5) 
C(15) -C(16)    1.363(5)                    C(45) -C(46)    1.365(5) 
C(16) -C(17)    1.448(5)                    C(46) -C(47)    1.445(5) 
C(17) -C(22)    1.411(5)                    C(47) -C(48)    1.407(5) 
C(17) -C(18)    1.413(5)                    C(47) -C(52)    1.418(5) 
C(18) -C(19)    1.378(5)                    C(48) -C(49)    1.374(5) 
C(19) -C(20)    1.393(6)                    C(49) -C(50)    1.397(6) 
C(20) -C(21)    1.379(6)                    C(50) -C(51)    1.371(6) 
C(21) -C(22)    1.402(5)                    C(51) -C(52)    1.392(5) 
C(24) -C(25)    1.395(5)                    C(54) -C(55)    1.388(5) 
C(24) -C(29)    1.399(5)                    C(54) -C(59)    1.395(5) 
C(25) -C(26)    1.384(5)                    C(55) -C(56)    1.393(5) 
C(26) -C(27)    1.393(5)                    C(56) -C(57)    1.389(5) 
C(27) -C(28)    1.393(5)                    C(57) -C(58)    1.399(5) 
C(28) -C(29)    1.381(5)                    C(58) -C(59)    1.379(5) 
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TABLE 3.  Bond angles (°) with standard uncertainties in parentheses. 
 
C(27) -O(1)  -C(30)    116.4(3)             C(57) -O(2)  -C(60)    115.9(3) 
C(12) -N(1)  -C(1)     108.1(3)             C(42) -N(3)  -C(31)    107.7(3) 
C(12) -N(1)  -C(13)    124.2(3)             C(42) -N(3)  -C(43)    124.8(3) 
C(1)  -N(1)  -C(13)    127.5(3)             C(31) -N(3)  -C(43)    127.3(3) 
C(22) -N(2)  -C(15)    108.2(3)             C(52) -N(4)  -C(45)    108.5(3) 
C(22) -N(2)  -C(23)    125.5(3)             C(52) -N(4)  -C(53)    125.1(3) 
C(15) -N(2)  -C(23)    126.4(3)             C(45) -N(4)  -C(53)    126.4(3) 
C(2)  -C(1)  -N(1)     110.6(3)             C(32) -C(31) -N(3)     110.8(3) 
C(2)  -C(1)  -C(6)     127.8(3)             C(32) -C(31) -C(36)    126.8(3) 
N(1)  -C(1)  -C(6)     121.6(3)             N(3)  -C(31) -C(36)    122.4(3) 
C(1)  -C(2)  -C(7)     106.6(3)             C(31) -C(32) -C(37)    106.2(3) 
C(1)  -C(2)  -C(3)     123.4(3)             C(31) -C(32) -C(33)    123.8(3) 
C(7)  -C(2)  -C(3)     129.8(3)             C(37) -C(32) -C(33)    129.9(3) 
C(2)  -C(3)  -C(16)    111.5(3)             C(46) -C(33) -C(32)    111.4(3) 
C(2)  -C(3)  -C(14)    109.9(3)             C(46) -C(33) -C(44)    110.8(3) 
C(16) -C(3)  -C(14)    110.8(3)             C(32) -C(33) -C(44)    110.5(3) 
C(2)  -C(3)  -C(4)     106.9(3)             C(46) -C(33) -C(34)    109.9(3) 
C(16) -C(3)  -C(4)     109.8(3)             C(32) -C(33) -C(34)    106.3(3) 
C(14) -C(3)  -C(4)     107.7(3)             C(44) -C(33) -C(34)    107.8(3) 
C(5)  -C(4)  -C(3)     113.2(3)             C(35) -C(34) -C(33)    112.7(3) 
C(4)  -C(5)  -C(6)     111.8(3)             C(34) -C(35) -C(36)    112.1(3) 
C(1)  -C(6)  -C(24)    113.6(3)             C(31) -C(36) -C(54)    113.0(3) 
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C(1)  -C(6)  -C(5)     107.3(3)             C(31) -C(36) -C(35)    108.0(3) 
C(24) -C(6)  -C(5)     111.7(3)             C(54) -C(36) -C(35)    111.9(3) 
C(8)  -C(7)  -C(12)    118.1(3)             C(38) -C(37) -C(42)    118.1(3) 
C(8)  -C(7)  -C(2)     135.1(3)             C(38) -C(37) -C(32)    135.0(3) 
C(12) -C(7)  -C(2)     106.7(3)             C(42) -C(37) -C(32)    106.8(3) 
C(9)  -C(8)  -C(7)     117.6(3)             C(39) -C(38) -C(37)    117.5(3) 
C(8)  -C(9)  -C(10)    123.7(3)             C(40) -C(39) -C(38)    124.1(3) 
C(8)  -C(9)  -Br(1)    118.3(3)             C(40) -C(39) -Br(3)    118.2(3) 
C(10) -C(9)  -Br(1)    117.8(3)             C(38) -C(39) -Br(3)    117.6(3) 
C(11) -C(10) -C(9)     118.9(3)             C(39) -C(40) -C(41)    119.9(3) 
C(10) -C(11) -C(12)    118.7(3)             C(42) -C(41) -C(40)    116.9(3) 
N(1)  -C(12) -C(11)    129.0(3)             N(3)  -C(42) -C(41)    127.9(3) 
N(1)  -C(12) -C(7)     108.1(3)             N(3)  -C(42) -C(37)    108.5(3) 
C(11) -C(12) -C(7)     122.9(3)             C(41) -C(42) -C(37)    123.6(3) 
C(16) -C(15) -N(2)     111.1(3)             C(46) -C(45) -N(4)     111.0(3) 
C(15) -C(16) -C(17)    105.7(3)             C(45) -C(46) -C(47)    105.6(3) 
C(15) -C(16) -C(3)     126.8(3)             C(45) -C(46) -C(33)    127.3(3) 
C(17) -C(16) -C(3)     127.5(3)             C(47) -C(46) -C(33)    127.1(3) 
C(22) -C(17) -C(18)    118.1(3)             C(48) -C(47) -C(52)    117.7(3) 
C(22) -C(17) -C(16)    106.8(3)             C(48) -C(47) -C(46)    134.8(3) 
C(18) -C(17) -C(16)    135.1(3)             C(52) -C(47) -C(46)    107.4(3) 
C(19) -C(18) -C(17)    118.1(4)             C(49) -C(48) -C(47)    118.3(3) 
C(18) -C(19) -C(20)    123.4(4)             C(48) -C(49) -C(50)    123.3(3) 
C(18) -C(19) -Br(2)    118.3(3)             C(48) -C(49) -Br(4)    118.5(3) 
Chapter 5 
 
 
 
285 
 
C(20) -C(19) -Br(2)    118.3(3)             C(50) -C(49) -Br(4)    118.2(3) 
C(21) -C(20) -C(19)    119.6(4)             C(51) -C(50) -C(49)    119.5(3) 
C(20) -C(21) -C(22)    118.1(4)             C(50) -C(51) -C(52)    118.3(3) 
N(2)  -C(22) -C(21)    129.1(4)             N(4)  -C(52) -C(51)    129.7(3) 
N(2)  -C(22) -C(17)    108.3(3)             N(4)  -C(52) -C(47)    107.4(3) 
C(21) -C(22) -C(17)    122.6(4)             C(51) -C(52) -C(47)    122.8(3) 
C(25) -C(24) -C(29)    117.4(3)             C(55) -C(54) -C(59)    118.0(3) 
C(25) -C(24) -C(6)     119.2(3)             C(55) -C(54) -C(36)    119.1(3) 
C(29) -C(24) -C(6)     123.4(3)             C(59) -C(54) -C(36)    122.9(3) 
C(26) -C(25) -C(24)    122.4(3)             C(54) -C(55) -C(56)    122.0(3) 
C(25) -C(26) -C(27)    119.0(3)             C(57) -C(56) -C(55)    119.0(3) 
O(1)  -C(27) -C(26)    124.2(3)             O(2)  -C(57) -C(56)    124.5(3) 
O(1)  -C(27) -C(28)    116.0(3)             O(2)  -C(57) -C(58)    115.7(3) 
C(26) -C(27) -C(28)    119.8(3)             C(56) -C(57) -C(58)    119.8(3) 
C(29) -C(28) -C(27)    120.2(3)             C(59) -C(58) -C(57)    120.2(3) 
C(28) -C(29) -C(24)    121.1(3)             C(58) -C(59) -C(54)    121.1(3) 
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TABLE 4.  Torsion angles (°) with standard uncertainties in parentheses. 
 
C(12) -N(1)  -C(1)  -C(2)     -1.0(4)      C(42) -N(3)  -C(31) -C(32)    -0.7(4) 
C(13) -N(1)  -C(1)  -C(2)   -175.4(4)      C(43) -N(3)  -C(31) -C(32)  -174.9(4) 
C(12) -N(1)  -C(1)  -C(6)    178.4(3)      C(42) -N(3)  -C(31) -C(36)   177.3(3) 
C(13) -N(1)  -C(1)  -C(6)      4.1(6)      C(43) -N(3)  -C(31) -C(36)     3.1(6) 
N(1)  -C(1)  -C(2)  -C(7)      0.5(4)      N(3)  -C(31) -C(32) -C(37)     0.4(4) 
C(6)  -C(1)  -C(2)  -C(7)   -178.9(3)      C(36) -C(31) -C(32) -C(37)  -177.5(3) 
N(1)  -C(1)  -C(2)  -C(3)    175.8(3)      N(3)  -C(31) -C(32) -C(33)   176.4(3) 
C(6)  -C(1)  -C(2)  -C(3)     -3.6(6)      C(36) -C(31) -C(32) -C(33)    -1.6(6) 
C(1)  -C(2)  -C(3)  -C(16)   106.5(4)      C(31) -C(32) -C(33) -C(46)   101.4(4) 
C(7)  -C(2)  -C(3)  -C(16)   -79.3(4)      C(37) -C(32) -C(33) -C(46)   -83.7(4) 
C(1)  -C(2)  -C(3)  -C(14)  -130.2(4)      C(31) -C(32) -C(33) -C(44)  -134.9(4) 
C(7)  -C(2)  -C(3)  -C(14)    44.0(5)      C(37) -C(32) -C(33) -C(44)    40.0(5) 
C(1)  -C(2)  -C(3)  -C(4)    -13.6(5)      C(31) -C(32) -C(33) -C(34)   -18.2(4) 
C(7)  -C(2)  -C(3)  -C(4)    160.7(3)      C(37) -C(32) -C(33) -C(34)   156.6(3) 
C(2)  -C(3)  -C(4)  -C(5)     46.7(4)      C(46) -C(33) -C(34) -C(35)   -70.4(4) 
C(16) -C(3)  -C(4)  -C(5)    -74.4(4)      C(32) -C(33) -C(34) -C(35)    50.3(4) 
C(14) -C(3)  -C(4)  -C(5)    164.9(3)      C(44) -C(33) -C(34) -C(35)   168.8(3) 
C(3)  -C(4)  -C(5)  -C(6)    -65.8(4)      C(33) -C(34) -C(35) -C(36)   -66.1(4) 
C(2)  -C(1)  -C(6)  -C(24)   112.7(4)      C(32) -C(31) -C(36) -C(54)   114.9(4) 
N(1)  -C(1)  -C(6)  -C(24)   -66.6(4)      N(3)  -C(31) -C(36) -C(54)   -62.8(5) 
C(2)  -C(1)  -C(6)  -C(5)    -11.2(5)      C(32) -C(31) -C(36) -C(35)    -9.4(5) 
N(1)  -C(1)  -C(6)  -C(5)    169.4(3)      N(3)  -C(31) -C(36) -C(35)   172.8(3) 
C(4)  -C(5)  -C(6)  -C(1)     43.6(4)      C(34) -C(35) -C(36) -C(31)    41.0(4) 
C(4)  -C(5)  -C(6)  -C(24)   -81.6(4)      C(34) -C(35) -C(36) -C(54)   -84.0(4) 
C(1)  -C(2)  -C(7)  -C(8)    176.4(4)      C(31) -C(32) -C(37) -C(38)   176.4(4) 
C(3)  -C(2)  -C(7)  -C(8)      1.4(6)      C(33) -C(32) -C(37) -C(38)     0.8(7) 
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C(1)  -C(2)  -C(7)  -C(12)     0.2(4)      C(31) -C(32) -C(37) -C(42)     0.0(4) 
C(3)  -C(2)  -C(7)  -C(12)  -174.8(3)      C(33) -C(32) -C(37) -C(42)  -175.6(3) 
C(12) -C(7)  -C(8)  -C(9)      0.9(5)      C(42) -C(37) -C(38) -C(39)     1.6(5) 
C(2)  -C(7)  -C(8)  -C(9)   -174.9(4)      C(32) -C(37) -C(38) -C(39)  -174.5(4) 
C(7)  -C(8)  -C(9)  -C(10)    -2.7(6)      C(37) -C(38) -C(39) -C(40)    -2.4(6) 
C(7)  -C(8)  -C(9)  -Br(1)   173.9(3)      C(37) -C(38) -C(39) -Br(3)   173.2(3) 
C(8)  -C(9)  -C(10) -C(11)     2.4(6)      C(38) -C(39) -C(40) -C(41)     1.1(6) 
Br(1) -C(9)  -C(10) -C(11)  -174.3(3)      Br(3) -C(39) -C(40) -C(41)  -174.5(3) 
C(9)  -C(10) -C(11) -C(12)    -0.2(6)      C(39) -C(40) -C(41) -C(42)     1.1(6) 
C(1)  -N(1)  -C(12) -C(11)  -177.7(4)      C(31) -N(3)  -C(42) -C(41)  -177.2(4) 
C(13) -N(1)  -C(12) -C(11)    -3.1(6)      C(43) -N(3)  -C(42) -C(41)    -2.9(6) 
C(1)  -N(1)  -C(12) -C(7)      1.1(4)      C(31) -N(3)  -C(42) -C(37)     0.7(4) 
C(13) -N(1)  -C(12) -C(7)    175.7(3)      C(43) -N(3)  -C(42) -C(37)   175.1(4) 
C(10) -C(11) -C(12) -N(1)    177.1(4)      C(40) -C(41) -C(42) -N(3)    175.8(4) 
C(10) -C(11) -C(12) -C(7)     -1.5(6)      C(40) -C(41) -C(42) -C(37)    -1.8(6) 
C(8)  -C(7)  -C(12) -N(1)   -177.7(3)      C(38) -C(37) -C(42) -N(3)   -177.6(3) 
C(2)  -C(7)  -C(12) -N(1)     -0.8(4)      C(32) -C(37) -C(42) -N(3)     -0.5(4) 
C(8)  -C(7)  -C(12) -C(11)     1.2(5)      C(38) -C(37) -C(42) -C(41)     0.5(6) 
C(2)  -C(7)  -C(12) -C(11)   178.1(3)      C(32) -C(37) -C(42) -C(41)   177.6(4) 
C(22) -N(2)  -C(15) -C(16)    -1.2(4)      C(52) -N(4)  -C(45) -C(46)    -0.4(4) 
C(23) -N(2)  -C(15) -C(16)   180.0(4)      C(53) -N(4)  -C(45) -C(46)  -179.0(4) 
N(2)  -C(15) -C(16) -C(17)     0.3(4)      N(4)  -C(45) -C(46) -C(47)    -0.3(4) 
N(2)  -C(15) -C(16) -C(3)   -179.2(3)      N(4)  -C(45) -C(46) -C(33)   179.3(3) 
C(2)  -C(3)  -C(16) -C(15)   -12.1(5)      C(32) -C(33) -C(46) -C(45)    -5.0(5) 
C(14) -C(3)  -C(16) -C(15)  -134.9(4)      C(44) -C(33) -C(46) -C(45)  -128.5(4) 
C(4)  -C(3)  -C(16) -C(15)   106.2(4)      C(34) -C(33) -C(46) -C(45)   112.5(4) 
C(2)  -C(3)  -C(16) -C(17)   168.5(3)      C(32) -C(33) -C(46) -C(47)   174.5(3) 
C(14) -C(3)  -C(16) -C(17)    45.7(5)      C(44) -C(33) -C(46) -C(47)    51.0(4) 
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C(4)  -C(3)  -C(16) -C(17)   -73.2(4)      C(34) -C(33) -C(46) -C(47)   -68.0(4) 
C(15) -C(16) -C(17) -C(22)     0.6(4)      C(45) -C(46) -C(47) -C(48)  -179.9(4) 
C(3)  -C(16) -C(17) -C(22)  -179.9(3)      C(33) -C(46) -C(47) -C(48)     0.5(6) 
C(15) -C(16) -C(17) -C(18)  -179.7(4)      C(45) -C(46) -C(47) -C(52)     0.8(4) 
C(3)  -C(16) -C(17) -C(18)    -0.1(7)      C(33) -C(46) -C(47) -C(52)  -178.8(3) 
C(22) -C(17) -C(18) -C(19)     2.6(5)      C(52) -C(47) -C(48) -C(49)     1.3(5) 
C(16) -C(17) -C(18) -C(19)  -177.2(4)      C(46) -C(47) -C(48) -C(49)  -177.9(4) 
C(17) -C(18) -C(19) -C(20)     0.8(6)      C(47) -C(48) -C(49) -C(50)     0.9(6) 
C(17) -C(18) -C(19) -Br(2)  -179.5(3)      C(47) -C(48) -C(49) -Br(4)  -178.6(3) 
C(18) -C(19) -C(20) -C(21)    -2.9(6)      C(48) -C(49) -C(50) -C(51)    -2.0(6) 
Br(2) -C(19) -C(20) -C(21)   177.4(3)      Br(4) -C(49) -C(50) -C(51)   177.5(3) 
C(19) -C(20) -C(21) -C(22)     1.6(6)      C(49) -C(50) -C(51) -C(52)     0.7(6) 
C(15) -N(2)  -C(22) -C(21)  -175.4(4)      C(45) -N(4)  -C(52) -C(51)  -176.9(4) 
C(23) -N(2)  -C(22) -C(21)     3.4(6)      C(53) -N(4)  -C(52) -C(51)     1.8(6) 
C(15) -N(2)  -C(22) -C(17)     1.5(4)      C(45) -N(4)  -C(52) -C(47)     0.9(4) 
C(23) -N(2)  -C(22) -C(17)  -179.6(4)      C(53) -N(4)  -C(52) -C(47)   179.6(4) 
C(20) -C(21) -C(22) -N(2)    178.3(4)      C(50) -C(51) -C(52) -N(4)    178.9(4) 
C(20) -C(21) -C(22) -C(17)     1.8(6)      C(50) -C(51) -C(52) -C(47)     1.5(5) 
C(18) -C(17) -C(22) -N(2)    178.9(3)      C(48) -C(47) -C(52) -N(4)    179.5(3) 
C(16) -C(17) -C(22) -N(2)     -1.3(4)      C(46) -C(47) -C(52) -N(4)     -1.1(4) 
C(18) -C(17) -C(22) -C(21)    -3.9(5)      C(48) -C(47) -C(52) -C(51)    -2.5(5) 
C(16) -C(17) -C(22) -C(21)   175.9(3)      C(46) -C(47) -C(52) -C(51)   176.9(3) 
C(1)  -C(6)  -C(24) -C(25)   158.2(3)      C(31) -C(36) -C(54) -C(55)   153.9(3) 
C(5)  -C(6)  -C(24) -C(25)   -80.2(4)      C(35) -C(36) -C(54) -C(55)   -83.9(4) 
C(1)  -C(6)  -C(24) -C(29)   -21.2(5)      C(31) -C(36) -C(54) -C(59)   -27.7(5) 
C(5)  -C(6)  -C(24) -C(29)   100.3(4)      C(35) -C(36) -C(54) -C(59)    94.5(4) 
C(29) -C(24) -C(25) -C(26)    -0.7(6)      C(59) -C(54) -C(55) -C(56)     0.9(5) 
C(6)  -C(24) -C(25) -C(26)   179.8(4)      C(36) -C(54) -C(55) -C(56)   179.4(3) 
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C(24) -C(25) -C(26) -C(27)     1.3(6)      C(54) -C(55) -C(56) -C(57)    -0.8(6) 
C(30) -O(1)  -C(27) -C(26)    -0.6(6)      C(60) -O(2)  -C(57) -C(56)     0.7(6) 
C(30) -O(1)  -C(27) -C(28)  -179.8(4)      C(60) -O(2)  -C(57) -C(58)  -178.1(4) 
C(25) -C(26) -C(27) -O(1)    179.1(4)      C(55) -C(56) -C(57) -O(2)   -179.0(3) 
C(25) -C(26) -C(27) -C(28)    -1.8(6)      C(55) -C(56) -C(57) -C(58)    -0.3(5) 
O(1)  -C(27) -C(28) -C(29)  -179.0(4)      O(2)  -C(57) -C(58) -C(59)  -180.0(3) 
C(26) -C(27) -C(28) -C(29)     1.8(6)      C(56) -C(57) -C(58) -C(59)     1.2(6) 
C(27) -C(28) -C(29) -C(24)    -1.3(6)      C(57) -C(58) -C(59) -C(54)    -1.0(6) 
C(25) -C(24) -C(29) -C(28)     0.7(6)      C(55) -C(54) -C(59) -C(58)     0.0(6) 
C(6)  -C(24) -C(29) -C(28)  -179.8(4)      C(36) -C(54) -C(59) -C(58)  -178.4(4) 
 
7. X-ray of structure (24d) 
 
 
Figure Captions 
 1. ORTEP1 representation of the molecule (50% probability ellipsoids; H-atoms  
  given arbitrary displacement parameters for clarity) 
 2. Molecular packing projected down the a-axis showing the hydrogen bonding  
  scheme 
    (equivalent isotropic spheres for atoms; uninvolved H-atoms omitted for clarity) 
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Definition of Terms 
  Function minimized:  w(Fo2 – Fc2)2 
      where  w = [ 2(Fo2) + (aP)2 + bP]‐1 and P = (Fo2 + 2Fc2) / 3 
        Fo2 = S(C – RB) / Lp 
      and   2(Fo2) = S2(C + R2B) / Lp2 
      S  = Scan rate 
      C  = Total integrated peak count 
      R  = Ratio of scan time to background counting time 
      B  = Total background count 
      Lp = Lorentz‐polarization factor 
 
  R‐factors:  Rint = |<Fo2> – Fo2| / Fo2  summed only over reflections for which 
more 
              than one symmetry equivalent was 
measured. 
      R(F) = ||Fo| – |Fc|| / |Fo|   summed over all observed reflections. 
      wR(F2) = [w(Fo2 – Fc2)2 / w(Fo2)2]1/2  summed over all reflections. 
 
  Standard deviation of an observation of unit weight (goodness of fit):   
      [w(Fo2 – Fc2)2 / (No – Nv)]1/2 
      where  No = number of observations;  Nv = number of variables 
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NOTES 
 
 The structure of C28H26N2O (GQ-20-1-F30) has been solved and refined successfully 
with no unusual features.  Since the space group is centrosymmetric, the compound in the crystal 
is racemic.  The relative configuration of the two stereogenic centres is 3S*,6R* (using the atom 
numbering in the X-ray model). 
 
EXPERIMENTAL 
 
  Crystal‐Structure Determination. – A crystal of C28H26N2O, obtained from CH2Cl2, was 
mounted on a glass fibre and used for a low‐temperature X‐ray structure determination.  All 
measurements were made on an Agilent Technologies SuperNova area‐detector diffractometer2 
using Cu K radiation ( = 1.54184 Å) from a micro‐focus X‐ray source and an Oxford 
Instruments Cryojet XL cooler.  The unit cell constants and an orientation matrix for data 
collection were obtained from a least‐squares refinement of the setting angles of 8821 
reflections in the range 4° < 2 < 153°.  A total of 1878 frames were collected using  scans with 
 offsets, 2.3‐9.2 seconds exposure time and a rotation angle of 1.0° per frame, and a crystal‐
detector distance of 55.0 mm. 
  Data reduction was performed with CrysAlisPro2.  The intensities were corrected for 
Lorentz and polarization effects, and an empirical absorption correction using spherical 
harmonics2 was applied.  The space group was uniquely determined by the systematic absences.  
Equivalent reflections were merged.  The data collection and refinement parameters are given in 
Table 1.  A view of the molecule is shown in the Figure. 
  The structure was solved by direct methods using SHELXS97 3, which revealed the 
positions of all non‐hydrogen atoms.  The non‐hydrogen atoms were refined anisotropically.  All 
of the H‐atoms were placed in geometrically calculated positions and refined by using a riding 
model where each H‐atom was assigned a fixed isotropic displacement parameter with a value 
equal to 1.2Ueq of its parent atom (1.5Ueq for the methyl groups).  The refinement of the 
structure was carried out on F2 by using full‐matrix least‐squares procedures, which minimised 
the function w(Fo2 – Fc2)2.  The weighting scheme was based on counting statistics and 
included a factor to downweight the intense reflections.  Plots of w(Fo2 – Fc2)2 versus 
Fc/Fc(max) and resolution showed no unusual trends.  A correction for secondary extinction was 
not applied. 
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  Neutral atom scattering factors for non‐hydrogen atoms were taken from Maslen, Fox 
and O'Keefe4a, and the scattering factors for H‐atoms were taken from Stewart, Davidson and 
Simpson5.  Anomalous dispersion effects were included in Fc6; the values for f' and f" were those 
of Creagh and McAuley4b.  The values of the mass attenuation coefficients are those of Creagh 
and Hubbel4c.  The SHELXL97 program7 was used for all calculations. 
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Table 1.  Crystallographic Data 
 
Crystallised from  CH2Cl2   
Empirical formula  C28H26N2O   
Formula weight [g mol‐1]  406.53   
Crystal colour, habit  colourless, plate   
Crystal dimensions [mm]  0.04  0.05  0.30   
Temperature [K]  160(1)   
Crystal system  monoclinic   
Space group  P21/n  (#14)   
Z  4   
Reflections for cell determination  8821   
2 range for cell determination [°]  4 – 153   
Unit cell parameters  a [Å]  10.87950(13)   
  b [Å]  10.63345(11)   
  c [Å]  19.0796(3)   
   [°]  90   
   [°]  95.3655(13)   
    [°]  90   
  V [Å3]  2197.58(5)   
F(000)  864   
Dx [g cm‐3]  1.229   
(Cu K) [mm‐1]  0.580   
Scan type     
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2(max) [°]  153.2   
Transmission factors (min; max)  0.096; 1.000   
Total reflections measured  22996   
Symmetry independent reflections  4582   
Rint  0.060   
Reflections with I > 2(I)  3750   
Reflections used in refinement  4582   
Parameters refined  282   
Final  R(F) [I > 2(I) reflections]  0.0608   
  wR(F2) (all data)  0.1717   
Weights:  w = [2(Fo2) + (0.0900P)2 + 0.9378P]‐1 where P = (Fo2 + 2Fc2)/3   
Goodness of fit  1.056   
Final max/  0.001   
 (max; min) [e Å‐3]  0.62; ‐0.34   
(d(C – C)) [Å]  0.002 – 0.004   
Chapter 5 
 
 
 
295 
 
TABLE 2.  Bond lengths (Å) with standard uncertainties in parentheses. 
 
O(1)  -C(25)    1.371(2)                    C(8)  -C(9)     1.381(3) 
O(1)  -C(28)    1.426(2)                    C(9)  -C(10)    1.402(3) 
N(1)  -C(12)    1.372(2)                    C(10) -C(11)    1.378(3) 
N(1)  -C(2)     1.375(2)                    C(11) -C(12)    1.396(2) 
N(2)  -C(21)    1.365(3)                    C(14) -C(15)    1.357(3) 
N(2)  -C(14)    1.370(3)                    C(15) -C(16)    1.446(3) 
C(1)  -C(2)     1.369(2)                    C(16) -C(17)    1.400(3) 
C(1)  -C(7)     1.436(2)                    C(16) -C(21)    1.406(3) 
C(1)  -C(6)     1.502(2)                    C(17) -C(18)    1.388(3) 
C(2)  -C(3)     1.499(2)                    C(18) -C(19)    1.410(3) 
C(3)  -C(15)    1.520(3)                    C(19) -C(20)    1.356(4) 
C(3)  -C(13)    1.547(3)                    C(20) -C(21)    1.393(3) 
C(3)  -C(4)     1.554(3)                    C(22) -C(27)    1.386(2) 
C(4)  -C(5)     1.525(3)                    C(22) -C(23)    1.393(2) 
C(5)  -C(6)     1.544(3)                    C(23) -C(24)    1.378(3) 
C(6)  -C(22)    1.518(2)                    C(24) -C(25)    1.390(2) 
C(7)  -C(8)     1.409(3)                    C(25) -C(26)    1.385(2) 
C(7)  -C(12)    1.415(2)                    C(26) -C(27)    1.392(2) 
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TABLE 3.  Bond angles (°) with standard uncertainties in parentheses. 
 
C(25) -O(1)  -C(28)    117.82(14)           N(1)  -C(12) -C(11)    
129.27(16) 
C(12) -N(1)  -C(2)     108.78(14)           N(1)  -C(12) -C(7)     
107.99(14) 
C(21) -N(2)  -C(14)    109.2(2)             C(11) -C(12) -C(7)     
122.73(16) 
C(2)  -C(1)  -C(7)     106.86(15)           C(15) -C(14) -N(2)     
110.9(2) 
C(2)  -C(1)  -C(6)     123.78(17)           C(14) -C(15) -C(16)    
105.16(19) 
C(7)  -C(1)  -C(6)     129.16(16)           C(14) -C(15) -C(3)     
125.7(2) 
C(1)  -C(2)  -N(1)     109.92(15)           C(16) -C(15) -C(3)     
128.96(18) 
C(1)  -C(2)  -C(3)     127.41(16)           C(17) -C(16) -C(21)    
117.45(19) 
N(1)  -C(2)  -C(3)     122.55(15)           C(17) -C(16) -C(15)    
134.80(18) 
C(2)  -C(3)  -C(15)    111.30(14)           C(21) -C(16) -C(15)    
107.73(19) 
C(2)  -C(3)  -C(13)    107.98(15)           C(18) -C(17) -C(16)    
119.8(2) 
C(15) -C(3)  -C(13)    110.09(17)           C(17) -C(18) -C(19)    
120.3(2) 
C(2)  -C(3)  -C(4)     106.36(15)           C(20) -C(19) -C(18)    
121.3(2) 
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C(15) -C(3)  -C(4)     110.44(16)           C(19) -C(20) -C(21)    
117.8(2) 
C(13) -C(3)  -C(4)     110.58(15)           N(2)  -C(21) -C(20)    
129.8(2) 
C(5)  -C(4)  -C(3)     112.75(16)           N(2)  -C(21) -C(16)    
107.0(2) 
C(4)  -C(5)  -C(6)     112.36(15)           C(20) -C(21) -C(16)    
123.3(2) 
C(1)  -C(6)  -C(22)    115.01(14)           C(27) -C(22) -C(23)    
117.14(16) 
C(1)  -C(6)  -C(5)     108.57(15)           C(27) -C(22) -C(6)     
124.21(15) 
C(22) -C(6)  -C(5)     111.14(15)           C(23) -C(22) -C(6)     
118.61(15) 
C(8)  -C(7)  -C(12)    118.18(17)           C(24) -C(23) -C(22)    
121.73(15) 
C(8)  -C(7)  -C(1)     135.39(17)           C(23) -C(24) -C(25)    
120.08(15) 
C(12) -C(7)  -C(1)     106.43(15)           O(1)  -C(25) -C(26)    
124.54(15) 
C(9)  -C(8)  -C(7)     118.88(18)           O(1)  -C(25) -C(24)    
115.86(15) 
C(8)  -C(9)  -C(10)    121.76(18)           C(26) -C(25) -C(24)    
119.60(16) 
C(11) -C(10) -C(9)     120.87(19)           C(25) -C(26) -C(27)    
119.22(15) 
C(10) -C(11) -C(12)    117.58(18)           C(22) -C(27) -C(26)    
122.23(15) 
Chapter 5 
 
 
 
298 
 
TABLE 4.  Torsion angles (°) with standard uncertainties in parentheses. 
 
C(7)  -C(1)  -C(2)  -N(1)      1.3(2)      N(2)  -C(14) -C(15) -C(3)    
177.5(2) 
C(6)  -C(1)  -C(2)  -N(1)   -174.0(1)      C(2)  -C(3)  -C(15) -C(14)   
152.0(2) 
C(7)  -C(1)  -C(2)  -C(3)    177.2(2)      C(13) -C(3)  -C(15) -C(14)    
32.3(3) 
C(6)  -C(1)  -C(2)  -C(3)      1.9(3)      C(4)  -C(3)  -C(15) -C(14)   
-90.1(3) 
C(12) -N(1)  -C(2)  -C(1)     -1.6(2)      C(2)  -C(3)  -C(15) -C(16)   
-33.4(3) 
C(12) -N(1)  -C(2)  -C(3)   -177.8(1)      C(13) -C(3)  -C(15) -C(16)  -
153.1(2) 
C(1)  -C(2)  -C(3)  -C(15)   134.2(2)      C(4)  -C(3)  -C(15) -C(16)    
84.5(2) 
N(1)  -C(2)  -C(3)  -C(15)   -50.4(2)      C(14) -C(15) -C(16) -C(17)   
179.8(2) 
C(1)  -C(2)  -C(3)  -C(13)  -104.9(2)      C(3)  -C(15) -C(16) -C(17)     
4.3(4) 
N(1)  -C(2)  -C(3)  -C(13)    70.6(2)      C(14) -C(15) -C(16) -C(21)    
-1.5(3) 
C(1)  -C(2)  -C(3)  -C(4)     13.8(2)      C(3)  -C(15) -C(16) -C(21)  -
177.0(2) 
N(1)  -C(2)  -C(3)  -C(4)   -170.7(2)      C(21) -C(16) -C(17) -C(18)     
0.1(3) 
C(2)  -C(3)  -C(4)  -C(5)    -45.2(2)      C(15) -C(16) -C(17) -C(18)   
178.7(2) 
C(15) -C(3)  -C(4)  -C(5)   -166.1(2)      C(16) -C(17) -C(18) -C(19)    
-0.3(3) 
C(13) -C(3)  -C(4)  -C(5)     71.8(2)      C(17) -C(18) -C(19) -C(20)     
0.2(4) 
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C(3)  -C(4)  -C(5)  -C(6)     64.7(2)      C(18) -C(19) -C(20) -C(21)     
0.1(4) 
C(2)  -C(1)  -C(6)  -C(22)  -112.2(2)      C(14) -N(2)  -C(21) -C(20)   
179.8(3) 
C(7)  -C(1)  -C(6)  -C(22)    73.6(2)      C(14) -N(2)  -C(21) -C(16)     
0.5(3) 
C(2)  -C(1)  -C(6)  -C(5)     13.0(2)      C(19) -C(20) -C(21) -N(2)   -
179.6(3) 
C(7)  -C(1)  -C(6)  -C(5)   -161.2(2)      C(19) -C(20) -C(21) -C(16)    
-0.3(4) 
C(4)  -C(5)  -C(6)  -C(1)    -44.4(2)      C(17) -C(16) -C(21) -N(2)    
179.6(2) 
C(4)  -C(5)  -C(6)  -C(22)    83.1(2)      C(15) -C(16) -C(21) -N(2)      
0.7(3) 
C(2)  -C(1)  -C(7)  -C(8)    179.9(2)      C(17) -C(16) -C(21) -C(20)     
0.2(3) 
C(6)  -C(1)  -C(7)  -C(8)     -5.1(3)      C(15) -C(16) -C(21) -C(20)  -
178.7(2) 
C(2)  -C(1)  -C(7)  -C(12)    -0.5(2)      C(1)  -C(6)  -C(22) -C(27)    
24.9(3) 
C(6)  -C(1)  -C(7)  -C(12)   174.5(2)      C(5)  -C(6)  -C(22) -C(27)   
-99.0(2) 
C(12) -C(7)  -C(8)  -C(9)     -0.1(2)      C(1)  -C(6)  -C(22) -C(23)  -
157.3(2) 
C(1)  -C(7)  -C(8)  -C(9)    179.5(2)      C(5)  -C(6)  -C(22) -C(23)    
78.8(2) 
C(7)  -C(8)  -C(9)  -C(10)    -0.3(3)      C(27) -C(22) -C(23) -C(24)     
0.5(3) 
C(8)  -C(9)  -C(10) -C(11)     0.4(3)      C(6)  -C(22) -C(23) -C(24)  -
177.4(2) 
C(9)  -C(10) -C(11) -C(12)    -0.0(3)      C(22) -C(23) -C(24) -C(25)    
-0.2(3) 
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C(2)  -N(1)  -C(12) -C(11)   179.9(2)      C(28) -O(1)  -C(25) -C(26)     
8.8(3) 
C(2)  -N(1)  -C(12) -C(7)      1.2(2)      C(28) -O(1)  -C(25) -C(24)  -
171.8(2) 
C(10) -C(11) -C(12) -N(1)   -178.9(2)      C(23) -C(24) -C(25) -O(1)   -
179.6(2) 
C(10) -C(11) -C(12) -C(7)     -0.4(3)      C(23) -C(24) -C(25) -C(26)    
-0.1(3) 
C(8)  -C(7)  -C(12) -N(1)    179.2(1)      O(1)  -C(25) -C(26) -C(27)   
179.4(2) 
C(1)  -C(7)  -C(12) -N(1)     -0.5(2)      C(24) -C(25) -C(26) -C(27)     
0.0(3) 
C(8)  -C(7)  -C(12) -C(11)     0.5(2)      C(23) -C(22) -C(27) -C(26)    
-0.7(3) 
C(1)  -C(7)  -C(12) -C(11)  -179.2(2)      C(6)  -C(22) -C(27) -C(26)   
177.1(2) 
C(21) -N(2)  -C(14) -C(15)    -1.5(4)      C(25) -C(26) -C(27) -C(22)     
0.4(3) 
N(2)  -C(14) -C(15) -C(16)     1.9(3) 
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TABLE 5.  Selected bond lengths (Å) and angles (°) involving H-atoms. 
 
N(1)  -H(1)     0.880                       N(2)  -H(2)     0.880 
 
C(12) -N(1)  -H(1)     125.6                C(21) -N(2)  -H(2)     125.4 
C(2)  -N(1)  -H(1)     125.6                C(14) -N(2)  -H(2)     125.4 
 
TABLE 6.  Hydrogen bonding geometry (Å, °). 
 
 D    H      A            D-H         H···A       D···A       D-H···A 
 
N(1)-H(1)···O(1')         0.88        2.07        2.8810(19)  153.0 
 
Primed atoms refer to the molecule in the following symmetry related 
positions: 
'  x, -1+y, z  
 
Only one of the two N-H groups in the molecule acts as a donor for 
hydrogen bonds. This intermolecular interaction with the methoxy O-atom 
of a neighbouring molecule links the molecules into extended chains 
which run parallel to the [010] direction and can be described by a 
graph set motif8 of C(10). 
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CHAPTER 6 
Conclusions and Outlook 
 The role of gold as an important tool in all fields of synthetic organic chemistry is one of 
the fast growing sectors of modern organic chemistry. In the last twenty years, gold has been 
recognized as a powerful carbophilic Lewis acid able to activate unsaturated moieties triggering 
the discovery of new and original methods to form new C-C bonds. In this context, a rapidly 
developing area involves the rearangement of propargyl esters towards 1,2-acyloxy migration 
and/or [3,3]-sigmatropic rearrangement to construct molecular complexity. However, beyond the 
ability of gold to coordinate alkynes, allenes or alkenes, gold has also proved to be extremely 
powerful Lewis acid triggering ring-expansion processes. This PhD work was initially aimed at 
the discovery of new synthetic stratergies based on the reactivity of gold with propargyl esters and 
strained rings.  
 In this thesis, we have discovered a gold-catalyzed cycloisomerization of 1- and 3-
substituted cyclopropyl propargyl esters in a versatile route for the construction of 5- and 6-
membered rings. In the case of 1-substituted cyclopropyl propargyl esters, a novel Au-catalyzed 
homo-Rautenstrauch rearrangement was achieved providing access to cyclohexenones and 
cyclopentenyl ketones under mild conditions. Enantiomerically enriched products were also 
prepared using chiral starting materials. The high degree of stereochemical configuration transfer 
showed in these transformations suggests that gold-stabilized nonclassical carbocations are 
involved as key intermediates. The interesting issue of a possible stereochemical configuration 
transfer in these systems was addressed both experimentally and computationally. The reaction 
seems to be stereospecific in the cyclization step but evidences of a process where gold-promoted 
cyclopropyl ring opening/epimerization/ring closure competes with the cyclization event, thus 
eroding the stereochemical information transfer of the process, were also obtained. 
 After these results, the next question was how to capitalize on the non-classical gold-
stabilized carbocations for the stereocontrolled synthesis of 5- and 7-membered rings. We 
envisioned that a reaction sequence involving propargyl esters  and dienes  could be orchestrated 
such that gold not only catalyzed the 1,2-acetoxy migration and subsequent cyclopropanation, but 
could also reactivate the in situ generated vinyl acetate, thereby triggering a formal homo-Cope 
rearrangement to give seven-membered rings in a straightforward manner. Furthermore, if alkenes 
are used instead of dienes, highly substituted cyclopentenyl acetates could be obtained upon 
cyclopropyl ring opening. The reaction favors trans-2,3-disubstituted cyclopentenyl acetates 
through a tightly bound carbocationic transition state. The formal [4+3] cycloaddition catalyzed 
by gold represents an attractive alternative to previously reported rhodium-catalyzed reaction both 
in terms of atom economy and functional group tolerance. In addition, this methodology has 
allowed a formal enantioselective synthesis of the marine sesquiterpenoids frondosins A and B. 
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 To finish, we conducted an investigation on the role of gold as a Lewis acid for the 
activation of cyclopropyl conjugated alkynes toward nucleophilic additions. Trans-alkenyl gold 
complexes have been proposed as intermediates in the nucleophilic attack of the gold-activated π-
alkyne complexes. We decided to investigate this concept more in depth using indole derivatives 
in the presence of stabilized alkynyl cyclopropyl rings for the synthesis of highly substituted 
tetrahydrocarbazoles. The regioselectivity of the process is remarkable for N-protected indoles. 
However, the process seems to be no regioselective for non-protected ones. Remarkably, the 
reaction in presence of stoichiometric amounts of base improves considerable the regioselectivity 
of this transformation. A detailed mechanistic study focused on elucidating each individual step 
along the process was carried out. The formation of tetrahydrocarbazoles can be explained via 
gold-catalysis or via combination of both gold and acid catalysis. A desirable extension of this 
chemistry involves the development of asymmetric catalysis by using chiral ligands on gold or by 
introducing chirality in the starting materials. 
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